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10 I Chapter 1
M edicine is no t only a science; it is also an art. I t  does no t consist o f compounding pills and plasters; it 
deals w ith  the very processes o f life, which m u st be understood before they m ay be guided. (Paracelsus (c. 
1493-1541))
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Background
Physical sym ptom s such as headache, back pain, dizziness an d  fatigue are com m on in the 
general population . Two th irds of m en an d  four fifth  of w om en repo rt a t least one physical 
sym ptom  in the last tw o w eeks.1;2 H ow ever m ost people do no t contact professional m edical care 
for these sym ptom s.3;4 W hen people contact their G eneral P ractitioner (GP) for these sym ptom s 
80% rem ain  restricted  to one doctor-patien t contact,5 suggesting  tha t m ost of these sym ptom s 
are transient.
1
In about 25-50% of all sym ptom s p resen ted  in  prim ary  health  care, no evidence can be found  for 
an  underly ing  physical disease, and  shou ld  be considered as m edically unexplained  sym ptom s 
(MUS).6;7 In specialist care these percentages are even higher, ranging  from  30-70%.8;9 MUS 
usually  d isappear spontaneously  in  the course of tim e or as a consequence of the physician 's 
m anagem ent. A recent D utch s tudy  found  tha t only 2.5% of the patien ts in  general practice 
presen ting  w ith  m edically unexplained  sym ptom s m eet criteria for chronicity.“  H ow ever, this 
m inority  represen t a maj or p roblem  in health  care for the follow ing reasons:
a. patien ts w ith  persistent MUS suffer from  their sym ptom s, are functionally  im paired , and  
are at risk for potentially  harm ful additional testing  and  treatm ent;
b. these patien ts are a b u rd en  for the health  care system  as they are responsible for high, 
often unnecessary, health  care costs;
c. patien ts w ith  persistent MUS are often d issatisfied w ith  the m edical care they receive 
du ring  their illness;
d. these patients often cause feelings of frustra tion  and  irrita tion  in  their physicians; and
e. the suitability , applicability  an d  effectiveness of specific in terventions tow ards patients 
w ith  persistent MUS in  prim ary  care are lim ited.
The problem s described above are at the basis of the stud ies reported  in  this thesis, w hich 
together aim ed at gaining m ore insight into the care patien ts w ith  persis ten t MUS expect 
(the patient), the w ay  GPs experience the care they deliver for these patients (the doctor) an d  the 
care GPs deliver du rin g  encounters w ith  these patients (the consultation) in  o rder to guide new  
in tervention  strategies for these patients.
Confusing terms 
Definitions in literature
In the scientific literature there is d iscussion an d  debate for the best te rm  to describe physical 
com plaints of patien ts w hen  the aetiology is unclear. L ipow ski defined somatisation as the 
tendency to experience an d  com m unicate psychological distress in  the form  of som atic
sym ptom s tha t the patien t m isin terprets as signifying serious physical illness.11 In DSM-IV 
somatisation disorder is defined as a history  of m any physical com plaints (four pain  sym ptom s, 
tw o gastro in testinal sym ptom s, one sexual sym ptom  an d  one pseudoneuro-logical sym ptom ) 
beginning before the age of 30 tha t occur over a period  of several years. Escobar in troduced  the 
concept of abridged somatisation, a construct for less severe form s of som atisation  characterized 
by four or m ore unexplained  physical sym ptom s in  m en and  six or m ore unexplained  physical 
sym ptom s in  w om en.12 In functional somatic syndromes a set of unexplained  sym ptom s is 
clustered into a syndrom e. In th is w ay  each m edical specialty has his ow n functional som atic 
syndrom e. For exam ple Chronic Fatigue Syndrom e (CFS) in  in ternal m edicine, Irritable Bowel 
Syndrom e (IBS) in  gastroenterology and  Fibrom yalgia (FM) in  rheum atology. In N ijm egen the 
te rm  chronic nervous functional somatic sym ptom s has been developed.13 Patients m eet this 
diagnostic category w hen  they repeated ly  p resen t physical sym ptom s tha t rem ain  m edically 
unexplained  after adequate exam ination, in  com bination w ith  the (presum ed) presence of 
psychosocial problem s or psychological distress. This d iagnostic category has been  included  in 
the C ontinuous M orbidity  Registry (CMR) system  w hich w as in troduced  by the N ijm egen 
D epartm ent of Family M edicine in  1971.13-16 T o our know ledge, the CMR is the only classification 
system  w ith  a separate  category for patients w ith  persis ten t MUS. In a fu rthe r elaboration  of 
chronic nervous-functional sym ptom s, the theory  of 'somatic fixation' w as developed. Somatic 
fixa tion  is the consequence of continuous one-sided em phasis on the som atic aspects of 
sym ptom s and  health  problem s resu lting  in  people becom ing m ore and m ore entangled  in  and 
dependen t of health  care.17;18 This theory  explicitly acknow ledges the role of the physician  in  the 
developm ent of persisten t MUS.
Which term w ill we use in this thesis?
A num ber of term s an d  definitions are used  for persisten t sym ptom s w ithou t obvious 
pathology. Somatisation has been criticized, as it suggests tha t physical sym ptom s originate from  
psychosocial distress. F urtherm ore th is te rm  assum es pathogenic processes and  tendencies, 
such as illness behaviour, on  the p a rt of the patient, w ith o u t considering at all the role of the 
physician.19 C oncerning functional somatic syndromes, researchers argue tha t the existing 
definitions of these ind iv idual syndrom es are of lim ited value because: (1) the substantial 
overlap betw een  the ind iv idual syndrom es and  (2) the sim ilarities betw een them  ou tw eigh  the 
differences.20 Furtherm ore, there is som e confusion regard ing  its core concept as it m ay refer to a 
functional disturbance of organs or the b ra in  system s or it m ay refer to the function  of sym ptom s 
w ith in  the fram ew ork  of secondary  gain.21 This also applies for the term  chronic nervous- 
functional somatic sym ptom s. It has been criticized for suggesting  (1) the translation  of m ental 
distress into physical sym ptom s, (2) the im plication th a t patien ts ho ld  on  to som atic a ttribu tion  
of sym ptom s, and  (3) a 'function' of the sym ptom s in  expressing psychological distress.22 
H ow ever, a lthough  doctors m ay th ink  the te rm  'functional' is pejorative, patients do not
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perceive it as such.23 The te rm  persistent medically unexplained sym ptom s has gained popularity  
du ring  recent years am ong general practitioners. A lthough  it defines patien t's  sym ptom s by 
w hat they are not, rather than  by w hat they are, and  a lthough it reflects dualistic thinking, this 
term  is purely  descriptive and  the m ost neu tra l as it does no t indicate an  underly ing  causal 
m echanism  or in terpretation .24 H ow ever, it has negative connotations for patients.23
These various term s an d  definitions reflect the difficulties in  the concept of unexplained  bodily 
com plaints w hich is no t unequivocally  defined.25 As a consequence of conceptual problem s 
doctor-patien t com m unication an d  sym ptom  explanation  du ring  consultation  is ham pered .23 
Furtherm ore, it com plicates research in  th is popu la tion  as a appropria te  selection of the study  
popula tion , a accurate definition of reference standards and  a useful definition of outcom e 
m easures are lacking.26
In the light of the foregoing, w e decided to use the term  persistent medically unexplained sym ptom s 
(persistent MUS) in  this thesis, because w e th ink  th is is the m ost neu tra l te rm  and  because this 
te rm  is w idely  accepted in  today 's scientific com m unity and  in  prim ary  care.
The patient, the doctor and the consultation
In 1979 researchers of the d epartm en t of Fam ily M edicine of the R adboud U niversity  N ijm egen 
M edical Centre in  the N etherlands s ta rted  a s tudy  of som atic fixation.17 This s tudy  cu lm inated  in  
the book ' To heal or to harm. The prevention o f somatic fixation  in general practice' by R ichard Grol et 
al.18 The concept of som atic fixation connected a theory  of health  an d  illness w ith  consultation 
skills. Somatic fixation assum es a tendency w ith in  patients to persistently  experience 
sym ptom s, frequently  as a consequence of psychological problem s. Patients w ho are inclined 
tow ards som atic fixation also tend  to inadequate help  seeking behav iour and  dependence on 
health  care professionals. The resu lt of these tendencies is tha t the patien t focuses on his or her 
body and  denies the relation  betw een  bodily  sym ptom s and  psychosocial problem s.
A ccording to tha t theory, the GP has pow erful tools to p reven t som atic fixation and  w ith  it 
persisten t MUS. These tools -  consultation  and  com m unication  skills -  com prise a goal-oriented 
and  system atic approach, effective m anagem ent of the doctor-patien t relationship  and  
adequate trea tm en t of bo th  som atic an d  psychosocial sym ptom s. H ow ever, desp ite the use of 
these tools, a sm all group of patients ends up  w ith  persisten t MUS. Research on  the m anagem ent 
by GPs of those functionally im paired  and  suffering patien ts and  regard ing  the care these 
patients expect is still lim ited .
Elaborating on the theory of som atic fixation and  the role of the patient, the doctor and  the 
consultation w e w ill (1) explore the know ledge regard ing  the problem s arising  w hen  GPs m eet 
patients w ho have developed persisten t MUS in  daily practice, and  (2) indicate know ledge gaps 
regard ing  the care GPs deliver an d  the care patients expect w hen  encountering  w ith  persistent 
MUS.
The patient
Patients w ith  persis ten t MUS often have the feeling tha t doctors do no t acknow ledge the 
legitim acy of their sym ptom s, an d  th a t they constantly  have to oppose their doctor's 
skepticism .27 M any patients feel tha t their doctors label them  as 'psychological cases'.28;29 
Furtherm ore, patien ts have the feeling tha t GPs don 't take them  seriously because GPs often tell 
them  'it is nothing ' or 'you do no t have a disease'.27;30'33
Patients w ith  distinct functional syndrom es are often dissatisfied w ith  the m edical care they 
receive du ring  their illness.28;34 They sense the need  to fight to gain recognition and  acceptance 
from  their GP. Often, these patien ts consider their doctor incom petent and  them selves as 
experts regard ing  their ow n sym ptom s.35 Patients w ith  persisten t MUS use strategies to keep up 
m edical atten tion  w hen  they m eet an  atm osphere of d istrust in  the consultation. These include 
som atizing (i.e. persisting  in  bodily  explanations), claim ing u n d er cover (i.e. referring  to other 
au thorities such as TV or a neighbour w ho is a doctor), and  p lead ing  (crying and  begging) to 
catch the doctor's interest.32;36
Which care do patients with persistent MUS expect?
The frequently  expressed dissatisfaction by patients w ith  the m edical care received during  
illness m ight orig inate from  the m ism atch betw een  w hat patien ts w an t an d  w h at they actually 
receive from  their GP. A nalysis of v ideo taped  consultations show ed this m ism atch clearly 
du ring  the initial p resen tation  of MUS in  prim ary  care. Salm on et al. show ed tha t patients w ith  
MUS w ish  to have a convincing, legitim ating an d  em pow ering explanation for their sym ptom s 
w hich, unfortunate ly , is no t given by their GP.37-40 F urtherm ore they indicated  tha t they w an t 
m ore em otional su p p o rt from  their GP.30 H ow ever, research tow ards preferences of patients 
w ith  persistent MUS regard ing  the care they expect an d  receive in  prim ary  care is still lacking.
The doctor
Research po in ted  ou t th a t doctors often experience patien ts w ith  persisten t MUS as difficult to 
m anage.27;41 Furtherm ore, they indicate tha t effective m anagem ent strategies are lacking.42 In 
fact, m any  GPs th in k  tha t persisten t MUS are associated w ith  personality  or psychiatric 
disorders.4443 Furtherm ore, m any doctors regard  persisten t MUS as an  expression of 
psychological distress w ith  patients failing to see the connection betw een  the physical
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sym ptom s and  the psychological distress.'41;44 A ccording to m any GPs, the physical sym ptom s 
are no t the real problem .44 In addition , m any doctors rem ain  skeptical about physical sym ptom s ^  
tha t cannot be explained by  a physical disease.45 C om pared w ith  patien ts w ith  'real' diseases, 
patients w ith  persisten t MUS do no t have m uch  prestige in  the m edical arena.46 In fact, research 
has show n tha t doctors' judgm ents regard ing  the intensity  of pain  felt by patients is associated 
w ith  the presence or absence of supporting  m edical evidence.47 W hen there is objective m edical 
evidence for the pain, doctors w ere m ore inclined to accept the patien t's  claim  regard ing  the pain  
intensity. Furtherm ore, doctors tend  to believe tha t there is incongruence betw een the 
p resen tation  of MUS and  the actual b u rd en  in  th is case.45
W hen facing patien ts w ith  persisten t MUS, m any GPs feel p ressu rized  to offer somatic 
interventions.44148 This feeling of being  pressu rized  has been w idely  a ttribu ted  to patients' belief 
th a t sym ptom s are caused by physical disease and  to their rejection of psychological help.42;49 
In conclusion, GPs' subjective feelings of being p ressurized  for som atic in terventions as w ell as 
GPs' skepticism  regard ing  persisten t MUS helps to explain their dissatisfaction w ith  
consultations w ith  patien ts w ith  persisten t MUS and  the w idespread  labelling of them  as 
'heartsink ' or 'difficult' patients.42;50-53 H ow ever, despite this frustra tion  an d  skepticism , m any 
GPs believe th a t patien ts w ith  persisten t MUS shou ld  be m anaged  in  prim ary  care as p rov id ing  
reassurance, counselling an d  acting as a 'gatekeeper' to preven t inappropria te  investigations are 
considered im portan t roles for GP m anagem ent.42
How do GPs experience the care they deliver fo r  these patients ?
As can be expected from  the aforem entioned difficulties w ith  patien ts w ith  persisten t MUS, GPs 
experience difficulties in  their m anagem ent of these patients. P revious stud ies revealed that 
these difficulties are m ainly associated w ith  the com m unication and  the doctor-patient 
relationship  w ith  these patients.27;45;54-59 H ow ever, m ost stud ies d id  no t focus specifically on  GPs' 
experiences of the care they deliver to patients w ith  persisten t MUS. As patien ts w ith  persistent 
MUS w ill keep attend ing  the consulting  hours of their GPs w ith  their sym ptom s, GPs have to 
find  strategies to specifically deal w ith  the com m unication and  the doctor-patien t relationship 
du ring  the encounters w ith  these chronic patients. U nfortunately , how ever, know ledge about 
these strategies and  GPs ' experiences, w hich are bu ilt over tim e du rin g  the continu ing  process of 
GPs' health  care delivery for these patients, is still lacking.
The consultation
A num ber of stud ies regard ing  the doctor-patien t com m unication du rin g  consultations w ith  
MUS patients have been published .38* 61 The results of these stud ies are im portan t because they 
dem onstrate tha t GPs com m unicate w ith  MUS patien ts m ore poorly than  prev iously  thought.
In contrast to consultations w ith  patien ts w ith  explained sym ptom s, GPs d id  explore the 
sym ptom s, feelings, concerns, opinions and  expectations of the patien t less adequately  in 
consultations w ith  patients w ith  MUS. It seem s tha t the doctor-patient com m unication in 
patients w ith  MUS is less patien t-cen tred  com pared to patien ts w ith  explained sym ptom s. 
A lthough  patien t-cen tred  com m unication is of m ajor im portance, the results dem onstrated  that 
doctors com m unicated inadequately  in  precisely those consultations w here patient-centred  
com m unication is m ost desired  an d  advantageous.38
These stud ies also show ed tha t patien ts w ith  MUS d id  n o t request som atic in te rventions m ore 
frequently  than  patien ts w ith  m edically explained sym ptom s. A dditionally , patien ts w ith  MUS 
d id  n o t ask for an  explanation  or require reassurance m ore often than  patien ts w ith  m edically 
explained sym ptom s. These findings refute the GPs' subjective feeling of being pressurized. The 
only difference betw een  patients w ith  explained sym ptom s and  patients w ith  unexplained  
sym ptom s w as tha t patien ts w ith  MUS desired  m ore em otional support from  their GP.60 
H ow ever, GPs w ere less em pathic tow ard  these patients. Furtherm ore, in  consultations w ith  
patien ts w ith  MUS, GPs are m ore inclined to offer a p rescrip tion  than  th a t patien ts asked for a 
prescrip tion  them selves (70% versus 58%). Sim ilar results w ere found  w ith  respect to proposals 
for add itional tests (35% versus 13%) and  suggestions for referrals (20% versus 14%).
D uring  m ost consultations (m ore th an  95%) w ith  patien ts w ith  MUS, patients ind icated  one or 
m ore psychosocial problem s. Furtherm ore they suggested  tha t the problem (s) m ay cause or 
influence their sym ptom s. H ow ever, m ost GPs do n o t seem  to respond  to these cues.62;63
What care do GPs deliver during encounters with patients with persistent MUS ?
D octor-patient com m unication  in  patien ts w ith  MUS is a com plex phenom enon. M ost studies 
described above stud ied  the doctor-patien t in teraction  du ring  the initial p resen tation  of MUS 
and  d id  no t focus on patien ts w ith  persistent MUS.38;60-61 H ow ever, in  general m ost of the tim e 
MUS are transien t an d  im prove w ithou t fu rther in te rventions after one or tw o consultations. 
W hen sym ptom s evolve into a chronic an d  d isabling  condition  (i.e. persistent MUS), encounters 
as w ell as doctor-patient com m unication becom e m ore com plicated. H ow ever, know ledge of 
the doctor-patien t com m unication  in  patien ts w ith  persistent MUS is still lacking.
Rationale for this thesis
As described above, there is already substantial know ledge regard ing  the problem atic 
interaction  w hen  GPs m eet patients du rin g  the presen tation  of MUS. H ow ever m ost of this 
research d id  n o t focus specifically on patien t w ith  persistent MUS. The initial presen tation  of
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MUS does n o t rep resen t a large problem  for health  care, as m ost of these sym ptom s are transient 
and  have a good prognosis. The m ain  problem  w ith  MUS patien ts rises w hen  these sym ptom s 
develop tow ards a chronic condition  in  w hich patien ts persistently  p resen t MUS to their GP. 
From  this po in t on  the GP has to find  a w ay  to m anage these patien ts in  o rder to im prove 
patients' subjective w ell-being, sym ptom  reduction  and  quality  of life, to p reven t potential 
harm ful investigations an d  referrals, an d  to preven t GPs ow n dissatisfaction and  frustra tion
• l1 l1 L* L 7;38;64;65w ith  these patients.
To im prove the quality  of care for patien ts w ith  persistent MUS, w e need  insight into the care GPs 
deliver and  the care patien ts expect. This w ill lead to a better u n derstand ing  of strategies for the 
m anagem ent of patients w ith  persisten t MUS by GPs. Furtherm ore, given the lim ited 
suitability , applicability  an d  effectiveness of specific in te rventions in  p rim ary  care (such as an ti­
depressants, cognitive behavioural therapy  and  rea ttribu tion  therapy) for patien ts w ith  
persisten t MUS,66-70 know ledge of pa tien ts  op in ions, GPs' v iew s an d  docto r-pa tien t 
com m unication m ight guide new  in tervention  strategies for patien ts w ith  persistent MUS in 
p rim ary  care an d  enhance the satisfaction of GPs as w ell as patients w hile encountering  daily GP 
practice.
Objectives of this thesis
The aim  of th is thesis w as to ob ta in  m ore insight in  w h a t happens w h en  GPs encounter patients 
w ith  persistent MUS an d  w hich  problem s then  arise. Specifically w e w ere in terested  in  the care 
GPs deliver an d  the care patien ts expect w hen  v isiting  the GP w ith  persistent MUS. Therefore, we 
designed a s tudy  to evaluate the three essential parts  in  the care for these patients: the patient, 
the doctor an d  the consultation.
R egarding the patient w e aim ed to answ er the follow ing research questions:
1. W hat are the characteristics of patien ts w ho presen t persisten t MUS in  prim ary  care?
2. W hat is the course of MUS an d  w hich  factors influence its course?
3. W hat are patients' opinions about encounters in  w hich they presen t persisten t MUS?
R egarding the doctor w e aim ed to answ er the follow ing research questions:
1. W hat are GPs' perceptions abou t encounters w ith  patien ts w ith  persis ten t MUS?
R egarding their consultations w e aim ed to answ er the follow ing research questions:
1. H ow  do G Ps talk  to patients w ith  persisten t MUS d u ring  encounters in  w hich  patients 
p resen t persisten t MUS?
W e fu rtherm ore s tud ied  the literature aim ing to find  starting points fo r  im proving the management 
of patients w ith  persisten t MUS. We therefore aim ed to answ er the follow ing research 
questions:
1. W hat are, according to experts in  the field, im portan t an d  effective elem ents in  the 
treatm ent of MUS in prim ary  care?
2. W hich explanatory  m odels for MUS are described in  the literature?
Outline of this thesis 
The patient
In C hapter 2 w e p resen t data abou t com orbidity, referrals, diagnostic tests, and  hospital 
adm issions over a period  of 10 years p rior to the diagnosis chronic functional som atic sym ptom s 
in  four general practices participating  in  the C ontinuous M orbidity  Registry (CMR) of the 
un iversity  of Nijmegen.
C hapter 3 contains a system atic review  an d  best-evidence synthesis of the literature on the 
course of MUS, som atisation  disorder, hypochondriasis, an d  rela ted  prognostic factors.
C hapter 4 includes patients' opinions about encounters in  w hich  they p resen t persisten t MUS. 
As w e consider the doctor-patien t relationship  as a key factor in  the m anagem ent of patients 
w ith  persisten t MUS, w e specifically explored patients' opinions about the doctor-patient 
relationship.
The doctor
C hapter 5 describes GPs' perceptions abou t encounters w ith  patients w ith  persisten t MUS. We 
focused on perceptions abou t explaining MUS to patien ts an d  GPs' perceptions abou t how  
relationships w ith  these patien ts evolve over tim e in  daily practice.
The consultation
C hapter 6 describes a consultation  w ith  a patien t w ith  unexplained  palp ita tions du ring  
vacuum ing  w hich changed m y personal com m unication skills du ring  encounters w ith  patients 
w ith  persisten t MUS.
C hapter 7 prov ides insights in  how  GPs talk  to patien ts w ith  persisten t MUS du ring  their 
encounters. W e focused prim arily  on GPs' exploration  of patients' sym ptom s and  problem s and 
GPs distribu tion  of the available tim e on different stages in  the persisten t MUS consultations.
Starting points for improving the management
In C hapter 8 w e p resen t the results of a qualitative analysis of narrative review s and  scientific 
editorials to explore experts opinions regard ing  effective m anagem ent strategies for patients 
w ith  MUS.
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C hapter 9 prov ides an  overview  of explanatory  m odels (i.e. m odels of explaining the n a tu re  of 
the sym ptom s) of MUS described in  the scientific literature tha t m ay be of use in  daily general 
practice.
C hapter 10 contains the results of a sym posium  an d  w orkshop  on MUS in  prim ary  care held  a t 
the W onca W orld Conference 2007 in  Singapore. D uring  this m eeting  w e focused on  detecting 
know ledge gaps in  MUS and  establishing priorities in  MUS research.
In C hapter 11 the results of this thesis are critically review ed, and  recom m endations for clinical 
practice, m edical education  and  fu tu re  research are given.
1
Reference List
1 H outveen  JH. De dokter kan  n iets v inden. A m sterdam : Uitgeverij Bert Bakker; 2009.
2 Kroenke K, Spitzer RL. G ender differences in  the reporting  of physical and  som atoform  
sym ptom s. Psychosom  M ed 1998; 60(2):150-155.
3 G reen LA, Fryer GE, Jr., Y aw n BP, Lanier D, D ovey SM. The ecology of m edical care 
revisited. N  Engl J M ed 2001; 344(26):2021-2025.
4 van  de L isdonk EH. E rvaren en aangeboden  m orbid iteit in  de huisartspraktijk . Thesis. 
N ijmegen: K atholieke U niversiteit N ijm egen, 1985.
5 van  der L inden M, W estert G, de Bakker D, Schellevis F. Tw eede N ationale S tudie naar 
ziekten en  verrich tingen  in  de huisartspraktijk: k lachten en aandoeningen  in  de bevolking 
en in  de huisartsprak tijk  (Second N ational Survey of m orbidity  and  in terventions in  general 
practice: sym ptom s an d  diseases in  the popu la tion ). 2004.
Ref Type: Report
6 Peveler R, K ilkenny L, K inm onth AL. M edically unexplained  physical sym ptom s in  
prim ary  care: a com parison of self-report screening questionnaires and  clinical opinion. J 
Psychosom  Res 1997; 42(3):245-252.
7 Barsky AJ, Borus JF. Som atization and  m edicalization in  the era of m anaged  care. JAMA 
1995; 274(24):1931-1934.
8 N im nuan  C, H otopf M, W essely S. M edically unexplained  sym ptom s: an  epidem iological 
s tudy  in  seven specialities. J Psychosom  Res 2001; 51 (1):361-367.
9 Reid S, W essely S, C rayford T, H otopf M. M edically unexplained  sym ptom s in  frequent 
a ttenders of secondary health  care: retrospective cohort study. BMJ 2001; 322(7289):767.
10 V erhaak PF, Meijer SA, V isser AP, W olters G. P ersistent p resen tation  of m edically 
unexplained  sym ptom s in  general practice. Fam Pract 2006; 23(4):414-420.
11 L ipow ski ZJ. Som atization: the concept and  its clinical application. A m  J Psychiatry 1988; 
145(11):1358-1368.
12 Escobar JI, G olding JM, H ough  RL, Karno M, B urnam  MA, W ells KB. Som atization in  the 
com m unity: relationship  to disability and  use of services. A m  J Public H ealth  1987; 
77(7):837-840.
13 van  W eel-B aum garten EM. D epression: the long-term  perspective. A follow -up s tudy  in 
general practice. Thesis. N ijmegen: R adboud U niversity  N ijm egen M edical Centre, 2000.
14 van  Weel C. V alidating  long term  m orbidity  recording. J Epidem iol C om m unity H ealth  
1995; 49 Suppl 1:29-32.
15 van  W eel C, de G rauw  WJ. Fam ily practices reg istra tion  netw orks contribu ted  to prim ary  
care research. J Clin Epidem iol 2006; 59(8):779-783.
16 van  W eel C. The C ontinuous M orbidity  Registration Nijmegen: background  an d  history  of a 
D utch general practice database. Eur J G en Pract 2008; 14 Suppl 1:5-12.:5-12.
20 I Chapter 1
General introduction | 21
17 van  Eijk JT, G rol R, H uygen  FJ, M esker P, M esker-N iesten J, van  M ierlo G et al. The fam ily 
doctor an d  the p revention  of som atic fixation. Fam ily System s M edicine 1983;
1:5-15.
18 G rol R. To heal or to harm . The p revention  of som atic fixation in  G eneral Practice. London: 
Royal College of G eneral Practitioners; 1981.
19 K irm ayer LJ, Robbins JM. Three form s of som atization  in  prim ary  care: prevalence, co­
occurrence, an d  sociodem ographic characteristics. J N erv M ent Dis 1991;
179(11):647-655.
20 W essely S, N im nuan  C, Sharpe M. Functional som atic syndrom es: one or m any? Lancet 
1999; 354(9182) :936-939.
21 Creed F, G uthrie E, Fink P, H enningsen  P, Rief W, Sharpe M et al. Is there a better term  than  
"medically unexplained  sym ptom s"? J Psychosom  Res 2010; 68(1):5-8.
22 de W aal MW, A rnold IA. Som atoform  d isorders in  general practice. Epidem iology, 
trea tm en t and  com orbidity  w ith  depression an d  anxiety. Thesis. Leiden: U niversiteit 
Leiden, 2006.
23 Stone J, W ojcik W, D urrance D, Carson A, Lewis S, M acKenzie L et al. W hat should  w e say to 
patien ts w ith  sym ptom s unexplained  by disease? The "num ber needed  to offend". BMJ 
2002; 325 (7378):1449-1450.
24 de W aal MW, A rnold  IA, Eekhof JA, van  H em ert AM. Som atoform  d isorders in  general 
practice: prevalence, functional im pairm ent and  com orbidity  w ith  anxiety an d  depressive 
disorders. Br J Psychiatry 2004; 184:470-6.:470-476.
25 van  Bokhoven MA. Blood test o rdering  for unexplained  com plaints in  general practice. The 
feasibility of a w atchful w aiting  approach. Thesis. M aastricht: M aastricht U niversity, 2008.
26 van  Bokhoven MA, Koch H, van  der WT, D inant GJ. Special m ethodological challenges 
w hen  s tudy ing  the diagnosis of unexplained  com plaints in  p rim ary  care. J Clin Epidem iol 
2008; 61(4):318-322.
27 M alterud K. Sym ptom s as a source of m edical know ledge: u n derstand ing  m edically 
unexplained  d isorders in  w om en. Fam  M ed 2000; 32(9):603-611.
28 Page LA, W essely S. M edically unexplained  sym ptom s: exacerbating factors in  the doctor- 
patien t encounter. J R Soc M ed 2003; 96(5):223-227.
29 K ouyanou K, P ither CE, Rabe-H esketh S, W essely S. A com parative s tudy  of iatrogenesis, 
m edication  abuse, and  psychiatric m orbidity  in  chronic pain  patien ts w ith  and  w ithou t 
m edically explained sym ptom s. Pain 1998; 76(3):417-426.
30 Peters S, Stanley I, Rose M, Salm on P. Patients w ith  m edically unexplained  sym ptom s: 
sources of patients' au thority  an d  im plications for dem ands on m edical care. Soc Sci Med 
1998; 46(4-5):559-565.
31 Salm on P, Peters S, S tanley I. Patients' perceptions of m edical explanations for som atisation  
disorders: qualitative analysis. BMJ 1999; 318(7180):372-376.
32 Johansson EE, H am berg K, L indgren G, W estm an G. "I've been crying m y w ay"--qualitative 
analysis of a group of fem ale patients' consultation  experiences. Fam Pract 1996; 13(6):498- 
503.
33 N ettleton  S, W att I, O 'M alley L, D uffey P. U nderstand ing  the narratives of people w ho live 
w ith  m edically unexplained  illness. Patient Educ Couns 2005; 56(2):205-210.
34 D eale A, W essely S. Patients' perceptions of m edical care in  chronic fatigue syndrom e. Soc 
Sci M ed 2001; 52(12) :1859-1864.
35 Salm on P. Patients w ho p resen t physical sym ptom s in  the absence of physical pathology: a 
challenge to existing m odels of doctor-patient interaction. Patient Educ Couns 2000; 
39(1):105-113.
36 W erner A, M alterud  K. It is hard  w ork  behaving  as a credible patient: encounters betw een 
w om en  w ith  chronic pain  an d  their doctors. Soc Sci M ed 2003; 57(8):1409-1419.
37 Ring A, D ow rick C, H um phris G, Salm on P. Do patien ts w ith  unexplained  physical 
sym ptom s pressurise general p ractitioners for som atic treatm ent? A qualitative study. BMJ 
2004; 328(7447):1057.
38 Epstein RM, Shields CG, M eldrum  SC, Fiscella K, Carroll J, Carney PA et al. Physicians' 
responses to patients' m edically unexplained  sym ptom s. Psychosom  M ed 2006; 68(2):269- 
276.
39 D ow rick CF, Ring A, H um phris  GM, Salm on P. N orm alisation of unexplained  sym ptom s 
by general practitioners: a functional typology. Br J G en Pract 2004; 54(500):165-170.
40 Coia P, M orley S. M edical reassurance and  patients' responses. J Psychosom  Res 1998; 
45(5):377-386.
41 W oivalin T, K rantz G, M antyran ta T, R ingsberg KC. M edically unexplained  sym ptom s: 
perceptions of physicians in  p rim ary  health  care. Fam  Pract 2004; 21 (2) :199-203.
42 Reid S, W hooley D, C rayford T, H otopf M. M edically unexplained  sym ptom s--G Ps' 
a ttitudes tow ards their cause an d  m anagem ent. Fam  Pract 2001; 18(5):519-523.
43 Sharpe M, M ayou R, W alker J. Bodily sym ptom s: new  approaches to classification. J 
Psychosom  Res 2006; 60(4) :353-356.
44 W ilem an L, M ay C, C hew -G raham  CA. M edically unexplained  sym ptom s an d  the problem  
of pow er in  the prim ary  care consultation: a qualitative study. Fam  Pract 2002; 19(2):178- 
182.
45 A sbring P, N arvanen  AL. Ideal versus reality: physicians perspectives on  patien ts w ith  
chronic fatigue syndrom e (CFS) and  fibrom yalgia. Soc Sci M ed 2003; 57(4):711-720.
46 A lbum  D, W estin  S. Do diseases have a p restige hierarchy? A survey  am ong physicians and  
m edical students. Soc Sci M ed 2008; 66(1):182-188.
47 Tait RC, Chibnall JT. Physician judgm ents of chronic pain  patients. Soc Sci M ed 1997; 
45(8):1199-1205.
22 I Chapter 1
General introduction | 23
48 A rm strong D, Fry J, A rm strong  P. Doctors' perceptions of p ressu re from  patien ts for 
referral. BMJ 1991; 302(6786):1186-1188.
49 G oldberg  DP, Bridges K. Somatic p resen tations of psychiatric illness in  prim ary  care 
setting. J Psychosom  Res 1988; 32(2):137-144.
50 G arcia-C am payo J, Sanz-Carrillo C, Yoldi-Elcid A, Lopez-A ylon R, M onton C. M anagem ent 
of som atisers in  p rim ary  care: are fam ily doctors m otivated? A ust N  Z J Psychiatry 1998; 
32(4):528-533.
51 H artz  AJ, N oyes R, Bentler SE, D am iano PC, W illard JC, M om any ET. U nexplained 
sym ptom s in  prim ary  care: perspectives of doctors and  patients. G en H osp Psychiatry 2000; 
22(3):144-152.
52 Steinm etz D, Tabenkin H. The 'difficult patient' as perceived by fam ily physicians. Fam 
Pract 2001; 18(5):495-500.
53 M athers N, Jones N, H annay  D. H eartsink  patients: a s tudy  of their general practitioners. Br 
J G en Pract 1995; 45(395):293-296.
54 W alker EA, U nutzer J, K aton WJ. U nderstand ing  an d  caring for the d istressed  p atien t w ith  
m ultip le  m edically unexplained  sym ptom s. J A m  Board Fam Pract 1998;
11(5):347-356.
55 Lin EH, K aton W, V on Korff M, Bush T, Lipscom b P, Russo J et al. F rustra ting  patients: 
physician  and  patien t perspectives am ong distressed h igh  users of m edical services. J Gen 
In tern  M ed 1991; 6(3):241-246.
56 W alker EA, K aton WJ, Keegan D, G ardner G, Sullivan M. P redictors of physician  frustra tion  
in  the care of patients w ith  rheum atological com plaints. G en H osp Psychiatry 1997; 
19(5):315-323.
57 L undh  C, Segesten K, B jorkelund C. To be a helpless helpoholic--GPs' experiences of w om en 
patien ts w ith  non-specific m uscular pain. Scand J Prim  H ealth  Care 2004; 22(4):244-247.
58 Sm ith S. D ealing w ith  the difficult patient. P ostgrad  M ed J 1995; 71(841):653-657.
59 H ahn  SR, Thom pson KS, W ills TA, S tern V, B udner NS. The difficult doctor-patient 
relationship: som atization, personality  an d  psychopathology. J Clin Epidem iol 1994; 
47(6):647-657.
60 Salm on P, Ring A, D ow rick CF, H um phris  GM. W hat do general practice patients w an t 
w hen  they p resen t m edically unexplained  sym ptom s, and  w hy do their doctors feel 
p ressurized? J Psychosom  Res 2005; 59(4):255-260.
61 Ring A, D ow rick CF, H um phris  GM, Davies J, Salm on P. The som atising effect of clinical 
consultation: W hat patien ts and  doctors say an d  do no t say w hen  patien ts presen t m edically 
unexplained  physical sym ptom s. Soc Sci M ed 2005; 61 (7):1505-1515.
62 Cegala DJ. A s tudy  of doctors' and  patients' com m unication du rin g  a p rim ary  care 
consultation: im plications for com m unication training. J H ealth  C om m un 1997; 
2(3):169-194.
63 Salm on P, D ow rick CF, Ring A, H um phris GM. Voiced b u t unheard  agendas: qualitative 
analysis of the psychosocial cues tha t patients w ith  unexplained  sym ptom s presen t to 
general practitioners. Br J G en Pract 2004; 54(500):171-176.
64 Lucassen P, olde H artm an  TC, Borghuis MS. Som atische fixatie. Een n ieuw  leven voor een 
oud  begrip. H uisarts en W etenschap 2007; 50(1):11-15.
65 Sm ith GR, Jr., M onson RA, Ray DC. Patients w ith  m ultip le  unexplained  sym ptom s. Their 
characteristics, functional health , and  health  care utilization. A rch In tern  M ed 1986; 
146(1):69-72.
66 Kroenke K. Efficacy of trea tm en t for som atoform  disorders: a review  of random ized  
controlled trials. Psychosom  M ed 2007; 69(9):881-888.
67 S um athipala A. W hat is the evidence for the efficacy of treatm ents for som atoform  
disorders? A critical review  of prev ious in tervention  studies. Psychosom  M ed 2007; 
69(9):889-900.
68 M orriss R, G ask L, D ow rick C, D unn  G, Peters S, R ing A et al. R andom ized trial of 
rea ttribu tion  on psychosocial ta lk  betw een  doctors and  patien ts w ith  m edically 
unexplained  sym ptom s. Psychol M ed 2010; 40(2) :325-333.
69 M orriss R, D ow rick C, Salm on P, Peters S, D unn  G, Rogers A et al. C luster random ised  
controlled trial of train ing  practices in  rea ttribu tion  for m edically unexplained  sym ptom s. 
Br J Psychiatry 2007; 191:536-42.:536-542.
70 M ultidisciplinary guideline m edically unexplained  sym ptom s an d  som atoform  d iso rders]. 
Trim bos In s titu u t/N e th e rlan d s  Institu te  of M ental H ealth  and  A ddiction, editor. 2009. 
H outen, L adenius C om m unicatie BV.
Ref Type: Report
24 I Chapter 1




Background. Reliable longitud inal data  of patien ts w ith  functional som atic sym ptom s in 
general practice are lacking.
Aim. T o identify  distinctive features in  patien ts w ith  chronic functional som atic sym ptom s, 
and  to determ ine w hether these sym ptom s sup p o rt the hypothesis of the existence of specific 
som atic syndrom es.
Design. O bservational study , w ith  a com parison control group.
Setting. Four prim ary  care practices affiliated w ith  the U niversity  of N ijm egen in  The 
N etherlands.
Methods. One h u n d red  and  eighty-tw o patien ts d iagnosed  betw een  1998 and  2002 as 
having chronic functional som atic sym ptom s and  182 controls m atched by age, sex, 
socioeconomic status, an d  practice w ere included. D ata on com orbidity, referrals, diagnostic 
tests, an d  hospital adm issions over a period  of 10 years p rio r to the diagnosis w ere collected. 
M edication use an d  num ber of visits to the general practitioner (GP) w ere extracted from  the 
m om ent com puterized  reg istration  w as started.
Results. In the 10 years before the d iagnosis chronic functional som atic sym ptom s, 
significantly m ore patien ts than  controls p resen t functional som atic sym ptom s in  at least two 
body  system s, an d  used  m ore som atic and  psychotropic drugs. They v isit the GP tw ice as much, 
statistically had  significantly m ore psychiatric m orbidity , and  w ere referred  m ore often to 
m ental health  w orkers and  som atic specialists. The num ber of patients undergo ing  diagnostic 
tests w as higher for patien ts w ith  chronic functional som atic sym ptom s th an  for controls, bu t 
hospital adm issions rates w ere equal.
Conclusion. Patients w ith  chronic functional som atic sym ptom s have a great d iversity  of 
functional som atic sym ptom s. They use m ore som atic an d  psychotropic drugs than  controls in 
the years before diagnosis. M oreover, they show  h igh  rates of referrals and  psychiatric 
m orbidity . The diversity  of sym ptom s of patients w ith  chronic functional som atic sym ptom s 
suppo rts  the concept tha t sym ptom s do no t cluster in  w ell-defined distinct syndrom es. 
Therefore, patients w ith  chronic functional som atic sym ptom s shou ld  preferably no t be 
classified into m edical subspecialty  syndrom es.
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Introduction
M edically unexplained  sym ptom s are com m on, and  account for one in  five new  consultations in 
p rim ary  care.1;2 In 20-25% of all p rim ary  care visits, no serious m edical (that is, organic) cause is 
found  to explain  the patien t's  p resen ting  sym ptom , and  20-40% of the patients seen by m edical 
specialists do n o t receive a clear diagnosis.3;4 The presen ted  sym ptom s are then  referred  to as 
'm edically unexplained ' or 'functional'.5 Functional, or rather m edically unexplained, som atic 
sym ptom s are ranked  second on  the list of the 10 m ost com m on physical sym ptom s in  prim ary 
care and  have an  incidence rate of 70 per 1000 patien t years in  the N etherlands.6
A lthough an  occasional v isit to the general p ractitioner (GP) for a functional som atic sym ptom  
seem s natu ra l, repeated  consultations because of these sym ptom s represen t a serious problem . 
Patients w ho do this are often d iagnosed as hav ing  'chronic functional som atic sym ptom s'. 
Psychological d istress or psychosocial problem s are p resum ed  to be the u nderly ing  causes.7 As 
such, diagnosing chronic functional som atic sym ptom s requires the patien t to repeatedly  
presen t physical sym ptom s tha t rem ain  m edically unexplained  after adequate exam ination, 
an d  indications, from  the patients' personal circum stances of p resum ed  psychosocial problem s 
or psychological distress.
As patien ts w ith  chronic functional som atic sym ptom s are functionally  im paired , have high 
rates of com orbid psychiatric disorders, an d  are at risk of unnecessary  diagnostic procedures 
an d  treatm ents, 1;4;<M1 a correct d iagnosis is of param oun t im portance. H ow ever, m ost research on 
this topic has been  perform ed either on  unselected population-based  sam ples,12^ 3 or in  selected 
patien ts referred  to secondary  care.14;15 M oreover, m ost of these stud ies m ake use of 
questionnaires in  w hich patien ts have to recall a varie ty  of sym ptom s existing for a considerable 
am ount of tim e.10;16;17 This m ethod  has been show n to p roduce unstable results in  w hich  lifetime 
sym ptom s p resen t a t baseline are n o t rem em bered a t follow -up.18 Research on patien ts from  
prim ary  care settings in  w hom  the diagnosis h ad  been m ade on  reliable longitudinal data is 
generally lacking.
M oreover, there is considerable debate reg a rd in g  the question  of w hether functional som atic 
sym ptom s cluster in  well defined distinct syndrom es, such as fibrom yalgia, chronic fatigue 
syndrom e, or tension headache, or w hether these specific som atic syndrom es are largely an 
artefact of m edical specilization.7;19 In th is debate reliable data on  p rim ary  care patien ts are also 
needed , w hereas m ost research on this topic is perform ed in  referred  popu la tions2“21 
concentrating on  specific sym ptom s,22-24 or in  com m unity sam ples25 using  questionnaires in  
w hich inconsistencies of recall m ay have a great effect on  the assessm ent of the u ltim ate 
diagnosis.1826 The aim s of th is study , therefore, are to explore w ith  longitud inal data:
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•  how  and  how  often patien ts w ith  chronic functional som atic sym ptom s p resen t to their 
GP an d  other m edical institutions,
•  w hether patien ts w ith  chronic functional som atic sym ptom s indeed  presen t m ore 
functional som atic sym ptom s in  the years before the diagnosis,
•  if sym ptom s presen ted  by patients w ith  chronic functional som atic sym ptom s sup p o rt 
the existence of specific som atic syndrom es.
Methods
Continuous Morbidity Registration database
This s tudy  uses data from  the C ontinuous M orbidity  R egistration (CMR) database, a project of 
the departm en t of Fam ily M edicine of the U niversity  of N ijm egen the N etherlands.27-30 This 
project w as started  in  1971 in  four practices in  an d  a round  N ijm egen31 and  m onitors a popu la tion  
of approxim ately  12 000 patients, represen tative of the D utch popu la tion  w ith  regard  to age and 
sex. Every episode of illness seen by, or reported  to, the GP is registered as soon as it is 
established using  an  adap ted  version  of the E-list.32 D iagnoses and  codes are corrected w hen  
necessary. O ver m any years, m onthly  m eetings of all GPs involved are held  to discuss 
classification problem s, to m onitor the application  of diagnostic criteria, and  to discuss coding 
problem s of hypothetical case histories. As well as m edical data, the follow ing inform ation is 
available: age, sex, socioeconomic sta tus (low, m iddle an d  high), an d  m arital status. In the 
beginning the reg istra tion  w as perform ed on the m edical chart; since 1994 a com puterized 
reg istra tion  has been used.
Patients with chronic functional somatic symptoms
W e selected all patien ts from  the CMR database in  w hom  chronic functional som atic sym ptom s 
w ere d iagnosed for the first tim e betw een  1998 an d  2002 (n = 182). For a period  of 10 years before 
this diagnosis, the follow ing variables had  been collected: sociodem ographic characteristics; 
m orbidity  data; an d  d ata  on  referrals, diagnostic tests, and  hospital adm issions. Use of medical 
facilities w as assessed by the num ber of contacts w ith  the GP. D ata on m edication  use could  be 
extracted from  w hen  com puterized  reg istra tion  started , and  m edication  data w ere transform ed 
in to  the p resc rib ed  daily  dose by u sin g  the  A natom ica l T herapeu tica l C hem ical 
C lassification/D efined Daily Doses (ATC/D D D ) system .33 As a proxy of som atic m orbidity , w e 
assessed three prevalen t categories of chronic d isorders (diabetes m ellitus, as thm a/ch ron ic  
obstructive pu lm onary  disease [COPD], and  cardiovascular diseases) and  th ree prevalent 
categories of self-lim iting d isorders (skin d isorders, m usculoskeletal, and  airw ay) in  o rder to 
s tudy  the hypothesis tha t patien ts w ith  chronic functional som atic sym ptom s are at risk for 
som atic m orbidity .37
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W e allocated the registered functional som atic sym ptom s to specific body  system s; for exam ple, 
gastro in testinal or m usculoskeletal, as described by Escobar et al.10 Irritable bow el syndrom e 
and  hyperventila tion  syndrom e, som etim es regarded  as m edically unexplained  sym ptom s, are 
n o t included  in  this study.
For each patien t w ith  chronic functional som atic sym ptom s, a control m atched by  age, sex, 
socioeconomic sta tus, and  practice w as d raw n  from  the CMR population. The only exclusion 
criterion in  the control g roup  w as the diagnosis chronic functional som atic sym ptom s. Patients 
w ho w ere controls had  to have had  at least one registered  episode of illness du ring  the period 
they h ad  been on the practice list. For controls, the sam e inform ation as described for patients 
w ith  chronic functional som atic sym ptom s w as obtained from  1990-2000.
Statistical methods
O ur analysis p rim arily  involved com paring patients w ith  chronic functional som atic sym ptom s 
w ith  their m atched controls. S tatistical analyses w ere conducted  using  SPSS 9.0. D escriptive 
statistics w ere calculated for all variables. The data  on  specific body  system s w ere analysed 
using  exploratory  factor analysis, an d  then  sim plified by varim ax rotation. The j 2 test and 
s tuden t's  t-test w ere used  for com paring m eans of consultations and  m edication  use in  both  
groups. O dds ratios (ORs) an d  95% confidence in tervals (CIs) w ere used  as the m ain 
m easurem ent for associations, particularly  w ith  regard  to functional som atic sym ptom s, 
com orbidity, referrals, diagnostic tests and  hospital adm issions. All P-values are tw o-tailed.
Characteristics of subjects
Of the 182 included  patients w ith  chronic functional som atic sym ptom s included  in  the study, 
141 (77.5%) w ere w om en; the m ean age of all patien ts w as 42.0 years (range = 10-85 years). Most 
subjects w ere of low (44.5%) or m iddle (42.9%) socioeconomic class.
Functional somatic symptoms
The incidence rate  of patien ts w ith  chronic functional som atic sym ptom s w as 3.5 per 1000 
patien t years, w hereas the prevalence of patien ts know n to have chronic functional som atic 
sym ptom s is established on 68.8 per 1000 patien t years.
Controls
Results
The p resen ted  functional som atic sym ptom s in  various body system s in  patien ts and  controls is 
d isplayed in  T able 1. For each sym ptom  group, patients and  controls differ significantly
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Table 1. Distribution of functional somatic symptoms in the various body systems (n = 182)
Patients (%) Controls (%) Odds ratio (95% CI)‘
Pseudoneurological 54 (29.7) 13 (7.1) 5.5 (2.8 to 11.1)
G astrointestinal 69 (37.9) 15 (8.2) 6.8 (3.6 to 13.1)
M usculoskeletal 58 (31.9) 6 (3.3) 13.7 (5.5 to 36.5)
C ardiorespiratory 74 (40.7) 16 (8.8) 7.1 (3.8 to 13.5)
H eadache and  o ther pain 80 (44.0) 15 (8.2) 8.7 (4.6 to 16.6)
Pseudopsychiatric 150 (82.4) 48 (26.4) 13.1 (7.7 to 22.4)
O thers 66 (36.3) 10 (5.5) 9.8 (4.6 to 12.2)
U nknow n 67 (36.8) 0 (0)
a Statistical significant difference between patients and controls.
(P<0.05). It is rem arkable tha t m any patien ts had  sym ptom s in  various body  system s -  a finding 
tha t is supported  by the factor analysis (Figure 1) -  as it is often considered tha t there are a 
num ber of w ell-defined distinct functional som atic syndrom es, clustering  a round  physical 
sym ptom s of one body  system . M oreover, factor analysis suggests that, on  the one hand, 
gastrointestinal, card iorespiratory , an d  pseudopsychiatric sym ptom s are linked and, on  the
Figure 1. Symptom diversity in patients with chronic functional somatic symptoms and their matched controls
controls
patients
number of affected body systems
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other, tha t pseudoneurological sym ptom s, m usculoskeletal sym ptom s, an d  headache an d  other 
pain, are linked w ith  each other. S ignificantly m ore patien ts than  controls p resen ted  sym ptom s 
in  tw o or m ore body system s (87.9 versus 19.8%; OR = 29.5, 95% CI = 16.0 to 54.9). Of all the 
patients, 25 % presen ted  sym ptom s in  four or m ore body  system s.
H alf of the patien ts had  th ree or m ore episodes of functional som atic sym ptom s before he or she 
w as d iagnosed as having chronic functional som atic sym ptom s; 25% of the patients had  five or 
m ore episodes before chronic functional som atic sym ptom s w ere diagnosed.
Comorbidity: somatic and psychiatric
Patients w ith  chronic functional som atic sym ptom s had  significantly m ore psychiatric 
d isorders in  com parison w ith  controls (OR = 2.4) (T able 2). Patients d id  no t have a m uch higher 
rate  of chronic and  self-lim iting som atic com orbidity, an d  they had  only slightly  m ore episodes 
of self-lim iting airw ay problem s th an  controls.
Consultations, referrals, diagnostic tests and hospital admissions
The num ber of consultations in  patients w ith  chronic functional som atic sym ptom s is 
significantly h igher (n = 9.8 versus n = 4.2, P<0.001), as the num ber of subjects referred  for 
diagnostic testing  (n = 156 versus n = 140, OR = 1.8). The num ber of hom e visits w as equal in  both  
groups. A bout three-quarters of patien ts h ad  been referred  to som atic specialists, com pared 
w ith  about half of the controls. A bout one-th ird  of the patients had  been referred  to m ental 
health  sources com pared  w ith  less th an  10% in  controls. H ospital adm issions w ere the same. 
These data  are ou tlined  in  T able 2.
Medication use
The results regard ing  m edication  use are detailed  in  Table 3. W e found  tha t patien ts w ith  
chronic functional som atic sym ptom s used  a significant m ore som atic m edication  (2.6 versus 
1.5, P<0.001) an d  psychotropic drugs (0.4 versus 0.05, P<0.001) per year com pared  w ith  controls. 
The n um ber of patien ts using  an tidepressan ts and  benzodiazepines is statistically different in 
bo th  groups (35.6% versus 5.9%; 52.5% versus 12.7% respectively, P<0.001).
In patients using m edication, an tidepressan ts w ere used for a m ean of 20 days a year and 
benzodiazep ines for 9 days a year com pared  w ith  5 and  4 days, respectively, in  controls. 
H ow ever, these findings do no t reach statistical significance. M oreover, there is no difference in 
prescribed daily dose for patien ts an d  controls.
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Table 2. Number of consultations, comorbidity, referrals, diagnostic tests, and hospital admissions in patients 
and controls (n = 182)
Patients Controls P-value Odds ratio (95% CI)
GP consultations in one yeara
(mean [range])
Practice visits 00\oCMLOfN00Os LOo<N <0.001b -
H om e visits 0.2 (0-3.5) 0.3 (0-7.1) 0.53 -
C om orbidity  (n [%]) 
Somatic chronic:
D iabetes M ellitus 5 (2.7) 4 (2.2) - 1.3 (0.3 to 5.7)
A sthm a/C O PD 20 (11.0) 10 (5.5) - 2.1 (0.9 to 5.0)
C ardiovascular 16 (8.8) 8 (4.4) - 2.1 (0.8 to 5.5)
Somatic self-limiting:
Skin 96 (52.7) 82 (45.1) - 1.4 (0.9 to 2.1)
M usculoskeletal 130(71.4) 115(63.2) - 1.5 (0.9 to 2.3)
A irw ay 136 (74.7) 113 (62.1) - 1.8 (1.1 to 2.9)b
Psychiatric0 41 (22.5) 20 (11.0) - 2.4 (1.3 to 4.4)b
Referrals (n [%])
Somatic: M edical 130 (71.4) 97 (53.3) - 2.2 (1.4 to 3.5)b
Somatic: P a ram ed ica l 129 (70.9) 87 (47.8) - 2.6 (1.7 to 4.2)b
M ental H ealth 59 (32.4) 15 (8.2) - 5.3 (2.8 to 10.3)b
Diagnostic teste (n[%]) 156 (85.7) 140 (76.9) - 1.8 (1.0 to 3.2)b
H ospital adm issions (n [%])
Somatic 57 (31.3) 51 (28.0) - 1.2 (0.7 to 1.9)
Psychiatric 1 (0.5) 1 (0.5) - 1.0
an = 118: one general practice did not use the computerised registration, so consultation could not be established in this practice. bStatistically significant 
difference between patients and controls P<0.05. Including schizophrenia, depression, psychoses, hysteria, phobia, neuroses, post-traumatic stress 
disorder, alcoholism, use of street drugs. Including physiotherapist, dietician. Including hematological tests, x-ray examinations, ultrasonography, 
electrocardiography.
Discussion
Strengths and limitations of this study
The streng th  of the p resen t s tudy  is tha t the patien ts w ho w ere included  w ere those w ho 
consulted  their GP, irrespective of the presen ted  sym ptom s. Therefore, a th reshold  of relevance 
of the sym ptom s for the patien t w as established and  w e w ere able to analyse all sym ptom s 
presented . M ost population-based  stud ies assess all sym ptom s irrespective of the perceived 
need  for help.10;16;17 M oreover, in  popula tion-based  studies, in terv iew ing  patien ts repeatedly  
does n o t lead to a consistent classification of som atoform  d isorders,18 w hereas our classification 
of the p resen ted  m orbidity  is based on very  stable data ,29;34 in  w hich longitud inal research is 
allow ed and  recall bias w ill no t occur.
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Table 3. Medication use in patients and controlsa (n = 118)
Patients Controls P-value Odds ratio (95% CI)
N um ber of som atic m edication per year (mean [range]) 
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ntidepressants, benzodiazepines and other psychotropic drugs, n =
established in this practice. bStatistically 
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The lim itations of the s tudy  are the retrospective use of data in  existing m edical records an d  the 
possible in terdoctor varia tion  of the diagnosis of chronic functional som atic sym ptom s.35 The 
in terdoctor varia tion  is partly  a consequence of n o t having explicitly sta ted  criteria for chronic 
functional som atic sym ptom s in  the CMR. This subjectivity w ill possibly alw ays exist because 
d iagnosing chronic functional som atic sym ptom s rem ains an  in te rp re tation  of the sym ptom s, 
and  is influenced by foreknow ledge an d  context.27 H ow ever, it is know n from  the literature that 
the GP's judgem ent on  som atisation  seem s valid  in  daily practice. M oreover, additional 
validation  of clinical judgem ent is possible th rough  longitud inal follow -up.36 The subjectivity of 
the diagnosis and  the doctor-patient relationship  also m ake im portan t contributions to the 
genesis and  persistence of functional som atic sym ptom s.37 The doctor's know ledge of the 
patien t's  com plaints is an  im portan t issue an d  is associated w ith  a better outcome.
Of all variables described, only consult frequency is directly linked w ith  the diagnosis of chronic 
functional som atic sym ptom s -  as such, the higher frequency of GP visits w as to be expected a 
priori.38
Summary of main findings
This is the first observational s tudy  using  longitud inal data  describing patien ts in  w hom  
consulting  the GP for functional som atic sym ptom s has becom e a regular w ay  of presenting. 
D uring the 10 years before the d iagnosis of chronic functional som atic sym ptom s is established 
by the GP, patients consult their GP tw ice as m uch, use m uch  m ore som atic and  psychotropic 
m edication, have m ore psychiatric m orbidity  and  are m ore often referred  to m ental health  
w orkers th an  controls. D uring  these 10 years, the num ber of diagnostic tests is slightly h igher in 
patients and  the num ber of hospital adm issions is equal in  com parison w ith  controls. Patients 
w ith  chronic functional som atic sym ptom s are m ore likely to p resen t sym ptom s in  tw o or m ore 
body  system s and  they p resen t a higher num ber and greater diversity  of sym ptom s to the GP 
th an  control patients. GPs in  th is s tudy  appear to classify patien ts as having chronic functional 
som atic sym ptom s after three episodes of p resen ting  w ith  functional som atic sym ptom s.
Comparison with the existing literature
The find ing  tha t patients could be recognized as hav ing  chronic functional som atic sym ptom s 
after they had  experienced three episodes of functional som atic sym ptom s presen ted  in  tw o or 
m ore body system s, is an  im portan t one. Functional som atic sym ptom s are often recognized 
after hav ing  excluded other possible diagnosis. This m ay be associated w ith  unnecessary  and 
possibly harm ful diagnostic strategies and  m ay prom ote som atic fixation. Early identification of 
these patien ts could  preven t som atic fixation, an d  enables the GP to m odify h is /h e r  
p roceedings.39 A dditionally , this find ing  w as confirm ed using  factor analysis and  show s that 
functional som atic sym ptom s probably  do no t cluster in  w ell defined specific som atic 
syndrom es. It also suggests tha t sym ptom  varia tion  is great in  these patients.
The concept of patien ts w ith  functional som atic syndrom es presen ting  sym ptom s in  m any body 
system s has also been  sup p o rted  by recent stud ies.20 Therefore, the existence op specific som atic 
syndrom es shou ld  be challenged. W ith a b road-based  approach, the GP m ight be the 
appropria te  p ractitioner to diagnose and trea t these patien ts by em phasizing the biom edical as 
w ell as the psychosocial factors involved in  sym ptom  p roduction  an d  perception .40
The find ing  th a t patien ts w ith  chronic functional som atic sym ptom s d id  no t have a higher rate of 
chronic and  self-lim iting som atic com orbidity  is rem arkable because it is sta ted  in  the literature 
tha t som atisation  w ith  m ore frequen t exam ination  m ay increase the chance for chronic diseases 
to be d iscovered.36 W e found  th a t m ore frequent consultation  d id  n o t lead to m ore d iagnosed 
chronic an d  self-lim iting diseases in  patien ts w ith  chronic functional som atic sym ptom s.
The diagnosis chronic functional som atic sym ptom s is no t recorded  as such in  the DSM-IV 
classification. It no doub t exists as p art of the spectrum  som ew here betw een  som atisation
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disorder and  som atoform  disorder no t o therw ise specified. The condition  resem bles the 
concept of 'abridged  som atization ',10 b u t is no t based  on  the num ber of sym ptom s. Both 
'abridged som atization ' and  chronic functional som atic sym ptom s presum e underly ing  
psychological distress. The prevalence of som atisation  d isorder according to the DSM-IV in 
p rim ary  care is low because of the stringent c r ite r ia “141 O n the other hand , less severe form s of 
som atization  have a m ajor im pact on  quality  of life and  on  the use of health  services, an d  are 
m ore prevalent.
Implications for further research and clinical practice
Patients w ith  chronic functional som atic sym ptom s m ay be considered as persistent 
com plainers an d  consequently  labelled as 'difficult' patients. The condition  m ay indeed  reflects 
a greater propensity  to com plain; how ever, as is apparen t from  the excess of psychiatric 
com orbidity , patients w ith  chronic functional som atic sym ptom s also have m ore reason to 
com plain. W ith regard  to these patients, it seem s tha t consulting  the GP for functional somatic 
sym ptom s has becom e a regular w ay  of presenting , b u t it m ight also be tha t patien ts w ho attend 
m ore often are at h igher risk of being  considered as chronic functional som atic sym ptom s. 
M oreover, the diagnosis m ight relate to fru stra ted  doctors as a consequence of lack of 
understand ing , or failures in  the com m unication  betw een  doctor and  patient.
Chronic functional som atic sym ptom s are a m ajor cause of m orbidity  an d  deserve further 
investigation  to estim ate the im portance of the doctor-patien t relationship , the feasibility of 
treatm ents, and  the u n derstand ing  of the aetiology of functional sym ptom s to identify  patients 
w ho are likely to becom e persisten t com plainers an d  develop the behavioural p a tte rn  of patients 
w ith  chronic functional som atic sym ptom s.
Also, the overlap of chronic functional som atic sym ptom s w ith  the v arious DSM-IV diagnoses 
shou ld  be studied . This is im portan t because the valid ity  of the classification of m ental d isorders 
is useful, b u t also questionable.42 Thinking in  narrow  syndrom es m ight h inder an  appropria te  
in te rp re tation  of the patien t's  syndrom es.
Patients repeated ly  p resen ting  functional som atic sym ptom s to the GP in tw o or m ore body 
system s, particu larly  w hen  com bined w ith  psychological com plaints, shou ld  be regarded  as 
candidates for the diagnosis of chronic functional som atic sym ptom s. It seem s tha t the 
presen ted  functional som atic sym ptom s are p art of a single syndrom e and  th a t sym ptom  
varia tion  is great in  these patients. Therefore, the GP, w ho is considered as being know ledgeable 
about underly ing  psychosocial problem s, shou ld  diagnose, treat, and  accom pany these 
patients.
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Objective. To study  the course of m edically unexplained  sym ptom s (MUS), som atisation  
d isorder and  hypochondriasis and  rela ted  prognostic factors. K now ledge of prognostic factors 
in  patien ts p resen ting  persisten t MUS m ight im prove our u nderstand ing  of the naturalistic 
course and  the identification of patien ts w ith  a h igh  risk of a chronic course.
Methods. A com prehensive search of M edline, PsycInfo, CINAHL and  EMBASE w as 
perform ed to select stud ies focusing on  patien ts w ith  MUS, som atisation  d isorder and 
hypochondriasis and  assessing prognostic factors. S tudies focusing on patien ts w ith  single­
sym ptom  unexplained  disorder or distinctive functional som atic syndrom es w ere excluded. A 
best-evidence synthesis for the in te rp re tation  of results w as used.
Results. O nly six stud ies on  MUS, six stud ies on  hypochondriasis, an d  one s tudy  on 
ab ridged  som atisation  could  be included. A pproxim ately  50 to 75% of the patien ts w ith  MUS 
im prove, w hereas 10 to 30% of patien ts w ith  MUS deteriorate. In patients w ith  hypochondriasis 
recovery rates vary  betw een  30% to 50%. In stud ies on  MUS an d  hypochondriasis w e found  
som e evidence tha t the n um ber of som atic sym ptom s at baseline influences the course of these 
conditions. Furtherm ore, the seriousness of the condition  at baseline seem ed to influence the 
prognosis. C om orbid anxiety and  depression do n o t seem  to pred ic t the course of 
hypochondriasis.
Conclusions. Due to the lim ited num bers of stud ies an d  their h igh  heterogeneity , there is a 
lack of rigorous em pirical evidence to identify  relevant prognostic factors in  patien ts p resenting  
persisten t MUS. H ow ever, it seem s tha t a m ore serious condition  at baseline is associated w ith  a 
w orse outcom e.
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Introduction
M edically unexplained  sym ptom s (MUS) are com m on in  prim ary  care.1 In 25-50% of all p rim ary  
care visits, no  som atic cause is found  to explain  the patien t's  p resen ting  sym ptom s.2 It is 
generally believed th a t persisten t presen tation  of MUS is a chronic and  disabling  d isorder.3 
H ow ever, in  m any patien ts MUS are transien t and  have a good prognosis. A recent D utch study 
found  th a t only 2,5% of the attendees in  general practice p resen ting  w ith  such sym ptom s m eet 
criteria for chronicity.4
In a recent review , researchers sta ted  tha t in  population-based  an d  prim ary  care sam ples, MUS 
is the com m on characteristic of the D S M -IV  an d  ICD-10  som atoform  disorders including 
som atisation  and  hypochondriasis.5-7 Som atisation is characterized by recurren t and  frequent 
presen tation  of MUS w hereas hypochondriasis is characterized by excessive w orry  about illness 
an d  the belief of hav ing  an  und iagnosed  physical d isease.
D espite the low  prevalence of persisten t MUS, it represen ts a serious problem  in p rim ary care. 
Patients are functionally  im paired , have h igh  rates of com orbid psychiatric d isorders and  are at 
risk for unnecessary, potentially  harm ful diagnostic procedures an d  treatm ents.2,3,8 M oreover, 
p a rt of the b u rd en  to G Ps are the difficulties in  explaining the sym ptom s, find ing  a shared 
un derstand ing  necessary to reach reassurance an d  acceptation of the sym ptom s and  the lack of 
trea tm en t op tions.9,10 Often, GPs label these patien ts as 'heartsink patien ts' or 'helpoholic 
patien ts '.11 For patients, as w ell as GPs and  the health  care system  it is im portan t to prevent 
persisten t MUS. Therefore, GPs shou ld  be able to recognize patien ts w ith  a h igh  risk of 
persisten t MUS. H ow ever, GPs experience difficulties in  d istinguish ing  self lim iting MUS from  
persisten t MUS.12 K now ledge of prognostic factors m ay im prove our m anagem ent of patients 
w ith  MUS, as patients w ith  a good prognosis can be reassured  about the favourable spontaneous 
recovery rates, w hereas a m ore intensive approach  includ ing  som e form  of rea ttribu tion  or 
cognitive behavioural therapy  m ight be ind icated  from  the beginning in  the h igh-risk groups. 
The aim  of our s tudy  is to gain insight in  the course of MUS an d  in  factors influencing its course .
Method
Data sources and search strategy
W e system atically review ed prospective cohort stud ies in  p rim ary, secondary or tertiary  care on 
patients w ith  MUS, som atoform  d isorders an d  hypochondriasis. W e s tud ied  som atisation 
disorder, MUS and  hypochondriasis together because they appear to have m uch  in  common: 
m edically unexplained  sym ptom s, typical illness and  sick role behaviour, d isproportionate 
disability an d  preoccupation  w ith  health  and  illness.7
A lthough  there are m any other general term s to describe physical sym ptom s w ith o u t an  organic 
explanation, w e use the te rm  'm edically unexplained  sym ptom s' as none of these term s are ideal 
and  this is the m ost neu tra l description.13'14
W e d id  no t include clinical trails in  this review  as the patien ts recru ited  into trails are often not 
represen tative of the popu la tion  w ith  the d isorder.15'16 M oreover, participating  in  a trial can 
influence the n a tu ra l course of the sym ptom s as participating  in  a trial can be considered as an 
in tervention  in  itself.
W e searched in  the MEDLINE database for publications published  betw een  1965 and  1 June 
2006, in  PsycINFO betw een  1967 and  1 June 2006, in  CINAHL betw een  1982 and  1 June 2006 and 
in  EMBASE betw een  1965 an d  1 June 2006. W e obtained additional references from  the reference 
lists of review  articles and  retrieved original papers. W e used  the follow ing keyw ords: 
s o m a to f o rm  d i s o r d e r ,  h y p o c h o n d r ia s i s ,  n e u r a s th e n i a ,  c o n v e r s io n  d is o r d e r ,  
psychophysiological d isorder, functional som atic sym pt* an d  m edically unexplained*.
W e com bined this search using  the Boolean operator AND w ith  the sensitive MEDLINE search 
for clinical stud ies on  prognosis.17 The search strategy is show n in  A ppendix  A. There w ere no 
lim itations regard ing  the language of publication. W e tested  the search strategy on 30 
publications abou t m edically unexplained  sym ptom s in  our ow n database and  found  the search 
strategy to be sensitive as all know n articles w ere found.
Study selection
T oH  and  MB independen tly  screened the titles and  abstracts of all identified  citations to identify 
eligible articles. W hen w e could  n o t decide on inclusion, w e consulted  the full publication.
If after study ing  the com plete m anuscrip t d isagreem ent persisted , w e consulted  a th ird  
review er (FvdL). W e used  C ohen's kappa statistic ( k )  to assess agreem ent betw een  the two 
review ers.18 Inclusion criteria were: prospective cohort design, focus on prognosis of patients 
w ith  m edically unexplained  sym ptom s an d  a follow -up of 3 m onths or more.
W e excluded stud ies th a t focused prim arily  on  patien ts w ith  m edical or psychiatric disease 
(except som atoform  d isorders and  hypochondriasis). W e also excluded stud ies tha t focused on 
p a tien ts  su ffe rin g  from  sin g le-sy m p to m  u n ex p la in e d  d iso rd e r  (tension  headaches, 
dysm enorrhoea) or patients suffering from  distinctive functional som atic syndrom es (irritable 
bow el syndrom e, chronic fatigue syndrom e) because w e w ere in terested  in  the course and 
p ro g n o sis  of u n d iffe re n tia te d  m ed ica lly  u n e x p la in e d  sy m p to m s. W e fo cu se d  on 
undifferen tia ted  MUS as w e assum e tha t these are m ore difficult to hand le for the physician  than
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single sym ptom  unexplained  disorders and  distinctive functional syndrom es. After all, the 
latter give m ore opportun ity  to explain  the sym ptom s to patients. Finally, there is evidence that 
the nam e of a condition influences prognosis.19 S tudies on  ch ild ren  an d  adolescents (age < 18 
years) and  stud ies on  specific groups of patients such  as refugees, street prostitu tes etc, w ere 
excluded. Case-control studies, cross-sectional stud ies and  case stud ies w ere also excluded.
Data extraction
Two review ers (ToH and  MB) independen tly  scored the m ethodological quality  of the included 
studies. W e used  a standard ized  checklist of p redefined  criteria (see A ppendix  B), w hich has 
been used  in  previous prognostic review s.20'21 The list is based on theoretical considerations and  
m ethodological aspects described by H udak  et al.22 an d  A ltm an.23 W e m odified these checklists 
according to new  insights.24 W e tested  the quality  assessm ent checklist in  a p ilo t assessm ent. A 
detailed  explanation  of each criterion is given in  A ppendix  C. Each criterion w as scored positive 
(+), negative (-) or unclear (?). The total quality  score is the sum  of all the criteria tha t are scored 
positive. The m axim um  quality  score is 21. W e calculated the quality  of a s tudy  as the percentage 
of the m axim um  score.
W e discussed disagreem ents in  the scoring of quality  item s in  a consensus m eeting. In a case of 
persisting  d isagreem ent betw een  the tw o review ers a th ird  review er (FvdL) m ade the final 
decision.
W e categorized quality  criteria into four m ajor form s of bias: selection bias, com pleteness of 
follow -up, inform ation bias an d  confounding. Furtherm ore, w e defined stud ies w ith  a quality 
score of 60% or h igher as stud ies w ith  h igh  quality .25
The tw o review ers (ToH an d  MB) independen tly  extracted the inform ation from  the selected 
papers by using standard ized  an d  p re-tested  data-extraction form s. The extracted inform ation 
involved data  on  s tudy  popula tion , d iagnostic criteria, inclusion and  exclusion criteria, setting, 
type of prognostic factors, du ration  of follow -up, outcom es an d  data on  associations. In a case of 
d isagreem ent, w e reached consensus after d iscussion w ith  a th ird  review er (FvdL).
Data synthesis
W e did  n o t p lan  statistical pooling as w e an ticipated  considerable heterogeneity . Therefore, a 
qualitative analysis (best evidence synthesis) w as perform ed to sum m arize the value of the 
prognostic indicators. Furtherm ore, we considered the streng th  of evidence regard ing  a 
prognostic factor as strong, m oderate, w eak or inconclusive depending  on  consistency of the 
findings an d  on quality  of the s tudy  :26'27
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-  strong: consistent findings (> 75% of the stud ies reporting  on a factor show ed the same 
direction  of the association) in  at least tw o h igh  quality  studies
-  m oderate: consistent findings (> 75 % of the stud ies reporting  on  a factor show ed the same 
direction  of the association) in  one h igh  quality  cohort and  at least one low  quality  study
-  weak: findings of one h igh  quality  cohort or consistent findings (> 75% of the studies 
reporting  on a factor show ed the sam e direction of the association) in  at least th ree or m ore 
low quality  studies
-  inconclusive: inconsistent findings irrespective of s tudy  quality , or less th an  th ree low 
quality  stud ies available
We only presen t prognostic factors w hich in  at least one s tudy  show ed a statistically significant 
association. Preferably, w e derived the associations from  the m ultivariate results. If only 
un ivariate  resu lts w ere presen ted  in  the original study , w e used these un ivariate  associations to 
determ ine the streng th  of evidence.
W e presen t results of the stud ies on  MUS, som atisation d isorder and  hypochondriasis 
separately.
Figure 1. Selection of studies
Excluded (n=50) 
after reading the full 
publication
Excluded (n=5) 
after discussion for 
consensus
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Results
W e retrieved  a to tal of 4867 publications from  searches of the various electronic b ibliographies 
(1673 Pubm ed, 933 Psychinfo, 1222 CINAHL an d  1039 EMBASE) (see F igure 1). A fter screening 
the titles and  abstracts, 68 abstracts seem ed to fulfil the inclusion criteria. A fter assessing the full 
publication, 13 articles fulfilled all inclusion criteria and  w ere included  in  our review .28-40 Major 
reasons for excluding papers were: focus no t on  patien ts w ith  m edically unexplained  sym ptom s 
(n=30) an d  no s tudy  of prognostic factors (n=14). The reference lists of the retrieved papers did 
n o t reveal any relevant publication. Six stud ies reported  on MUS,28-31'36'37 six stud ies on 
hypochondriasis32-35,38,39 an d  one s tudy  on abridged  som atization .40 The abridged  definition of 
som atisation  requ ired  the presence of four sym ptom s in  m ales and  six sym ptom s in  fem ales.41 
W e d id  no t find  any prospective cohort stud ies on  D S M -IV  som atoform  disorders.
The interobserver agreem ent for inclusion betw een  the tw o review ers (ToH, MB) w as k = 0,73 
(95 % -CI: 0.59 -  0.87). We considered the streng th  of agreem ent to be 'good' .42
Study characteristics
W e found  6 studies on MUS. Table 1 gives the data of the quality  assessm ent of the included 
studies. The quality  score of MUS publications ranged  from  62% to 86%. As none of the included 
studies described a treatm ent subsequent to inclusion in the s tudy  cohort (item L), w e cannot 
decide on  w hether the n a tu ra l course w as s tud ied  or course du ring  trea tm en t (as usua l). Loss to 
follow -up ranged  from  0 to 27%.
W e found  one prospective cohort s tudy  on abridged  som atisation. The quality  of this 
publication  scored 67%.
W e in c lu d ed  6 stud ies  on  hypoch o n d riasis . The m ethodo log ical qua lity  score of 
hypochondriasis publications ranged  from  57% to 76%. (see Table 1) As in  the MUS studies, in 
these six hypochondriasis stud ies application  of treatm ents w as n o t described. So w hether the 
n a tu ra l course or course du ring  trea tm en t w as s tud ied  cannot be concluded. Selection bias and 
confounding  w as p resen t in  all studies an d  in four of the six studies inform ation bias w as 
p resen ted .32'33'38'39 (see T able 1) Loss to follow -up ranged  from  4% to 36,6%.
A sum m ary  of the s tudy  characteristics is p resen ted  in  Table 2, includ ing  population , setting, 
diagnostic criteria, follow -up an d  baseline characteristics.
Four of the six studies on MUS are perform ed in The N etherlands. S tudies rep o rtin g  on MUS 
defined MUS as sym ptom s tha t could no t be a ttribu ted  to a clear organic cause according to the 
physician 's judgm en t after a tho rough  physical exam ination  including  laboratory  tests. So, 
physician 's judgm en t w as often the m ost im portan t diagnostic instrum ent.
Table 1. Results of the methodological quality of prognostic cohort studies on MUS, abridged somatisation 
and hypochondriasis
A B C D F G  I J N O P L Q R E H K M S T U
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c  i U- C om pleteness Inform ation  . Q uality  ScoreQ uality  criteria Selection bias - .  , . C onfounding  D escriptive item s ^  a ,of fo llow -up  b ias °  r  scorea (%)
MUS
K ooim an et al., 
200430
+ + + + - + + + + + + - + + - + + + + + + 18 86.0
De G uch t et al.,
200429
+ + + + + + + + + - + - - + + - + + + - + 16 76.2
Speckens et al., 
199636
+ + + + + + + + + - + + - + + + + + - 16 76.2
C arson  et al., 
200331
+ + + + + + + + + + + + + + 14 66.6
Speckens et al., 
199637
+ + + + - - + - + - + - + - - + + + + - + 13 61.9
H enn ingsen  et al.,
200528
+ + + + + + + + + + + + + 13 61.9
Abridged somatisation
G ureje an d  Simon,
1999
+ - + + + + + + + + + + + + + 14 66.6
Hypochondriasis
N oyes et al., 
199435
+ + + + - - + - + + + - + + - + + + + + + 16 76.2
Barsky et al., 
199833
+ + + + - + + - + - + + - + + + + + - 14 66.7
Barsky et al., 
2000
+ + + + + + + - + - - + - + + + + - - 13 61.9
Barsky et al., 
1993
+ - + ? + + + + + + + + + + 12 57.1
F ernandez  et al., 
200538
+ + + + - - + - + + - + - - - + + + + - 12 57.1
Sim on et al.,
200139
+ - + + - + + + - + - - - - + + + + + - 12 57.1
a Total '+ '.
In these six MUS stud ies w e found  h igh  levels of heterogeneity  regard ing  clinical setting 
(prim ary care, secondary  care and  tertiary  care), num bers enrolled  in  the cohort (80 to 377 
patients), du ration  of follow -up (6 to 15 m onths) and  loss to follow -up (0 to 27%). O nly two 
stud ies reported  on the du ration  of sym ptom s at baseline.28'36 Speckens et al.36 (1996) reported  a 
m edian  du ration  of sym ptom s of 7,8 m onths (range 0-168), w hereas H enningsen  et al.28 (2005) 
reported  a m ean  du ration  of 70 ± 94 m onths (m edian 26).
The s tudy  on  abridged  som atisation  w as perform ed in  prim ary  care from  15 sites in  14 countries 
and  enrolled  1596 patien ts into the cohort. A bridged  som atisation  w as diagnosed according to 
the Somatic Sym ptom s Index (SSI). D ura tion  of sym ptom s at inclusion w as no t reported.
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All stud ies on  hypochondriasis used  a form al diagnostic in terview  to diagnose patien ts w ith  
hypochondriasis as sta ted  in  the D SM -III-R . (see Table 2) F ernandez et al.38 (2005) included 
patients w ith  health  anxiety. These patien ts share m any characteristics w ith  patients suffering 
from  hypochondriasis.38 D espite the use of form al diagnostic interview s, there w as considerable 
heterogeneity  in  the six included  studies. D uration  of follow -up (one to five years), num bers 
enrolled  in  the cohort (50 to 129 patients) and  loss to follow -up (4 to 37%) vary  considerable 
betw een the included  studies. O nly tw o stud ies reported  on duration  of sym ptom s at baseline. 
N oyes et al.35 (1994) included  patients w ith  a m edian  du ration  of sym ptom s of 19 (range 2-144) 
m o n th s. F ernandez et al .38 (2005) reported  tha t w orries on  health  s ta rted  m ore than  5 years ago in  
36% of the patients, w hereas in  12% of the patien ts these w orries started  in  the last 6 m onths.
Course of MUS, somatisation disorder and hypochondriasis
Five ou t of 6 articles on  MUS reported  on the course of the sym ptom s (see Table 2). Based on 
prevalence, the typical MUS patien t in  our review  is fem ale, betw een  35 and  45 years o ld  and 
consulted  a p rim ary  care practice or secondary  care o u tpa tien t clinic. Irrespective of the clinical 
setting, the m ajority of the patients w ith  MUS (50 to 75%) im prove du ring  follow -up. H ow ever, 
abou t 10% to 30% of the patien ts deterio ra te .
Five ou t of six stud ies on  hypochondriasis reported  on the course of hypochondriasis. Based on 
prevalence, the typical hypochondriasis patien t is again  fem ale and  betw een  35 an d  45 years old. 
Fifty to 70% of the patien ts w ith  hypochondriasis d id  no t recover. O nly Sim on et al.39 found  a 
recovery rate in  hypochondriasis patients of 85%.
The only s tudy  on  som atisation  d isorder s tud ied  a m odified concept.40 Recovery rates w ere 
com parable w ith  the data found  in  stud ies on  MUS pa tien ts .
Prognostic factors of MUS, somatisation disorder and hypochondriasis
In Table 3 a sum m ary  of outcom es m easures, prognostic factors an d  (strength of) significant 
associations is given. A part from  the h igh  heterogeneity  in  s tudy  characteristics, w e also found 
considerable heterogeneity  in  prognostic factors an d  outcom e m easures in  the 13 studies 
included  in  this review.
Four of the six publications on  MUS stud ied  po ten tia l prognostic factors on  the outcom e
29,30,36,37'sym ptom  change '.
There is som e evidence th a t the num ber of sym ptom s at baseline pred ic t the course of MUS. (see 
Table 4) M oreover, it seem s tha t the m ore serious the condition  at baseline, the m ore 
unfavourable the prognosis. This is rep resen ted  by the factors G eneral H ealth  Perception






/  of main study characteristics and course of MUS, abridged somatisation, and hypochondrias
Gender
Number Duration of (M/F) and 
Study enrolled follow-up Loss to age 
First quality in Criteria for [months follow-up (years±S.D.) 
author (%) Settingcountry cohort diagnosis (range)] [n ,(%)] at baseline Course
MUS
K ooim an 
et al., 
2004s”
81 G enera l in terna l 
m edicine outpatien t 
clin ic/T he 
N etherlands
127 Judgem en t 
investigato rs on base 
of in tern is t's  final 
conclusion
14.1 (12.2-17.8) 0 43:84
40.2±12.7
62% im proved; 
38% no t 
im proved
De G ucht 
et al.,
200429
76 P rim ary  care 
p ra c tices/
The N etherlands
377 Judgm en t FP 6 59 (16.0) 103:274
43.5±12.2
53.1% decrease 
of sym ptom s; 






76 G enera l m edical 
ou tpatien t c lin ic / 
The N etherlands
81 Judgem en t 
investigato rs on 











67 G enera l neu ro logy  
ou tp atien ts /U K
90 Judgm en t
neuro logist
8 24 (27.0) 24:42b
42b






62 G enera l m edical 
ou tpatien t c lin ic / 
The N etherlands
87 Judgm en t physician 11.6±0.8 5 (6.0) N o t given  
N o t given
20% recovered; 
51% im proved; 
18% same;
11% w orse
H enningsen  
et al.,
200528
62 T ertiary  care clin ics / 
G erm any
186 Judgm en t of 2 
physicians







67 Prim ary 
ca re /E u ro p e, 
S ou th  A m erica, US
1596 D iagnostic
in terv iew
12 525 (32.9) N o t given  
N o t given
51.3% rem itted ;
48.7%




76 M edicine clin ic/U S 50 D iagnostic
in terv iew
13.8 (12.6-20.3) 2 (4.0) 10:38b
39.6±0.9b
33% rem itted ; 


















36.5% rem itted ;
63.5%








50.2±5.0 22 (36.6) 11:27b
48.0±15.2b
34.2% rem itted ;
65.8%








22.2 (12-35) 6 (21.4) N o t given  





57 P rim ary  care hea lth  
ce n tre /S p a in
25 Sem i-structured  
in terv iew  and  
questionnaires
11.3 4 (16.0) 6:19
40.1
52% rem itted ; 




57 Prim ary 
ca re /E u ro p e, 






N o t given  
N o t given
84.5% rem ited ;
15.5%
u n rem itted
Q : cohort 1.
Q : cohort 2.
a N um ber of MUS; 3.6 % missing.
b Baseline characteristics on ly  ca lculated fo r pa tien ts  w h o  com pleted  the fo llow -up  period . 
c A ccord ing  to  the clinical global im provem en t scale. 
d T ransien t hypochondriasis. 
e H ealth  anxiety.
f Loss to fo llow -up only ca lculated fo r the w hole cohort of the W orld  H ealth  O rganization 's  P sychological Problem
, 67
study.
in  G enera l H ealth  Care (PPGHC)
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Table 3. Prognostic factors
F irst au th o r O utcom e m easures P rognostic  factors D ire c tio n  of s ig n if ican t associa tions
S tren g th  of 
asso c ia tio n 3
MUS
K ooim an 
et al., 
200430
(1) S ym ptom  change
(2) C hange in  general 
h ea lth  perception




(a) A lexithym ia
(b) Sociodem ograpic 
characteristics
(c) M edical h istory
(d) M ental p roblem s
(e) Illness behav iour
(f) S ym ptom  characteristics
(g) A ttribu tion
S ym ptom  change
- L onger d u ra tio n  of the sym ptom : absence of 
im provem en t
- H igher n u m b er of physical sym ptom s: 
absence of im provem en t
C hange in general hea lth  percep tio n  (GHP)
- L ow er initial G H P  at baseline: p o o r G H P  at 
fo llow -up
- H igher n u m b er of physical sym ptom s: p o o r 
G H P at fo llow -up
- Less pain: p o o r G H P  at fo llow -up
£=0.01 (0.005), P<.05 
£=0.05 (0.02), P<.05
£=-0.04 (0.01), P<.01 
£=0.07 (0.03), P<.05 
£=-0.03 (0.01), P<.05
De G ucht 
et al.,
200429
(1) C hanges in  nu m b er 
of MUS
(2) S ym ptom  persistence 
o rrecu rren c e
(a) N eurotic ism
(b) A lexithym ia
(c) N egative o r positive 
affective state
(d) Sociodem ographics
N um ber of MUS
- N egative affect increase from  T1 to T2: 
increase
-P o s itiv e  affect decrease from  T1 to  T2: 
increase
P resence of a consistently  h ig h  n u m b er of
MUS
- Fem ale: increase
- C onsisten tly  h igh  nega tive affect: increase
- D ifficulty in  identify ing  feelings (dim ension 
of alexithym ia): increase
OR=1.78 (1.33 to  2.39) 
OR=0,71 (0.54 to  0.94)
OR=2.29 (1.14 to  4.62) 
OR=2.77 (1.46 to  5.27) 




(1) C hange in  sym ptom s
(2) C hange in  functional 
im pairm en t
(a) G ender
(b) Age
(c) N u m b er and  d u ra tio n  
of sym ptom s
(d) Psychiatric d iso rders
C hange in sym ptom s
- Fem ale gender: absence of im provem en t
- H igher n u m b er of sym ptom s: absence of 
im provem ent
C hange in func tiona l im pairm en t (FI):
(b, 95% CI)
- H igher FI at baseline: h ig h er FI a t fo llow -up
- H igher age: h ig h er FI a t fo llow -up
OR=2.7 (1.01 to 7.4) 
£=1.0 (0.1 to  1.9)
£=0.30 (0.17 to  0.43) 




(1) C hange in  global 
clinical im provem en t
(a) A ge
(b) G ender
(c) H ealth  status
(d) M ental state
C hange in global clinical im p ro v e m e n t 




(1) Recovery of 
sym ptom s
(2) C hange in  m edical 
care u tilization
(a) H ypochondriasis 
(questionnaire; WI)
(b) H ypochondriasis 
(interview )
(c) Illness attitude
(d) S om atosensory 
am plification
Recovery of sym ptom sb
- H igher scores on hypochondriasis 
questionnaire (WI): less recovery
C hange in m edical care u tilization  (num ber of
m edical visits)
- H igher scores on illness behav iour subscale 
of the illness a ttitu d e  scale: increase of 
n u m b er of m edical visits
£=-0.89 (-1.58 to  -0.20) 
£=0.31 (0.09 to  0.52)
H enningsen  
et al.,
200528
(1) Affective and 
cognitive sym ptom s
(2) Som atoform  
sym ptom s
(3) H ypochondriasis
(4) Q uality  of life
(a) A ttribu tion Affective an d  cognitive sym ptom s
- O rganic causal a ttribu tion : m ore depressive 
sym ptom s
Q uality  of life











(b) Self-rated p o o r hea lth
(c) O ccupational disability
(d) Physic ian-ra ted  po o r 
physical hea lth
(e) D epression
(f) G enera lized  anxiety 
d iso rder
(g) Age
(h) N u m b er of curren t 
sym ptom s a t baseline
Persistence of ab ridged  som atisation
- Self-rated p o o r overall health : persistence
- M o d era te /sev e re  occupational disability: 
persistence
OR=1.82 (1.32 to  2.52) 
OR=1.55 (1.17 to  2.06)
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Table 3. Prognostic factors (continued)




(1) R em ission of 
hypochondriasis
(2) Levels of 
hypochondriacal 
sym ptom s
(a) D em ographics
(b) H ealth  care u tilization
(c) Social ad justm en t
(d) O verall function ing
(e) D uration  an d  scores of 
hypochondriacal 
sym ptom s
(f) H ealth  percep tio n
(g) Sensitivity  to  bodily  
sensations and 
env ironm en ta l stim uli
(h) Personality , 
neuro tic ism , 
extroversion
(i) C om orbid  dep ression  or 
anxiety
R em ission of hypochondriasisb
- L ow er scores of hypochondriaca l sym ptom s 
on WI: rem ission
- L ow er scores of h ypochondriaca l sym ptom s 
on SSI: rem ission
- L ow er m ean  ra tin g  of hypochondriasis: 
rem ission
- S horter m ean  d u ra tio n  of illness: rem ission
- H ig h er level of overall functioning: rem ission
Level of hypochondriacal sym ptom s
- M ore unrealistic fe a r of illness: h ig h er
- H ig h er scores on SSI: h ig h er
- H ig h er som atosensory  am plification: h ig h er
- H igher scores on som atisation  (SCL-90): 
h ig h er
-H ig h e r  level of neuro ticism : h igher
- O ld er age: h ig h er






r=0.4; P =01 
r=0.4; P =01 
r=0.39; P = 01 
r=0.38; P = 02
r=0.36; P=.02 





(1) R em ission of 
hypochondriasis
(a) H ypochondriacal 
sym ptom s (WI an d  SSI)
(b) H ypochondriacal 
som atic com plain ts (26- 
item s SSI)
(c) Sym ptom s 
am plification
(d) Functional status
(e) P sychiatric com orbidity
(f) M edical com orbidity
R em ission of hypochondrias is  
- D ecreases in h y pochondriaca l som atic 





(1) R em ission of 
hypochondriasis
(a) H ypochondriacal 
som atic com plain ts (26- 
item s SSI)
(b) Som atosensory 
am plification
(c) N orm ative beliefs abou t 
hea lth  and  sickness
R em ission of hypochondrias is  
- The 3-w ay in teraction  of h ea lth  no rm s x 
hypochondriaca l som atic com plain ts x 
am plification significantly  increased  the 












(c) Personality  d iso rd er
(d) H ealth  status
(e) Som atosensory 
am plification
(f) H ypochondriacal 
sym ptom s (WI)
(g) H ypochondriacal 
som atic com plain ts (SSI)
(h) In term ed iate activities 
of daily  living
N u m b er of h ypochondriaca l sym ptom s 
- H ig h er som atosensory  am plifications: m ore 
hypochondriaca l sym ptom s




(1) Persisten t health
anxiety
(a) D epression  /  anxiety
(b) N egative affectivity
(c) Som atic discom fort
(d) Personal an d  fam ily 
experiences re la ted  to 
illness th ro u g h o u t 
childhood
(e) C urren t stress and  
illness
(f) Sociodem ographics
(g) Satisfaction w ith  
m edical atten tion
(h) E valuation  of state of 
hea lth
(i) D egree of h ea lth  anxiety
Persistent h ea lth  anxietyb
- Less positive  m edical self- evaluation  of 
hea lth  p roblem s: persistence




S im on et al.,
200139
(1) Persistence of 
hypochondriasis
(a) A nxiety
(b) D epressive d iso rd er
N o significant association found
WI: W hitely Index; SSI: Som atic Sym ptom  Inventory; SCL-90: Sym ptom  Checklist-90.
A d justed  estim ates an d  95% CI. 
b O nly un iv aria te  resu lts  available (crude estim ates an d  95% CI, significant differences of associations). 
c The m easure of hypochondriacal sym ptom s at fo llow -up w as the su m  of the W hitely Index x 5.6 + the Som atic Sym ptom ,
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(GHP), degree of pain, physical functioning and  illness behaviour. It is unclear w hether female 
gender p redicts an  unfavourable course of MUS as tw o stud ies found  tha t gender w as of 
prognostic significance, w hereas one s tudy  found  tha t gender w as no t of prognostic 
significance.31 S tudies on  com orbid m ental health  problem s such as affective state and 
alexithym ia show ed conflicting results.29'30'36
W e found  w eak evidence th a t poor self-evaluation of overall health  and  for occupational 
disability a t baseline predicts persistence of abridged  som atisation.40
Potential prognostic factors on  recovery of hypochondriasis w ere s tud ied  in  four publications 
(see Table 3).32'33'35'39 W e found  som e evidence for the num ber of som atic com plaints on the 
Somatic S ym ptom  Inventory (SSI) a t baseline pred ic ting  recovery of hypochondriasis. A higher 
score pred ic ts persistence of hypochondriasis (Table 4).33'35 F urtherm ore w e found  w eak 
evidence for the prognostic value on the course of hypochondriasis of sym ptom s scores on the 
W hitley Index, rate of severity  of hypochondriasis, duration , level of functioning and  degree of 
unrealistic fears of illness. A gain, it looks like tha t the m ore serious the condition  a t baseline, the 
m ore unfavourable the outcom e (i.e. persistence of hypochondriasis). Psychiatric com orbidity 
seem s n o t to influence the course of hypochondriasis,33'35'38'39 w hereas som atosensory 
am plification seem ed to influence the outcom e of hypochondriasis in  tw o stud ies M'æ
Discussion 
Main results
A lthough  a lot of research is done on the epidem iology of, an d  in terventions for m edically 
unexplained  sym ptom s, w e are n o t aw are of a system atic review  of the literatu re tha t focuses on 
the course and  the prognosis of m edically unexplained  sym ptom s. Creed and  Barsky7 
perfo rm ed  a system atic review  of the ep idem iology  of som atisa tion  d iso rder and  
hypochondriasis to exam ine the characteristics an d  associated features of these disorders. 
H ow ever, they d id  n o t system atically search an d  s tudy  prognostic factors.7 So, this is the first 
system atic review  w hich  system atically searched for stud ies on  prognostic factors in  this area. 
G enerally, the included  stud ies w ere of good quality. H ow ever, the heterogeneity  betw een 
those included  stud ies regard ing  clinical setting, num bers enrolled  in  the cohort, du ration  of 
follow -up, loss to follow -up, prognostic factors and  outcom e m easures used  is considerable. 
This lim its direct com parability  of the stud ies and  m akes it difficult to d raw  reliable conclusions.
The stud ies on  MUS and  abridged  som atisation  show ed im provem ent rates of 50 % or m ore. This 
is better th an  w e expected. H ow ever, 10 to 30% of patients w ith  MUS deteriorate. G iven the large
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Table 4. Strength of evidence of prognostic factors w ith a significant influence on outcome in multivariate analysis
Prognostic factor Outcome QS>60% QS<60% Strength ° f
evidence
MUS
Affective s ta te /d ep ress iv ity
Fem ale gender
A lexithym ia
Sym ptom  du ra tio n
N u m b er of sym ptom s
H ypochondriasis questionnaire (WI)
Initial G H P
N u m b er of physical sym ptom s 
Pain
Physical function  
Age
Illness beh a v io u r subscale of IAS 
A ttribu tion
Sym ptom  change 
Sym ptom  change 
Sym ptom  change 
Sym ptom  change 
Sym ptom  change 
Sym ptom  change
C hange in  general h ea lth  perception  
C hange in  general h ea lth  perception  
C hange in  general h ea lth  perception  
C hange in  global clinical im provem en t 
Difference in  functional im pairm en t 
C hange in  m edical care u tilization  
Q uality  of life
y2 (50%) 
2 /3  (66%) 
1 /2  (50%) 
1 /2  (50%) 
2 /2  (l00%) 
1 /3  (33%)a
1 /1  (100%) 
1 /1  (100%) 
1 /1  (100%) 
1 /1  (100%) 
1 /1  (100%) 
1 /1  (100%)















Self-rated overall hea lth  
O ccupational disability
Persistence of ab ridged  som atisation  
Persistence of ab ridged  som atisation
1 /1  (100%) 




H ealth  n o rm s x som atisation  x am plification0 
H ypochondriacal som atic com plain ts (SSI) 
H ypochondriacal sym ptom s (WI)
Rating of hypochondriasis 
D uration  of illness 
Level of overall func tion ing  
U nrealistic  fear of illness 
H ypochondriacal sym ptom s (SSI) 
S om atosensory am plification 
Som atisa tion  (SCL-90)
N eurotic ism
Age
Social ad justm ent 
S om atosensory am plification 
Self-evaluation of hea lth  problem s 
D egree of self-judged h ea lth  anxiety
Rem ission of hypochondriasis 
Rem ission of hypochondriasis 
Rem ission of hypochondriasis 
Rem ission of hypochondriasis 
Rem ission of hypochondriasis 
Rem ission of hypochondriasis 
H ypochondriacal sym ptom  level 
H ypochondriacal sym ptom  level 
H ypochondriacal sym ptom  level 
H ypochondriacal sym ptom  level 
H ypochondriacal sym ptom  level 
H ypochondriacal sym ptom  level 
H ypochondriacal sym ptom  level 
N u m b er hypochondriacal sym ptom s 
C hange in  hea lth  anxiety 
C hange in  hea lth  anxiety
1 /1  (100%) 
2 /2  (100%)d 
1 /1  (100%) 
1 /1  (100%) 
1 /1  (100%) 
1 /1  (100%) 
1 /1  (100%) 
1 /1  (100%) 
1 /1  (100%) 
1 /1  (100%) 
1 /1  (100%) 
1 /1  (100%) 
1 /1  (100%)
1 /1  (100%) 
1 /1  (100%) 

















O nly factors are p resen ted  w h ich  scored significant associations in  a t least one study .
QS: Q uality  score; IAS: Illness A ttitu d e  Scale.
a Significant association only  in  one s tu d y  w ith  un iv aria te  analysis. 
b O nly u n iv aria te  analysis available
c O nly the th ree-w ay in teraction  significantly  im proved  the m odel an d  increased  the likelihood of a diagnosis of hypochondriasis at follow -up. 
d S ignificant association in one s tu d y  w ith  m ultiva riate  analysis an d  in  one s tu d y  w ith  un ivaria te  analysis.
num bers of patien ts p resen ting  w ith  MUS in p rim ary  an d  secondary care, deterio ration  of one 
th ird  of these patien ts still m eans tha t large num bers of patients w ith  MUS are going to get 
worse. The stud ies on  hypochondriasis show ed a less optim istic picture: the m ajority of these 
patients (50 to t 70%) do no t recover du ring  follow  up. This m ight be due to the definition of 
hypochondriasis w hich  requires patien ts to have sym ptom s for six m onths or m ore .
W e d id  no t find  any prospective s tudy  on  course or prognostic factors in  patien ts w ith  D SM -IV  
som atoform  disorders. As the evidence for the num ber of sym ptom s at baseline in  MUS as a 
prognostic factor originate from  only tw o of the included  MUS study, w e conclude that, there is 
som e evidence tha t the num ber of sym ptom s at baseline predicts the course of MUS. In the 
stud ies on hypochondriasis w e found  som e evidence tha t the som atic sym ptom  score on  the SSI
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at baseline p redicts the course of hypochondriasis. Furtherm ore, the condition  of patien ts w ith  
MUS at baseline, represen ted  by health  perception  and  physical functioning, and  the condition 
of patien ts w ith  hypochondriasis a t baseline, rep resen ted  by ra ting  of severity, physical 
functioning an d  du ration  of illness, show ed a w eak  association w ith  the outcom e of MUS and 
hypochondriasis. So, w e conclude tha t there is som e evidence tha t the seriousness of the 
conditions of patients w ith  MUS or hypochondriasis a t baseline m ight be of prognostic 
significance.
W e found  only w eak  evidence for m any other prognostic factors. Evidence on gender to be of 
prognostic significance w as inconclusive. Rem arkably, w e found  no evidence to su p p o rt the 
influence of psychiatric com orbidity  and  personality  traits on  the course of MUS, abridged  
som atisation  and  hypochondriasis.
Comparison with the literature
A lthough  only a m inority  of the MUS presen ted  du ring  consultation  resu lt in  a chronic 
condition, patien ts w ith  MUS are problem atic in  health  care.4 Physicians perceive these patients 
as difficult and  dem anding.43,44 They also believe tha t patien ts w ith  MUS increase health  care 
costs due to sickness absence an d  service use, th a t they are at risk for unnecessary diagnostic 
procedures. Physicians express the need  to preven t som atic fixation in  these patients.45-47 
H ow ever, w e found  tha t the prognosis of MUS in  prim ary  and  secondary care is more 
favourable then  expected, as the m ajority of the patients w ith  MUS im prove. A possible 
explanation  for th is finding is tha t im provem ent of sym ptom s is partly  caused by regression to 
the m ean because sym ptom s are on  their w orst w hen  selecting patien ts du ring  p rim ary  or 
secondary  care clinic visits.
H ow ever, our find ing  th a t the m ajority of the patients w ith  hypochondriasis do no t recover is 
sup p o rted  by the literatu re in  w hich hypochondriasis is considered to be a chronic 
condition.3'48,49 A lthough, according to the literature, spontaneous recovery of hypochondriasis 
is rare, w e found  recovery rates of 35% to 50%. A possible explanation  for th is find ing  m ight be 
the procedure as requ ired  for inclusion in  the s tudy  cohorts. This p rocedure is an  extensive 
clinical assessm ent consisting of diagnostic interview s an d  add itional testing  and  m ight in  itself 
be of therapeutic im portance.50'51
G iving the m any factors hypothesized  to be prognostic for a chronic course of MUS, 
som atisation  d isorder an d  hypochondriasis, there is n o t m uch evidence on these factors. 
A lthough  personality  traits, includ ing  neuroticism  an d  alexithym ia,52'53 an d  psychiatric 
com orbidity, includ ing  anxiety an d  depression54-56 have been dem onstrated  to be associated 
w ith  MUS an d  hypochondriasis, only a lim ited num ber of stud ies have exam ined their
prognostic value. In th is review  w e d id  n o t find  evidence for their prognostic value.29'30'33'35"39 
H ow ever, in  w ell defined m edically unexplained  syndrom es such as chronic fatigue syndrom e 
and  irritable bow el syndrom e the evidence on prognostic factors is m uch  stronger.57-61 Cairns et 
al. found  tha t less fatigue severity  at baseline, a sense of control over sym ptom s and  not 
a ttribu ting  illness to a physical cause w ere associated w ith  a good outcom e.57 Their findings of 
the prognostic significance of the fatigue severity  at baseline is in  line w ith  our find ings.
Strengths and limitations
In this system atic review , w e used  an  extensive search strategy to identify  relevant studies. We 
ad d ed  rigor to our s tudy  by pre-testing  the search strategy on publications abou t MUS in our 
ow n database an d  by searching all relevant databases w ithou t language restriction. M oreover, 
w e had  good interobserver agreem ent for in- an d  exclusion. Finally, w e independently  
extracted data an d  assessed the quality  of included  stud ies w ith  a validated  checklist.
Because the quality  of the ind iv idual s tudy  influences outcom es, w e presen ted  our results 
together w ith  a quality  score of each study. So, w e v isualize the susceptibility  of each s tudy  for 
bias. C urrently , no  standard ized  m ethod  is available to assess the quality  of prognostic studies.
Therefore, w e used  a checklist of p redefined  criteria w hich  has been used  in  prev ious prognostic
20'21reviews.
The m edian  num ber of participan ts enrolled  in  the cohorts of the included  stud ies in  this review  
is 87. O nly one s tudy  on  MUS, one s tudy  on abridged  som atisation  an d  none of the stud ies on 
hypochondriasis enrolled  m ore th an  200 patients into the cohort.29,40 These low  num bers of 
participan ts in  the cohorts lim its the streng th  of the evidence concerning outcom e and 
prognostic factors.
O nly a m inority  of the included  stud ies p resen ted  sufficient data on  the du ration  of sym ptom s at 
baseline. Therefore, it is no t clear w hether the s tudy  patien ts w ere all included  at a sim ilar point 
in  the course of their disease. S tudies reporting  du ration  of sym ptom s at baseline show ed a 
considerable range of du ration  of sym ptom s. This also lim its the in te rp re ta tion  of our results.
A nother lim itation of th is review  is the absence of a detailed descrip tion  of treatm ents during  
follow -up. The results of our s tudy  app ly  to the course of MUS, hypochondriasis and 
som atisation  d isorder in  the m edical system . W e assum e th a t du ring  the stud ies in  all patients 
som e k ind  of treatm ent has been applied , a lthough  no s tudy  reported  on th is .
As statistical pooling w as n o t possible because of the h igh  heterogeneity  of s tudy  populations, 
prognostic factors an d  outcom e m easures am ong included  studies, w e perform ed a best
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evidence synthesis. A lthough  such a qualitative analysis is n o t as objective as a m eta-analysis, 
w e w ere able to sum m arize the value of prognostic indicators w hich takes the m ethodological 
quality  into account.62
Implications for further research and clinical practice
The pessim istic v iew s of GPs an d  their w orries about the developm ent of som atic fixation in 
patients w ith  MUS an d  ab ridged  som atisation  m ight no t alw ays be justified  as the m ajority of 
these patien ts generally have a favourable prognosis. H ow ever, the m ajority of the patien ts w ith  
hypochondriasis do no t recover suggesting  tha t hypochondriasis is a m ore severe condition.
Establishing the num ber of som atic sym ptom s an d  seriousness of the condition  in  patien ts w ith  
MUS or hypochondriasis du ring  the first consultations m ight help GPs to value the risk of 
persistence and  m ay guide GPs w hether to offer only reassurance abou t the favourable 
prognosis or, for the h igh-risk patients, a m ore intensive approach  such as reattribution . 
H ow ever, due to its heterogeneity , the data  collated in  this system atic review  on prognostic 
factors are inadequate to identify  predictors of the course of MUS, som atisation  disorder and  
hypochondriasis. Therefore, it is difficult to advise clinicians how  to d istinguish  betw een 
patien ts w ith  low  and  h igh  risks of persistence.
A lthough  it is w idely  accepted th a t personality  traits an d  com orbid depression an d  anxiety are 
associated w ith  MUS, som atisation  disorder an d  hypochondriasis, stud ies exam ining their 
prognostic value show  conflicting results. As a consequence of the paucity  of cu rren t research, 
there is need  for m ore well conducted  prospective cohort stud ies w ith  a reasonable n um ber of 
patien ts (>200 patients), in  w hich  assessm ent of treatm ents du rin g  follow -up an d  inclusion of 
patien ts at a sim ilar po in t in  the course of their disease are im portan t topics.
A lthough  w e know  for long tha t the doctor-patient relationship  effects the outcom e of 
consultations an d  can be therapeutic, none of the included  stud ies took the doctor-patient 
relationship  into account.63-65 The m ore non-specific aspects of consultation  such as described in 
the patien t-cen tred  clinical m ethod  needs atten tion  in  fu tu re  research.66
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Appendix A. Search strategy
(som atoform  disorder [mesh] OR som atization  [tw] OR som atisation  [tw] OR hypochondriasis 
[mesh] OR neurasthen ia  [mesh] OR conversion d isorder [mesh] OR som atoform  disorder* [tw] 
OR hypo ch o n d riasis  [tw] OR neurasthen*  [tw] OR conversion  d isorder*  [tw] OR 
p sy c h o p h y s io lo g ic a l  d is o r d e r  [M esh] OR p sy c h o so m a tic  m e d ic in e  [M esh] OR 
psychophysiological disorder* [tw] OR psychosom at* [tw] OR psychosom atic m edicine [tw] 
OR functional som atic sympt* [tw] OR functional som atic syndrom * [tw] OR functional 
syndrom * [tw] OR unexplained  sympt* [tw] OR m edically unexplained  [tw] OR unexplained 
m edical sympt* [tw] OR psychogen* [tw] OR non-organ* [tw] OR non-specific com plain* [tw] 
OR non-specific sympt* [tw]) A N D  (incidence[M eSH:noexp] OR m ortality[M eSH Terms] OR 
follow  up  studies[M eSH :noexp] OR prognos*[Text W ord] OR predict*[Text W ord] OR 
course*[Text W ord]) A N D  (((Prospective stud ies [mesh] OR cohort stud ies [mesh] OR follow- 
up  stud ies [mesh] OR observational stud* [tw] OR prospective stud* [tw] OR cohort stud* [tw] 
OR follow -up stud* [tw])) OR ((random ized controlled trial [pt] OR contro lled  clinical trial [pt] 
OR random ized  controlled trials [mh] OR random  allocation [mh] OR double-blind  m ethod 
[mh] OR single-blind m ethod  [mh] OR clinical trial [pt] OR clinical trials [mh] OR "clinical trial" 
[tw] OR ((singl* [tw] OR doubl* [tw] OR trebl* [tw] OR tripl* [tw]) AND (mask* [tw] OR blind* 
[tw])) OR "latin square" [tw] OR placebos [mh] OR placebo* [tw] OR random * [tw] OR research 
design [mh:noexp] OR com parative s tudy  [mh] OR evaluation  stud ies [mh] OR follow -up 
stud ies [mh] OR prospective stud ies [mh] OR cross-over stud ies [mh] OR control* [tw] OR 
prospectiv* [tw] OR volunteer* [tw]) NOT (anim al [mh] NOT hu m an  [mh])))
Appendix B. Criteria list for assessing the methodological quality of 




A. Description of inception cohort + /  - /  ?
B. Description of study population + /  - /  ?
C. Description of relevant inclusion and exclusion criteria + /  - /  ?
D. Definition of chronic functional somatic symptoms + /  - /  ?
E. Number of subject in study population ä 200 + /  - /  ?
Response
F. Response rate ä 75% + /  - /  ?
G. Information about non-responders versus responders + /  - /  ?
Follow-up (extend and length)
H. Follow-up of at least 12 months + /  - /  ?
I. Loss-to-follow-up < 20% + /  - /  ?
J. Information about completers versus those loss-to-follow-up + /  - /  ?
K. Prospective data collection + /  - /  ?
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Treatment
L. Description of possible treatment in cohort 
Outcome
M. Clinically relevant outcome measures 
N. Standardized assessment of symptom outcome
O. Standardized assessment of functional outcome 
Prognostic factors
P. Standardized assessment of potential prognostic factors 
Analysis
Q. Appropriate univariate crude estimates 
R. Appropriate multivariate analysis techniques 
Data presentation
S. Frequencies of most important outcome measures presented 
T. Frequencies of most important prognostic factors presented 
U. Influence of prognostic factors presented
+, positive (design or conduct adequate);
-, negative (design or conduct inadequate);
?, unclear (insufficient information)
+ / - /
+ / - /
+ / - /
+ / - /
+ / - /
+ / - /
+ / - /
+ / - /
+ / - /
+ / - /
Appendix C. Explanation of the criteria of the checklist for 
methodological quality
A. Description of inception cohort
Positive if it is described in what setting the subjects were recruited (i.e. general population, patients attending the 
general practitioner, inpatient or outpatient setting).
B. Description of study population
Positive if it is described which subjects from the inception cohort are recruited and if age and sex are described.
C. Description of relevant inclusion and exclusion criteria
Positive if it is described how subjects were identified with chronic functional somatic symptoms (CFSS) or 
somatization.
+ = CFSS or somatization diagnosed by the general practitioner or standardized diagnostic interview
- = CFSS or somatization diagnosed by a (standardized) self-administered symptom checklist 
? = not clear
D. Definition of chronic functional somatic symptoms
Positive if the definition is described of CFSS or somatization.
E. Num ber of subjects in study population ä 200
Positive if the number of subjects with CFSS or somatization in the study population was at least 200 at baseline.
F. Response rate ä 75%
Positive if response rate is at least 75%. Response rate: the number of patients in the study population, divided by the 
number of subjects in the inception cohort.
G. Information about non-responders versus responders
Positive if demographic or clinical information (such as age and sex) was presented for responders and 
nonresponders, or if there was no selective response, or no nonresponse.
H. Follow-up of at least 12 months
Positive if the follow-up period was at least 12 months.
I. Loss-to-follow-up < 20%
Positive if total number of patients with CFSS or somatization was at least 80% at the end of follow-up compared to 
the number of participants with CFSS or somatization at baseline. Loss to follow-up: the number of patients in the 
study population at baseline minus the number of patients at the main health status measurement for the main 
outcome measure at the end of follow-up, divided by the number of patients in the study population at baseline.
J. Information about completers versus those loss-to-follow-up /  dropouts
Positive if demographic or clinical information (such as age and sex, disease characteristics and other potential 
prognostic predictors) was presented for completers with CFSS or somatization and those lost to follow-up at the 
main moment of outcome measurement, or if there was or no selective loss-to-follow-up, or no loss-to-follow-up.
K. Prospective data collection
Postive if main outcome measures on potential prognostic predictors was collected prospectively.
L. Description of possible treatm ent in cohort
Positive if treatment subsequent to inclusion in cohort is fully described or standardized. Also positive if no treatment 
is given.
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+ = treatm ent/multivariate correction for treatment in analysis, or no treatment given
- = different treatment regimens, not clear how outcome is influenced by it 
? = not clear if any treatment is given 
M. Clinically relevant outcome measures
Positive if at least one of the following outcome measures is presented: CFSS /  somatization diagnosis, symptoms, 
remission or recurrence, functional status, social functioning, lost days of work, quality of life, impairment, mortality. 
N. Standardized assessment of symptom outcome
Positive if standardized questionnaires or objective outcome measurements of at least one of the following three 
outcome measures were used for each follow-up measurement:
a. CFSS /  somatization diagnosis
b. Symptoms
c. Remission or recurrence
O. Standardized assessment of functional outcome
Positive if standardized questionnaires or objective outcome measurements of at least one of the following six 
outcome measures were used for each follow-up measurement:
a. functional status
b. social functioning
c. lost days of work
d. quality of life
e. impairment
f. mortality
P. Standardized assessment of potential prognostic factors
Positive if standardized questionnaires or objective measurements were used at baseline of at least 4 of the following 




d. family history of CFSS/somatization
e. race
f. social economic status (SES)
g. education level
h. number of episodes of CFSS/somatization
i. sick leave
j. functional impairment
k. comorbidity (i.e. anxiety disorder or chronic disease)
l. duration of symptoms
m. social support
n. stressful life events
o. difficult doctor-patient relationship
p. coping strategy
q. perception of symptoms (i.e. illness attitude, somatosensory amplification)
r. personality traits
Q. Appropriate univariate crude estimates
Positive if separate univariate (repeated measures) analysis of variance were calculated for each dependent measure. 
R. Appropriate multivariate analysis techniques
Positive if multivariate (repeated measures) analysis of variance were calcultated for changes among the dependent 
measures occuring during the follow-up interval.
S. Frequencies of most im portant outcome measures presented
Positive if frequency, percentage or mean, median (interquartile range) and standard deviation/confidence intervals 
are reported of the most important outcome measures.
T. Frequencies of most im portant prognostic factors presented 
Positive if:
a. frequency of percentage is reported, or
b. mean and standard deviation or standard error are reported, or
c. median and interquartile range are reported, or
d. if the influence of each separate factor is reported 
U. Influence of prognostic factors presented
Positive if the influence of each separate prognostic factor on the natural course of CFSS or somatization is presented.
Course and prognosis, a systematic review | 63
Reference List
1 Kroenke K, M angelsdorff AD. C om m on sym ptom s in  am bulatory  care: incidence, 
evaluation, therapy, and  outcom e. Am  J M ed 1989; 86(3):262-266.
2 Barsky AJ, Borus JF. Som atization and  m edicalization in  the era of m anaged  care. JAMA 
1995; 274(24):1931-1934.
3 Kellner R. Som atization and  H ypochondriasis. N ew  York: Praeger; 1986.
4 V erhaak PF, Meijer SA, V isser AP, W olters G. Persistent p resen tation  of m edically 
unexplained  sym ptom s in  general practice. Fam Pract 2006; 23 (4) :414-420.
5 A m erican Psychiatric A ssociation. D iagnostic and  statistical m anual of m ental d isorders. 4 
ed. W ashington (DC) : A m erican Psychiatric Association; 1994.
6 W orld H ealth  O rganisation. The ICD-10 classification of m ental an d  behavioural disorders: 
diagnostic criteria for research. Geneva: W orld H ealth  O rganisation; 1993.
7 Creed F, Barsky A. A system atic review  of the epidem iology of som atisation  disorder and 
hypochondriasis. J Psychosom  Res 2004; 56(4):391-408.
8 Sm ith GR, Jr., M onson RA, Ray DC. Psychiatric consultation  in  som atization  d isorder. A 
random ized  controlled study. N  Engl J M ed 1986; 314(22):1407-1413.
9 Deyo RA, Diehl AK. Patient satisfaction w ith  m edical care for low -back pain. Spine 1986; 
11(1):28-30.
10 olde H artm an  TC, franke L, Lucassen PLBJ, van  Spaendonck K.P.M., van  W eel C. 
Explaining the unexplainable: fam ily physicians' m anagem ent of patien ts w ho frequently  
p resen t m edically unexplained  sym ptom s. A focus group  study. A nn Fam  M ed 2008; 
subm itted.
11 Epstein RM, Q uill TE, M cW hinney IR. Som atization reconsidered: incorporating  the 
patien t's  experience of illness. A rch In tern  M ed 1999; 159(3):215-222.
12 Rosendal M, Bro F, Sokolow ski I, Fink P, Toft T, O lesen F. A random ised  controlled trial of 
brief train ing  in  assessm ent an d  treatm ent of som atisation: effects on  GPs' a ttitudes. Fam 
Pract 2005; 22(4):419-427.
13 M ayou R, Farm er A. ABC of psychological medicine: Functional som atic sym ptom s and  
syndrom es. BMJ 2002; 325(7358):265-268.
14 R ief W, S h arp e  M. S o m ato fo rm  d iso rd e rs -n e w  a p p ro a c h e s  to  c lass ifica tio n , 
conceptualization, and  treatm ent. J Psychosom  Res 2004; 56(4):387-390.
15 Bennett JC. Inclusion of w om en in  clinical trials--policies for popu la tion  sub g ro u p s. N  Engl J 
M ed 1993; 329(4):288-292.
16 Laupacis A, W ells G, R ichardson WS, Tugw ell P. Users' guides to the m edical literature. V. 
H ow  to use an  article abou t prognosis. Evidence-Based M edicine W orking G roup. JAMA 
1994; 272(3):234-237.
17 W ilczynski NL, H aynes RB. O ptim al search strategies for identify ing m ental health  content 
in  MEDLINE: an  analytic survey. A nn G en Psychiatry 2006; 5:4.
18 Cohen J. A coefficient of agreem ent for nom inal scales. E ducational an d  psychological 
m easurem ent 1960; 20:37-46.
19 H am ilton  WT, G allagher AM, Thom as JM, W hite PD. The prognosis of different fatigue 
diagnostic labels: a longitud inal survey. Fam  Pract 2005; 22(4):383-388.
20 H erm ens ML, van  H ou t HP, T erluin B, v an  der W indt DA, Beekm an AT, v an  DR et al. 
The prognosis of m inor depression in  the general population: a system atic review . Gen 
H osp Psychiatry 2004; 26(6):453-462.
21 Scholten-Peeters GG, V erhagen AP, Bekkering GE, van  der W indt DA, Barnsley L, 
O ostendorp  RA et al. Prognostic factors of w hiplash-associated  disorders: a system atic 
review  of prospective cohort studies. Pain  2003; 104(1-2):303-322.
22 H udak  PL, Cole DC, Frank JW. Perspectives on prognosis of soft tissue m usculoskeletal 
disorders. Int J Rehabil Res 1998; 21(1):29-40.
23 A ltm an DG. System atic review s of evaluations of prognostic variables. BMJ 2001; 
323(7306):224-228.
24 H ayden  JA, Cote P, Bom bardier C. Evaluation  of the quality  of prognosis stud ies in 
system atic review s. A nn In tern  M ed 2006; 144(6):427-437.
25 K uijpers T, van  der W indt DA, v an  der H eijden GJ, Bouter LM. System atic review  of 
prognostic cohort stud ies on  shoulder disorders. Pain  2004; 109(3):420-431.
26 Sackett DL, S traus SE, R ichardson WS. H ow  to practice and  teach EBM. G uidelines. 
Edinburgh: Churchill Livingstone; 2000.
27 A riens GA, van  MW, Bongers PM, Bouter LM, van  der WG. Physical risk factors for 
neck pain. Scand J W ork Environ H ealth  2000; 26(1):7-19.
28 H enningsen  P, Jakobsen T, Schiltenw olf M, W eiss MG. Som atization revisited: diagnosis 
and  perceived causes of com m on m ental disorders. J N erv  M ent Dis 2005; 193(2):85-92.
29 De G ucht V, Fischler B, H eiser W. Personality  an d  affect as determ inants of m edically 
unexplained  sym ptom s in  prim ary  care; A follow -up study. J Psychosom  Res 2004; 
56(3):279-285.
30 K ooim an CG, Bolk JH, Rooijmans HG, Trijsburg RW. A lexithym ia does n o t p red ic t the 
persistence of m edically unexplained  physical sym ptom s. Psychosom  M ed 2004; 
66(2):224-232.
31 Carson AJ, Best S, Postm a K, Stone J, W arlow  C, Sharpe M. The outcom e of neurology 
ou tpatien ts w ith  m edically unexplained  sym ptom s: a prospective cohort study. J N eurol 
N eurosurg  Psychiatry 2003; 74(7):897-900.
32 Barsky AJ, Bailey ED, Fam a JM, A hern  DK. P redictors of rem ission in  DSM 
hypochondriasis. Com pr Psychiatry 2000; 41(3):179-183.
33 Barsky AJ, Fam a JM, Bailey ED, A hern  DK. A prospective 4- to 5-year s tudy  of DSM-III- 
R hypochondriasis. A rch G en Psychiatry 1998; 55(8):737-744.
34 Barsky AJ, C leary PD, Sarnie MK, K lerm an GL. The course of transien t hypochondriasis. 
A m  J Psychiatry 1993; 150(3):484-488.
64 I Chapter 3
Course and prognosis, a systematic review | 65
35 N oyes R, Jr., Kathol RG, Fisher MM, Phillips BM, Suelzer MT, W oodm an CL. O ne-year 
follow -up of m edical ou tpatien ts w ith  hypochondriasis. Psychosom atics 1994; 35(6):533- 
545.
36 Speckens AE, van  H em ert AM, Bolk JH, Rooijmans HG, H engeveld  MW. U nexplained 
physical sym ptom s: outcom e, u tiliza tion  of m edical care an d  associated factors. Psychol 
M ed 1996; 26(4):745-752.
37 Speckens AE, van  H em ert AM, Spinhoven P, Bolk JH. The diagnostic an d  prognostic 
significance of the W hitely Index, the Illness A ttitude Scales and  the Som atosensory 
A m plification Scale. Psychol M ed 1996; 26(5):1085-1090.
38 F ernandez C., Fernandez R., Isaac A m igo D. Characteristics an d  one-year follow -up of 
p rim ary  care patien ts w ith  health  anxiety. P rim ary Care an d  C om m unity Psychiatry 
2005; 10(3):81-93.
39 Sim on GE, G ureje O, Fullerton  C. Course of hypochondriasis in  an  in ternational p rim ary 
care study. G en H osp Psychiatry 2001; 23(2):51-55.
40 G ureje O, S im on GE. The na tu ra l history  of som atization in  prim ary  care. Psychol M ed 
1999; 29(3):669-676.
41 Escobar JI, W aitzkin H, Silver RC, G ara M, H olm an A. A bridged  som atization: a study  
in  p rim ary  care. Psychosom  M ed 1998; 60(4):466-472.
42 C hm ura KH, Periyakoil VS, N oda A. K appa coefficients in  m edical research. Stat M ed 
2002; 21(14):2109-2129.
43 Lin EH, K aton W, Von Korff M, Bush T, Lipscom b P, Russo J et al. F rustra ting  patients: 
physician  an d  patien t perspectives am ong  d istressed  h igh  users of m edical services. J 
G en In tern  M ed 1991; 6(3):241-246.
44 Ring A, D ow rick C, H um phris G, Salm on P. Do patients w ith  unexplained  physical 
sym ptom s pressurise general p ractitioners for som atic treatm ent? A qualitative study. 
BMJ 2004; 328(7447):1057.
45 Sm ith GR, Jr., M onson RA, Ray DC. Patients w ith  m ultip le  unexplained  sym ptom s.
Their characteristics, functional health , and  health  care utilization. A rch In tern  M ed 
1986; 146(1):69-72.
46 Barsky AJ, E ttner SL, H orsky J, Bates DW. Resource u tiliza tion  of patients w ith  
hypochondriacal health  anxiety and  som atization. M ed Care 2001; 39(7):705-715.
47 Grol R. To heal or to harm . The p revention  of som atic fixation in  G eneral Practice. 1981.
48 Kellner R. Prognosis of trea ted  hypochondriasis. A clinical study. Acta Psychiatr Scand 
1983; 67(2):69-79.
49 Kellner R. D iagnosis and  treatm ents of hypochondriacal syndrom es. Psychosom atics 
1992; 33(3):278-289.
50 G uthrie  B. W hy do general p ractitioners take blood? A cross-sectional s tudy  of use of 
b lood tests in  UK general practice. Eur J G en Pract 2001; 7:138-142.
51 Little P, Cantrell T, Roberts L, C hapm an J, L angridge J, Pickering R. W hy do GPs 
perform  investigations?: The m edical an d  social agendas in  arrang ing  back X-rays. Fam 
Pract 1998; 15(3):264-265.
52 V assend O. N egative affectivity, subjective som atic com plaints, and  objective health  
indicators. M ind and  body still separated? In: M aes S, Leventhal H, Johnston M, editors. 
In ternational review  of health  psychology, vol. 3. Chichester: W iley; 1994. 97-118.
53 De G ucht V, H eiser W. A lexithym ia an d  som atisation: quantita tive review  of the 
literature. J Psychosom  Res 2003; 54(5):425-434.
54 Fink P. Psychiatric illness in  patien ts w ith  persisten t som atisation. Br J Psychiatry 1995; 
166(1):93-99.
55 Barsky AJ, W yshak G, K lerm an GL. Psychiatric com orbidity  in  DSM-III-R 
hypochondriasis. A rch G en Psychiatry 1992; 49(2):101-108.
56 N oyes R, Jr., Kathol RG, Fisher MM, Phillips BM, Suelzer MT, W oodm an CL. Psychiatric 
com orbidity  am ong patien ts w ith  hypochondriasis. G en H osp Psychiatry 1994; 16(2):78- 
87.
57 Cairns R, H otopf M. A system atic review  describing the prognosis of chronic fatigue 
syndrom e. O ccup M ed (Lond) 2005; 55(1):20-31.
58 Thabane M, K ottachchi DT, M arshall JK. System atic review  an d  m eta-analysis: The 
incidence and  prognosis of post-infectious irritable bow el syndrom e. A lim ent 
Pharm acol Ther 2007; 26(4):535-544.
59 Joyce J, H otopf M, W essely S. The prognosis of chronic fatigue an d  chronic fatigue 
syndrom e: a system atic review . QJM 1997; 90(3):223-233.
60 C hitkara DK, van  T ilburg MA, Blois-M artin N, W hitehead WE. Early life risk factors that 
contribute to irritable bow el syndrom e in  adults: a system atic review. Am  J 
G astroenterol 2008; 103(3):765-774.
61 El-Serag HB, P ilgrim  P, Schoenfeld P. System ic review: N atu ra l history  of irritable bow el 
syndrom e. A lim ent Pharm acol Ther 2004; 19(8):861-870.
62 L icht-Strunk E, van  der W indt DA, van  M arw ijk HW , de HM , Beekm an AT. The 
prognosis of depression  in  older patien ts in  general practice an d  the com m unity. A 
system atic review . Fam  Pract 2007; 24(2):168-180.
63 Stew art MA, M cW hinney IR, Buck CW. The d o c to r/p a tie n t relationship  and  its effect 
up o n  outcom e. J R Coll G en Pract 1979; 29(199):77-81.
64 Balint M. The doctor, his patien t and  the illness. Edinburgh: C hurchill Livingstone; 2000.
65 M cW hinney IR. A textbook of Fam ily M edicine. N ew  York; Oxford: O xford U niversity 
Press; 1989.
66 S tew art M. Reflections on the doctor-patient relationship: from  evidence an d  experience. 
Br J G en Pract 2005; 55(519):793-801.
66 I Chapter 3




Purpose. The interaction  betw een  FPs an d  patien ts w ith  persisten t m edically unexplained 
sym ptom s (persistent MUS) is described as com plicated. A lthough  perspectives of patients 
w ith  an  initial presen tation  of MUS are stud ied , research on  perspectives of patien ts w ith  
persisten t MUS are lacking. K now ledge of opinions of patien ts w ith  a long history  of p resenting  
MUS m ight guide in terventions to im prove the care for these patients.
Methods. A qualitative approach, in terv iew ing  17 patients w ith  persisten t MUS. D ata w ere 
analyzed using  an  iterative process according to the principles of constant com parative 
analysis.
Results. Patients w ith  persisten t MUS stressed the im portance of a personal continuing 
doctor-patien t relationship. Such a relationship  is bu ilt on  physician  attitude , medical 
com petence, availability and  shared  authority . Patients w an t to be taken  serious in  a non- 
judgm enta l open  com m unication style. They appreciate a tho rough  exploration  an d  a 
com prehensible explanation  of the sym ptom s. Furtherm ore, they w an t a com petent FP w ho is 
easy accessible and  w ho engage them  as partners in  the consultation  and  the decision m aking 
process.
Conclusions. Patients w ith  persisten t MUS value a healing  FP-patient relationship. They 
apprecia te a patient-centered  com m unication an d  orien tation  to care in  w hich personal 
continuity  and  continuity  of the relationship  are im portan t elem ents.
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Physical sym ptom s such as headache, back pain, dizziness an d  fatigue are com m on in  the 
general popu la tion  and  m ost people do no t contact professional m edical care for these 
sym ptom s.1-3 In  those w ho do p resen t these sym ptom s, physicians often do n o t find  an  organic 
cause (i.e. m edically unexplained  sym ptom s).4;5 Fortunately, m edically unexplained  sym ptom s 
(MUS) have a beneficial course w hether or no t as a resu lt of physicians' m anagem ent.6 Only a 
m inority  of patien ts w ill develop persistent MUS. Exactly these patients rep resen t a serious 
problem  in health  care as they suffer from  their sym ptom s, are functionally  im paired , and  are at 
risk for po tentially  harm ful additional testing  and  treatm ent.5;7
The interaction  betw een  FPs an d  patien ts w ith  persistent MUS is described as com plicated. 
Encounters betw een  FPs and  these patients often leave bo th  w ith  fru stra tion  and  confusion.8-10 
W hile the FP perspective on persistent MUS has been stud ied ,11;12 research on patients' v iew s and  
experiences regard ing  the care they receive is still lim ited. K now ledge in  this area is necessary in 
order to im prove the care for these patients.
Existing know ledge regard ing  patien t perspectives on MUS originates from  patients w ith  an 
initial p resen tation  of unexplained  sym ptom s.11;13-15 This research po in ted  ou t tha t patien ts often 
feel stigm atized an d  no t taken  serious,16 th a t they often w ish  to have a convincing, legitim ating 
an d  em pow ering  explanation  for their sym ptom s,17-20 an d  tha t they w an t em otional suppo rt 
from  their FP.21 Furtherm ore, analysis of v ideo taped  consultations in  p rim ary  care revealed  a 
m ism atch betw een  w h a t patien ts w ith  initial MUS w an t and  w hat they actually  receive from  
their FP.13;14 This m ism atch m ight explain w hy patien ts frequently  express their dissatisfaction 
w ith  the m edical care received du rin g  their illness. H ow ever, it is unclear to w hat extent these 
results can be generalized  to patien ts w ith  persistent MUS in prim ary  care. S tudies in  patients 
w ith  the distinctive functional syndrom es chronic fatigue syndrom e (CFS) and  irritable bowel 
syndrom e (IBS) concluded tha t patients feel dissatisfied because of the delay of or confusion 
over the diagnosis, the a ttitude of the doctor and  the inadequate an d  often conflicting 
inform ation given by their doctors.22123
In o rder to im prove the m anagem ent of patients w ith  persistent MUS in fam ily m edicine, we 
perform ed an  interview  s tudy  focusing on the op inions of patien ts w ith  a long history  of 
p resen ting  MUS to their FP.




W e conducted  17 sem i-structured  in terview s w ith  patien ts w ith  persisten t MUS w ho recently 
attended  the FP. W e selected 12 patien ts from  the C ontinuous M orbidity  R egistration (CMR) 
project and  5 patien ts from  three practices of the authors.
CMR project
W e selected patien ts w ho w ere d iagnosed w ith  persistent MUS for the first tim e betw een  2006 
and  2008 from  the CMR database. W e invited  patients aged > 18 years, w ho w ere longer than 
one year on  the practice list, w ithou t language barriers, psychiatric diseases (anxiety disorder, 
depressive disorder, PTSS, d ru g  or alcohol abuse) or cognitive disabilities according to their FP 
(n = 59). These patien ts w ere sent a letter an d  if necessary a rem inder in  w hich  w e asked them  to 
participate in  an  interview  s tudy  regard ing  the quality  of care they receive from  their FP. A total 
of 31 patien ts responded  to this letter an d  12 patien ts vo lun teered  to participate.
In the CMR project of the D epartm ent of Prim ary an d  C om m unity care at the R adboud 
U niversity  N ijm egen M edical Centre every episode of illness seen by, or reported  to, the FP is 
reg istered  as soon as it is established using  an  adap ted  version  of the E-list.24-27 As far as w e are 
aw are, the CMR project is the only m orbidity  reg istra tion  system  w ith  a structural possibility to 
classify patien ts w ith  persisten t MUS .28;29
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Table 1. Patient characteristics
Characteristic









- With partner 9
- With partner and children 4
- Single 4
Time on practice list
- < 1 year 0
- 1-3 years 2
- 3-5 years 2
- > 5 years 13
a Education level was classified as low (primary and lower secondary education), m iddle (upper secondary education, until age 17-18), and
high (pre-university, higher vocational training, and university)
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Authors practices
The 5 patients selected from  the authors' practices w ere used  to test the in terview  guide and  to 
train  the interview  technique. They w ere selected as they persisten tly  consulted  w ith  sym ptom s 
tha t could no t be attribu ted  to a clear organic cause (as described in  the CMR project). We 
included  these patien ts in  the analysis as the interview s p rov ided  rich data.
Sociodem ographic details (age, sex, m arital status, level of education, and  tim e on  the practice 
list) w ere obtained from  the participants. A sum m ary  of patien ts characteristics of the 17 
in terview ed patients is show n in T able 1.
Semi-structured interviews
One of the au thors (JN) conducted  the sem i-structured  interview s at the patien t's  hom e. These 
in terview s w ere recorded, transcribed verbatim , an d  en tered  into A tlas.ti, a softw are p rogram  
for the analysis of qualita tive data. The in terview er w as gu ided  by a list of topics, based on 
im portan t topics h igh ligh ted  in  the literature regard ing  patients' v iew s on  MUS. (see Table 2) 
O pen  questions w ere used  to encourage patients to com m unicate their v iew s on  im portan t 
aspects of the care they receive for their persisten t MUS.
As the collection of data and  the analysis in  qualitative research is an  iterative process, two 
researchers (ToH, PL) ad d ed  relevant topics to the interview  topic list after a prelim inary 
analysis of the first five interview s. Ideas an d  though ts th a t em erged in  prim ary  stages of the 
analysis w ere b rough t back to subsequent interview s as the s tudy  proceeded.
Analysis
The interview s w ere analysed independen tly  by tw o researchers (ToH, HvR) after read ing  the 
transcrip ts several tim es to fam iliarize them selves w ith  the data. The tw o researchers coded the 
transcrip ts and  com pared  an d  discussed these codes w ith  each other. Codes in  each interview  
w ere com pared w ith  those in  other interview s. A dditional codes, w hich em erge from  
discussions w ere also applied  to the transcripts. Concepts and  categories em erged th rough  this 
iterative process of coding, analysis an d  discussion (constant com parative qualita tive 
analysis).30;31 The resu lts of the analysis w ere d iscussed w ith  a th ird  researcher (PL). Data 
collection continued  un til sa tu ra tion  w as reached an d  no new  them es em erged.32
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Table 2. Interview guidebook
Jnderstanding, recognition and support
- Do you think your FP understands your symptoms and problems?
- Are you satisfied with the help and support you get from your FP?
- Does your FP take your symptoms serious?
;Ps' consulting behaviour
- Did you discuss your own thoughts a n d /o r concerns regarding your symptoms with your FP?
- Did you get enough space to communicate your own feelings and emotions during the consultations?
- Did your FP do additional diagnostic tests, and what do you think of that?
- Did your FP give you the advice to come back for a new, possibly longer consultation?
ime and attention
- Do you think you get enough space and time to discuss your symptoms and problems?
- Do you think your FP has enough attention during the consultation?
- Did you feel hurried during the consultation?
knowledge and interest in the patient's context
- Does your FP know about your personal circumstances?
- Did your FP discuss the influence of your symptoms/problems on your daily life?
- Did you discuss ways of coping with your symptoms/problems during consultation?
xplanation and reassurance
- How did your FP explain the symptoms to you?
- Did your FP give you a diagnosis for your symptoms?
- What did you think of the explanation of your symptoms, did it satisfy you?
- Did your FP give you advice on how to handele your symptoms?
hared decision making
- What did you expect your FP was going to do (referral, additional diagnosic tests, etc.) w ith your symptoms?
- Did your FP explain/discuss the treatment plan to /w ith  you?
- Did you and your FP make a shared decision on the treatment plan?
rust
- How do you characterize/perceive the doctor-patient relationship?
- Did the doctor-patient relationship change over time?
uality of care
- Are you satisfied w ith the quality of care you received from your FP for your symptoms/problems?
- Which elements in the quality of received care are important and which are less important for you?
Results
FP-patient relationship
Patients indicate tha t they w an t a w arm , personal continuing FP-patient relationship. Such a 
relationship  m akes it easier for patien ts to discuss sym ptom s and  problem s w ith  their FP. 
Patients m ention th a t there has to be a m atch betw een  the FP and  the patient. Furtherm ore, they 
state tha t the FP-patient relationship  is bu ilt over tim e.
'it used to be that the distance between the doctor and the patient was really big. Now, the distance is 
much smaller. You're basically on the same footing now [...] I find  that much nicer'
(P1 : fem ale, age 59)
'I have the sense that it clicks. I feel good and safe there. I don ' t feel like that there are certain things I 
would be reluctant to say' (P13: fem ale, age 28)
'I've had the same FP since I was 19 so you really do know each other, also because, before all the vague 
complaints started, I would go to m y FP for this or that, a sore throat and what not. And,actually, my 
history of vague health complaints is already so long that we 've come to know what to expect from each 
other and how to play into each other. ' ( P3: fem ale, age 33)
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W e could d istinguish  four key-them es on w hich, according to the in terv iew ed patients, a 
satisfy ing FP-patient rela tionsh ip  is build: physicians attitude , m edical com petence, 
availability and  shared  authority . These com ponents are described in  F igure 1.
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Patients state that they w ant an FP w ith  an  open m ind using a non-judgm ental com m unication 
style. Such a com m unication m akes patients feel at ease and  free to tell their story. Furtherm ore, it 
makes patients feel free to visit their FP. Patients expect an FP to be an  attentive listener show ing a 
lot of understanding.
'and then he says, have a seat. A nd then I start to talk, of course (...) and he listens. (...) he let's me first 
tell my story (...) I can say whatever I want to say. So, that's nice.' (P4: female, age 29)
'she has an active way of listening. She knows me (...) then responds and her voice is so understanding. 
It's like, Okay, I understand that is very frustrating for you.' (P3: female, age 33)
'You just notice that she really listens. She is not thinking, what am I going to eat this evening?' (P13: 
female, age 28)
Patients appreciate FPs w ho take the sym ptom s as well as the person seriously. W hen patients 
notice that the FP does not take them  seriously, they hesitate or even postpone to go to the FP. 
Furtherm ore, they feel powerless, according to the interview ed patients. Know ing that the FP 
takes him  or her seriously is reassuring. Some patients fear that frequently visiting the FP will have 
a negative influence on  the FP's attitude. Patients state that it can take quite some tim e before they 
have the feeling of being taken seriously.
'I'm  always reluctant to go to my FP because I don't feel like I am taken seriously. (...) It's really 
humiliating and it makes you really feel sad because you have pain and you can't explain it. You can't 
ju st say, I do have pain! I need more tests.' (P5: female, age 76)
'I: Do you have any idea how long it took before you got the impression that he does take you seriously, 
that he believes you? P: Well, I think that it took about a year.' (P9: male, age 75)*
* I = interviewer; P =patient
Patients appreciate it if the FP pays attention to emotions. W hen the FP is no t paying attention to 
the patient's fears, this can result in  a feeling of no t being taken seriously. Patients state that talking 
about the fear is not always enough, sometim es a referral for reassurance is necessary.
'so that more attention is paid to your feelings? Yeah, I'd  definitely appreciate that. Yes.'
(P1: female, age 59)
'I: And were you able to then discuss that fear with your FP? P: Yes, I did do that. I said, I am scared. And  
he dealt with that well. He said, What are you scared of? I am scared that I have some kind of cancer in my 
bowels. Then he examined my belly and he started to talk about stress (...) I really appreciated the fact 
that he did that but, in the back of my mind, I thought (...) I think that he kind of felt that and so he said, 
Well, I'll refer you to your specialist.' (P6: female, age 60)
2. Medical competence
Patients w an t a skillful and  com petent FP. Someone who, from  the first presentation, takes a close 
look at the sym ptom s to find out w hat is w rong and w ho gives good advice. They w an t a doctor 
w ho reacts quickly, sharply and adequately to the sym ptom s presented during  the consultation. 
Furtherm ore, the FP's attitude has to be positive and supporting.
'I'll take care of that for you. I know we'll make it through this.' (P1: female, age 59)
'that it's properly examined to determine if  something is wrong or if  it is serious or if  it ju st requires some 
rest, that someone just takes a look to find  out what's going on and just gives you good advice.' (P13: 
female, age 28)
W hen the FP and  the patient together get stuck w ith  the sym ptom s, som e patients stress that 
referral to specialty care is necessary.
'sometimes, I think, send someone to the specialist earlier. All too often, it's we'll try this medication 
first. I f  it doesn't work, we'll try another kind of medication. Then you can keep coming back and only 
after a really long time do you get a referral.' (P5: female, age 76)
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Some patients stress the im portance of getting a diagnosis for their sym ptom s. Patients state that 
such a diagnosis is im portant bo th  for them selves and  for their FP. H owever, patients realize and 
accept the difficulty FPs face w hen  searching for a diagnosis for their vague complaints.
'on the one hand, it changes absolutely nothing. On the other, it allows me to label it and then I can look 
for a solution more effectively. A nd I think that it is also important for my FP. Then he can also be more 
focused and effective in looking for a solution together with me.' (P3: female, age 33)
All patients stressed the need for an  explanation for their sym ptom s in  com prehensible language. 
Different explanations from  different doctors confuse patients. Patients expect explanations about 
w hat is going on in  their body. They w an t to know  w here their sym ptom s come from  and  how 
their body functions.
'Then she explains it to me in a really simple fashion. She says, this and that...and that's why your body 
reacts differently and that's why you have those complaints. (...) Now she is the first that has given me 
that kind of concrete information' (P8: female, age 27)
Patients also m ention exam ples of explanations w hich contain a link betw een physical and 
psychological processes.
'He explained that the mind and the body are connected, and that maybe, yeah, i f  (...) the psychological 
pressure were off (...) then maybe things would improve. So, I totally understood the explanation.'
(P8: female, age 27)
If the FP does not know  the origin of the sym ptom s, patients appreciate the doctor m entioning 
this.
Experiences of the past are taken into account w hen  patients judge the FP's medical competence. 
Patients regard a good past perform ance of the FP in  d iagnosing and  treating sym ptom s as very 
im portant: it strengthens the FP's medical com petence and patients' tru st in  the doctor.
'earache, ear drops - you walk around with this for a week and only then do they send you to the hospital. 
You end up with a double ear infection that has to be lanced...yeah, then I'm  angry!'
(P5: female, age 76)
'usually he [the FP] tries to figure it out himself. He suspected that there was something in my knee 
because of strain or overuse. And what did it turn out to be? Indeed, it was strain. He was right!'
(P4: female, age 29)
Sometimes patients question the medical com petence as a result of stories of other patients in 
w hom  som ething w ent wrong.
3. Availability
Patients have experienced quite some frustrations concerning the access to their FP. They m ention 
that their 'own' FP is not available during  evenings, n ights and w eekends. M oreover, not all FPs 
w ork fulltime. Some patients find  it difficult that they have to w ait several days before they can see 
their FP. Furtherm ore, patients dislike discussions w ith  the practice nurse before they are allow ed 
to have an appointm ent w ith  their FP.
'He only works 2 or 3 days a week. So, usually, when you call to make an appointment, he's already 
booked. The first available appointment is normally about 2 weeks away. I think that's really 
unfortunate.' (P11:female, age 52)
'Whenever you call for something or about something, the assistant always screens the calls and won't 
put you through. I want to speak to the doctor himself about something. Then you need to do a lot to be 
put through, (...) I say, I want to speak to him directly, and then the assistant says, But what is it about? 
And, it's no tpossib le.andit's constant blocking' (P11: female, age 52)
Patients state that they need an FP w ho takes tim e for them. The lim ited consultation time 
sometim es has a negative influence on the contact w ith  the FP, m any patients consider the 
standard  of 10 m inutes consultation tim e too short. Some m entioned the long tim e they spend  in 
the w aiting room  and  the feeling of hurry  w hich this causes during  the consultation.
'It's not like, you're in, you're out. He really does take the time for you. He lets you finish talking.'
(P4: female, age 29)
'Yeah, you always have to wait. You're never seen on time (...) I feel the time pressure and I see it clearly 
in him [the FP]. (...) Obviously, that's not good.' (P11: female, age 52)
Patients appreciate follow-up appointm ents, especially w hen  initiated by the FP, and  the 
possibility of longer consultation time. Active involvem ent from  the FP, for example visiting a 
patient spontaneously after a major event, is highly appreciated by the patients.
'I had to come back on regular intervals - every three or four weeks or so. Not that they send you out on 
your own to figure it out. No, it's nice that they keep tabs on you.' (P4: female, age 29)
'I think that they are really concerned and involved and empathic. We have experienced this over the past 
couple of months [as m y father was being cared for prior to his passing] in many different ways. (...) The 
FP was wonderful. We got phone calls asking how he was. I am really happy with the guidance and help 
we received from the FP.' (P1: female, age 59)
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4. Shared authority
Patients state that they w an t to be engaged as partners in  the consultation, to look and search 
together for possibilities and  solutions. Patient appreciate the FP for initiating the search for 
solutions and for explaining w hy a certain solution is preferable. How ever, some patients w ant to 
make their ow n choice based on  the provided inform ation. They expect the FP to respect their 
decision.
'we think about things together. It's not one-way like that I have to think about things on my own. 
Together, we come up with the best approach and determine what's possible.' [...] Together, we try to 
find  the best solution, and then I trust that she [the FP] is the one who takes the lead. That's best.'
(P10: female, age 52)
'she [the FP] helps me make decisions by providing the information needed to make the decision'
(P3: female, age 33)
W hen patients them selves provide solutions, for exam ple in  com plem entary or alternative 
medicine, they expect support and  a positive reaction from  their FP. Some patients stress the 
im portance of clarifying their ow n ideas, thoughts, w ishes and  needs to the FP.
'the FP wasn't open to that. In any event, he didn't suggest it. And when I then said, maybe this is 
something for a homeopath?, he said, Yeah, that's up to you. I don't really have a lot of faith in that. So, 
obviously, I'm  not really encouraged to explore those options. I don't think that's very good.'
(P11: female, age 52)
'Well, then, at a certain point in time, I ju st decided to go see a craniosacral therapist. He thought that 
was odd. It's crazy that she [the FP] didn't tell me that that also exists.' (P1: female, age 59)
Patients stress their problem s w ith  FPs resistance for referral. But w hen  an  FP im m ediately agrees 
w ith  the requested referral or additional test, patients m entioned to be surprised. A positive 
response to a request for referral is not always necessary as long as the FP has a proposal for further 
inquiry.
'then you have to practically beg: Can you please refer me to the neurologist?' (P7: female, age 49)
,I said, at home, to my husband, I am going to demand a bowel examination. I was incredibly surprised 
that he [the FP] was okay with that. I expected that he would say that that wouldn't be necessary.'
(P6: female, age 60)
'He [the FP] always tries to find  a way to help you himself. I really appreciate that. It's better than being 
referred to all sorts of other practitioners and agencies.' (P4: female, age 29)
Discussion 
Summary of main findings
Patients w ith  persistent MUS stressed the im portance of a personal continuing FP-patient 
relationship. A ccording to these patients, such a relationship is built on  four components: 
physician attitude, medical com petence, availability and shared authority. Patients w an t to be 
taken serious by an  FP w ith  an  open m ind w ho uses a non-judgm ental com m unication style. 
Furtherm ore they w ant a skillful and com petent FP w ho is supporting  and  offers a 
com prehensible explanation for their sym ptom s. Patients w ith  persistent MUS also w ant easy 
access to their 'own' FP w ho takes tim e to explore and discuss the patients' sym ptom s a n d /o r  
problem s. Finally, patients w ant to be engaged as partners in  the consultation in  a w ay they can 
make their ow n choices based on the provided information.
Comparison with existing literature
Studies on opinions of persistent MUS patients in  prim ary care regarding the doctor-patient 
relationship are scarce. S tudies on  expectations of patients du ring  the initial presentation of MUS 
suggest that physician attitude and  medical com petence are im portan t at the beginning of an 
episode of unexplained sym ptom s. H owever, our patients w ith  persistent MUS considered also the 
availability of the doctor and  shared authority  of major im portance. This is probably due to the 
fact that during  the course of persistent MUS personal continuity (i.e. the im portance of seeing a 
personal doctor) and  continuity of the relationship w ith  the FP becomes m ore and  more 
im portant.
Shared authority  reflects the patients' expectations concerning their FP to listen to their treatm ent 
proposals and  to go th rough  a process of shared decision making. Churchill in terview ed fifty 
practitioners, w ho w ere identified as "healers" by their peers. Sharing authority  appeared to be 
one of the eight healing skills. This skill is described as sharing the responsibility for healing at the 
very beginning of the consultation, recognizing the patient as a 'fellow expert', w ith  a particular 
level of expertise, and having and  show ing confidence in  the relationship w ith  the patient.33 Scott 
conducted in-depth  interview s about healing relationships w ith FPs and  their patients. A key 
process w hich em erged from  these interview s w as 'appreciating pow er'. Engaging patients as 
partners in  decisions about diagnosis and  treatm ent w as seen as quintessential. These FPs 
reported that m ost often they w ork  to increase patients' pow er.34
Patients opinions on  the doctor-patient relationship in  our study  (Figure 1) show  great overlap 
w ith  'the healing relationship m odel' of Scott et al. and  'the eight healing skills' of Churchill et al.33;34 
However, the patients interview ed by Scott et al. w ere not selected on basis of their illnesses, but 
they suffered from  different chronic illnesses. A lthough w e selected patients based on the
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presence of persistent MUS, their perspective upon  the relationship w ith  the doctor does not seem 
to differ from  the other patients w ith  chronic conditions. Furtherm ore patients' opinions 
regarding the doctor-patient relationship in  our study seem  to be in  line w ith  the opinions of a 
specific group of practitioners regarding healing skills. Churchill described the im portance of 
taking tim e for the patients and dem onstrating that there is space for their story. This fits perfectly 
w ith  the w ish  of the patients w ith  persistent MUS: they w ant their FP to be m indfully present, 
listening to their story and  giving them  room  to tell their story.
Strengths and limitations
This is the first study on opinions of patients w ith  persistent MUS about the doctor-patient 
relationship. M ost of the patients interview ed in  our study  know  their FP for m ore than  5 years. 
Furtherm ore they are included in the study  because they visit their FP frequently w ith  MUS and 
because they are all currently receiving care for persistent undifferentiated MUS from  their FP. 
Therefore, our results reflect the opinions of patients w ho have had  recent and  relatively m any 
contacts w ith the health care system  and  their FP. These patients have built their opinions about 
the doctor-patient relationship on a b road experience w ith  medical services. As the attitude of FPs 
tow ards patients w ith  MUS is often negative,“ one could expect that the interview ed patients are 
m ore likely to have experienced their consultations as unsatisfactory and  stressful and therefore 
they m ight be m ore critical about the doctor-patient relationship than  others. On the other hand, 
m ost patients included in  this study know  their FP already for m ore than  5 years, w hich possibly 
implicates satisfaction w ith  their FP.
The qualitative m ethod has been recom m ended as the best m ethod to explore and  clarify patients' 
opinions.35 By using a cyclical and  interactive w ay of collecting and  analyzing data, 'progressive 
focusing' and  exploration of patients' opinions in  dep th  w as possible.36 Transcribing the 
interview s verbatim , entering the full texts into Atlas.ti, and coding and  re-organizing data by two 
independen t researchers, strengthens our findings. A lthough small, the num ber and 
characteristics of participants included in  our study are considered adequate for capturing an 
optim al variety of opinions.37 The findings presented here, how ever, reflect the perceptions of a 
small group of patients and m ay not represent the views of patients in  general. The validity  of our 
analysis is enhanced by the diversity of train ing and experience of the analysis team  (experienced 
FP and a psychiatrist) and reflexivity (reflecting on our ow n experiences).38
A w eakness of the study is that patients w ere recruited by sending them  a letter and  a rem inder to 
ask for participation in  a study  regarding the quality of care they receive from  their FP. Only 12 of 
the 31 patients (39%) agreed to participate. This m ight have caused response bias as patients who 
are satisfied w ith their FP are possibly m ore inclined to participate in  such a study. Therefore, 
certain specific view points could have been left out of sight in  this study.
Interview ed patients d id  not m ention any expectation about receiving inform ation about the 
prognosis of the sym ptom s. None of the patients m ade rem arks about discussing the duration  of 
sym ptom s. This m ight be due to the fact that alm ost all in terview ed patients had  chronic 
com plaints and assum e that the doctor w ill not be able to predict the duration  of the symptoms.
The doctor-patient relationship is built over tim e and  over m any consultations. Interviewing 
patients regarding their opinions on the doctor-patient relationship gives only a snapshot in  time. 
Patients m ay change their perspective over tim e as a response to the sym ptom s, diseases, life 
events, a n d /o r  other circumstances.
Implications for further research and clinical practice
Like patients presenting initial MUS to their FP, patients w ith  persistent MUS w an t an  medical 
com petent FP w ith  an  open non-judgem ental attitude. H owever, patients w ith  persistent MUS also 
w an t personal continuity and  a therapeutic doctor-patient relationship.39 A n easily accessible FP 
w ho is willing to see the patient as a partner in  the decision m aking process contributes to a 
patient-centered orientation to care w hich is highly valued  by these patients.
The doctor-patient relationship largely depends on the com m unication style of the FP. Further 
research should  focus on studying and  m axim izing the therapeutic effects of FPs' com m unication 
to achieve better health  outcom es in  patients w ith  persistent MUS. As patients appreciate a non- 
judgm ental and  attentive listening style, educational program s in  health  com m unication 
interventions as m indful com m unication m ight be of h e lp M;41 Furtherm ore, studying  the effects of 
the (im provem ent of the) quality of the FP-patient relationship on  sym ptom s, im pairm ent and 
satisfaction of patients will gain significant insights into the how  FP-patient relationships 
contribute to healing and well-being of patients w ith  persistent MUS.
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Background. Persistent p resen tation  of m edically unexplained  sym ptom s (MUS) is 
troublesom e for general p ractitioners (GPs) and  causes pressure on  the doctor-patient 
relationship. As a consequence, GPs face the problem  of establishing an  ongoing, preferably 
effective relationship  w ith  these patients. This s tudy  aim s at exploring GPs' perceptions about 
explaining MUS to patien ts and  about how  relationships w ith  these patients evolve over tim e in 
daily practice.
Methods. A qualitative approach, in terv iew ing  a purposive sam ple of tw enty-tw o D utch 
GPs w ith in  five focus groups. D ata w ere analyzed according to the principles of constant 
com parative analysis.
Results. GPs recognise the im portance of an  adequate explanation  of the diagnosis of MUS 
b u t often feel incapable of being able to explain it clearly to their patients. GPs therefore indicate 
tha t they try  to reassure patien ts in  non-specific w ays, for exam ple by telling patients that there 
is no  disease, by using  m etaphors and  by norm alizing  the sym ptom s. W hen patients keep 
re tu rn ing  w ith  MUS, GPs report the im portance of m ain ta in ing  the doctor-patient relationship. 
GPs describe th ree d ifferent m odels to do this; m utua l alliance characterized by ritual care (e.g. 
regular physical exam ination, regular doctor visits) w ith  approval of the patien t and  the doctor, 
am bivalent alliance characterized by ritua l care w ithou t approval of the doctor an d  non-alliance 
characterized by cutting  off all reasons for encounter in  w hich sym ptom s are no t of som atic 
origin.
Conclusion. GPs feel difficulties in  explaining the sym ptom s. GPs repo rt that, w hen  
patien ts keep presen ting  w ith  MUS, they focus on m ain ta in ing  the doctor-patient relationship  
by using  ritua l care. In th is care they m eticulously balance betw een  m ain ta in ing  a good doctor- 
patien t relationship  and  the p revention  of un in tended  consequences of unnecessary 
interventions.
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Background
In 25 to 50 percen t of the contacts patien ts p resen t m edically unexplained  sym ptom s (MUS) to 
the general practitioner (GP).1'2 A lthough  it is only a m inority  (2.5 percent) of these contacts tha t 
w ill resu lt in  a chronic condition associated w ith  recurren t consultations, extensive 
investigations an d  referrals, th is m inority  of chronic patien ts represen ts a serious problem  in 
p rim ary  care.3 Persistent p resen tation  of MUS is troublesom e for the GP because m any GPs 
experience difficulties in  the com m unication and  the rela tion  w ith  these patients .4-11
There is evidence tha t the difficulties in  com m unication m ay resu lt from  m isperceptions of 
patien ts' needs and  w orries by GPs.12 GPs feel p ressu rized  by patients to apply  biom edical 
in te rventions b u t they do no t have m uch to offer in  a strictly biom edical w ay .13'14 A t the sam e 
tim e, m ost patien ts w ith  MUS do no t overtly  insist on  additional som atic in terventions. They 
prim arily  w an t to be understood  and  seek em otional support, w hich doctors do no t p rov ide.15-18 
M oreover, the lack of a biom edical exp lanation  h inders GPs in  adequately  telling patien ts w hat 
is w rong .19 As a consequence patients' needs are unm et, reassurance w ill be ham pered  an d  relief 
of sym ptom s w ill be com plicated.20'21
Recent research has show n th a t the curren t m anagem ent of patien ts w ith  MUS shou ld  consist of: 
com m unicating  to the patien ts th a t the sym ptom s are real, m aking patients feel understood , 
engagem ent of the GP to establish com m on g round  w ith  the patient, offering a detailed 
explanation  about the natu re  of the com plaints, an d  if necessary sym ptom atic relief.22-25
By definition, patien ts w ith  persisten t MUS will keep attend ing  the consulting hours of their 
GPs w ith  MUS. H ow ever, they w ill also face o ther health  care problem s, for exam ple serious 
som atic disease.26 G iven the im portance of a good relation  w ith  the patien t in  the ligh t of 
continuity  of care, GPs have to find  strategies to specifically deal w ith  these patien ts.10 To our 
know ledge it is no t know n how  GPs do this an d  how , according to GPs, this relationship  evolves 
over tim e.27 Furtherm ore, w e need  to know  GPs' opinions about explaining the n a tu re  of 
unexplained  sym ptom s to patien ts w ith  persisten t MUS du ring  consultations, in  o rder to 
develop m ore effective in terventions for these patients.
In this qualita tive exploratory  s tudy  w e focus on  GPs' perceptions of giving explanations to 
patients w ith  persis ten t MUS an d  on  GPs' perceptions abou t the doctor-patient relationship  and 
how  the relationship  evolves over time.
Methods
W e conducted  five focus groups w ith  22 D utch GPs to s tudy  their v iew s on MUS. Each focus 
group consisted of 4 to 5 GPs. W e used a purposive sam pling  strategy to increase the external 
valid ity  of our results w ith  respect to the variety  of existing v iew s am ong GPs. From  the 
literature, w e considered the follow ing characteristics as relevant for this variety: age, gender, 
w ork ing  experience, num ber of listed patients, 'academ ic w ork ing  career', geographical 
location of practice (city versus rural) an d  site of education .28"31
Each focus group w as hom ogenous for the characteristics 'academ ic w ork ing  career' and 
'geographical location' (Table 1); participan ts otherw ise represen ted  a varie ty  of the listed 
characteristics (T able 2).
W e chose focus groups ra ther than  ind iv idual in terview s to use group interaction  w hich 
stim ulates participan ts to explore an d  clarify their v iew s into m ore dep th .32 D iscussions w ere 
facilitated by  a skilled m oderator, and  lasted  for approxim ately  one and  a half hour.
Follow ing the guidelines for conducting  focus groups, the m oderator used a discussion guide to 
direct the d iscussion an d  to fulfil the research aim s (Table 3). The d iscussion guide w as m ainly 
based on  im portan t topics h igh ligh ted  in  the lite ra tu re .
The discussions w ere tape-recorded w ith  the participants' consent an d  com pletely verbatim  
transcribed. D ata collection and  analysis proceeded  as an  iterative process. Two researchers 
(ToH, LH) ad d ed  relevant an d  new  topics to the d iscussion guide after a p relim inary  analysis of 
each session. In this w ay, ideas an d  though ts tha t em erged in  prim ary  stages of the analysis w ere 
b rough t fo rw ard  in  subsequent focus groups as the s tudy  proceeded.
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Finally, the first au thor verified  the transcrip tion  and  en tered  all data  into A tlas.ti, a softw are 
p rogram  used  to su p p o rt the analysis of qualitative data.
Table 1. Focus group charcteristics
characteristic
Focus group 1 GPs with an academic working career in Radboud University Nijmegen Medical Center
Focus group 2 GPs without an academic working career working in a rural area
Focus group 3 GPs without an academic working career working in a rural area
Focus group 4 GPs with an academic working career in VUmc Amsterdam or AMC University Amsterdam
Focus group 5 GPs without an academic working career working in a city
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Table 2. Key characteristics of purposive sample of general practitioners



















Not practicing at hthe moment 1
Age in years (range) 47 (31-58)
Experience as a GP in years (range) 15 (0-30)
* fu l l  tim e: 80% to  100% fu l l  tim e
Table 3. Focus group interview guidebook
What are the characteristics of patients with 
persistent MUS?
- Regarding patient characteristics?
- Regarding symptom characteristics?
- Do you have problems to recognize these patients?
How do you call patients with persistent MUS? - Which terms do you use to characterize these patients?
- Which terms do you tell to your patients?
What's the aetiology of persistent MUS? - What is the nature of these symptoms?
- When do patients experience these symptoms?
- Why do these symptoms persist for such a long time?
Do you explain the diagnosis persistent MUS to 
your patients?
- Do you think explanation is important in consultations with 
these patients?
- How do you explain the diagnosis persistent MUS to the 
patient?
- Which specific words do you use during explanation of the 
symptoms?
How do you manage patients with persistent 
MUS?
- How do you deliver health care to them?
- What do you do with requests for additional research?
- Which problems do you face in the management of these 
patients?
- How do you manage diagnostic uncertainty?
- Do you feel capable to manage these patients?
How do you describe the doctor-patient 
relationship with those patients?
- Is the doctor-patient relationship important, and why?
- Do you experience problems in the doctor-patient relationship?
How do you experience the MUS consultations? - Which problems do you face during the MUS consultation?
Analysis
A nalysis follow ed the principles of constant com parative analysis in  w hich transcrip ts are 
subsequently  them atically coded.33 The m ain  aim  of this analysis is to organize responses by 
them e an d  explore sim ilarities and  differences in  an d  betw een  g roups.
Two researchers (ToH, LH) read  all in terview s several tim es to fam iliarize them selves w ith  the 
data. They independen tly  m ade a first categorization by coding m eaningful sentences. Initial 
codes w ere discussed, seeking agreem ent on  their content. In the event of d isagreem ent, the 
opinion of a th ird  researcher (PL) w as sought. We grouped  the codes into them es to identify  key 
features of GPs' v iew s on MUS. R ecurrent and  im portan t them es w ere frequently  discussed and 
refined as p a rt of an  ongoing iterative process.34 D uring the entire analysis w e constantly  
m atched the developing them es w ith  the transcrip ts an d  w ith  available scientific literature on 
th is subject. Therefore, these repeated  them es are g rounded  in  the data an d  n o t im posed onto the 
data  by the researcher. W e also checked our developing them es for inconsistencies w ith  the 
transcripts.
D ata collection continued  un til sa tu ra tion  w as reached w ith  no new  m ajor them es arising  from  
analysis of the fifth  focus group.
The valid ity  of our findings w ere explored by checking our results in  an  independen t group  of 
GPs w ho had  no specific in terest in  MUS. They ju d g ed  the results to be consistent w ith  their 
perceptions an d  experiences.35
Results
The GPs in  this s tudy  considered the explanation  of the natu re  of the sym ptom s as w ell as 
m ain ta in ing  the doctor-patient relationship  as a difficult b u t im portan t task  in  help ing  patients 
w ith  persisten t MUS.
GPs w ith  an  academ ic w ork ing  career discussed m ore abou t the classification and  curren t 
theories abou t patien ts w ith  persisten t MUS. GPs w ithou t an  academ ic w ork ing  career had  a 
m ore clear focus on the difficulties they experience in  daily  practice w ork ing  w ith  these pa tien ts . 
We could  no t find  fu rthe r m ajor differences betw een  the perspectives of academ ic an d  non­
academ ic GPs. Furtherm ore, w e could  n o t find  differences in  perspective betw een  ru ra l and 
u rb an  w orking  GPs.
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GPs' perceptions of giving explanations
Im portance of explanations an d  difficulties in  explaining w ere recurren t them es in  the focus 
group  discussions. The first focus group discussion (GPs w ith  an  academ ic w ork ing  career in 
N ijm egen) revealed  th a t difficulties in  a good explanation w as an  im portan t topic in 
consultations w ith  MUS patients. D uring the focus groups w ith  GPs w ithou t an  academic 
w ork ing  career (focus group 2, 3 and  5) w e discussed in  d ep th  the w ays of explaining MUS to the 
patient. Both GPs w ith  an  academ ic w orking  career (focus g roup  4) as GPs w ithou t an  academic 
w ork ing  career stressed the im portance of a clear explanation. In focus group  5, no new  them es 
on  the im portance of explanation  cam e u p .
GPs stressed the im portance of a clear explanation of the sym ptom s. A n adequate explanation 
w as regarded  as im portan t in  b o th  reassu ring  patien ts tha t there is no serious disease, and  in 
help ing  patien ts to accept tha t there is no t alw ays a m edical exp lanation  for physical sym ptom s.
"GP13 (male, 5 years GP working experience): But you need to explain damned well. GP12 (male, 29 
years GP working experience): The doctor has the monopoly of truth, so you need to be very clear about 
the cause of the symptoms. D on't be vague because otherwise a patient will return home muddled 
which make things worse" [FG 3]
GPs sta ted  tha t adequate form ulated  explanations m ay help patients und erstan d  the connection 
betw een  their psychosocial life an d  the sym ptom s. A ccording to the GPs, patients' family 
m em bers an d  patien ts' colleagues also w ish  an  explanation  of the sym ptom s too, especially 
w hen  patients have benefits of being ill.
A lthough  GPs firm ly agreed on  the im portance of a clear explanation of the sym ptom s they 
experience difficulties in  doing this. GPs have difficulties indicating  from  w hich conditions the 
sym ptom s originate. W e see th is from  the vague and  avoid ing  answ ers of the GPs to the 
questions of the m oderator an d  the long silence after a question  of the m oderator on this topic.
"GP4 (male, 26 years GP working experience): I explain to patients which symptoms are bothering 
them and I leave the diagnosis in the middle. I accept the symptoms as such and ask about the 
consequences o f the symptoms. GP3 (female, 8 years GP working experience): Yes, I avoid diagnostic 
terms too and I confine m yself to the particular symptom and I explain that it could be anything. 
Moderator: But which terms do you use? (moments of silence) GP2 (male, 17 years GP working 
experience): I discuss with them a different way of coping with their symptoms which may relieve 
them." [FG 1]
"GP5 (male, 7 years GP working experience): In these patients there is often no connection between 
symptoms and problems in daily life. A t  least I can't see one. GP7 (male, 25 years GP working 
experience): I often tell them that we are not yet knowledgeable. Particularly about patients who really 
have difficulties with their symptoms, yes, you have to respond differently. GP5: But, when you ask me 
'where exactly do the symptoms come from, that chronic fatigue', then I don't have an answer" [FG 2]
O ur analysis revealed  three approaches, according to GPs, to explain  the unexplained 
sym ptom s. First, GPs indicate tha t they tell patients there is no disease. H ow ever, GPs highlighted  
the dilem m a of how  to com m unicate the find ing  of a p atien t suffering from  sym ptom s w ithout 
evidence of any physical anom aly. They describe tha t they try  to reassure patients w ith  
statem ents tha t 'noth ing is w ro n g '.
"GP9 (female, 19 years GP working experience): Yes, I always say: I don't know it either. I t is not your 
heart, not your lungs, we did not find  any abnormality. GP6 (female, 1 year GP working experience): 
Yes, I recognize what [GP9] is saying: at least we can conclude that it's nothing serious. We have 
examined a lot, but the question as to what you are actually suffering from is difficult to answer. GP5 
(male, 7 years GP working experience): Yes, these symptoms are not caused by a disease" [FG 2]
Secondly, GPs indicate tha t they use metaphors to give patien ts som e insight in  the hypothesized 
interactions betw een  sym ptom s and  psychosocial life. GPs reported  tha t they use m etaphors -  
often a tangible physical m echanism  indicating  som e k ind  of im balance betw een  load and 
capacity -  th a t reflect their tacit beliefs an d  ideas about the natu re  of MUS. A ccording to the GPs, 
som etim es the m etaphor facilitates a d iscussion of psychological or social problem s.
"GP5 (male, 7 years GP working experience): Every human being has a weak spot and i f  there's 
something wrong you feel it there. GP9 (female, 19 years GP working experience): I always tell them to 
compare it with a heavily overloaded elevator. GP7 (male, 25 years GP working experience): I 
recognize your story, I always tell patients that everyone has a backpack and this backpack can be too 
heavy. " [FG 2]
Thirdly, GPs indicate tha t they normalize the symptoms of the patients, te lling patien ts tha t having 
sym ptom s is a p art of norm al life. GPs reported  th a t they explain to the patien t tha t the 
sym ptom s are w ith in  a com m on, acceptable range, tha t they are n o t dangerous and that 
d iagnostic procedures or trea tm en t are no t necessary .
"GP10 (female, 1 year GP working experience): I normalize. I mean, I explain to patients that it is 
normal, that it's not strange. I try to normalize as much as possible. GP12 (male, 29 years GP working 
experience): Yes. GP10 : saying that it is part of normal life. GP12: Yes" [FG 3]
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GPs' perceptions of the evolving doctor-patient relationship
In all focus groups GPs discussed the im portance of the doctor-patien t relationship. The 
difficulties arising  in  the relationship  w as a recurren t them e. Focus g roups w ith  GPs w ithou t an 
academ ic w ork ing  career (focus group 2, 3 an d  5) d iscussed the w ay of dealing  w ith  the doctor- 
patien t relationship  in  patien ts w ith  persisten t MUS. Furtherm ore, focus group  4 an d  5 GPs 
discussed the difficulties they face in  the relationship  w ith  these pa tien ts .
GPs in tend  to clarify the link (as supposed  by them ) betw een som atic experiences and 
psychosocial circum stances of the patient. In other w ords, they indicate to try  to change the 
agenda. W hen talk ing about psychosocial circum stances is no t successful, GPs reported  th a t they 
suggest and  discuss a range of activities: do ing som e sports, g iving m ore frequen t consultations 
for the sym ptom s, using  a sym ptom  diary, tak ing  m edication  or referring  to a social w orker.
W hen changing the agenda doesn 't w ork  ou t w ell, GPs reported  tha t they focus on  dealing with 
the doctor-patient relationship. W ithin th is strategy w e could d istinguish  th ree different doctor- 
patien t relationship  models.
A first doctor-patien t relationship  m odel can be characterized as mutual alliance. This alliance is 
realized by som e sort of ritual care. GPs sta ted  th a t they use rituals w ith  seem ingly m utual 
approval and  tha t these rituals em erge gradually  after m any consultations.
"GP9 (female, 19 years GP working experience): A t a certain moment in your approach of the patient, 
when a patient has had all diagnostic procedures and many referrals, then comes the moment when one 
realizes: this is the only way this patient can live. Consequently I let him consult me sporadically, even 
without complaints [...] A nd  when he feels such a ritual is sufficient, examining his heart, lungs and 
blood pressure, reassurance is reached to keep him happy for some time. [...] GP7 (male, 25 years GP 
working experience): Finally, you have created some kind of relationship, some kind of game in which 
patients are quite satisfied with little. Someone listening [...] a pat on the back. " [FG2]
Exam ples of those rituals are regular physical exam ination, referral to a physio therapist, 
prescribing m edication or perform ing additional investigations, all w ith  preserv ing  a good 
relationship  w ith  the patien t an d  keeping in  m ind  the un in tended  consequences of unnecessary 
interventions.
"GP16 (male, 23 years GP working experience): Sometimes I ju st wait and see, and take care not to 
cause any damage in these patients" [FG4]
GPs said  tha t these rituals are connected w ith  requests or w ishes of the patien ts an d  th a t they 
prim arily  aim  a t reaching agreem ent. GPs reported  tha t they prov ide this k ind  of care w ith  
w arm th  and  em pathy  an d  th a t they assum e th a t patients are satisfied w ith  it.
The second doctor-patien t relationship  m odel is ambivalent alliance. As sta ted  by the GPs, this 
m odel is characterized by the sam e rituals as in  the first m odel, b u t in  fact the GPs do n o t agree 
w ith  the rituals an d  are u n h ap p y  w ith  the situation. There is often a negative colouring in  GPs' 
u tterances abou t this m ethod.
"GP14 (male, 15 years GP working experience): Nowadays I ask patients to undress and I practice all 
sorts of complicated physical examinations I can think of, and when I have done all the physical 
examinations; then I say: everything is all right, you are healthy and then they go home satisfied [...] A  
patient visits me six times for a referral note, yes, when he or she comes for the third time, then I agree 
with a referral, inevitable, otherwise you have an argument and in m y working experience that does 
not work at all [...]"[FG4]
GPs reported  tha t the am bivalent alliance indicates a d isagreem ent w ith  supposed  requests for 
m edical in te rventions as m edical necessity of these in te rventions is doubtful. They reported  that 
in  these situations the patien t is in  control of the situation.
The th ird  relationship  m odel appearing  from  the discussions is non-alliance. GPs reported  that 
th is m odel rarely  occurs in  daily practice. They sta ted  tha t th is m odel is characterized by cutting  
off all reasons for encounter in  w hich sym ptom s are no t of som atic orig in  by tak ing  a cool, 
objectifying m edical gaze.
"GP12 (male, 29 years GP working experience): sometimes it is easier to be very short, in a way of 'you 
have to find  out for yourself1. Go to a social worker and do not bother me with that problem again. Just 
be practical. Then it does not bother me at all. The patient is the one with the problem, it is not m y 
problem, it is your problem, and you have to solve that with the social worker." [FG3]
In this non-alliance m odel, GPs reported  tha t in  case of an  absence of a som atic explanation  for 
the sym ptom s, they com m unicate th is negative find ing  directly to the patien t and  at the sam e 
tim e give the m essage tha t the patien t shou ld  no t consult w ith  these k inds of p rob lem s.
A nalysis in  and  betw een  the focus group  discussions revealed tha t each GP has a p referred  w ay 
of hand ling  the relationship  problem . GPs w ho stressed the im portance of the relationship 
preferred  the m utua l alliance m odel, w hereas GPs w ho stressed the im portance of changing the 
agenda seem ed to rely on the am bivalent alliance m odel. N on-alliance w as no t frequently  
m entioned. O ne GP sta ted  tha t he coped w ith  patien ts w ith  persisten t MUS in such  a w ay  during  
his GP residency. One GP to ld  tha t he used  th is non-alliance m odel to cope w ith  these patients 
du ring  out-of-our-services.
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Discussion
GPs are aw are of the im portance of explaining the diagnosis of MUS adequately  to patien ts w ith  
persisten t unexplained  sym ptom s. H ow ever, they face difficulties in  explaining the n a tu re  of 
the sym ptom s during  the encounter w ith  these patients. GPs state tha t they use th ree different 
approaches to explain  the sym ptom s to the patients; norm alization  of sym ptom s, telling 
patients tha t there is no disease, an d  using  m etaphors. A ccording to the literature, 
norm alization  of sym ptom s an d  telling patien ts tha t they don 't have a disease is n o t effective 
and  m ay even resu lt in  m ore health-care seeking.19,36 This m ight contribute to the fact th a t a sm all 
b u t relevant p roportion  of MUS patien ts becom e persisten tly  im paired  and  keep a ttending  the 
GP.37 M etaphors, on  the other hand , can be useful in  reaching shared  u nderstand ing  betw een 
patien t an d  doctor because they are tangible and  non-blam ing, although  there is lim ited 
evidence for their effectiveness.36,38 Seem ingly, there is a paradox in  argu ing  th a t physicians 
shou ld  p rovide explanations for a problem  th a t they them selves describe as unexplained. 
H ow ever, m ost com plaints p resen ted  in  prim ary  care rem ain  at the level of a sym ptom  
diagnosis an d  never resu lt in  the diagnosis of a disease.39 The connotation  'unexplained ' in 
m edically unexplained  sym ptom s indicates tha t the sym ptom s are n o t explainable from  the 
reduction ist disease fram ew ork.40 H ow ever, these sym ptom s are frequently  explainable in  other 
term s given by m odels as the som atosensory  am plification m odel or the cognitive-perceptual 
m odel.41 A pparently , GPs lack the com petence to use these available m odels adequately  in 
patien ts presen ting  w ith  persis ten t MUS. H ow ever, searching for a sym ptom  explanation 
together w ith  the patien t is an  im portan t task  of GPs in  daily  practice as it gives them  the 
o ppo rtun ity  to establish com m on g round  on w hich they can jointly  und erstan d  and  m anage the 
patients' needs.42
GPs realize the usefulness and  im portance of a good relation in  encounters w ith  these patients, 
a lthough  they face difficulties in  pu tting  this into practice w hen  explaining and  rem oval of 
sym ptom s is n o t feasible. W hen patien ts keep p resen ting  MUS, GPs repo rt tha t the doctor- 
patien t relationship  evolves into th ree d ifferent m odels characterized by the presence or 
absence of m utua l u n derstand ing  an d  a careful balance betw een  m ain ta in ing  the doctor-patient 
relationship  an d  p reven ting  un in ten d ed  consequences of the interventions.
A lthough GPs recognize the lim itations and  difficulties of establishing an  ongoing and  
preferably effective relationship  w ith  these persisten t MUS patien ts in  daily practice, they 
seem s to take responsibility  to bu ild  and  m ain ta in  such a relationship. Taking th is responsibility 
fits into the philosophy  of p rim ary  care in  w hich a long-term  an d  continuous relationship  in  
general practice is em phasized .20,43 These relationships evolve over tim e and  are bu ilt on  regular 
consultations as well as other shared  experiences.20,26 It is know n from  the literature tha t bu ild ing
on an d  establishing an  effective and  satisfactory doctor-patient relationship  has an  appreciable 
im pact on  health  outcom es for patients.44
GPs sta ted  th a t d ifferent relationship  m odels w ith  patien ts w ith  persisten t MUS develop over 
time: m u tua l alliance, am bivalent alliance and  non-alliance. These relationship  m odels are, as 
far as w e know , n o t described elsew here. The mutual alliance m odel, an d  to a lesser degree the 
ambivalent alliance m odel, can be conceptualized as com prising a positive relationship  and 
collaboration w ith  m utua l approval betw een patien t and  doctor.45 The goal of this collaboration 
is to m ain ta in  the doctor-patient relationship  by p rov id ing  em otional su p p o rt th rough  some 
k ind  of ritua l care. In this strategy GPs keep in  balance the doctor-patient relationship  an d  the 
u n in ten d ed  consequences of in terventions. Reaching m utual alliance corresponds w ith  
findings tha t patien ts w ith  MUS seek a h igh  level of em otional su p p o rt rather than  som atic 
in terventions.17'46
C hew -G raham  po in ted  o u t th a t GPs w ho experience difficulties in  the relationships w ith  some 
groups of patien ts felt tha t concentrating  on m ain ta in ing  the doctor-patient relationship  make 
them  to collude w ith  patien ts an d  their sym ptom s.47 It is possible tha t GPs in  the 'ambivalent 
alliance ' m odel are h indered  by this collusion and  feel un h ap p y  w ith  the ritua l care.
O ne could argue tha t the p resen ted  m odels for the doctor-patient relationship  are doctor- 
centred. This m ay be the resu lt of the aim  of our s tudy  to exam ine GPs' perceptions. W e asked the 
GPs in  the focus groups how  they m anage patien ts w ith  persisten t MUS. In other w ords, we 
asked for their ow n GP perspective. In response they described how  they struggle to preserve 
their relation  w ith  the patient. In this respect the GPs are w ork ing  patient-centred . M oreover, 
the m utual alliance strategy as w ell as the am bivalent alliance strategy incorporate certain  
elem ents of patient-centredness such as find ing  com m on g round  regard ing  m anagem ent and 
enhancing the doctor-patien t relationship .48 H ow ever, a m ore patien t-cen tred  approach  in 
w hich an  exploration  of the patients' needs and  expectations in  o rder to support patients' self 
m anagem ent an d  coping w ith  the sym ptom s, d id  no t come up  in  the focus groups. GPs d id  no t 
in troduce several other aspects of patien t-cen tredness such as disclosing patients' concerns and 
suffering, an d  focussing on patients' self m anagem ent an d  coping.49 W e assum e th a t this can be 
explained by the fact tha t d u rin g  our focus group  interview s w e focussed on  situations in  daily 
practice in  w hich GPs felt th a t they get stuck w ith  these patient. Possibly, strategies as disclosing 
concerns, relief of suffering, an d  focussing on  self m anagem ent and  coping had  failed in  an 
earlier stage of the doctor-patient contact.
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Strengths and limitations of this study
The qualitative m ethod  is appropria te  to explore an d  clarify w hat GPs th ink  abou t these patients 
and  w hat they experience in  the consultations w ith  these patients.32 H ow ever th is m ethod does 
n o t prov ide insight in  the GPs actual behaviour. By using  a cyclical an d  interactive w ay  of 
collecting an d  analyzing data, 'progressive focusing' and  exploration  of GPs' perceptions in 
dep th  w ere realized .50 In  focus group  discussions the participan ts influence each other by 
listening an d  discussing. Such group  dynam ics m ay silence ind iv idual contrasting  op inions and 
resu lt in  the articulation  of group norm s or early consensus before all view s w ere fully 
expressed.32 H ow ever, the goal is no t to reach consensus. Instead, our goal w as to s tudy  how  GPs 
as professionals th ink  about patien ts w ith  persisten t MUS. It w ou ld  nevertheless be in teresting  
to analyze how  ind iv idual participan ts influenced each other du ring  the discussion, b u t this was 
n o t the aim  of our study. To reach an  optim al variety  of opinions, w e used a purposive sam pling 
strategy. A lthough  sm all, the num ber of participan ts is considered adequate for th is pu rpose.32 
By using  a purposive sam pling  strategy w e have cap tu red  the variety  of opinions presen t in  the 
popu la tion  of G Ps.
As MUS are n o t equally  d istribu ted  am ong m en and  w om en and  m en and  w om en  have different 
expectations an d  experiences of clinical encounters,6 a gender perspective m ay enhance 
understand ing . H ow ever, w e d id  n o t s tudy  the differences in  th ink ing  abou t patients w ith  
persisten t MUS betw een  fem ale versus m ale GPs, as in  this s tudy  w e focussed on  eliciting GPs' 
perceptions of giving explanations and  their perceptions about the doctor-patient relationship.
A lthough  w e know  from  recent research th a t there are cu ltu ral differences in  the d istribu tion  of 
MUS an d  the m eaning  an d  significance of a sym ptom  depends on the perceived relationship  
w ith  diseases in  a culture,51-53 GPs d id  no t spontaneously  in troduce their opinions on  cultural 
aspects of persisten t MUS du ring  the focus group  discussions.
This qualitative s tudy  exam ines GPs' perceptions an d  no t actual behaviour. W e deliberately 
chose to s tudy  the perceptions because actual behaviour m ay resu lt from  perceptions to a certain 
degree. M oreover, this s tudy  is p art of a larger project in  w hich  w e exam ine actual behaviour 
and  com m unication strategies of GPs in  a video registration s tudy  and  the patien t perspective in 
a qualita tive interview  study.
W e describe our results by using  the phrase 're lationship m odels'. A lthough  w e are aw are of the 
overlap w ith  com m unication strategies, w e th ink  tha t 're lationship m odels' is a m ore 
appropria te  term  in the context of our findings as it reflects the opinions of the GPs tha t 
m ain ta in ing  the relationship  w ith  those patients is of m ajor im portance. GPs indicate th a t they 
m ain ta in  the relationship  n o t only by the w ay  they com m unicate b u t also by  the w ay they take 
care for these patients.
T ape-recording the discussion, m ultip le  coding d u rin g  analysis an d  our triangu lation  strategy 
of asking independen t GPs to judge our results to be consistent w ith  their ow n perceptions and 
experience, ad d ed  to the rigor of the study.
F urther stud ies using  a m ixed m ethod  m ethodology m ay reveal effective m ethods of explaining 
sym ptom s to patien ts w ith  MUS. M oreover, it w ou ld  be useful to s tudy  the effects of the three 
relationship  m odels reported  by the GPs on outcom es and  satisfaction in  patients. In research, as 
w ell as education  w e should  face the challenge of explain ing the unexplained sym ptom s and 
bu ild ing  a tru ly  effective doctor-patient relationship  w ith  these fascinating patients. W ith the 
resu lts of fu rther research w e w ou ld  like to address the challenge of explaining unexplained 
sym ptom s adequately  and  bu ild ing  effective doctor-patient relationships w ith  these patients, 
preferably  by educating  doctors w ith  tools how  to do so.
Conclusion
G Ps are aw are of the im portance of explaining MUS adequately  to their patients, how ever they 
have difficulties in  do ing so. GPs repo rt that, w hen  patients keep p resen ting  w ith  MUS, they 
focus on m ain ta in ing  the doctor-patient relationship  by using  ritual care. These relationships 
evolves into th ree d ifferent m odels characterized by the presence or absence of m utual 
un derstand ing  and  a careful balance betw een  m ain ta in ing  the doctor-patien t relationship  and 
preven ting  un in tended  consequences of the in te rven tions.
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Introduction. D uring  consultations, the perspective of the patien t and  the fam ily physician 
come together. In  o rder to reach a shared  view  about the sym ptom s it is im portan t to know  the 
agenda of the patient. Cues (i.e. non-explicit rem arks tha t can enclose a special m eaning) can 
serve as a tool to clarify the agenda.
Case Report. In  th is article, w e describe a patien t w ith  unexplained  palp ita tions during  
vacuum ing. D uring one of the follow ing consultations she p rov ided  an  im portan t psychosocial 
cue w hich  changed m y perspective on  her palp ita tions, resu lting  in  a deeper u n derstand ing  of 
her sym ptom s.
Discussion. Recognition an d  exploration  of cues is im portan t for reaching m utua l 
un derstand ing  of doctors and  patients about the sym ptom s. M oreover, it enhances the 
therapeutic  relationship  and  im proves illness outcom es and  patien t satisfaction.
Conclusion. N oticing cues in  the m edical consultation  helps to und erstan d  the patien t's  real 
w orries. It gives us, as doctors, a better u n derstand ing  of the patien t's  perspective.
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A n im portan t task  for fam ily physician  (FPs) is listening to patien ts.1,2 The patien t's sym ptom s 
are d iscussed by  the patien t an d  the doctor together du ring  consultation. Patients have their 
ow n ideas, w orries an d  expectations abou t their sym ptom s an d  so has the FP, p artly  because of 
w hat he w as tau g h t in  m edical education , b u t m ainly because of his experience.3,4 D uring 
consultation the perspectives of the patien t an d  the FP come together.
One of the m ost im portan t tasks of the FP is to com e to a m utua l u n derstand ing  w ith  the patient: 
a shared  view  abou t the sym ptom s.5 To reach this agreem ent, the doctor needs to know  the 
agenda of the patient. This can be achieved by exploring the patien t's  expectations, cognitions 
an d  em otions.5-7 T hrough this w ork ing  style, the doctor enhances the patien t's  satisfaction, 
adherence an d  health .8,9
In  daily practice it appears to be difficult to get to know  the agenda of the patien t.10 In 
approxim ately  half of all consultations the doctor does n o t reveal the reason for encounter and  
the w orries of the patien t.9 In abou t 20% of all consultations the patien t has an  unvoiced 
biom edical or psychosocial agenda.11
D uring  a consultation patien ts often give cues. Cues are non-explicit rem arks tha t can enclose a 
special m eaning. They can po in t tow ards ideas, w orries or expectations the patien t has not 
shared  before.3 N oticing and  exploring the patien t's  'cues' is helpful, it can serve as a 'tool' to 
clarify the agenda of the patien t.3,5 H ow ever, doctors appears to have great difficulty in  detecting 
an d  respond ing  to m ore ind irect form s of com m unication such as cues.12 The follow ing case 




A 79 year old w om an  visits m e (ToH) w ith  sym ptom s of fatigue and  palp ita tions. The sym ptom s 
started  w hile vacuum ing; she frequently  had  to stop do ing it ju st to recover for a w hile. She is 
very  active, b u t the years seem  to sta rt counting. She asks me w hy she sudden ly  developed 
palpitations. She is w orried  because she never had  them  before. F urther h istory  tak ing  does not 
give any indication  for an  underly ing  cause of the palp itations. Because she has palp itations 
du ring  exertion, I w an t to exclude a cardiac problem . W ith the patien t's  approval I decide to 
m ake an  electrocardiogram  an d  test her b lood to exclude cardiac and  other causes for the 
palpitations.
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The f ollowing consultations
The electrocardiogram  is norm al, the b lood test reveals a hypothyroidism . This could explain 
her fatigue, b u t no t her palpitations. I reassure her, an d  after d iscussing th is w e decide together 
tha t I w ill prescribe her thyrax. W e settle a couple of appo in tm en ts for follow  u p  consultations. 
D uring these consultations I ad just the thyrax dosage and  also have a chat w ith  her. G radually  I 
get to know  her a little better. She tells m e m ore about her history  an d  background. I enjoy these 
consultations. W ith the thyrax the thyro id  function norm alises an d  the fatigue d isappears 
alm ost com pletely.
A special consultation
Six w eeks after the first consultation, she com es for a follow -up visit again. H er b lood has been 
tested  and  her thyro id  function is stable. She is happy  an d  satisfied w ith  th is new s. Then she 
brings up  her palp ita tions again. She w an ts to know  w hether it is possible tha t they are caused 
by  her thyro id  problem . I ask her if they have increased since the sta rt of the thyrax, w hich she 
denies. I explain to her tha t the palp ita tions are probably  unrela ted  to her hypo thyro id ism  and  
probably  benign. She seem s to accept this and  says : 'Well doctor, it is all about how  life is lived'.
'W hat a rem arkable sentence' I think. I show  m y w onder and  ask: 'Well then, how  is life lived?' 
A nd in  fron t of me, there and  then  a story  unfolds tha t had  been unknow n to me. A t the age of 16 
she w en t into a convent. Initially she h ad  a good tim e there, b u t this changed w hen  a new  m other 
superior w as appo in ted  w ith  w hom  she could  no t get on. M other superior allo tted  her all the 
nasty  tasks and  she d egraded  her to being  a cleaner. For a long tim e she d id  no t do anyth ing  but 
scrubbing floors. She w as teased  an d  co ld-shouldered by her fellow  sisters. Years of bullying 
follow ed. A couple of tim es she tried  to b ring  up  th is subject, b u t they d id  no t seem  to hear her. 
D uring th is period  she often had  physical sym ptom s, as a resu lt of w hich she could  no t perform  
her cleaning tasks. A fter living in  the convent for 15 years she had  to leave -  cast ou t from  the 
convent.
W ith aston ishm ent I listen to her story an d  she says: 'Gosh, doctor, I have never to ld  th is to 
anybody ' an d  'm aybe tha t is w hy I get these palp ita tions d u rin g  vacuum ing. I w ill th ink  about it 
at hom e'. W e ta lk  som e m ore an d  she leaves m y consultation  room  noticeably relieved, w ith  the 
w ords 'thanks for listening docto r'.
Half a year later
D uring the follow -up visit for her thy ro id  problem  the w om an  is cheerful. I realize tha t it has 
been half a year since the day tha t she to ld  m e tha t special story. I ask her about her palpitations. 
She tells me tha t she has had  them  a couple of tim es since the last consultation, b u t she is hard ly  
bo thered  by them  anym ore. V acuum ing has becom e easier now  an d  she feels better too. She says 
everything is fine n o w .
110 I Chapter 6
Case report | 111
Reflection on the case
D uring the first consultation  I (ToH) collected data by asking open  ended  questions, 
sum m arising  and  asking directive questions. Furtherm ore, I a im ed at searching for a biom edical 
diagnosis of her palpitations. I looked a t her palp ita tions from  a biom edical po in t of view  and 
w an ted  to exclude a cardiac cause. W hen I found  a hypothyro id  function  w ith  the b lood test I 
m ainly focused on the m edical policy and  m anagem ent plan, w ithou t reconsidering the 
palp ita tions an d  w ithou t legitim ising patien t's  feelings.
Looking back on th is case I realised  tha t initially I h ad n 't dw elled  on the fact tha t the palp itations 
came up  especially du ring  vacuum  cleaning. W hy of all tim es d id  she get them  du ring  vacuum  
cleaning? At this stage I shou ld  have show n m y curiosity. D id she get palp ita tions because of the 
exercise or could  it be linked to vacuum  cleaning in  particular? A better exploration  of her 
cognitions and  w orries abou t the palp ita tions w ou ld  have been helpful. H ow ever, the follow ing 
consultations gave m e the o pportun ity  to ask questions regard ing  patien t's  social s ituation  and 
history  an d  bu ild  the doctor-patien t relationship. Thanks to the rem ark: 'Well doctor, it's all 
abou t how  life is lived ', I w as capable of leaving m y biom edical po in t of view. Together w ith  the 
patien t I found  a deeper m eaning  in  her sym ptom s.
D id m y consultation skills change since this case? Yes, they certainly have. T hrough this case I 
becam e keener on  p icking up  cues patien ts give du ring  the consultation. Cues are an  easy tool in 
doctor-patient com m unication and  very  useful in  daily practice. Of course, I do no t know  for 
sure if there is a causal relationship  betw een  telling the story and  her im provem ent. But the 
patien t seem ed to benefit from  discussing the possible relationship , especially considering her 
relief at the end of the consultation.
Cues in the consultation
In prim ary  care there is a trad ition  of pay ing  atten tion  to cues an d  their m eaning. R ecognition of 
cues and  exploration  of their m eaning is im portan t for the m utua l u n d erstan d in g  of the doctor 
and  the patient. W ith the patient-centeredness m ovem ent at the end  of the 1980s, paying 
a tten tion  to the significance of cues becam e in  vogue again.5
R esponding to patients' cues is one of the m ost im portan t tools for a successful consultation .13 
Cues are described in  d ifferent w ays by d ifferent authors. G ask an d  U sherw ood refer to verbal 
and  nonverbal expressions of the patien t tha t h in t at psychosocial or social problem s.13 Livinson 
et al describe 'cues' as direct or ind irect expressions w ith  in form ation abou t patients' life and 
feelings.14 Balint uses the w ord  'offers' for expressions by  the patien t about the significance of 
their sym ptom s and  for expressions about the reason for encounter w ith  the FP.15 Branch and  
M alik describe cues as 'w indow s of opportun ity ' for the doctor to show  em pathy .16 It is
im portan t to detect an d  respond  to cues a t the tim e they are offered by the patients.13 N ot 
addressing  cues du ring  clinical encounters m ay inhibit patients from  fu rthe r disclosures. 
Berkatis et al reported  a significant relationship  betw een  the doctor's response to em otional cues 
and  the patien t's  disclosure.17 M oreover, cues enable better understand ing  of patients' life, 
cognitions an d  em otions.18'19 Recognition and  exploration  of them  has another advantage. It 
show s th a t the FP is listening carefully, w an ts to und erstan d  the m eaning of the sym ptom s and  is 
in terested  in  the patient.3 By picking up  cues an d  exploring them , the FP enhances the 
therapeutic relationship  and, as a consequence, im proves illness outcom es an d  patient 
satisfaction.17'20
W e know  tha t doctors have difficulties recognising cues. Livinson et al exam ined how  patients 
p resen ted  cues an d  how  FPs reacted  to them .21 In m ore than  half of the consultations, cues w ere 
p resen t (average of 2.6 cues per consultation). Patients in itiated  71% of the cues them selves and 
29% w ere in itiated  by the FP asking open  questions. In a m ajority of the consultations (79%), FPs 
m issed the oppo rtun ity  to react to the cues given in  the consultation. M oreover, these 
consultations w ere of significantly longer duration . Butow et al found  the sam e results in  their 
s tudy  of verbal cues in  cancer patients: oncologists d id  no t consistently detect and  address cues 
for em otional support. C onsultations in  w hich  oncologists responded  to higher proportions of 
patients' cues d id  n o t last longer than  other consultations.22 Cegala analysed v ideo taped  
p rim ary  care consultations of 16 doctors w ith  32 patients, and  found  tha t doctors rarely  provide 
in form ation in  the absence of a direct patien t question.12 M oreover, patients' ind irect cues of 
inform ational and  em otional needs are far m ore com m on than  direct p atien t questions. Thus, a 
focus on cues of needs in  the clinical encounter is im portant.
Salm on et al s tud ied  consultations abou t m edically unexplained  sym ptom s an d  show ed that 
m ost patients gave explicit cues about em otional or social problem s.23 M ost FPs reacted to these 
cues by either blocking or facilitating a discussion abou t psychosocial issues. The FPs w ho 
blocked a discussion d id  n o t pay atten tion  to the cues, they refocused on  the sym ptom s and  
norm alised  the w orries of the patien t or stressed patients' ow n responsibility. The FPs w ho 
facilitated a d iscussion abou t psychosocial issues d id  so by asking questions about the 
experiences of the patien t and  by exploring the problem s of the patient. H ow ever, w hen  the FPs 
gave an  explanation  of the sym ptom s, the FPs rarely  took the psychosocial problem s into 
account. C onsequently, patients' concerns w ere no t addressed  an d  reassurance failed.
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M ost people in te rp re t their sym ptom s in  the context of their personal, fam ily an d  life 
experiences. Active listening and  noticing cues, as described in  this case report, can help  FPs to 
get to know  their patients.1
D iscovering the patients' real w orries an d  getting  to know  their stories gives us, as doctors, a 
better u n derstand ing  of their ow n w orld .24 In addition , m utua l u nderstand ing  leads to a higher 
satisfaction w ith  care for bo th  patien t and  doctor an d  it strengthens the doctor-patient 
relationship .3,25,26 Rem arkable w ords, strange clauses, sentences tha t you  do no t directly 
understand  -  ask  for their m eaning. It b rings the patien t's  an d  the doctor's w orld  closer together.
Conclusion
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Objectives. To study doctor-patient interaction styles in consultations with patients 
presenting persistent medically unexplained symptoms (MUS) and to study on which stages of 
the consultation patients and doctors focus within the available time.
Methods. Exploratory, qualitative analysis of transcripts of 20 videotaped consultations 
between family physicians (FP) and persistent MUS patients.
Results. Patients presented many symptoms in a rather unstructured way. However, FPs 
hardly used structuring techniques such as agenda setting and summarizing. Patients with 
persistent MUS got much opportunity to tell their story, but the reasons for encounter, their 
beliefs and concerns were not discussed in a structured manner. Although consultations were 
focused on these issues, mostly patients themselves initiated discussion of their ideas, concerns 
and expectations. FPs' extensive explanations of the origin of the symptoms often did not take 
patients' beliefs and concerns into account.
Conclusions. Due to patients' multiple symptom presentation and the absence of FPs' 
structuring techniques, consultations of persistent MUS patients proceed rather unfocused. 
However, patients got ample opportunity to tell their story.
Practice implications. Persistent MUS patients might benefit from structured
consultations focused on the exploration of the reason for encounter.
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Introduction
Patients complaining of physical symptoms in the absence of physical disease are common in 
primary care. These symptoms are often described as medically unexplained symptoms 
(MUS) .u  In patients with MUS, symptoms or impairment improve when consultations meet the 
patients' expectations or when patients feel understood.3 Recently, two studies showed that 
physicians' communication during the initial presentation of MUS is hampered.4'5 Epstein et al. 
concluded that physicians face lack of time and do not explore and validate the MUS patient's 
reason for visit, their ideas, expectations and concerns.4 Kappen and Van Dulmen concluded 
that family physicians (FPs) explore patients' concerns mainly medically.5 Despite these 
physicians' communication barriers during the initial presentation of MUS,6 only a minority (2.5 
percent) of the patients will evolve into a chronic disabling condition of persistent MUS.7 From 
this moment communication is often the only tool FPs have in handling these patients.4'8 
However, doctor-patient interaction styles in consultations with patients with persistent MUS 
have not been well studied, and may bring important insights to improve the quality of care of 
these patients.
Consultations between doctors and persistent MUS patients are not straightforward but can be 
considered as complex consultations.9 As symptoms are medically unexplained, the link 
between cause and symptom is unclear, and FPs are uncertain about the way forward.10 
Persistent MUS patients are aware of the complex nature of their problems.11-13 They have to 
present complex and multifaceted reasons for consulting, discuss concerns about the symptoms 
and problems, and choose whether or not to present emotional aspects of their problems, in a 10­
15 minutes consultation.13-15 It is understandable that both patients and FPs report insufficient 
time to deal effectively with persistent MUS during consultations.16'17 However, it is still not clear 
how patients and FPs reach their goals during the consultations and on which stages in the 
consultation they focus.
Therefore, the aim of this study is to analyze (1) how patients present and how FPs explore the 
patients' symptoms and problems during consultations and (2) on which stages of the 
consultation they focus within the available time.
Methods
Data source: Dutch National Survey of General Practice
Data for the present study were drawn from the Second Dutch National Survey in General 
Practice (DNSGP-2).18 This survey is a large-scale research project carried out in the Netherlands 
between May 2000 and April 2002 and studied a representative sample of 104 family practices
with 195 FPs and 399,068 listed patients. The survey comprised an epidemiologic study about 
the work of FPs and a video observation study of consultations in which each participating FP 
consented to video tape approximately 20 clinical encounters on two arbitrary days. A total of 
142 FPs (72.8% ) agreed to participate in the video observation study.19 Prior to the consultation, a 
research assistant informed the patients and asked informed consent about the video 
observation. A total of 2784 patients participated in the video-observation study, 377 patients 
(11.9%) refused. Before and after the videotaped encounter patients completed a questionnaire 
about sociodemographic characteristics, presented symptoms and general health status. 
Immediately after the consultation, FPs completed a questionnaire with items on characteristics 
of the FP, questions about how familiar the FP was with the patient and how the FP valued the 
psychosocial and work related aspects of the presented symptoms. Furthermore, FPs rated on a 
5-point Likert-type scale (extremes labeled as 'not at all' and 'very much') whether they believed 
psychosocial factors played a role in the problem presented during the consultation. FPs coded 
patients' symptoms and diagnoses according to the International Classification in Primary Care 
(ICPC) system.20'21
Selection of patients with medically unexplained symptoms
We selected from the video-observation study all videotaped consultations in which medically 
unexplained symptoms were the main subject of the encounter. Inclusion criteria were: (1) 
patients consulting their own FP, (2) consultations for physical symptoms for which the patient 
had consulted the FP before and in which, according to the FP, the symptoms were related to 
psychosocial factors ('much'/'very much' on 5-point Likert-type scale), (3) age of the patient > 18 
years and (4) no psychiatric diagnosis and/or social diagnosis according to the ICPC during this 
consultation. Exclusion criteria were: bad sound-quality and consultations by one of the 
authors. When more than one video consultation of a FP appeared in our selection, only the first 
consultation was included. Two independent researchers (ToH and SvD or EvR) looked at the 
video recordings and established whether medically unexplained symptoms were the main 
topic. Encounters were included in the final sample when both researchers agreed. In case of 
disagreement, we excluded the consultation. We used Cohen's kappa statistic ( k )  to assess 
agreement between the two researchers.22
Data analysis
Data analysis started by using qualitative methods to develop a coding scheme of FPs' 
exploration of the patients' symptoms and problems.23 The theoretical framework guiding the 
analysis was the broad concept of the biopsychosocial model.24 This model proposes illness to be 
viewed as a result of interacting mechanisms at the biomedical, interpersonal and 
environmental levels. The model is widely used in primary care consultations. Using this model 
in consultations implies that patients' symptoms, illness beliefs, anxiety, concerns, illness 
behavior and social environment are addressed.25
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The included videotaped consultations were completely and anonymously verbatim 
transcribed and entered into Atlas.ti. The qualitative analyses were executed with this software 
program, a package for detailed coding in qualitative data analysis.
We analyzed the transcripts using the principles of constant comparative analysis.26 During this 
analysis transcripts are subsequently thematically coded. The main aim of this analysis is to 
organize utterances by theme and to explore similarities and differences between consultations.
Two researchers (T oH, EvR) read all transcripts several times to familiarize themselves with the 
data. They independently made a first categorization by applying codes to meaningful words 
and sentences in the transcripts. These codes were discussed and refined during consensus 
meetings. When additional codes emerged these were discussed and applied to the transcripts. 
Concepts and categories emerged through this iterative process of coding, analysis and 
discussion. Codes appearing from the utterances of the participants in the consultations are 
presented in T able 1. During the iterative process of qualitative analysis we noticed the complex 
structure of the consultations. To gain a better understanding of this complex structure we 
decided to code the stages of the consultation, apart from the utterances of the participants 
during the consultation. These stages were derived from the Dutch FPs' communication skills 
training program15,27,28 (T able 2). After 8 videotaped consultations, the first results of the analysis 
were discussed with a senior researcher (PL). Data collection continued until no significant new 
themes emerged (saturation).29 This was achieved after 15 consultations. To quantify on which 
stages of the consultation patients and FPs focus within the available time of the consultation, 
we calculated, as a proxy, the percentage of text in the transcript (the number of text lines of a 
particular stage of the consultation divided by the total number of text lines of the consultation) 
spent on each of the different stages.
Ethical approval
The study was carried out according to Dutch privacy legislation rules. The privacy regulation 
was approved by the Dutch Data Protection Authority.
Results
Sample characteristics
The total number of video consultations in the Second Dutch National Survey of General 
Practice (DNSGP2) was 2784. Fifty nine of these video consultations met our inclusion criteria 
and were screened by one of the authors (ToH). In 14 cases more than one video consultation of a 
FP appeared in the selection, 4 video consultations had a bad sound quality and in 1 video
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consultation one of the authors (PL) was the FP. These 19 video consultations were excluded. 
Therefore, a total of 40 video consultations could be included for screening by two independent 
researchers (ToH and SvD or EvR). Because MUS was not the main topic of the consultation in 20 
of these video consultations, a total of 20 video consultations could be included for further 
analysis (Figure 1). The interobserver agreement for inclusion was k = 0.79 (95%-CI: 0.59 -  0.99). 
We considered this level of agreement to be 'good'.
Eight (40%) of the patients involved in the final video consultation sample were men, aged 
between 25 and 80 (mean = 47) years. The 20 FPs consisted of 15 (75%) men, aged from 34 to 61 
(mean = 45) years with an average of 15.7 (range 3 -  30) years of FP working experience. Mean 
(and median) duration of consultation was 13.5 (12.1) minutes; ranging from 8.1 to 37.0 minutes.
Within the available time of the consultation, patients and doctors focus most on the story of the 
patient, discussion and exploration of patients' beliefs and concerns, and on explaining the 
symptoms (respectively 21.8, 18.7 and 16.8% of the total amount of text is spent on these stages) 
(Table 3). Agenda setting, summarizing and evaluation of the consultation was limited.
Figure 1. Selection of persistent MUS video consultations
Excluded (n = 2725) 
according to criteria
Excluded (n = 14) 
because more than one 
video consultation of a 
FP in the selection
Excluded (n = 20) 
because MUS was not 
the main topic of the 
video consultation
Excluded because of 
bad sound quality (n = 4) 
and because one of the 
authors (PL) was the FP 
in the video consultation 
(n = 1)
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Table 1. Codes appearing from  utterances of the participants of the persistent MUS consultations 
Codes
Story of the patient (narrative) 
Symptoms
Patients' beliefs and expectations 
Patients' fears and concerns
Consequences on patients' daily activities and illness behavior 
Consequences on patients' social environment 
Explanation
Table 2. Stages of the consultation
Story of the patient (narrative)
The retelling, in patients' own words, of a series of unfolding events regarding the symptoms, representing the 
patient individual viewpoint
Agenda setting
Agreement (between patient and FP) of the issues which should be discussed during the consultation
Discussion /  exploration of the symptoms
Discussion and exploration of the characteristics of the symptoms (nature, location, intensity, frequency and 
duration)
Discussion /  exploring of the reason for encounter (RFE)
Discussion and exploration of the reason for encounter, including the patients' expectations regarding the 
actions of the doctor
Discussion /  exploring of patients' beliefs and concerns"
Discussion and exploration of patients' ideas regarding the symptoms, such as patients' own explanations, 
symptom attribution, patients' own influences on the symptoms (self-efficacy), concerns and (negative) 
emotions regarding the symptoms
Discussion /  exploration of the consequences on patients' daily activities, social environm ent and illness 
behaviorb
Discussion and exploration of patients' behaviour in response to the symptoms, the way patients cope with 
their symptoms, the consequences of the symptoms on patients' daily activities, the influences of the symptoms 
on patients' social life, and reactions and opinions of the people in patients' surroundings.
Summarizing
FPs' summary of the symptoms, reason for encounter, beliefs, concerns and consequences of the symptoms 
presented during the consultation
Physical examination
The process by which the FP performs a physical examiniation
Explanation
FPs' explanation of the origin of the symptoms presented during the consultation
Evaluation of the consultation (including making a follow-up appointment)
Evaluation of the consultation, including the question whether the consultation has been helpful, explanation 
a n d /o r advices, whether the reason for encounter has been answered, and whether follow-up appointments 
have been made.
a Matches with the codes "patients' beliefs and expectations" and "patients' fears and concerns" that appeared from the utterances of participants of 
persistent MUS consultations.
b Matches with the codes "consequences on patients' daily activities and illness behavior" and "consequences on patients' social environment" that 
appeared from the utterances of participants of the persistent MUS consultations.
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Table 3. The percentage of text in the transcripts spent n each of the different stages of the consultation
Persistent MUS patient 
Mean
Story of the patient (narrative) 21.8
Agenda setting limited
Symptom exploration 7.9
Reason for encounter (RFE)
Initiated by the FP 
Initiated by the patient
0.6
2.1
Patients' beliefs and concerns
Initiated by the FP 
Initiated by the patient
4.8
13.9
Consequences on patients' daily activities, social 
environm entand illness behavior
Initiated by the FP 






Evaluation of the consultation limited
Other” 28.3
a Quantifying physical examination is not possible by using the proxy percentage of text spent.
” Talk/discussion regarding medically explained symptoms (for example: presentation of a pneumonia, discussion on therapies for asthma, 
discussion and management of hypertension, etc.).
Patients' symptom presentation
Most (95%) persistent MUS patients presented more than one symptom. Three quarters of the 
patients presented medically unexplained symptoms as well as medically explained symptoms. 
The average number of symptoms presented was 3.6 (range 1 -  5). The average number of MUS 
presented was 2.4 (range 1 -  5). The most common symptoms were musculoskeletal (n = 15), 
gastrointestinal (n = 8) and general and unspecified symptoms (n = 11), such as feeling ill, 
weakness/tiredness, sweating or swelling.
Persistent MUS patients presented multiple symptoms and seemed to switch from one 
symptom to another during all stages of the consultation.
They often started to discuss new symptoms and concerns after the FP finished history taking, 
physical examination and explanation. (Quotation 1)
Quotation 1 (P11 116-12;023-111)
[Patient's story, symptom 1]*
P: It's  either painful gas or it's a lot o f pain in m y belly. A nd  m y bowel movements happen or don ' t
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happen but they look kind o f weird. But it will go away. It's  always gone away eventually.
D : Okay, so you have had these comp laints for years.
[Medical exploration]
D: Abnormal bowel movements. No blood or mucus ?
P: No. No.
D: Firm and pulpy, no diarrhea?
P: No, I don't have that.
[No physical examination]
[Explanation]
D: Okay, it seems to me that you have irritable bowel syndrome - sensitive intestines - and that can 
cause cramps. About 20% of the population has this kind of bowel problem to some extent. It's not 
malignant and there is no infection. It's  ju s t that the intestines don't function optimally. A nd  so 
it's important that you get enough fiber and that you take the powders (movicolon).
[Patient's story, symptom 2]
P: A nd  the itch. It won ' t go away and it's awful.
D: So, we have to deal with the itch.
P: Yes, it's ridiculous but it's sometimes really bad on m y face and on my back, it's the worst -  it's 
always the same place. I've had it for a really long time.
* the words between brackets represent the codes given by the researchers and used in the 
constant comparative analysis
Patients' attempts to address their needs
In most encounters, the patients' reason for seeking help remained unclear. Although clarifying 
the reason for encounter (RFE) is an important task for the FP in order to reach a more focused 
communication, in 13 consultations (65%) there was no exploration of the reason for encounter 
at all. The absence of FPs' exploration of the reason for encounter might be the reason why 
patients themselves try to initiate such a discussion. It appeared from the data that during 
consultations in which the reason for encounter was discussed (n = 7), most of the time the 
patients themselves initiated talking about this subject (n = 5). (Quotation 2) Only in two 
consultations the doctor initiated the discussion on the reason for encounter.
Discussions on the reason for encounter took 2.7% (range 0 -  15.7) of the text in the transcripts. 
(Table 3)
Quotation 2 (P8 C10208; 24-31)
P: A nd  when I go to bed, I feel very restless. I have these heart palpitations.
D: Yes,
P: So I was wondering - 1 read about something called beta-blockers. I don ' t know i f  that applies to 
my situation but -
D: Hmm
P: Someone told me about propanolol. I was wondering i f  that was something for me.
D: Yeah, okay.
In all but two video consultations patients started talking about their beliefs and concerns. 
However, in the two encounters in which no discussion on beliefs and concerns took place, the 
patient tried to initiate such a discussion but the FP refrained from responding (Quotation 3). In 
the encounters in which beliefs and concerns were discussed, patients mostly initiated such a 
discussion: in 16 consultations (89%) patients made attempts to initiate discussion, whereas in 9 
consultations (50%) FPs did. This is also reflected in the amount of text spent in the transcripts of 
the consultations on this topic. The total amount of text spent in the transcripts regarding 
discussing patients' beliefs and concerns initiated by the patient or by the FP is 13.9% (range 0 - 
40.1), respectively 4.8% (range 0 -  17.8). (Table 3)
It is noteworthy that in the majority of the consultations (10 out of 18) in which patients' beliefs 
and concerns were discussed, discussion of these beliefs and concerns only took place for a 
limited number of symptoms presented during the consultation.
Quotation 3 (P1 C2601;132-140)
P: It's  not good at all. I feel m yself going so unbelievably downhill.
D: This is something you need to discuss with a neurologist. You can make an appointment with 
one. I'll write a referral letter and you can pick that up at m y assistant's desk. But your legs: that's 
also an issue for you ?
P: Yes, I know I have a lot of weight to carry but, oh my, that's not easy. It's  like something is 
broken in m y brain. I think every time, 'I have to lose weight, I have to lose weight, ' and, at the very 
same moment, I stuffmyself. It ju st doesn't work that way up here (P points to head).
D: You need to lose weight but you eat too.
The consequences of the symptoms on patients' daily activities, social environment and illness 
behavior was less well discussed. In 9 consultations (45%) there was no discussion of these 
themes at all. Again, most of the time discussion of these consequences of the symptoms was 
initiated by the patients namely in 7 consultations; in one consultation this discussion was 
initiated by the FP as well as the patient and in three consultations the FP initiated the 
discussion. (Quotation 4) Almost 3% (2.7; range 0 -  12.3) of the total amount of text in the 
transcripts of the consultations spent on talking about the consequences of the symptoms on 
daily activities, social environment and illness behavior was initiated by the patient against 1.1% 
(range 0 -  7.4) initiated by the FP. (see T able 3)
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Quotation 4 (P2 C070-13;34-45)
D: How are you sleeping?
P: A t night, I sleep okay now, but during the day, I try not to spend time in bed. It's  nice to know 
that I can go to bed but then I restrain myselfwith, 'No, I can't stay in bed all day. ' A nd  then I try to 
do some s tu ff around the house -  the dishes, vacuuming, dusting.
D: So you do that?
P: A nd  then I try to sleep at night. A nd when I wake up in the morning, I have those puffy eyes. 
A nd those chewable pills, I don't take them one after another anymore. Or should I keep taking 
them ? Because sometimes I still have - especially when I have to bend over, I still see stars.
D: But you eat well ?
P: Yes, i f  I know that I need some kind of feeling or is that not necessary?
In nearly all consultations there was much opportunity for explanation of the symptoms. The 
total amount of text in the transcripts about explanations is 16.8% (range 0 -  52.9). (Table 3) 
Although almost one fifth of the text in the transcripts was spent on explaining the symptoms, 
patients responded on FP explanations with new remarks about their symptoms, beliefs and 
concerns.
Furthermore, most of the time, explanations given by the FPs did not incorporate beliefs and 
concerns that patients presented during the consultation. Moreover, FPs attempts to reassure 
patients were often not focused on the patients' concerns. (Quotation 5)
Quotation 5 (P4 C077-04:4-9;21-26; 80-85; 109-11)
[Patient concerns]
P: I'm  having problems with m y throat, esophagus again. I feel it when I am doing exercise. It 
doesn 't have anything to do with m y heart, does it? I have it every time I roll over at night.
D: Yes
P: I don't know but I think that it's lower. It's  like something is stuck there.
[Reason for encounter and patient concerns]
P: I've also had chest pains so I wanted to ask i f  you would be willing to take a look. I'm  a little 
concerned. I'd  ju st like to know for sure that there ' s nothing going on.
D : I f  we know that it's your throat and not your heart, then that ' s good.
P: Yes.
[Explanation]
P: I was also really busy earlier this week. I've been feeling kind of hurried the last little while so I 
took a seresta pill and the pain in my throat went away.
D: Yes, that could mean that the tension that you feel inside is coming out through your throat, like 
your throat is literally being choked.
P: Yes, I do have that kind of feeling.
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[Patient response]
P: But m y heart has nothing to do with it?
D: No, your heart has nothing to do with it.
FPs' structuring behavior
In the video consultations, FPs gave patients with persistent MUS much opportunity to tell their 
story (21.8% (range 5.1 -  80.7) of the text in the transcripts). However, FPs did not do an in-depth 
inquiry of the symptoms (7.9% (range 0 -  39.4) of the text in the transcripts). In 50% of the 
consultations (n = 10) there was no in-depth inquiry of the presented symptoms at all. In half of 
the consultations in which an in-depth inquiry of the symptoms was performed, the FP did not 
explore all medically unexplained symptoms presented during that consultation. Furthermore, 
it appeared from the video consultations that FPs hardly use structuring techniques, such as 
agenda setting, announcing and performing physical examination and summarizing the 
information obtained during the consultation. Agenda setting was explicitly performed in one 
consultation . Physical examination was performed in eight consultations and a summary was 
given in only one consultation.
Discussion and conclusion
Discussion
Our findings of the difficulties of discussing the reason for encounter and patients' beliefs and 
concerns regarding the symptoms during the persistent MUS consultations are in line with the 
findings of Epstein et al.4 Furthermore, it is known from direct observation of patients' 
presentations of MUS that almost all patients provide opportunities for FPs to address 
psychosocial issues, psychosocial concerns.5,3“ Our study adds rigor to these findings as we 
studied doctor-patient communication in persistent MUS consultations. Our results indicate 
that doctor-patient communication can be improved by focusing on the exploration of patients' 
beliefs and concerns and incorporating these into FPs' explanatory and reassuring strategies. 
These findings are important as discussion of patient's ideas and concerns, shared 
understanding and clarifying the reason for encounter contribute to a more satisfactory 
consultation according to patients.31
The observations of our study confirm that the chaotic structure of most MUS consultations 
reflect the chaotic narrative of the people who live with MUS.32 Nettleton highlighted that the 
narratives of MUS patients shared many features of chaos narratives.33 These narratives are 
characterized by confusion and uncertainty in the absence of a diagnosis and prognosis.32 
Moreover, these narratives are difficult to 'listen' to and difficult to 'hear', because it reminds us
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of our own vulnerability and limitations.34 This might explain why FPs have difficulties in 
structuring the persistent MUS consultations and why patients present multiple symptoms in a 
rather unstructured way. Although giving patients time for their story is an important element 
of working patient-centered, persistent MUS patients might benefit from more focused patient- 
centered interaction style in which FPs structure the consultation and explore needs, concerns 
and beliefs. The ample opportunity patients get to tell their story and present their symptoms 
possibly reflect FPs' commitment with these patients which is in line with research on FPs 
perceptions about patients with persistent MUS.10 However, this commitment is worth to yield 
more effect.
This is the first study in patients with heterogeneous undifferentiated persistent MUS using 
consultations between doctor and MUS patients in which neither the doctor, nor the patient was 
aware of the subject of study. Doctor-patient communication studied in this way represents 
daily practice reality. Furthermore, FPs and patients in these consultations already built a 
doctor-patient relationship as they knew each other for a long time and had discussed the 
symptoms before. However, in most cases, a single consultation is not the beginning or the end 
of the story. Each new consultation carries over memories of previous ones, which might have 
influenced the videotaped consultations.35 This might explain why we found limited medical 
exploration of the presented symptoms and no physical examination in most consultations. 
However, we did not find utterances referring to the content of previous consultations on the 
symptoms presented.
Video-recording has been recommended as the best method for researching doctor-patient 
communication during consultations.36 According to Coleman, there is little evidence that 
video-recording influences the behavior of either the FPs or patients (i.e. Hawthorne effect), but 
it may cause bias in the characteristics of doctors and patients who agree to participate.37 
However, with a response rate of 89% in the DNSFP-2 and the attendance of a representative 
sample of family practices in The Netherlands, participation bias in our study will be limited. 
Furthermore, we found 2.1% (59 out of 2784) of the total number of video consultations in the 
DNSGP-2 concerned consultations with patients with persistent MUS. This is in line with the 
findings of Verhaak et al. that 2.5% of the patients in primary care present with persistent MUS.7
By quantifying on which stages of the consultation patients and FPs focus within the available 
time of the consultation, we studied the doctor-patient communication in persistent MUS 
consultations on different levels which improved our understanding of the role of the doctor- 
patient communication.23'38 We chose to quantify as measure of focus the number of text lines. We 
decided to this approach as it had in our view, face validity, but it is important to formally 
validate it in further study. Besides, we do realize that the FP's and patient's speaking rate, the
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duration of silences within the consultation and other non-verbal characteristics can make the 
number of text lines as a proxy of speech focus less reliable. As our goal was not to study doctor- 
patient interaction on micro level, we choose not to use conversation analysis techniques.39
The small sample size and the cross sectional nature of the qualitative analysis preclude 
definitive conclusions. Our findings should be confirmed in a larger, prospective qualitative 
study that could track doctor-patient communication regarding the unexplained symptoms 
over time.
Conclusion
Patients' showed a rather unfocused and fragmented presentation of multiple symptoms 
during all stages of the persistent MUS consultation. However, ways of giving structure to the 
consultation such as agenda setting and summarizing were hardly ever used by the FPs. Patients 
had ample opportunity to tell their story, but the reason for encounter, patients' beliefs and 
concerns were not discussed in a structured manner. Mostly, patients themselves initiated 
discussion on the reason for encounter, their beliefs and concerns and the consequences on daily 
activities, social environment and illness behavior. Furthermore, the extensive explanation of 
the origin of the symptoms they received from their FP was often not focused on their beliefs and 
concerns.
Although consultations with persistent MUS patients seemed quite patient-centered as patients 
have much opportunity for telling their story, patients might benefit more from a structured 
consultation focused on the exploration of their ideas, concerns and expectations.
Practice implication
Exploration and validation of patients' experiences of illness, patients' distress and patients' 
concerns and incorporating these items into explanations and reassurance may improve the care 
of patients with persistent MUS.
Educational interventions in graduate and advanced professional training, aiming at enhancing 
a systematic symptom exploration and reason for encounter, improving FPs symptom 
explanation and reassurance during the persistent MUS consultation should be developed and 
might result in a more focused patient-centered approach which can enhance the wellbeing of 
patients with MUS.
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Background. The feasibility as w ell as the suitability  of several therap ies for m edically 
unexplained  sym ptom s (MUS) in  prim ary  care app lied  by the fam ily physician  (FP) appeared  to 
be low. FPs need  effective and  acceptable strategies to m anage these functionally  im paired  
patients.
Objective. To review  im portan t and  effective elem ents in  the treatm ent of patients w ith  
MUS in  prim ary  care according to experts in  MUS research.
Methods. W e perform ed a system atic search of narrative review s an d  scientific editorials in  
M edline and  PsycINFO an d  triangu lated  our findings by conducting  a focus group  w ith  MUS 
experts.
Results. W e included  7 scientific editorials an d  23 narrative review s. A ccording to MUS 
experts the m ost im portan t elem ents in  the treatm ent of MUS are creating a safe therapeutic 
environm ent, generic in terventions (such as m otivational interview ing, giving tangible 
explanations, reassurance an d  regularly  scheduled  appointm ents) an d  specific in terventions 
(such as cognitive approaches an d  pharm acotherapy). Furtherm ore, MUS experts indicate that 
a m ulti-com ponent approach  in  w hich  these th ree im portan t elem ents are com bined are m ost 
helpful for patients w ith  MUS. In contrast to m ost specific interventions, opinions of MUS 
experts regard ing  generic in terventions and creating  a safe therapeutic relationship  seem  to be 
m ore based on theory and  experience than  on quantita tive research.
Conclusions. MUS experts h ighlight the im portance of generic in te rventions an d  doctor- 
patien t com m unication an d  relationship. H ow ever, stud ies show ing the effectiveness of these 
elem ents in  the m anagem ent of MUS in  prim ary  care is still scarce. Research as well as m edical 
practice shou ld  focus m ore on these non-specific aspects of the m edical consultation.
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Introduction
M edically unexplained  sym ptom s (MUS) are som atic sym ptom s tha t cannot be attribu ted  to a 
clear organic cause after appropria te  m edical assessm ent.1 MUS are a com m on and  im portan t 
problem  in prim ary  care. In 19% -  50% of all sym ptom s seen in  prim ary  health  care, no  evidence 
can be found  for any physical disease (i.e. MUS).2-4 M ost of the tim e MUS are transien t and  self 
lim iting an d  do no t need  fu rther m edical a tten tion  after one or tw o consultation(s). A recent 
D utch s tudy  found  th a t only 2.5% of the attendees in  general practice presen ting  w ith  MUS m eet 
criteria for chronicity.5;6 H ow ever, this m inority  of patien ts represen t a m ajor prob lem  in health  
care. These patients suffer from  their sym ptom s, are functionally  im paired  and  are at risk  of 
unnecessary  an d  possibly harm ful tests, referrals and  treatm ent.4;7 M oreover, scarce healthcare 
resources are w asted  w ith o u t clinical benefit.2 This leads to fru stra tion  for bo th  doctor and  
patient.
There is an  often com plex overlap betw een  MUS and  com m on m ental health  problem s, bo th  
longitud inally  and  cross-sectionally.8 For exam ple, som atic sym ptom s are com m on in m any 
psychiatric conditions, such as anxiety or depressive d isorders, an d  of p rim ary  care patients 
w ith  a diagnosable psychiatric d isorder, 50% -  70% initially presen t w ith  som atic sym ptom s. 9;1°
Several treatm ents for patien ts w ith  MUS have been described, w ith  considerable recent 
research focused in  prim ary  care. Some stud ies show  tha t an tidepressan ts and  cognitive 
behavioural therapy  (CBT) are effective in  the trea tm en t of persisting  MUS, im proving 
sym ptom s and  functional sta tus an d  reducing  psychological d istress.11;12 R eattribution  therapy, 
a structu red  in tervention  to provide an  explanation  of the m echanism  of patien ts' sym ptom s 
th ro u g h  negotiation  an d  patien t-cen tred  com m unication,13 is probably  n o t effective as three of 
four trials do no t show  any benefit.14 M oreover, in  one RCT rea ttribu tion  train ing  by FPs w as 
associated w ith  decreased quality  of life.15 W hile fam ily physicians (FPs) face a considerable 
w ork load  from  patients w ith  MUS, the applicability  of CBT is lim ited because m any patients do 
no t accept CBT as they do no t consider their com plaints to be 'psychological'. Thereby a coherent 
and  in tegrative m odel of disease m echanism s com bining pred isposing, p recip itating  and  
perpe tuating  factors is lacking.16
M oreover, the application  of m edication is generally seen as less su itable as it is a passive form  of 
treatm ent.17 In conclusion, the evidence in  this field is tha t specific in te rventions for patients 
w ith  MUS are at best of lim ited help for FPs.
Therefore, to im prove the care for patien ts w ith  MUS, it seem s valuable to consider expert 
opinions on  effective m anagem ent strategies for patients w ith  MUS. Scientific editorials and  
narrative review s are an  im portan t resource to learn  abou t the opinions of leaders in  the field .18
W e decided to s tudy  the elem ents experts consider im portan t an d  effective in  the m anagem ent 
of MUS in prim ary  care.
Methods
W e perform ed a system atic review  w ith  qualitative analysis of editorials and  narrative reviews. 
Both types of papers are usually  w ritten  by experts in  the field. Scientific editorials allow  leaders 
of research an d  clinical com m unities to com m unicate w ith  each other and  are a fo rum  for the 
expression of w idely  shared  expert beliefs and  opinions.18 N arra tive review s tell us w h a t is 
know n about therapies for patien ts w ith  MUS according to experts in  the field. The inform ation 
obtained from  the analysis of the system atic review  w as triangu lated  by a focus group w ith  
D utch experts in  the field.
Data sources and search strategy
In October 2009 w e perform ed a system atic search in  M edline an d  PsycINFO for narrative 
review s and  scientific editorials about MUS. W e used  tw o search strings an d  com bined these 
w ith  the Boolean operator AND. The first string  consisted of term s indicating  som atization  (for 
exam ple: som atization, som atoform  disorders, functional som atic syndrom e, sym ptom , 
m edically unexplained). The second search string  included  term s for trea tm en t (for exam ple 
therapy , intervention). The search strategy for M edline (see A ppendix  1) w as ad ap ted  for 
PsycINFO. W e p retested  the search  strategy on five im portan t articles tha t shou ld  be included  in 
our study. Furtherm ore, w e ob tained additional references from  the reference list of retrieved 
articles by system atically checking these .
A fter read ing  several articles w e found  tha t ideas an d  sta tem ents published  in  articles in  the 
years before 2004 w ere review ed an d  discussed in  m ore recent articles. Therefore, w e lim ited 
our search strategy to articles published  in  the last 5 years.
Selection of studies
Two review ers (MH, physician  w ith  an  in terest in  MUS; TCoH, FP w ith  an  in terest in  MUS) 
independen tly  read  all titles and  abstracts for inclusion. The full texts of the included  abstracts 
w ere read  by one review er (MH) w ho once again  checked for inclusion an d  exclusion criteria 
before definitive inclusion. W hen in  d oubt she consulted  the o ther review er (TCoH). Inclusion 
criteria w ere narrative review s or scientific editorials focussing on  the m anagem ent of patients 
w ith  MUS. W e excluded papers th a t focused prim arily  on diagnosis or classification. As we 
w ere in terested  in  im portan t elem ents in  the m anagem ent of undifferen tia ted  MUS and  not in 
the m anagem ent of specific sym ptom s or syndrom es (for instance m elatonin  for fibrom yalgia or 
probiotics for IBS), w e excluded articles abou t specific syndrom es or single unexplained
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sym ptom s. W e focused on undifferen tia ted  MUS as w e assum e tha t these are m ore difficult to 
handle for the physician  than  single sym ptom  unexplained  d isorders an d  functional 
syndrom es: the la tter give m ore oppo rtun ity  for guideline-based m anagem ent or a specific 
referral to a m edical specialist w ith  specific in terest regard ing  functional syndrom es. Papers on 
ch ildren  and  adolescents (age <18 years) and  papers on  specific groups of patients (for exam ple 
refugees, com m ercial sex w orkers) w ere excluded as well. W e calculated the in ter-review er 
agreem ent in  article selection based on  title and  abstracts w ith  kappa statistics.19 D isagreem ents 
w ere resolved du rin g  a consensus meeting.
Analysis
W e qualitatively  analysed the included  scientific editorials an d  narrative review s to explore 
expert opinions abou t im portan t elem ents in  the m anagem ent of MUS. A nalysis follow ed the 
princip les of constant com parative analysis, in  w hich included  stud ies are subsequently  
them atically  coded.20
To triangulate  the results of our qualitative analysis w e conducted  a focus group  m eeting. We 
inv ited  FPs w ho are participating  in  the guideline com m ittee on MUS in prim ary  care of the 
D utch College of G eneral P ractitioners. The participan ts' characteristics are listed in  Table 1. All 
five have a specific in terest in  m anaging  patien ts w ith  MUS in  p rim ary  care. M oreover, three 
participan ts d id  their PhD in this field.22-24 Follow ing the guidelines for conducting  focus groups, 
w e used  an  interview  guide to direct the d iscussion and  to fulfill the research aims. This 
interview  guide w as based on the key them es w e identified  du ring  the analyses of the articles 
(Table 2). The d iscussion w as facilitated by a m oderator (MH) an d  lasted  for ~1 hour. We
Two review ers (MH an d  TCoH) independen tly  read  tw o articles (one editorial and  one 
narrative review ) to develop a coding scheme. Initial codes w ere discussed, seeking agreem ent 
on  their content. A fter the tw o review ers agreed  on the coding scheme, one review er (MH) 
coded one editorial an d  one narrative review . This initial coding w as checked by the second 
review er (TCoH). Since no significant discrepancies w ere discovered, the first review er (MH) 
proceeded  to code the entire data set. In the event of doubt or am biguity  the first review er (MH) 
sough t the op in ion  of the second review er (TCoH). D uring  such a consensus m eeting the coding 
schem e w as review ed an d  if necessary m odified. Subsequently  the transcrip ts w ere recoded 
w ith  the m odified coding scheme. W e used  A tlas.ti qualita tive data  analysis softw are for coding 
and  recoding the transcripts. W e grouped  the codes into them es to identify  key features of 
experts opinion. Recurrent an d  im portan t them es, identified  by the researchers, w ere 
frequently  discussed an d  refined as p a rt of an  ongoing iterative process.21 D uring  the entire 
analysis w e constantly  m atched the developing them es w ith  the transcrip ts. Therefore, these 
repeated  them es are grounded  in  the data  an  no t im posed onto the data  by the researchers.
aud io taped  the discussions in  the focus group, transcribed the text and  en tered  it into Atlas.ti. 
Next, w e analysed  w ith  tw o review ers (MH an d  TCoH) the text according to the principle of 
constant com parative analysis and  com pared the results w ith  the findings from  the system atic 
review.
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T able  1 . C haracteristics of p a rtic ip a tin g  FPs in  the  focus g roup  d iscussion




W ork ing  hours
- Full tim e 0




- G roup 3
Age in  years (range) 51,4 (48-56)
Experience as a FP in  years (range) 18,6 (10-25)
T able  2. Focus g roup  in te rv iew  gu id e
O pen in g - W hat are im portan t elem ents in the m anagem ent of patients w ith  MUS?
- H ow  do y ou  im plem ent this in a consultation?
C reating  a safe therapeu tic  
en v ironm en t
- W hat are im portan t elem ents in the m anagem ent of patients w ith  MUS that 
create a safe environm ent?
- H ow  do y ou  im plem ent this in a consultation?
G eneric in te rv en tio n s - W hat are im portan t elem ents in the m anagem ent of patients w ith  MUS that 
belong to this them e?
- H ow  do y ou  im plem ent this in a consultation?
Specific in te rven tions - W hat are im portan t specific treatm ents for patients w ith  MUS?
- H ow  do y ou  im plem ent this in a consultation?
M ulti-com ponen t approach - W hat are im portan t s teps in  the m anagem ent of patien ts w ith  MUS?
- H ow  do y ou  im plem ent this in a consultation?
- W hen do  y ou  take w hich  step?
End - W ould  anyone like to add  elem ents in the m anagem ent of patients w ith  
MUS w hich  are n o t d iscussed today?
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Results
W e retrieved  960 articles from  the electronic databases (572 M edline an d  388 PsycINFO ). A total 
of 74 articles found  w ith  PsycINFO had  already been found  in  the M edline search (Fig. 1). After 
screening the titles and  abstracts, 53 papers fulfilled the inclusion criteria. The in ter-review er 
agreem ent w as k = 0.89 (95% confidence interval: 0.83-0.96). The full text of 7 of the 53 articles 
w as no t available in  the N ijm egen library  and  the au thors (living ou tside The N etherlands) had 
to be asked for a copy. As after 9 m onths no response came, these papers could  no t be included  in 
th is study. After read ing  the full publication, w e included  30 of the 46 articles in  our analysis. 
These articles concerned 23 narrative review s an d  7 scientific editorials.25-54
D uring  the analysis of the included  articles w e d istinguished  four key them es describing the 
im portan t elem ents in  the m anagem ent of MUS in  prim ary  care according to op in ion  leaders in 
the field: (i) creating a safe therapeutic environm ent, (ii) generic interventions, (iii) specific 
in te rventions an d  (iv) m ulti-com ponent approach. These them es w ill be d iscussed below.
Creating a safe therapeutic environment
A ccording to experts in  the field, a doctor has to actively create a safe therapeutic environm ent 
before h e /sh e  s tarts a therapy. In such a safe therapeutic  environm ent, the p atien t shou ld  have 
the oppo rtun ity  to talk  freely abou t the sym ptom s an d  problem s tha t bother h im /h e r. Experts 
state tha t a good doctor-patient relationship  an d  good com m unication are necessary to create 
such an  environm ent.
D octor-patient relationship
In 17 of the 30 included  papers, the im portance of the doctor-patient relationship  is stressed. 
H ow ever, only one expert referred  to quantita tive evidence from  a random ized  clinical trial 
w hich stud ied  the effectiveness of a patien t-cen tred  m ethod  to establish a good patient-provider 
relationship .35
Experts suggest tha t a good doctor-patient relationship  is necessary for a trea tm en t to be 
effective. A doctor can achieve this by being em pathic, by show ing the patien t th a t h e /sh e  takes 
the problem s and  sym ptom s seriously an d  tha t he /  she is w illing  to help the patient.
Conversations in the primary care setting usually take place in the context of long-standing, 
trusting doctor-patient relationships. Such relationships have been shown to be an important 
factor in the healing process.44
The doctor legitimized the patient's suffering, removed blame, and created a therapeutic alliance. 
The symptom and emotion were thereby linked.43
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Figure 1. Selection of studies
A good doctor-patient relationship  is no t only im portan t a t the sta rt of the therapy, according to 
experts, b u t also du ring  the course of the treatm ent. D octors should  find  a w ay  to deal w ith  the 
doctor-patient relationship  problem s w hich they face in  the contact w ith  these pa tien ts .
During the course of treatment, a relationship o f mutual trust with the patient should be 
maintained, but i f  some problem occurs, it should be addressed directly with the patient in a 
descriptive, yet non-judgmental manner.54
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Doctor-patient communication
In 18 of the 30 included  narrative review s an d  editorials experts discussed the doctor-patient 
com m unication. H ow ever, none of the MUS experts described quantita tive evidence for the 
effectiveness of the doctor-patien t com m unication.
A ccording to experts, clear an d  focused com m unication is an  im portan t elem ent in  creating a 
safe therapeutic environm ent. This m eans th a t a doctor should  listen carefully to his patien t and 
question the patien t extensively about the sym ptom s, the consequences of the sym ptom s for 
daily life and  w hat the sym ptom s m ean to the patient. It is also im portan t to ask the patien t about 
h is /h e r  cognitions, em otions, fears and  concerns regard ing  the sym ptom s. The doctor has to try 
to und erstan d  the patien t's  beliefs, sources of in form ation an d  know ledge gaps.
Better communication has been associated with higher satisfaction in a number of studies, as well 
as greater adherence and lower rates o f litigation, but few  studies have found a relationship 
between communication and disease or symptom outcomes.35
Successful management o f patients with M US has to address the subjective illness perceptions, 
possibly underlying illness fears and information-processing biases. However, this requires not 
only knowledge about the patient, but also behavioural skills in the doctor.32
MUS experts stressed that a clear and  focused com m unication betw een  doctor and  patien t can 
enhance the doctor-patient relationship  and  results in  a m ore patien t-cen tred  explanation  and 
m anagem ent of the sym ptom s. Furtherm ore, w hen  the influence of psychosocial factors has 
been elicited in  an  early stage of the consultation  the relevance of psychological factors becomes 
m ore acceptable for the patient.
To provide the patient with a qualifying explanation, it is necessary to thoroughly explore the 
patient's illness beliefs and symptom worries. Identification of the patient's dysfunctional beliefs 
and behaviours lends the possibility of helping the patient to modify them.27
Moreover, early recognition and communication of the fact that symptoms may not result from  
organic disease, and early appreciation of the role of psychosocial factors, may improve outcomes.34
In tw o papers, experts m entioned, w ithou t p rov id ing  quantita tive evidence, that giving a 
sum m ary  du rin g  MUS consultations m ay be im portan t.32;34 This sum m ary  should  include 
relevant physical, psychological, social factors and  possible links betw een  them . A ccording to 
the MUS experts, giving a sum m ary is a w ay of show ing that the doctor is an  a ttentive listener 
and  is in terested  in  the patien t's  sym ptom s an d  problem s. Furtherm ore, it helps the doctor to 
uncover the patien t's  op inions and  expectations an d  w hether or no t the p atien t agrees w ith  the 
treatm ent plan.
M otivationa l interviewing
In  13 of the 30 included  papers, MUS experts m ention m otivational in terv iew ing  to stim ulate 
patients' m otivation  and  to enhance the efficacy of specific in terventions. H ow ever, the experts 
do n o t refer to quantita tive evidence for m otivational in terview ing. A ccording to the MUS 
experts, doctors shou ld , for exam ple, encourage ap p ro p ria te  ac tiva ting  behaviour. 
Furtherm ore, they have to give patients practical an d  positive advice for lifestyle changes, 
w hich  they can app ly  stra igh t aw ay. Exam ples are recom m endations for (graded) exercise, 
dietary  advice, sleep routine, stress reduction  an d  relaxation.
The essence of these recommendations is: to convey to the patient that his symptoms are real, to 
offer positive advice and treatment and to engage the patient in an active role in alleviating the 
often chronic symptoms.[...] The evidence of non-pharmacological passive treatments, be they 
invasive or non-invasive, seems to be weaker than the evidence of non-pharmacological treatments 
that involve active patients ' cooperation.33
Encourage patients to bring about change in lifestyle and diet, such as exercising, maintaining 
regular hours and stopping use of alcohol, caffeine, nicotine and so forth.51
Furtherm ore, MUS experts stressed the im portance of involving patien t's  allies (family, friends, 
etc.) in  the m anagem ent of MUS in  prim ary  care. In this w ay, patients w ou ld  be m ore m otivated 
to m ake im portan t lifestyle changes.
Explanation
The im portance of explanation  of the sym ptom s in  the m anagem ent of MUS is m entioned in  22 
of the 30 included  papers. In none of the papers, MUS experts referred  to publications 
quantita tively  s tudy ing  the effectiveness of explanations. A ccording to the experts, a doctor 
shou ld  be able to give the patien t a tangible explanation  for h is /h e r  sym ptom s, w hich links the 
physical com plaints w ith  contextual factors and  psychosocial influences. G iving the patien t a 
positively form ulated  explanation  w ith  practical advice for m anagem ent w ou ld  enhance 
treatm ent outcom e. They state tha t explanations should  be person  centred  and  ad justed  to the 
patien t's  cognitions and  illness beliefs. H ow ever, MUS experts do no t give clear exam ples of 
explaining the sym ptom s to patients.
Explanations should integrate psychological and biological factors and provide patients and 
doctors with a model for managing the condition.26
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Reassurance
In  sixteen of the 30 included  papers, the im portance of reassurance is h ighlighted. N one of the 
MUS experts described the effect of reassurance quantitatively . In one narrative review , an 
expert described th a t the effect of diagnostic testing  depends on  w hat patien ts th ink  a norm al 
resu lt m eans.26
MUS experts suggest th a t doctors should  explain, educate, give advice an d  com m unicate in  
positive term s, in  o rder to reassure the patient. Som etim es additional tests or referrals will be 
necessary to reassure the patient. They suggest tha t p rio r to the diagnostic tests, the doctor has to 
explain w hat a norm al test resu lt w ill m ean. M oreover, the doctor shou ld  explain w hat the next 
step  w ill be if the results are norm al and  the sym ptom s persist. Furtherm ore, w hile m aking the 
choice for fu rthe r tests or referral, a doctor shou ld  consider the risk of iatrogenic harm  caused by 
the additional investigation  or referral, according to the MUS experts.
Discuss the planned examinations and their consequences with the patient as early as possible. 
Anticipate when you will stop with medical investigations. Avoid unnecessary medical 
investigations and petty diagnoses.34
Some MUS experts m ention  tha t norm alizing  sym ptom s and  test resu lts are likely to be m ore 
beneficial.27;34
Regularly scheduled appointments
In 9 of the 30 included  narrative review s and  editorials, MUS experts ind icated  tha t regularly  
scheduled  appo in tm ents shou ld  have a place in  the m anagem ent of patien ts w ith  MUS in 
p rim ary  care. One expert sta ted  tha t evidence from  random ized  controlled trials suggests that 
regularly  scheduled  appointm ents; perform ing a brief physical exam ination  at each visit, to 
look for signs of disease ra ther than  relying on sym ptom s an d  avoid ing  investigations and 
hospital adm issions, unless clearly indicated , decrease health  service use an d  increase physical 
functioning.26 H ow ever, the effect of counselling is n o t described quantitatively . A ccording to 
MUS experts, these regularly  scheduled  appoin tm ents enhance the doctor-patien t relationship.
A  schedule o f regular, brief follow-up office visits with the physician is an important aspect of 
treatment. This maintains the therapeutic alliance with the physician, provides a climate of 
openness and willingness to help, allows the patient an outlet for worry about illness and the 
opportunity to be reassured repeatedly that the symptoms are not signs of a physical disorder, and 
allows the physician to confront problems or issues proactively. Scheduled visits may also prevent 
frequent and unnecessary between-visit contacts and reduce excessive health care use.29
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Specific interventions
In the included  publications, MUS experts com m ented about the specific treatm ents: (i) 
cognitive approaches, (ii) pharm acotherapy , (iii) activating  therapy  an d  (iv) com plem entary 
and  alternative medicine.
Cognitive approaches
A lm ost all experts (in 28 of 30 included  papers) stress the im portance of cognitive approaches in 
the m anagem ent of MUS. Of these cognitive approaches, they m ost often m ention CBT. 
A lthough  they had  different opinions abou t the m agn itude of the effect of CBT, m any experts 
described the evidence quantitatively . For exam ple, one expert sta ted  tha t the resu lts of 31 CBT 
contro lled  trials for treatm ent of som atoform  disorders show ed tha t w ith  CBT, patients 
im proved  m ore than  controls in  71% of the stud ies.54 A nother expert sta ted  th a t 82% of patients 
w ith  MUS receiving CBT an d  64% of control subjects had  im proved  or recovered at 6-m onth 
follow -up and  tha t this difference w as m ain ta ined  a t 12-m onth follow -up.43 H ow ever, a th ird  
expert po in ted  ou t tha t the results of the effectiveness of CBT w ere no longer significant after 
controlling for covariates.44 Furtherm ore, H enningsen described m oderate evidence for the 
effectiveness of CBT in patients w ith  MUS or som atoform  d iso rder.33 In terp reta tion  of the 
effectiveness of CBT seem s com plicated as m ost of the tim e different varian ts of CBT are studied. 
M oreover, it is no t clear w hich  specific elem ents m ake the CBT effective.
In CBT, the therapist structures the patient's social and physical environment to promote 
appropriate behaviour (in this case, healthy social and personal adjustment without somatisation) 
and discourage inappropriate behaviour (that is, illness behaviour and preoccupation with 
physical symptoms).43
O ther cognitive therap ies s tud ied  in  the literature are relaxation train ing, rea ttribution , 
biofeedback, body m entalization  therapy  and  other form s of psychotherapy. M ost experts state 
tha t their contents and  results are very  heterogeneous, w hich  ham pers d raw in g  conclusions 
regard ing  their effectiveness.
Pharmacotherapy
In 23 of the 30 included  papers, MUS experts d iscussed the im portance of pharm acotherapy  in 
the m anagem ent of MUS. They suggested  tha t an tidepressan ts can be helpful and  prov ided  
quantita tive evidence for its effectiveness. For exam ple, one expert sta ted  tha t a system atic 
review  of 94 RCTs w ith  a total of 6595 patien ts w ith  MUS found  tha t antidepressan ts 
significantly im proved  sym ptom s (num ber needed  to trea t four).26 H ow ever, one expert stated  
tha t a literature search d id  n o t reveal any published  controlled stud ies evaluating  the efficacy of 
pharm acotherapy  for MUS (either the full or abridged  som atization d isorder diagnosis).45
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A ccording to MUS experts, an tidepressan ts can reduce sym ptom s of often co-m orbid 
depression of anxiety d iso rders. Furtherm ore, they m ight also be helpful in  relieving sym ptom s, 
like pain, in  the absence of a co-m orbid psychiatric disease. H ow ever, the doctor-patient 
relationship  and  com m unication m ay also play a role in  the effectiveness of an tidepressants, 
according to the experts.
A  literature review including a qualitative comparison of information on understanding and 
treatment of medically unexplained somatic symptoms was carried out by Burton (2003). He 
found that CBT and anti-depressant drug are both effective treatments, but their effects may be 
greatest when the patient feels empowered by the doctor to tackle his or her problem.55
W e found  som e com m ents on other pharm acotherapeutic agents being  stud ied  in  the literature, 
includ ing  anxiolytics. H ow ever, according to MUS experts, there is n o t m uch  evidence for their 
effectiveness in  the m anagem ent of MUS.
Activating therapy
A lthough  in  11 included  papers MUS experts described the possibility of activating  therapy, 
none of them  describe quantita tive evidence for the effectiveness of this therapy. A lot of 
different activating  therap ies like g raded  exercise, physio therapy  and  revalidation  are 
m entioned by the experts. The experts suggest tha t these therap ies can be beneficial in  some 
functional som atic syndrom es w hen  com bined w ith  other therapies. A ccording to MUS experts, 
patien ts shou ld  agree w ith  the activity. Furtherm ore, the activity  should  be person  centred  and  
relevant to the ind iv idual s ituation  an d  be structu red  so tha t it g radually  increases. D octors also 
need  to tell the patien t tha t h e /sh e  m ight feel tem porarily  w orse b u t tha t there w ill be benefits in 
the long term .
Expressive therap ies like creative therapy  or w riting  disclosure are also m entioned by MUS 
experts. H ow ever, they state tha t these therapies, like exercise therapies, seem  m ostly beneficial 
in  com bination w ith  o ther therapies.
Cognitive techniques, psycho-education and attention training are suggested to alter cognitive- 
perceptual factors, and should be combined with the modification of illness behaviour and graded 
activity.47
Complementary and alternative medicine
In four papers, MUS experts d iscussed the application  of com plem entary or alternative 
m edicine in  the m anagem ent of MUS. Q uantitative evidence w as no t m entioned. One expert 
argued  tha t St John's W ort show ed excellent efficacy on  s tandard ized  assessm ent instrum ents
and  outcom e m easures.42 Some experts m entioned h ypno therapy  for the m anagem ent of MUS. 
H ow ever, the experts sta ted  th a t it is no t clear w hich  specific elem ent of these therap ies is 
effective.
A  couple of interesting placebo controlled trials have recently been published reporting on the 
efficacy of St John's wort in the treatment of somatization disorder, undifferentiated somatoform 
disorder and somatoform autonomic dysfunction ( Volz, Murck, Kasper & Moller, 2002; Muller, 
Mannel, M urck & Rahlfs, 2004). A  Set of standardized assessment instruments and outcome 
measures were used in both studies and the data showed excellent efficacy, tolerability and safety 
of S t John ' s wort, independent of any existing depressive symptomatology.42
Multi-component approach
In m ost scientific editorials an d  review s experts indicate tha t m anagem ent of MUS should  
consist of a m ulti-com ponent approach  w hereby creating  a safe therapeutic environm ent, and 
general and  specific in te rventions are com bined. MUS experts often m entioned the s tepped  care 
m odel. In this m odel, severity  and  chronicity of the sym ptom s guide the m anagem ent.
Suchfindings lead to recommendations for stepped care as a basis for routine care:28 
Step 1: Reassurance, advice, and explanation in the medical clinic;
Step 2: Reassessment, more extended CBT-based discussion and encouragement of self-help;
Step 3: Reassessment, sessions of CB Tor other specialist care.
Results of focus group of experts in the field
The experts in  the focus group  discussion w ere inclined to discuss the im portance of a safe 
therapeutic environm ent (clear and  focused doctor-patient com m unication) and  generic 
in terventions (reassurance and explanations).
... most important is that people feel they have been taken seriously. Therefore attention and 
providing the opportunity to discuss all questions and concerns. (FP5, female, 25 years FP 
working experience)
Furtherm ore, participan ts suggested  the im portance of a tho rough  exploration  of patients' 
som atic sym ptom s, beliefs and  concerns, and  consequences of these sym ptom s on patients' 
daily  activities, social env ironm ent an d  illness behaviour in  o rder to reach a better 
un derstand ing  of the patients' sym ptom s and  problem s.
A ll symptoms have certain dimensions and the physical dimension is ju st one of them. However 
each symptom results in emotions, cognitions and illness behavior. I think that all these
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dimensions are important to explore. To look at all these dimensions together with the patient. 
Sometimes, most of the time, you will find  a starting-point for an intervention in one of these 
dimensions. (FP4, female, 24 years FP working experience)
Some partic ipants used a sym ptom  diary  du ring  the MUS consultations as a tool to explore the 
cognitions an d  em otions of the patient. In this sym ptom  diary  the patien t shou ld  w rite  the 
m om ent of occurrence of the sym ptom s and  h is /h e r  thoughts, fears an d  actions at tha t m om ent.
I ask patients to write down their own thinking, especially the thoughts not directly related to 
disease. (FP3, female, 10 years FP working experience)
The participan ts also indicated  the im portance of giving the patien t a positive tangible 
explanation  an d  practical advices. H ow ever, they d id  no t give exam ples of such explanations 
an d  advices. F urtherm ore they stressed the value of d iscussing psychosocial factors influencing 
the sym ptom s at an  early  stage in  the m anagem ent of these patients.
You have to explain patients at an early stage that you will use a somatic as well as a psychosocial 
pathway during the management of their unexplained symptoms. (FP1, 15 years FP working 
experience.)
The participan ts m entioned CBT, rea ttribu tion  an d  referrals to psychiatrist, psychologist or 
physio therap ist as specific in terventions. They also stressed the im portance of a good w orking 
relationship  w ith  these caregivers.
I try to teach the patient cognitive techniques, relaxation exercises, or I refer them to a 
physiotherapist. (FP 2,18 years FP working experience)
The participan ts agreed  th a t the m anagem ent of MUS shou ld  consist of a m ulti-com ponent and 
step-w ise approach. The severity  of the sym ptom s and  problem s m akes the FP decide w hat the 
next step  in  the m anagem ent w ill be.
It is nonsense to think that there should be one management for M US. It really depends on the type 
of symptoms, the type of patients and all dimensions that influence these symptoms. (FP4, female,
24 years FP working experience)
W hen w e com pare the results from  our literature review  w ith  the results of the focus group 
discussion, w e conclude tha t no additional therapeutic elem ents w ere found. H ow ever, the 
participan ts of the focus group  discussion explicitly em phasized  the im portance of a safe
therapeutic environm ent an d  generic in terventions. Furtherm ore, participan ts of the focus 
group d iscussion ind icated  tha t the m anagem ent of patien ts w ith  MUS shou ld  consist of a m ulti­
com ponent approach  in  w hich  creating a safe therapeutic environm ent, generic and  specific 
in terventions are com bined.
Discussion 
Summary of main findings
A ccording to MUS experts in  the field, the m ost im portan t elem ents in  the m anagem ent of MUS 
in p rim ary  care are: (i) creating a safe therapeutic environm ent th ro u g h  a good doctor-patient 
com m unication and  an  effective doctor-patient relationship , (ii) generic in terventions such  as 
m otivational interview ing, giving tangible explanations an d  reassurance an d  (iii) specific 
in terventions such as cognitive approaches and  pharm acotherapy. H ow ever, in  contrast to m ost 
specific interventions, experts rarely describe the effects of generic interventions, doctor-patient 
com m unication  an d  relationship  quantita tively  in  their scientific editorials an d  narrative 
review s. MUS experts indicate tha t a m ulti-com ponent approach  in  w hich  these th ree im portan t 
elem ents are com bined are m ost helpful for patien ts w ith  MUS.
Comparison with the literature
MUS experts stress the im portance of generic interventions, clear an d  focused com m unication, 
preserv ing  the doctor-patien t relationship  an d  other non-specific aspects of the consultation  
such as described in  the patient-centred  clinical m ethod  in  o rder to affect the outcom e of 
consultations an d  to reach a therapeutic consultation.56;57 H ow ever, they do no t describe the 
effects of these in terventions quantitatively . A lthough  the m anagem ent of MUS (especially in 
secondary  care) as well as research in  this area focus on p lanned  approaches an d  specific 
treatm ents, w e assum e tha t these non-specific aspects of the consultation elem ents, a lthough 
im portan t for all m edical problem s, are specifically relevant for the m anagem ent of MUS 
because of the paucity  of effective interventions.
In recent years, several trea tm ents of persisten t unexplained  sym ptom s have been in troduced  in 
prim ary  care such as CBT, rea ttribu tion  therapy , disclosure, group psychotherapy, psychiatric 
consultation, etc.23;5S"61 H ow ever, their effectiveness is questionable an d  som etim e these 
in terventions m ay be counterproductive .62 Experts' opinions about the im portance of the 
therapeutic environm ent, the doctor-patient relationship  and  com m unication and  the 
im portance of generic interventions indicate an  im portan t focus for practicing physicians to 
m anage patients w ith  MUS. These factors fit w ell into the dom ain  and  the principles of prim ary 
care.63 These elem ents shou ld  be app lied  in  rou tine daily practice, regardless of the orig in  of the
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sym ptom s. The doctor as m edicine, as Balint sta ted  years ago, m ight still be the m ost im portan t 
and  effective in tervention  for patien ts w ith  MUS.64
Recent stud ies suggest tha t doctors an d  patien ts have very  different perspectives on MUS and 
doctors' com m unication skills.65 They suggest a m ism atch betw een  w hat patien ts w ith  MUS 
w an t and  w hat they actually  receive from  their FP. Salm on et al.66 show ed tha t patien ts w ith  
unexplained  sym ptom s often presen t opportun ities for FPs to address psychological needs. FPs' 
engagem ent w ith  these cues, how ever, seem s lim ited. Furtherm ore, som e FPs provide 
reassurance w ithou t a clear explanation  of the sym ptom , w hile patien ts w ish  to have a 
convincing, legitim ating and  em pow ering  explanation.67-70 Finally, FPs generally show ed less 
em pathic responses tow ards patients w ith  M U S .71;72 These findings m ight explain w hy an 
effective an d  clear com m unication w ith  patien ts w ith  MUS m ight n o t be as straigh t fo rw ard  as it 
seem s and  w hy im plem entation  of the results of this s tudy  in  daily  practice m ay be com plex.
A lthough our s tudy  revealed im portan t elem ents in  the m anagem ent of MUS in p rim ary  care, 
w e did not s tudy  the effectiveness of these elem ents. The effectiveness of these separate 
elem ents is still n o t w ell know n. Research in  the fu tu re  should  address these issues in  o rder to 
im prove the care for all patients in  p rim ary  care, especially those w ith  MUS.
Strengths and limitations of this study
This s tudy  gives a b road  overview  of im portan t elem ents in  the treatm ent of MUS according to 
op in ion  leaders. O ur findings regard ing  the specific in te rventions like cognitive approaches 
an d  pharm acotherapy  w ere expected on beforehand. H ow ever, as these specific in terventions 
do no t help the FP m uch in  daily practice, our findings regard ing  the m ore generic interventions 
are even m ore im portant. The fact tha t w e found  lim ited references an d  quantitative 
descriptions of the effect of creating a save therapeutic  environm ent and generic in terventions 
reflects the necessity to s tudy  the effects of these non-specific aspects of the medical 
consultation. A lthough  such stud ies m ight face m ethodological problem s of m easuring  the 
effect of these elem ents on  patients' outcom e, there are a view  good exam ples of these k ind  of 
stud ies in  prim ary  care. T hom as73, for exam ple, show ed the im portance of being positive du ring  
consultations w ith  patien ts w ith  MUS in prim ary  care, w hereas van  Os et al.74 exam ined the 
effect of depression treatm ent, em pathy  an d  support, and  their in teraction  on patien t outcom es 
for depression in  p rim ary  care.
By perform ing our search in  only tw o databases (PubM ed and  PsycINFO), w e m ight have 
m issed som e im portan t editorials regard ing  the m anagem ent of MUS. H ow ever, m ost 
im portan t an d  h igh  quality  peer review ed journals w ill be p resen ted  in  our search. 
F urtherm ore, w e p retested  our search strategy on im portan t publications about MUS in our ow n
database and  w e could  retrieve all of them  by searching in  PubM ed and  PsycINFO. O ur good 
inter-observer agreem ent for inclusion an d  exclusion enhanced the quality  of our literature 
search. Furtherm ore, by  developing a coding schem e by tw o independen t review ers and 
checking the coding process of tw o papers, w e concluded tha t one review er (MH) w as able to 
code the entire data  set. Finally, by  conducting  a focus group  discussion in  add ition  to the 
qualitative analysis of the literature study , w e w ere able to triangulate  our findings w ith  
opinions of experts in  the field.
One could argue tha t there is som e overlap  betw een  the key them es tha t w e could  d istinguish  in 
this study. For exam ple, creating a safe therapeutic environm ent is interconnected  to m ost 
generic in terventions. Furtherm ore, som e generic interventions, such as m otivational 
interview ing, could  also be considered as a specific intervention . H ow ever, after an  in -dep th  
discussion du ring  the iterative process of analysis w e decide to categorize the d ifferent elem ent 
into one of the key themes: creating  a safe therapeutic  environm ent, generic in terventions or 
specific interventions.
As w e only included  scientific editorials an d  narrative review s, w e could  no t check w hether or 
no t the opinions and  statem ents m entioned in  the papers w ere in  concordance w ith  the findings 
of the original studies. For exam ple, som e experts sta ted  tha t norm alizing  sym ptom s is likely to 
be beneficial w hile recent literature suggested  th a t this is controversial.69 Furtherm ore, MUS 
experts d id  n o t give clear exam ples of how  to explain the sym ptom s to patien ts w hile exam ples 
of explanations in  p rim ary  care research do exist.69 H ow ever, by conducting  a focus group 
discussion in  add ition  to the literature study, w e w ere able to check if experts in  the field of MUS 
agreed  w ith  the opinions found  in  the narrative review s an d  scientific editorials. One could 
argue tha t by  only includ ing  n arrative review s an d  scientific editorials pub lished  in  the last 5 
years and  no t includ ing  original research, im portan t elem ents in  the m anagem ent of MUS (such 
as the narrative m edical approach) have been m issed. H ow ever, the valid ity  of our findings w as 
explored by checking our results du ring  a focus group discussion w ith  experts in  the field. No 
new  elem ents in  the m anagem ent of MUS appeared  from  th is discussion. Furtherm ore, they 
judged  the results to be consistent w ith  their perceptions and  experiences.73
Conclusions
The experts' opinions on  m anagem ent of MUS seem  to be m ore based on theory  and  experience, 
than  on h igh  quality  research. A lthough  opin ion  leaders do no t describe the evidence regard ing  
its effectiveness quantitatively , they em phasize the im portance of creating a safe therapeutic 
environm ent an d  other generic in terventions. Furtherm ore, in  accordance w ith  the evidence 
reg a rd in g  the effectiveness of specific in te rven tions (i.e cognitive app roaches and 
pharm acotherapy), experts indicate specific in terventions as im portan t elem ents in  the
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m anagem ent of patien ts w ith  MUS. C reating  a safe therapeutic environm ent and  generic 
in terventions such as m otivational interview ing, explanation, reassurance an d  regularly  
scheduled  appo in tm en ts m ight be key to im proving  the m anagem ent of patien ts w ith  MUS in 
p rim ary  care.
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Appendix 1. Search strategy
( s o m a to fo rm  d is o rd e r s [ m e s h ]  OR s o m a tiz a t io n [ tw ]  O R s o m a tis a t io n [ tw ]  OR 
hypoch o n d riasis[m esh ] OR n eu rasth en ia [m esh ] OR con v ersio n  d iso rd er[m esh ] OR 
som atoform  disorder*[tw] OR hypochondriasis[tw ] OR neurasthen*[tw ] OR conversion 
disorder*[tw] OR psychophysiologic disorders[M esh] OR psychosom atic medicine[M esh] OR 
psychophysiological disorder*[tw] OR psychosom at*[tw] OR psychosom atic m edicine[tw ] OR 
functional som atic sym pt*[tw ] OR functional som atic syndrom *[tw ] OR functional 
syndrom *[tw] OR unexplained  sympt*[tw] OR m edically unexplained[tw ] OR unexplained 
m edical sympt*[tw] OR psychogen*[tw] OR non-organ*[tw] OR non-specific complain*[tw] OR 
non-specific sympt*[tw]) AND (("therapy"[Subheading] OR "therapy"[tw] OR "treatm ent"[tw] 
OR "therapeutics"[M eSH  Terms] OR "therapeutics"[tw ]) OR ("therapeutics"[tw ]) OR 
("m anagem ent"[tw]) OR "intervention"[tw] OR interventions[tw ] OR ("therapies"[tw]) OR 
("therapeutic"[tw]) OR ("treatments"[tw]))
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Background. Medically unexplained symptoms (MUS) are common in primary health care. 
Both patients and doctors are burdened with the symptoms that negatively affect patients' 
quality of life. General practitioners (GPs) often face difficulties when giving patients legitimate 
and convincing explanations for their symptoms. This explanation is important for reassuring 
patients and for maintaining a good doctor-patient communication and relationship.
Objective. To provide an overview of explanatory models for MUS.
Study design. We performed a systematic search of reviews in PsycINFO and PubMed 
about explanatory models of MUS. We performed a qualitative analysis of the data according to 
the principles of constant comparative analysis to identify specific explanatory models.
Results. We distinguished nine specific explanatory models of MUS in the literature: 
somatosensory amplification, sensitisation, sensitivity, immune system sensitisation, 
endocrine dysregulation, signal filter model, illness behaviour model, autonomous nervous 
system dysfunction and abnormal proprioception. The nine different explanatory models focus 
on different domains, including somatic causes, perception, illness behaviour and 
predisposition. We also found one meta-model, which incorporates these four domains: the 
cognitive behavioural therapy model.
Conclusion. Although GPs often face difficulties when providing explanations to patients 
with MUS, there are multiple explanatory models in the scientific literature that may be of use in 
daily medical practice.
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Introduction
Medically unexplained symptoms (MUS) have a high prevalence in health care. Physical 
symptoms such as headache, backache, pain in muscles and joints and fatigue are common. In 
the general population two-thirds of men and four-fifths of women report at least one of these 
complaints in the previous two weeks.1 In about 25-50% of symptoms seen in primary health 
care, no evidence can be found for any physical disease .2'3 In specialist care these percentages are 
even higher, ranging from 30 to 70 %.4'5
MUS can become chronic. Patients with persistent MUS are at risk for extensive investigations 
and referrals, therefore becoming a great burden on health care.6'7 Doctors and patients are both 
burdened by the phenomenon of symptoms without disease. Bodily symptoms with unknown 
physical pathology have a great impact on patient functioning. Such patients suffer greatly from 
the symptoms and their quality of life is negatively affected.8'9
Unexplained physical symptoms are often confusing for both doctor and patient.10'11 Many 
general practitioners (GPs) feel powerless and irritated when patients repeatedly visit their 
practice with these symptoms.12 Patients often feel disbelieved and not taken seriously by their 
doctor.13 Although it is often suggested that GPs are pressured by patients with MUS to deliver 
somatic interventions, Ring et al pointed out that patients with MUS request somatic 
interventions less often than physicians offer them.14 Moreover, patients seek emotional support 
and a legitimate and convincing explanation for their symptoms.15-17
GPs recognise the importance of explaining the diagnosis of MUS adequately to patients with 
persistent MUS. However, they often face difficulties in explaining the nature of the symptoms 
during the clinical encounter with these patients.18 Therefore, we searched and analysed the 
literature for explanatory models for MUS. Providing an overview of such models can improve 
the knowledge and communication of GPs, thus enhancing the quality of care for patients with 
MUS.
Methods
Data sources and search strategy
We performed a qualitative analysis of systematic and narrative reviews on the topic of 
medically unexplained symptoms using the databases PubMed and PsycINFO. We decided to 
search for reviews, as in this type of article views of MUS and explanatory models are frequently 
discussed. Our search strategy consisted of two search strings which we combined with the
Boolean operator AND. The first string contained keywords regarding MUS, combined with the 
Boolean operator OR. The second string of our search strategy contained terms for explanatory 
models, combined with OR (see Figure 1). This search string was limited to reviews, the English 
and Dutch languages, articles published in the last five years, and age over18 years. We limited 
our search strategy to articles published in the last five years as most articles about explanatory 
models of MUS published before 2005 have been reviewed in more recent reviews.
We tested the accuracy of our search strategy by checking whether or not five key papers on 
explanatory models in MUS were included in the results.
Figure 1. Search strategy
("2005/01/01"[Publication Date] : "3000"[Publication Date]) AND (((((Model [tw] OR 
models [tw] OR conceptual*[tw] OR concept [tw] OR concepts OR pathophysiolog*[tw]
OR physiopatholog*[tw] OR mechanism* [tw] OR causal* [tw] OR cause [tw] OR 
explanat* [tw] OR etiology [tw] OR aetiology [tw] OR aitiology [tw] ) AND (somatoform 
disorder[mesh] OR somatization[tw] OR somatisation[tw] OR hypochondriasis[mesh]
OR neurasthenia[mesh] OR conversion disorder[mesh] OR somatoform disorder*[tw]
OR hypochondriasis[tw] OR neurasthen*[tw] OR conversion disorder*[tw] OR 
psychophysiological disorder[Mesh] OR psychosomatic medicine[Mesh] OR 
psychophysiological disorder*[tw] OR psychosomat*[tw] OR psychosomatic 
medicine[tw] OR functional somatic sympt*[tw] OR functional somatic syndrom*[tw]
OR functional syndrom*[tw] OR unexplained sympt*[tw] OR medically 
unexplained[tw] OR unexplained medical sympt*[tw] OR psychogen*[tw] OR non- 
organ*[tw] OR non-specific complain*[tw] OR non-specific sympt*[tw])))))
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Study selection
Two researchers (JvR, ToH) independently performed inclusion and exclusion of articles, 
studying title and abstract. In case of doubt they consulted the full paper. Disagreements on 
inclusion were discussed in a consensus meeting. All disagreements were easily resolved. We 
calculated inter-rater agreement for inclusion with kappa statistics.19
We excluded studies that focused primarily on patients suffering from single-symptom 
unexplained disorder (tension headaches, dysmenorrhoea) and distinctive functional somatic 
syndromes (irritable bowel syndrome, chronic fatigue syndrome) because we were interested in 
explanatory models of undifferentiated MUS in the literature. We focused on undifferentiated 
MUS as we assume that these are more difficult to explain than single symptom unexplained 
disorders and distinctive functional syndromes.20 We also excluded studies that focused 
primarily on patients with medical or psychiatric disease (except somatoform disorders). 
Studies on children and adolescents (age less than 18 years) and studies on specific groups of 
patients such as refugees, street prostitutes etc. were also excluded.
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Data-analysis
We analysed the included reviews for explanatory models describing the cause of MUS. The 
publications were fully entered into a computer database (Atlas.ti) suitable for qualitative 
processing. The collection and analysis of data from the included reviews was performed both 
parallel and cyclic, thus mutually influencing each other. First, two researchers (JvR and ToH) 
independently read the articles in which many different models were assembled, to develop a 
coding scheme of explanatory models. Initial coding was discussed to seek agreement on 
content. The coding was improved, adjusted, explicated and specified by applying the constant 
comparative method.21 One researcher (JvR) thematically coded the included articles in Atlas.ti 
according to the final coding scheme.
Results
We retrieved 710 articles from the search in the electronic databases (480 PubMed and 230 
PsycINFO). Sixty-five papers were duplicates. After two independent researchers screened title 
and abstract, 24 papers fulfilled the inclusion criteria (Figure 2). The inter-rater agreement 
(kappa) was 0.65 (95% CI: 0.51- 0.79), which was considered 'good'. Two articles were not 
available in the Netherlands and were therefore excluded. After reading the full text, 19 out of 22 
articles were included in our study.13,22-39 The three articles that were excluded reported on 
therapy /  diagnosis or somatic disease and one turned out to be a review of a book.
We could distinguish nine different explanatory models (somatosensory amplification, 
sensitisation, sensitivity, immune system sensitisation, endocrine dysregulation, signal filter 
model, illness behaviour model, autonomous nervous system dysfunction and abnormal 
proprioception) and one meta-model (the cognitive behavioural therapy model) that contains 
components of these nine different explanatory models. Each model is described, including 
citations and comments from the reviews.
Explanatory models
A. Somatosensory amplification theory
The process described as somatosensory amplification suggests that a physical sensation arises 
and that as a consequence, patients focus their attention on this sensation. They develop certain 
cognitions and attributions which further amplify the perception of these physical signals. This 
amplification results in a vicious circle in a way that symptoms are reinforced by patients' 
thoughts and concerns. As a result patients with MUS experience a range of feelings as more 
severe, more damaging, and more alarming.
' The strength of this model is its simple formulation, and it can even be used to explain the disorder 
to patients. The basic mechanisms used in this model, such as attention, perception, and 
attribution processes have some empirical validation, although the model neglects many other 
well-validated factors, or offers only indirect explanations for them.' (p. 837)22
'Petrie and Weinman (2003) have called for more attention to be given to symptom appraisal and 
we would widen this by calling for more attention to attention in general. The theoretical 
literature and some of the empirical literature supports this mechanism as being an important part 
of the cycle maintaining M U S.' (p. 791)23
'Amplification has, in general, been found to be related to reporting of somatic symptoms. 
However, there are conflicting reports on whether this is an independent effect or whether this is 
mediated by such factors as anxiety, depression and negative affect/neuroticism. Findings 
suggest that somatosensory amplification can only partially account for somatization, and that 
other mechanisms may also be important in this process. ' (p. 28)26
Figure 2. Selection o f studies




Duplicates (already found with
MEDLINE; n  = 65)
Screening title and abstract (n  = 645) 
by two independent reviewers
Excluded after reading title and
abtract (n  = 621)
Retrieving the full publication
(n  = 24)
Paper only available abroad (n  = 2)
Full text and article by one researcher
(n  = 22)
Excluded after reading the full
w ith a second researcher; n  = 3)
Final inclusion and analysis (n  = 19)
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B. Sensitisation theory
Sensitisation means having an enhanced somatic response to sensations as a result of former 
experiences of these sensations. In patients with MUS, repeated experiences of pain and 
symptoms can lead to memory traces at a neuronal level which increase sensitivity for future 
stimulation. This could result in normal benign stimuli being perceived as pain. A patient's body 
reacts stronger to stimuli when it has become more sensitive by earlier and repetitive 
encounters. The process of sensitisation has, besides a neural and sensory part, also a 
psychological component. In MUS in general, a larger memory complex may play a role. 
Experiencing a single symptom would not only sensitise this sensation, but would also activate 
a wider memory trace. This in turn, can result in the experience of other physical symptoms. 
Therefore, sensitization may cause a wide range of symptoms. Furthermore, expectations also 
play a role in further sensitisation.
'The development of symptom memories can be associated with cerebral restructuring. This has 
been shown for single pain symptoms, where already 24 hours of pain perception can cause 
neuronal reorganization (neural plasticity) that will facilitate and intensify further symptom  
perceptions (Arnstein, 1997). For the phenomenon of multiple physical complaints, a general 
symptom memory matrix can be postulated. ' (p. 830)22
' The repeated perception of physical signals in combination with uncertainty about the origin of 
the sensations can hinder the habituation that would ordinarily be expected. ' (p. 1000)27
C. Sensitivity theory
This theory suggests that some individuals are more vulnerable to develop MUS. This 
vulnerability can be based on personality traits, such as negative affect and neuroticism. 
Furthermore, patients with MUS seem to have difficulty in experiencing the relationship 
between bodily signals and emotions and thoughts. Catastrophic thinking may also play a part 
in the vulnerability of pain in these patients. There is little evidence for genetic influences, but 
many researchers suggest that early childhood experiences, such as abuse, insecure attachment 
and parental influence, play an important role in the development of MUS.
' Viewing the M US from the perspective of underlying developmental influences that affect the 
function of a variety of organs based on familial (genetic and environmental) predispositions 
rather than from traditional viewpoint o f isolated organ-originated diseases has at least two 
important implications. First, it provides a more parsimonious explanation for many findings 
that have been quite difficult to account for. (...) Second, and more importantly, it invites 
investigation of new areas of therapy that may otherwise escape consideration. ' (p. 142)28
'Studies within the framework o f attachment theory have provided clear evidence that insecure 
attachment patterns, and in particular an insecure dismissing attachment pattern, are associated 
with an avoidant style of affect regulation. ' (p. 21)29
D. Immune system sensitization theory
The brain has a cytokine system that reacts to the immune system. It monitors danger in parts of 
our body and coordinates the responses to these threats. The brain cytokine system is activated 
by the immune system and mediates the subjective, behavioral and physiological components 
of sickness, in a reversible way. It can be sensitised in response to activation during early stages 
of development, repetitive stimulation or prior exposure to immunological stimuli. The brain 
cytokine system, when sensitised, reacts very fast and is less likely to shut down after 
eliminating the initial stimulus. Furthermore the brain cytokine system can be triggered by non- 
immunological stimuli. In patients with MUS, a chronic immune activation with production of 
cytokines can act as a motivation for the brain to change priorities in face of the presented threat 
(such as stress or trauma) resulting in a feeling of being sick.
' The brain cytokine system also plays a key role in the experience of pain that is associated with 
danger, to the point that it has been proposed that pain is actually the main determinant of sickness 
behaviour rather than ju st a component of it (Watkins and Mayer, 2000). ' (p. 951)30
'The main medical implication of this view is that many somatization symptoms including 
depressed mood, fatigue, and pain may represent the expression o f a previously sensitized brain 
cytokine system that is reactivated by infectious or noninfectious trauma. ' (p. 853)31
'A growing body of evidence suggests that pathophysiological processes explain some of the 
aspects o f illness behaviour that are typically viewed as psychological in origin. The experience of 
general malaise or feeling sick has a physiological basis, mediated by centrally acting 
proinflammatory cytokines such as interleukin and tumour necrosis factor. ' (p. 56)32
E. Endocrine dysregulation theory
In the hypothalamus pituitary adrenal (HPA) axis, feedback loops exist to regulate the body's 
response to acute and chronic stress. Dysregulation of this axis has been found in patients with 
MUS. One interpretation is that prolonged activation has led to a 'burnout' response and a down 
regulation of HPA activity in MUS. Another suggestion is that hypocortisolism may in fact be a 
protective response of the body. Hypercortisolism has been found in patients with MUS. Early 
traumata during pregnancy or childhood can have long lasting effects on the stress sensitivity of 
the HPA axis which may be associated with increased prevalence of MUS.
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'The link so far found between central nervous system processes, such as the HPA axis, and 
immunological processes are intriguing but far from conclusive; the causal relationships are 
unclear, as are the nature o f the change in these systems in different conditions at different stages. 
There is however already sufficient data to propose hypotheses about some of the important links, 
for example, between life events, HPA axis and immune functioning, that could be tested in 
prospective studies.' (p. 791)23
'We can conclude that the relevance of the HPA-axis for the somatization syndrome is still 
unclear. HPA-activity definitely plays a role; however, this role might be unspecific, course 
depending, and multi-directional. ' (p. 998)27
F. Signalfilter theory
There is a permanent sensory stimulation from the body sending information to the brain. In 
healthy individuals, however, this 'sensory noise' is filtered, in order to ensure that the brain is 
not over-stimulated by information from physiological processes. In patients with MUS 'faulty 
filtering' leads to the inability of these patients to differentiate between information from 
physiological process (produced by the body) and information from pathophysiological 
processes (produced externally). Patients with MUS experience both types of information. 
Therefore, the number of physical sensations experienced by these patients is increased.
' The perception-filtering-model is in line with the findings on the relevance of memory processes 
and expectation, two empirically well-founded mechanisms not directly included in the other 
models. Further strength of this model is the close relationship to the neuronal process of 
perception. Therefore they offer a link between psychological and psychobiological findings on 
M U S.' (p. 837)22
' The effect of distraction on pain perception was demonstrated by Bantick et al., who found that 
distraction leads to reduced activity in pain-associated centers (Bantick et al., 2002), again 
supporting a signal-filter-model as presented. ' (p. 999)27
G. Illness behaviour theory
This theory hypothesises that patients' believes influence their behaviour. This behaviour can in 
turn affect physiology and symptoms, resulting in a vicious circle and maintaining symptoms. 
Avoidance of physical, social or mental activity can result in more symptoms. For example, 
when a patient with chronic fatigue believes she will get more tired by doing sports, she will stop 
all physical activity. This may result in an increase of bodily attention and physical 
deconditioning, ending in more awareness and susceptibility of physical symptoms. Therefore 
symptoms can be sustained because of patients' behaviour.
' There is actually relatively little literature concerning illness responses, despite a clinically 
prevalent belief that 'all or nothing coping' and avoidance behaviours are important in the onset 
and perpetuation of syndromes such as CFS. More longitudinal work of this nature is needed to 
clarify the role ofbehaviour in the development of M U S.' (p. 787)23
'Behavioral aspects are also important in operant conditioning of illness behavior, confirmation of 
health attitudes, and the development of physical deconditioning. While these aspects could be of 
major importancefor this patient group, their role has been insufficiently investigated in scientific 
trials.' (p. 836)22
'Cognitive, emotional and behavioural factors have the capacity to relieve symptoms and even 
change the brain. ' (p. 994)33
H. Autonomic nervous system dysfunction theory
Autonomic nervous system (ANS) dysfunction is a potential mechanism connecting 
psychosocial stress to MUS. In healthy controls, the change from attention tasks to rest periods is 
associated with a substantial decrease in heart rate activity ('recovery response'). This reduction 
of physiological activity after mentally distressing tasks is not present in patients with MUS. It is 
hypothesised that this is a result of a parasympathetic nerve system dysfunction, resulting in a 
long lasting increased heart rate and stress burden in these patients.
'To summarize the results on autonomic physiological activity, we can conclude that only few  
studies have addressed this question so far. Only small differences have been found, although there 
is some consistency indicating the involvement of the cardiovascular system. ' (p. 998)27
'We conclude that current available evidence is not adequate to firm ly reject or accept a role of 
A N S  dysfunction in functional somatic disorders and it would therefore be misleading to provide 
a definitive summary estimate.' (p. 108)34
I. Abnormal proprioception theory
Increased or abnormal proprioception can be a cause of physical symptoms in patients with 
MUS. It is suggested that patients with MUS demonstrate more exact and sensitive perception of 
their body than healthy individuals. In patients with MUS, minimal changes in muscle tension 
would lead to an enhanced feeling of abnormality. Therefore, benign physiological sensations 
(small changes in their body) can be interpreted as signs of a physical disease.
'I f  patients with M US perceive physical sensations more precisely, this could lead to increased 
likelihoods of perceiving even minor physical symptoms, although these differences could also be 
due to higher distraction by external stimuli in healthy controls. ' (p. 828)22
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J. Cognitive behavioural therapy model
This meta-model proposes that the cause of MUS is a self-perpetuating multi-factorial cycle, 
with interaction of different factors in several domains. This model provides a framework to 
incorporate patients' own personal perpetuating factors as well as predisposing and 
precipitating factors. Each factor can result in physical symptoms and/or distress. Doctor and 
patient together have to search for the patient's personal circumstances that might contribute to 
the distress. Furthermore, this meta-model incorporates processes from at least five different 
theories described above: sensitivity, sensitisation, somatosensory amplification, endocrine 
dysregulation and illness behaviour model.
'This is the explicit purpose of the CBT assessment: to form a coherent multi-factorial case 
conceptualization that forms the rationale for treatment. ' (p. 789)23
' The biopsychosocial perspective becomes increasingly sophisticated, thus allowing the formation 
of a tight chain of findings from psychology to specific disease processes playing a role in the 
etiology and maintenance of illness conditions.' (p. 182)39
'As such the autopoietic explanation o f M US as proposed by the CBT model both fits  the current 
data and could form a theoretically coherent basis for further research. More generally, the 
research bears out the over-arching CBT hypothesis that the autopoietic interaction o f distinct but 
linked systems could serve to produce physical symptoms in the absence of physical pathology. ' 
(p. 789)23
Discussion 
Summary of main findings
This review illustrates a considerable number of explanatory models of MUS, grounded in the 
scientific literature. We could distinguish nine different explanatory models of MUS in the 
literature: somatosensory amplification, sensitisation, sensitivity, immune system 
sensitisation, endocrine dysregulation, signal filter model, illness behaviour model, 
autonomous nervous system dysfunction and abnormal proprioception. Furthermore, we 
found one meta-model, the cognitive behavioural therapy model.
Some of the models aim at a physical explanation, such as the immune system sensitisation 
theory, the endocrine dysregulation theory, the autonomic nervous system dysfunction theory 
and the abnormal proprioception theory. Other models aim at a psychological explanation, such 
as the somatosensory amplification theory and the sensitivity theory. And some models
combine a physical and psychological explanation, such as the sensitisation theory, the signal 
filter theory and the illness behavior model.
The nine different explanatory models seek an explanation in different domains, including 
somatic causes, perception, illness behaviour and predisposition. The meta-model integrates 
these four domains.
Medical explanations in clinical practice
Current medical training focuses on acting (diagnosing and treating patients) instead of 
listening, explaining and reflecting. Several studies pointed out that patients seek legitimacy for 
their symptoms.16'40-42 They want to feel that the doctor accepts that the symptoms are real and 
warrant the doctor's attention.25 Therefore, good and relevant doctor consultation skills, 
including explaining symptoms, are needed. Plenty doctors think in terms of action and 
reaction, while the explanation of symptoms in itself might be the most important intervention 
for patients with MUS.43 Such explanations might prevent patients from extending or 
elaborating symptoms and doctors from providing investigations or somatic treatment.3 
Explanation as a consultation skill in its own right is rarely addressed in the literature and 
teaching programs. As education on explaining and explanatory models is limited in today's 
clinical education programs, medical students and GPs have little knowledge of theories and 
models which they can use during consultation. This might explain part of the difficulties GPs 
experience in giving an adequate and tangible explanation to patients with MUS. However, GPs 
indicate that they build their own explanatory models of medically unexplained symptoms 
based on their experience in daily practice.44 Furthermore, building acceptable and effective (i.e. 
reassuring) explanations together with the patient needs a mutual understanding of patients' 
beliefs, concerns and expectations regarding their symptoms.45,46 Knowledge of explanatory 
models of MUS, together with this mutual understanding and daily practice experiences can 
facilitate the doctor-patient communication and strengthen the doctor-patient relationship with 
these patients. Furthermore, mutual understanding between GP and individual patients on the 
aetiology of MUS might result in greater reassurance, patient satisfaction and commitment to 
the proposed interventions.25
Strengths and limitations of this study
In this qualitative analysis of the literature, we used an extensive and systematic search strategy 
to identify relevant reviews. Including the full text papers and having them coded by two 
independent researchers added rigour to our study. Moreover, we had good inter-rater 
agreement for inclusion and exclusion.
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By using a cyclical way of analysing data, we were able to focus and explore explanatory models 
in depth.47 Entering the full text of included studies into Atlas.ti and using constant comparative 
method to code and reorganise data strengthened our findings.
We limited our literature search to the past five years. It seems, however, that we have captured 
most explanatory models in the literature as the reviews included in our study also discussed 
and summarised explanatory models described in earlier literature. Although across cultures 
many systems of medicine provide sociosomatic explanations linking problems in family and 
community with bodily distress, we did not find culturally based explanatory models in our 
literature search.48
A qualitative analysis of the literature is not as objective as a meta-analysis. However, we were 
able to summarise the range of explanatory models grounded in the current scientific literature. 
As studying the scientific evidence of the different models was not the goal of our study, we are 
not able to draw conclusions on the degree of evidence of the explanatory models found in the 
literature.
Implications for future practice and research
This review illustrates quite a number of different explanatory models of MUS described in 
literature. Most theories are based on symptom perception, somatic causes, illness behaviour 
and predisposition. On the other hand, more progress has to be made towards a fuller 
understanding of the complex aetiology of MUS.
Further studies using in-depth interviews with GPs may reveal new explanatory models based 
on experiences in daily medical practice. This qualitative analysis of the literature examines 
explanatory models of MUS and not the usefulness of these models in clinical practice. 
Therefore, new research has to clarify the usefulness of the different explanatory models in daily 
practice. In addition, studies using a mixed method methodology have to point out patient 
preferences and the effectiveness of the explanatory models individually in family practice.
As persistent MUS are present in all medical specialties, these explanatory models should be 
integrated in the educational programs of all medical doctors in order to improve the quality of 
care for patients with persistent MUS.
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Background. M edically unexplained  sym ptom s (MUS) are frequently  presen ted  in  p rim ary  
care. U nfortunately, know ledge of these patients a n d /o r  sym ptom s in  prim ary  care is still 
lim ited. A vailable research com es m ainly from  Europe and  N orth  Am erica, w hile the 
perspectives of cultures such  as Africa, Asia an d  South  A m erica are relatively unknow n. To 
b ring  cultural perspectives together, a sym posium  and  w orkshop  on MUS in p rim ary  care w as 
held  at the W ONCA W orld Conference 2007 in  Singapore.
Objective. M ain goals of this sym posium  an d  w orkshop -  apart from  p resen ting  ongoing 
research an d  bring ing  together experts in  MUS -  w ere to detect know ledge gaps in  MUS an d  to 
establish priorities in  MUS research. This publication  focuses on the p roposed  research agenda.
Methods. U sing a nom inal group technique w e generated  research topics and  set priorities. 
R esearch topics w ere grouped  into research themes.
Results. Participants' (66 researchers and  GPs from  29 nationalities) m ost im portan t 
research topics w ere 'form ulating  a broadly  accepted definition of MUS', 'finding a strategy to 
recognize MUS better and  at an  earlier stage', 'study ing  the value of self-m anagem ent and 
em pow erm ent in  patien ts w ith  MUS' an d  'finding pred ic tors to decide w hich  strategy w ill best 
help the ind iv idual patien t w ith  MUS'. Priorities in  research them es of MUS are: (i) therapeutic 
options for patien ts w ith  MUS and  (ii) problem s in  consultations w ith  these patients.
Conclusions. M ore research on MUS in prim ary  care is needed  to im prove the consultations 
w ith  an d  m anagem ent of these patients. Internationally  p rim ary  care conferences are excellent 
for exchanging ideas and  form ulating  central issues of research.
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Acute m edically unexplained  sym ptom s (MUS) are com m on in  fam ily m edicine. Tw enty to fifty 
per cent of all contacts betw een patien t and  GPs concern unexplained  physical sym ptom s.1'2 
M ostly, these sym ptom s resolve or do no t need  fu rther m edical atten tion  after one consultation. 
H ow ever, there is a group of patien ts w ho frequently  consult the GP w ith  unexplained 
sym ptom s. In a D utch survey  of G P-patient contacts, the prevalence of patients w ith  at least four 
contacts per year for MUS w as 2,5 % .3 Frequent attenders w ith  MUS have a h igh  risk of extensive 
investigations an d  referrals.4 Only about a quarter of patients frequently  presen ting  MUS m et 
the criteria of one of the DSM-IV som atoform  categories (i.e. som atisation  or undifferentiated  
som atoform  disorder).5 This m eans tha t the m ajority of patien ts w ith  MUS in p rim ary  care are 
different from  patien ts m eeting DSM-IV criteria for som atoform  disorder. Consequently, this 
relevant group  of patien ts in  p rim ary  care deserve to be s tud ied  seperate ly .6 H ow ever, s tudy  
an d  hence know ledge of m any aspects of this group  of MUS patien ts is scarce. For instance, we 
are still debating  the exact definition and  classification of MUS w hich  is strongly  related to 
cu ltural differences.7 Then, w e know  little abou t the prognosis of the sym ptom s, an d  w e have 
lim ited know ledge abou t factors p red ic ting  the prognosis or its course of MUS over time. 
Furtherm ore, there is doubt abou t the best approach  to an d  trea tm en t of these pa tien ts .
Introduction
In the trad itional approach  of patien ts w ho repeated ly  p resen t MUS, GPs try  to reassure them  by 
giving som e -  b u t often inadequate -  explanation  abou t the sym ptom s. Furtherm ore, concerns 
of patien ts w ith  MUS are less likely to be explored and  facilitation of patients' talk  about 
psychosocial problem s is lim ited.8-10 As m any patien ts (and doctors) are no t satisfied by this 
trad itional approach, in  recent years som e research has been done on  cognitive behavioural 
therapy  (CBT)-based in terventions. These stud ies show  conflicting results. M ost stud ies show  
no effect of CBT in terventions on w ell-being, sick leave an d  lim itations due to the sym ptom s.11-14 
Several explanations m ay be offered for these d isappoin ting  results: the train ing  of the GPs 
m ight have been insufficient or im portan t issues such as the anxiety of the patien ts m ight not 
have been adequately  addressed . Furtherm ore, an  adequate explanation  of the sym ptom s and 
non-specific effects caused by m utua l trust, em pathy  and shared u n derstand ing  have n o t been 
stud ied .15 A lternatively, one m ight ask w hether the outcom es, such as num ber and  du ration  of 
sym ptom s, w ell-being, sick leave and  lim itations tha t doctors or researchers usually  study , are 
the outcom es tha t patien ts w ou ld  also prefer. W e m ust conclude tha t there are still m any 
uncertain ties abou t this group  of patients.
n
A lthough  MUS is a universally  com m on phenom enon, m ost research on MUS com es from  
Europe an d  N orth  A merica. The perspectives of o ther cultures such  as Africa, the Asia Pacific 
and  South  A m erica are relatively unknow n. It is know n from  recent research tha t there are 
cu ltu ral differences in  the d istribu tion  of MUS an d  the m eaning and  significance of a sym ptom
depends on  the perceived relationship  w ith  diseases in  a culture.7,16 M oreover, cu ltu ral and  
social norm s determ ine w hether a person  w ith  a particu lar MUS can ad o p t the sick role: cultures 
such as the Chinese reject psychological sym ptom s and  therefore cause psychosom atization.17 
Bringing these in ternational perspectives together m ight help to fill the gaps in  know ledge 
about MUS.
W e therefore organized  a sym posium  an d  a w orkshop  abou t MUS in  p rim ary  care du ring  the 
W ONCA W orld Conference 2007 (Singapore, July 26). O ur aim  w as to gather topics for research 
on MUS from  discussions w ith  researchers and  GPs from  all over the w orld  and  to prioritize 
these topics in  o rder to establish a global research agenda.
Methods
D uring the sym posium  'MUS in  fam ily m edicine: the state of the art', GP researchers presented  
ongoing research in  MUS in different countries all over the w orld. The tw o m ain  them es w ere 
the classification and  cu ltu ral varia tion  of MUS an d  the process of consultation  w ith  MUS 
patients.18-20 The sym posium  w as also m eant as an  in troduction  to the subsequent w orkshop. The 
aim  of th is w orkshop 'MUS in fam ily m edicine: w here shou ld  w e go?' w as to b ring  together GPs 
w ith  a b road  cu ltu ral variety  in terested  in  MUS to discuss ideas about research topics in  the field 
of MUS an d  to m ake choices on  w hich ideas needed  priority.
Participants in the workshop
In o rder to discuss the various perspectives of MUS research an d  bring  together GPs from  
different cu ltural backgrounds to look at the b roader p ic ture of MUS, w e invited  researchers and 
in terested  GPs from  different nationalities. The nationality  of each partic ipan t in  the w orkshop 
w as registered  by one of the organizers (TCoH).
Nominal group technique
In the w orkshop, w e used  the nom inal group  technique to generate a research agenda. In the 
nom inal group  technique, participan ts are b rough t together for discussion. The procedure 
usually  com prises four stages: generating  ideas, recording of those ideas, clarification and  
priority  voting .21 This m ethod  encourages contributions from  everyone by allow ing equal 
partic ipation  am ong participants. M oreover, it is a structu red , transparen t and  replicable w ay of 
synthesizing an d  generating  ideas .22
D uring the w orkshop, w e generated  ideas by stim ulating  discussion: w e allow ed 10 m inutes of 
b rainstorm ing  in  sm all groups to discuss w hat they though t to be the m ost relevant MUS 
research topics. Each sm all group  m ade a shortlist of their m ost im portan t research topics. We
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continued  w ith  an  inventory  of all relevant topics arising  from  these discussions. W e w rote the 
topics onto flip charts. If necessary, the discussion leaders (LJAH-F, EMvW-B) asked for 
clarification. After th is inventory, each partic ipan t w as asked to choose five topics w ith  the 
h ighest p riority  from  this list an d  rank  them . Finally, w e asked all the partic ipants to vote, 
allocating the h ighest score (5) to the m ost im portan t research topic, then  4 to the nex t m ost 
im portan t sta tem ent and  so on, by sticking coloured cards on the flip charts. The organizers of 
the w orkshop  and  preceding  sym posium  circulated the room  du ring  th is task, giv ing assistance 
w here needed.
The research topics w ith  the h ighest votes w ere p resen ted  to the audience and  discussed briefly 
to clarify possible research m ethodologies suitable to answ er the research question.
Data analysis
O ne of the researchers (TCoH) sum m ed the votes for each research topic tha t w as b rough t up. 
A ccording to the vo ting  scores, topics w ere ranked, p roducing  a list of the participants' 'priority 
research topics'. Identical scores w ere given the sam e ranking  num ber; research topics w ith  
h igher num ber of ind iv idual votes w ere listed  higher.23 Finally, research topics w ere grouped  
into research themes.
Results
Baseline characteristics of workshop attendees
A total of 66 researchers an d  GPs from  29 nationalities from  6 d ifferent continents a ttended  our 
w orkshop. (Table 1) Fourteen participan ts (21%) only attended  the in troduction  of the 
w orkshop.
Most important topics in MUS research
The nom inal group  technique resu lted  in  a total of 29 research topics. In Table 2, the ranking  of 
these research topics is show n.
A lm ost half (48%) of the audience agreed tha t the m ost im portan t p roblem  is tha t MUS are not 
clearly defined. There is need  for an  unam biguous definition of MUS tha t can be applied  
globally. W ithout a clear definition, research outcom es and  their m eaning rem ain  m udd led  and 
uncertain. As research abou t a definition is n o t possible, discussion and  reaching consensus is 
the best w ay  to solve this. A com m on consensus bu ild ing  m ethod is the D elphi technique.24 The 
purpose of this technique is to obtain  consensus on the opinions of 'experts' th rough  question 
rounds using  structu red  questionnaires. The audience em phasized  their preference of w ork ing  
as soon as possible on  a definition of MUS.
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W orkshop participants chose as second m ost im portan t research question  'w hat is the best 
strategy to recognize MUS in prim ary  care?' Patients w ith  MUS are functionally  im paired  an d  at 
risk for unnecessary diagnostic procedures and  treatm ents. Recognition of patien ts w ith  a high 
risk of persisten t MUS is therefore of param oun t im portance. H ow ever, in  the absence of a clear 
definition, study ing  this research question is difficult.
Thirdly, research abou t effective in te rventions in  patien ts w ith  MUS, especially self­
m anagem ent an d  patien t em pow erm ent, should  have priority  according to 40% of the 
w orkshop audience. W e shou ld  take the cu ltu ral background  and  patien t perspectives into
Table 1. N ationality of participants in the w orkshop on MUS
Asia 21
- Korea 1
- S ingapore 3
- India 1
- M alaysia 5
- China 3
- H ong K ong 3
- Philippines 2
- M ongolia 1
- Taiw an 1
- Thailand 1
M iddle East 6
- Dubai 1
- Q atar 2
- Israel 1
- Bahrain 1
- Saudi Arabia 1
Australia 3
Africa 7
- S outh Africa 2
- N igeria 5
Europe 22
- UK 4












Total number of attendees 66
Total number of participants 52a
a Fourteen  partic ip an ts  on ly  a tten d e d  the in troducto ry  p resen ta tion  of the w orkshop.
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Table 2. Ranking of research topics in the fie ld  o f MUS 





1 W hat is the definition of MUS? 25 91
2 W hat is the best strategy /  tool to recognize MUS in  prim ary  care and  w hen  do  I 
have to stop searching for a ra re  disease?
18 69
3 W hat is the effect of self-m anagem ent a n d /o r  patien t em pow erm ent in  patients 
w ith  MUS?
21 58
4 H ow  does the patient explain his sym ptom s and  w ha t do  patien ts do  w ith  the 
diagnosis MUS?
14 44
5 W hat do  doctors in p rim ary  care do w rong  and  r igh t in the consultations w ith  
patients w ith  MUS?
13 44
6 W hat is the aetiology of MUS? 11 40
7 W hich interventions in  p rim ary  care are effective in patien ts w ith  MUS? 11 35
8 W hat is the n a tu ra l course of M US in  p rim ary  care? 13 34
9 Are there cultural differences in  d iagnosing  MUS? 9 34
10 A t w ha t poin t should  w e intervene to prevent patients becom ing chronic 
presenters of MUS?
13 32
11 W hat is the effect of (the teaching of) com m unication skills of the doctor in 
consultations w ith  patien ts w ith  MUS?
12 30
12 W hat is the effect of a com prehensive assessm ent of global aspects (spiritual, 
psychosocial, contextual, fam ily view) of patien ts w ith  MUS?
9 27
13 W hat a lte rna tive /com plem entary  m edicine approaches/in te rven tions are 
effective in patients w ith  MUS?
9 23
14 W hat is the value of the use of m etaphors by  patients and  doctors in 
consultations on  MUS
6 20
15 W hat m ethod can w e use to m easure m uscle tension  in rest? 9 16
16 W hat is the influence of MUS on  the QOL of the patient and  the doctor? 5 14
17 Is there a re la tion  betw een M US preva lence /p resen ta tion  and  different health  
care system s (paym ent of care by  insurance or by  patien ts themselves)?
6 13
18 W hat is the efficacy of a stepped-care m odel in the therapy  of patients w ith  
MUS?
4 12
19 W hat is the influence of the role of the G P (gatekeeper - non-gatekeeper) on  the 
outcom e of MUS?
3 12
20 Is there a need  fo r a better categorisation of patients w ith  MUS? 5 10
21 W hat is the effect of a com m unity  a n d /o r  fam ily approach  in therapies on  the 
outcom e of MUS?
4 10
22 W hat a nd  to w ha t extent should  GPs explain to patients about MUS? 4 9
23 W hat is the re la tion  betw een MUS and  'heartsink' patients? 4 8
24 W hat is the difference betw een MUS and  hysteria? 2 8
25 H ow  do patients develop chronic MUS? 2 7
26 W hat is the influence of the dim ensions of the biopsychosocial m odel on  the 
developm ent of chronic MUS?
1 4
27 W hat is the difference betw een MUS and  hypochondria? 1 3
28 W hat are the view s of patients on MUS? 1 2
29 Are patien ts w ith  MUS satisfied w ith  the consultation? 0 0
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Table 3. Themes of research topics in the field  of MUS
Research topic Rank Totalscorea
Therapeutic options 195
- W hat is the effect of self-m anagem ent a n d /o r  patient em pow erm ent in patients w ith  MUS? 3
- W hich interventions in prim ary  care are effective in  patients w ith  MUS? 7
- W hat is the effect of (the teaching of) com m unication skills of the doctor in  consultations 11
w ith  patients w ith  MUS?
- W hat is the effect of a com prehensive assessm ent of global aspects (spiritual, psychosocial, 12
contextual, fam ily view) of patien ts w ith  MUS?
- W hat a lte rna tive /com plem entary  m edicine approaches/in te rven tions are effective in 13
patients w ith  MUS?
- W hat is the efficacy of a stepped-care m odel in the therapy  of patients w ith  MUS? 18
- W hat is the effect of a com m unity  a n d /o r  fam ily approach in  therapies on  the outcom e of 21
MUS?
Problems in  consultations: The doctors' perspective 174
- W hat is the best strategy /  tool to recognize MUS in  prim ary  care and  w hen  do I have to 2
stop searching for a rare  disease?
- W hat do  doctors in  p rim ary  care do  w rong  and  rig h t in  the consultations w ith  patien ts w ith 5
MUS?
- At w ha t po in t shou ld  w e intervene to p reven t patients becom ing chronic presenters of 10
MUS? 14
- W hat is the value of the use of m etaphors by  patien ts and  doctors in  consultations on  MUS? 22
- W hat and  to w hat extent shou ld  GPs explain to patients about MUS?
D efinition 120
- W hat is the definition of MUS? 1
- Is there a n eed  for a better categorisation of patients w ith  MUS? 20
- W hat is the relation  betw een MUS and  'heartsink ' patients? 23
- W hat is the difference betw een MUS a nd  hysteria? 24
- W hat is the difference betw een MUS a nd  hypochondria? 27
A etiology and course 115
- W hat is the etiology of MUS? 6
- W hat is the n a tu ra l course of MUS in prim ary  care? 8
- W hat m ethod can w e use to m easure m uscle tension in rest? 15
- W hat is the influence of MUS on the QOL of the patient and  the doctor? 16
- H ow  do  patients develop chronic MUS? 25
- W hat is the influence of the dim ensions of the biopsychosocial m odel on  the developm ent of 26
chronic MUS?
Cultural influences 59
- Are there cultural differences in  d iagnosing  MUS? 9
- Is there a re la tion  betw een MUS preva lence /p resen ta tion  and  different health  care system s 17
(paym ent of care by  insurance or by  patients themselves)?
- W hat is the influence of the role of the GP (gatekeeper -  non-gatekeeper) on the outcom e of 19
MUS?
Patient perspective 46
- H ow  does the patient explain his sym ptom s and  w hat do  patients do  w ith  the diagnosis 4
MUS? 28
- W hat are the view s of patients on  MUS? 29
- Are patients w ith  MUS satisfied w ith  the consultation?
a Sum  of the scores of each them e.
account. Probably, m ore than  one in tervention  is needed  to help patients w ith  MUS. Mixed 
m ethod  qualitative research w ith  doctors an d  patien ts m ay be the key to develop an  effective 
in tervention  for these patients.
Finally, w e discussed w hat doctors in  p rim ary  care m ight do w rong, an d  w h a t they do w ell, in 
consultations w ith  patien ts w ith  MUS. For instance, m edical investigations can reassure some 
patients b u t can w orsen  sym ptom s in  other patients. It w ou ld  be helpful to s tudy  predictors, in 
o rder to decide w hich  strategy w ill help the ind iv idual patien t w ith  MUS most.
Themes in MUS research
In Table 3, w e grouped  the research topic into six them es: (i) definition of MUS, (ii) aetiology and 
prognosis of MUS, (iii) problem s in the consultation  w ith  patien ts w ith  MUS, (iv) therapeutic 
options for patien ts w ith  MUS, (v) patien t perspectives an d  (vi) cultural differences. As appears 
from  this table, the m ost im portan t research them es w o rth  s tudy ing  w ere 'therapeutic options 
for patien ts w ith  MUS' an d  'problem s in  the consultation  w ith  patients w ith  MUS' (total score 
195 an d  174, respectively). Research abou t the definition of MUS got a total score of 120 and 
research abou t aetiology and  course 115. The research them es 'cultural differences' and  'the 
patien t perspective' w ere regarded  as less im portan t (total score of 59 and  46, respectively).
Discussion
Bringing together experts of MUS research an d  discussing the state of the a rt in  MUS research 
in ternationally  w as of great value: w e could  share the global perspective on MUS and  discuss 
ideas abou t fu tu re developm ents on MUS research. A lthough  cultural differences w ill play a 
role in the classification of patients w ith  MUS, an d  doctors' perspectives an d  m anagem ent of 
patien ts w ith  MUS, we d id  no t find  m any p rom inent cu ltu ral differences du ring  our 
sym posium  and  w orkshop. D octors from  all over the w orld  face m ore or less the sam e problem s 
in consultations w ith  patients w ith  MUS. The h igh  attendance rate and  the num ber of 
nationalities in our sym posium  and  w orkshop  reflect tha t MUS are p resen t all over the w orld  
an d  attract great atten tion  of GPs and  researchers.
The problem  in MUS th a t w as recognized m ost w as the indistinct an d  am biguous definition of 
MUS. There is need  for an  unam biguous definition of MUS because w ithou t a clear definition, 
research outcom es and  their m eaning rem ain  m udd led  and  unclear. This need  is even m ore 
u rgen t because in  the next versions of ICD-11 and  DSM-V the end of the som atoform  disorder 
category is being considered.25'26 D ifficulties arising  in  defining MUS are the connection betw een 
MUS and  prevalen t m ental health  d isorders such as depression and  anxiety and  functional 
som atic syndrom es such as fibrom yalgia an d  Irritable Bowel Syndrom e.27'28 Therefore, 
in tegrated  research in  prim ary  care an d  specialized services is needed.
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Important research themes worth studying appeared to be 'therapeutic options in patients with 
MUS' and 'problems within the consultation with patients with MUS'. Recent research already 
focus on these themes.20,29,30 There is need for more patient-oriented research, e.g. qualitative 
research and mixed method research, to learn more about the needs of patients with MUS.31 
Together with studying the course of MUS, this will provide GPs with instructions and advices 
for the best therapeutic approaches towards these patients.12,13 At best, the results of these studies 
should be combined with the development and investigation of suitable and effective 
interventions in these patients.
As far as we know, this is the first time that a research agenda in MUS has been defined by GPs 
from all over the world. The participation of 29 nationalities from 6 different continents extends 
the validity of the findings to cultures other than the Western culture. The strength of the 
nominal group technique as a method for defining the research agenda is its structured, detailed 
discussion. However, it may also lead to unrepresentative, unreliable judgements and 
contextual differences, such as differences in national health care systems. Furthermore, the lack 
of anonymity can make participants feel reserved to articulate their opinion.
We observed an interesting discrepancy: results of research as presented in the symposium 
focussed on miscommunication between doctors and patients as reason for persisting MUS, 
whereas in the workshop participants discussed MUS as if it were a real disease with its own 
aetiology and course. Patients often want to discuss psychosocial problems but doctors do not 
do so and choose a somatic pathway. This difference between patient's and doctor's perspective 
is regarded as a cause of persistence of symptoms. Consequently, these symptoms have a 
'course' and the workshop participants were particularly interested in that course. Only some 
MUS patients turn out to have a "real" somatic or psychological disease during follow-up. 
T urning all persistent unexplained symptoms into a disease is medicalising and not very helpful 
for patients, because they actually want to be heard and discuss their psychosocial problems. If 
doctors would facilitate this, more MUS might resolve.
Another interesting finding of our workshop was the fact that research on patient views was not 
considered as priority. Knowledge of patients' expectations is necessary to answer patients 
needs in consultations of MUS and enhances patients' satisfaction, adherence and health.32 The 
discussion on MUS as a real disease and the fact that only doctors participated in defining the 
research agenda might explain the lack of priority of patient views. Moreover, it shows that 
patient participation in defining a research agenda is needed in the future.
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It is clear from the literature, that more research on MUS in primary care is needed in order to 
provide an improvement of the management of these patients and a better understanding of the 
problems we face during consultations with patients with MUS. Moreover, it is important to 
exchange ideas and coordinate research efforts on MUS in primary care at an international level, 
in order to prevent redundancy. Future WONCA conferences, as well as other primary care 
oriented conferences, offer excellent opportunities for this purpose.
MUS in fam ily medicine: defining a research agenda | 191
Reference List
1 Peveler R, Kilkenny L, Kinmonth AL. Medically unexplained physical symptoms in 
primary care: a comparison of self-report screening questionnaires and clinical opinion. J 
Psychosom Res 1997; 42(3):245-252.
2 Burton C. Beyond somatisation: a review of the understanding and treatment of 
medically unexplained physical symptoms (MUPS). Br J Gen Pract 2003; 53(488) :231-239.
3 Verhaak PF, Meijer SA, Visser AP, Wolters G. Persistent presentation of medically 
unexplained symptoms in general practice. Fam Pract 2006; 23(4):414-420.
4 Smith GR, Jr., Monson RA, Ray DC. Patients with multiple unexplained symptoms.
Their characteristics, functional health, and health care utilization. Arch Intern Med 
1986; 146(1):69-72.
5 Smith RC, Gardiner JC, Lyles JS, Sirbu C, Dwamena FC, Hodges A et al. Exploration of 
DSM-IV criteria in primary care patients with medically unexplained symptoms. 
Psychosom Med 2005; 67(1):123-129.
6 de Waal MW, Arnold IA, Eekhof JA, van Hemert AM. Somatoform disorders in general 
practice: prevalence, functional impairment and comorbidity with anxiety and 
depressive disorders. Br J Psychiatry 2004; 184:470-6.:470-476.
7 Escobar JI, Gureje O. Influence of cultural and social factors on the epidemiology of 
idiopathic somatic complaints and syndromes. Psychosom Med 2007; 69(9):841-845.
8 Salmon P, Peters S, Stanley I. Patients' perceptions of medical explanations for 
somatisation disorders: qualitative analysis. BMJ 1999; 318(7180):372-376.
9 Epstein RM, Shields CG, Meldrum SC, Fiscella K, Carroll J, Carney PA et al. Physicians' 
responses to patients' medically unexplained symptoms. Psychosom Med 2006; 
68(2):269-276.
10 Salmon P, Humphris GM, Ring A, Davies JC, Dowrick CF. Why do primary care 
physicians propose medical care to patients with medically unexplained symptoms? A 
new method of sequence analysis to test theories of patient pressure. Psychosom Med 
2006; 68(4):570-577.
11 Arnold IA, Speckens AE, van Hemert AM. Medically unexplained physical symptoms 
The feasibility of group cognitive-behavioural therapy in primary care. J Psychosom Res 
2004; 57(6):517-520.
12 Morriss R, Dowrick C, Salmon P, Peters S, Dunn G, Rogers A et al. Cluster randomised 
controlled trial of training practices in reattribution for medically unexplained 
symptoms. Br J Psychiatry 2007; 191:536-42.
13 Rosendal M, Bro F, Sokolowski I, Fink P, Toft T, Olesen F. A randomised controlled trial 
of brief training in assessment and treatment of somatisation: effects on GPs' attitudes. 
Fam Pract 2005; 22(4):419-427.
192 I Chapter 10
MUS in family medicine: defining a research agenda | 193
14 Blankenstein AH, van der Horst HE, Schilte AF, de Vries D, Zaat JO, Andre KJ et al. 
Development and feasibility of a modified reattribution model for somatising patients, 
applied by their own general practitioners. Patient Educ Couns 2002; 47(3):229-235.
15 van Ravesteijn HJ, Lucassen PL, Hartman TC. Reattribution for medically unexplained 
symptoms. Br J Psychiatry 2008; 192:314-5.
16 Karasz A, Dempsey K, Fallek R. Cultural differences in the experience of everyday 
symptoms: a comparative study of South Asian and European American women. Cult 
Med Psychiatry 2007; 31(4):473-497.
17 Kirmayer LJ, Sartorius N. Cultural models and somatic syndromes. Psychosom Med 
2007; 69(9):832-840.
18 MUS of Chinese Patients Presenting to Primary Care. 18th WONCA World Conference 
Singapore: 2007.
19 Ring A, Dowrick C, Humphris G, Salmon P. Do patients with unexplained physical 
symptoms pressurise general practitioners for somatic treatment? A qualitative study. 
BMJ 2004; 328(7447):1057.
20 Ring A, Dowrick CF, Humphris GM, Davies J, Salmon P. The somatising effect of clinical 
consultation: What patients and doctors say and do not say when patients present 
medically unexplained physical symptoms. Soc Sci Med 2005; 61(7):1505-1515.
21 Van de Ven AH, Delbecq AL. The nominal group as a research instrument for 
exploratory health studies. Am J Public Health 1972; 62(3):337-342.
22 Raine R, Sanderson C, Hutchings A, Carter S, Larkin K, Black N. An experimental study 
of determinants of group judgments in clinical guideline development. Lancet 2004; 
364(9432) :429-437.
23 Tuffrey-Wijne I, Bernal J, Butler G, Hollins S, Curfs L. Using Nominal Group Technique 
to investigate the views of people with intellectual disabilities on end-of-life care 
provision. J Adv Nurs 2007; 58(1):80-89.
24 Green J, Britten N. Qualitative research and evidence based medicine. BMJ 1998; 
316(7139):1230-1232.
25 Rief W, Rojas G. Stability of somatoform symptoms--implications for classification. 
Psychosom Med 2007; 69(9):864-869.
26 Mayou R, Kirmayer LJ, Simon G, Kroenke K, Sharpe M. Somatoform disorders: time for 
a new approach in DSM-V. Am J Psychiatry 2005; 162(5):847-855.
27 Lieb R, Meinlschmidt G, Araya R. Epidemiology of the association between somatoform 
disorders and anxiety and depressive disorders: an update. Psychosom Med 2007; 
69(9):860-863.
28 Wessely S, Nimnuan C, Sharpe M. Functional somatic syndromes: one or many? Lancet 
1999; 354(9182):936-939.
n
29 Salmon P, Dowrick CF, Ring A, Humphris GM. Voiced but unheard agendas: qualitative 
analysis of the psychosocial cues that patients with unexplained symptoms present to 
general practitioners. Br J Gen Pract 2004; 54(500):171-176.
30 Salmon P, Ring A, Dowrick CF, Humphris GM. What do general practice patients want 
when they present medically unexplained symptoms, and why do their doctors feel 
pressurized? J Psychosom Res 2005; 59(4):255-260.
31 Borkan J.M. Mixed methods studies: a foundation for primary care research. Ann Fam 
Med 2004; 2(1):4-6.
32 Stewart MA, McWhinney IR, Buck CW. The doctor/patient relationship and its effect 
upon outcome. J R Coll Gen Pract 1979; 29(199) :77-81.
194 I Chapter 10




The aim of this thesis was to explore the care GPs deliver and the care patients expect when 
visiting the GP with persistent medically unexplained symptoms (MUS) in order to guide new 
feasible and effective intervention strategies for these patients in primary care. In this final 
chapter, the results of the previous chapters will be brought together for discussion and will be 
related to existing literature. Subsequently, methodological considerations will be discussed. 
Finally, implications and recommendations for intervention strategies, future research and 
primary care development will be considered.
Summary of main findings
Analyzing the results of the studies of this thesis, we could distinguish three main themes: 
course and prognosis of MUS, the mismatch in the doctor-patient communication, and the 
importance of the doctor-patient relationship. Before we will outline and summarize these 
themes, we have to notice that doctor-patient communication and doctor-patient relationship 
are strongly interconnected as they highly influence each other. However, we assume that the 
distinction between those two is worthwhile as doctor-patient communication focuses more on 
interaction styles within a single consultation whereas doctor-patient relationship covers a 
more longitudinal concept which is shaped throughout multiple consultations. For example, 
the doctor-patient relationship is build over multiple consultations whereas the doctor-patient 
communication is shaped in each single consultation.
Course and prognosis of MUS
In the first two studies (chapter 2 and 3) we examined the course and prognosis of MUS. 
Simultaneously we searched for patient characteristics which can help GPs in daily practice to 
identify patients who are at risk for persistent MUS.
By using the CMR registration project, we were able to determine patient characteristics during 
the ten years before the diagnosis of chronic functional somatic symptoms (CFSS). The CMR 
registration project has two unique features: (1) longitudinal registration which makes it 
possible to follow the development towards persistent MUS and (2) a defined code for MUS and 
persistent MUS (CMR classifies persistent MUS as chronic functional somatic symptoms 
(CFSS)). Patients with CFSS appeared to consult their GP twice as much, to use much more 
somatic and psychotropic medication, to have more psychiatric morbidity and to be more often 
referred to mental health workers then patients without CFSS. Furthermore, they are more 
likely to present symptoms in two or more body systems and to present a higher number and 
greater diversity of symptoms to the GP then patients without CFSS.
To identify relevant prognostic factors in patients presenting persistent MUS we also performed 
a systematic literature review on prognostic factors. The review showed that patients with MUS
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and abridged somatisation (the abridged definition of somatisation which requires the presence 
of four symptoms in males and six symptoms in females) had improvement rates of 50% or 
more. However, 10-30% of patients with MUS symptoms deteriorated during the 6 to 15 months 
follow-up period. Furthermore, the majority of patients with hypochondriasis did not recover 
during follow-up. We found that the seriousness of the condition at baseline (i.e. number of 
symptoms and severity of symptoms) might be of prognostic significance. We found no 
evidence to support the influence of psychiatric comorbidity and personality traits on the course 
of hypochondriasis.
Conclusion
The number, diversity and severity of symptoms are important characteristics in the course and 
prognosis of MUS. Establishing the number of presented symptoms and the seriousness of the 
condition in patients with MUS might help GPs to be aware of an increased risk of persistence of 
MUS.
The mismatch in the doctor-patient communication
Analysis of video consultation of patients with persistent MUS (chapter 7) indicated that 
patients present many symptoms in a rather unstructured way and GPs hardly used structuring 
techniques such as agenda setting and summarizing. Furthermore patients with persistent MUS 
got much opportunity to tell their story, but the reasons for encounter, their beliefs and concerns 
were not discussed in a structured manner. The extensive explanation of the origin of the 
symptoms given by the GP often did not take patients' beliefs and concerns into account. In the 
interview study, patients indicate (chapter 4) that they appreciate a non-judgmental and 
attentive listening style, a thorough exploration and a comprehensive explanation of this 
symptoms. So, based on our qualitative analysis of the doctor-patient communication, we 
conclude that there seems to be a mismatch between what patients with persistent MUS want 
and what GPs deliver to them. This mismatch emerges most obvious in the domains: 
'exploration' and 'explanation'.
Exploration
MUS experts (chapter 8) state that GPs should listen carefully to the patient and question them 
extensively about the symptoms, the consequences of the symptoms for daily life and the 
meaning of the symptoms for the patient. Furthermore they state that it is important to ask the 
patient about his cognitions, emotions, fears, and concerns regarding the symptoms. So, this 
concurs with what patients want as assessed in our interview study (chapter 4). Contrary to 
these recommendations, GPs seldom explore patients' ideas, concerns and expectations in a 
structured manner given their actual behaviour during the encounters with patients with 
persistent MUS (chapter 7). We showed in a case report that recognizing and exploring cues 
(non-explicit remarks) (chapter 6) can be a helpful tool for this exploration.
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Explanation
GPs are aware of the importance of explaining the symptoms to the patient (chapter 5). This is in 
line with the opinions of MUS experts (chapter 8), who stress the importance of providing 
patients with a tangible explanation for his/her symptoms. However, GPs indicate that they 
face difficulties to explain the nature of the presented unexplained symptoms (chapter 5). They 
state that they use three different approaches to explain the symptoms to the patients; 
normalization of symptoms, telling patients that there is no disease, and using metaphors. The 
findings of chapter 9 offered a number of templates around which GPs could further develop 
and specify their explanations. Some of these models aimed at a physical level of explanation, 
such as the endocrine dysregulation theory. Other models aimed at a more psychological level 
of explanation, such as the somatosensory amplification theory. And some models combined a 
physical and psychological levels of explanation, such as the sensitization theory. Finally, one 
model combined predisposing, precipitating and perpetuating factors such as somatic causes, 
perception, and illness behaviour.
The relevance of more focused explanation came from chapter 7 in which we found that GPs' 
extensive explanations of the origin of the symptoms often did not take patients' beliefs and 
concerns into accounts. This might be a result of the limited exploration of these issues. 
However, experts indicated the importance of linking the physical complaints with patients' 
cognitions and illness beliefs. Therefore, understanding of patients' ideas, concerns and 
expectations together with knowledge of the different explanatory models might help GPs to 
improve their communication with patients with persistent MUS.
The importance of the doctor-patient relationship
According to patients with persistent MUS (chapter 4), a good and effective doctor-patient 
relationship depends on: (1) a GP with an open mind who uses a non-judgmental 
communication style; (2) a skillful and competent GP who is supportive and who offers a 
comprehensible explanation for the symptoms; (3) easy access to their 'own' GP who takes time 
to explore and to discuss the patients' symptoms and/or problems; (4) being taken seriously; 
and (5) engagement as partners in the consultation in a way they can make their own choices 
based on the provided information. This means that patients value a personal continuing GP- 
patient relationship built on physician attitude, medical competence, availability and shared 
authority. These findings are in line with the opinions of GPs (chapter 5), who indicate the 
usefulness and importance of a good doctor-patient relationship in encounters with patients 
with persistent MUS. They are also in line with the opinions of MUS experts (chapter 8), who 
state that the doctor-patient relationship is an important tool in order to create a safe therapeutic 
environment for these patients. However, although patients, GPs and MUS experts recognize 
the importance of the doctor-patient relationship, GPs indicate (chapter 5) that they face 
difficulties in preserving the doctor-patient relationship during these encounters.
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Although GPs realize the usefulness and importance of a good doctor-patient relation in 
encounters with patients with persistent MUS, they face difficulties in putting this into practice. 
This is in particular the case when explaining what is wrong or relieving of symptoms is 
problematic. GPs try to overcome this by securing the relationship with some sort of ritual care 
(e.g. regular physical examination, regular doctor visits). Some GPs do this wholeheartedly, 
while others feel rather ambivalent with this ritual (chapter 5). Hereby, GPs carefully balance 
between the maintenance of the doctor-patient relationship, their inability in explaining MUS, 
and avoiding damage from drug therapy and interventions.
Comparison with the existing literature
Course and prognosis
The 'ecology of medical care' model explains that most people do not contact professional 
medical care for most of their complaints.1 Only a small minority of people contact a health care 
professional when they feel ill.1'2 Twenty to thirty percent of the encounters of this small 
minority concern symptoms that can not be explained by any physical disease.3-5 However, most 
of these episodes of illness remain restricted to one doctor-patient contact.6 Therefore we can 
conclude that most of the symptoms are transient and disappear spontaneously in the course of 
time or patients find a way to cope with their symptoms.7 This is in line with our findings. We 
have found that the prognosis of MUS in primary and secondary care is more favourable than 
expected, as the majority of the patients with MUS improve.
Creed and Barsky performed a systematic review of the epidemiology of somatisation disorder 
and hypochondriasis to examine the characteristics and associated features of these disorders.8 
Although they did not systematically search and study prognostic factors, they concluded that 
the number of longitudinal studies providing data concerning natural history and predictors of 
outcome is inadequate. Furthermore, they raised the hypothesis that abridged somatisation, 
somatisation disorder and hypochondriasis are closely connected to anxiety and depressive 
disorders.8 However, we could not confirm their hypothesis as in our review comorbid anxiety 
and depression did not have prognostic value. Personality traits, including neuroticism and 
alexithymia, have been demonstrated to be associated with MUS and hypochondriasis.9'10 
However, our review did not find evidence for their prognostic value.
Our studies pointed out that the number, diversity and severity of symptoms are important 
characteristics associated with the course of MUS. Patients with persistent MUS are more likely 
to report higher number of symptoms, greater diversity of symptoms or more severe symptoms. 
This is in line with the finding that patients with distinct functional somatic syndromes often 
have symptoms overlapping with other functional somatic syndromes indicating a high
number and great diversity of symptoms in these patients.11 Furthermore, patients with distinct 
functional somatic syndromes often present symptoms in many body systems.12 Due to the 
substantial overlap between the individual functional somatic syndromes the existence of 
distinct specific somatic syndromes should be questioned. Taking the fundamental unity of 
those syndromes into account, the GP, is the most appropriate practitioner to diagnose and treat 
these patients as (1) they use a broad-based and generic approach; and (2) they try to prevent 
iatrogenic harm of unnecessary interventions by using this approach.
In contrast to the limited numbers and considerable heterogeneity of studies focusing on the 
prognosis of patients with undifferentiated MUS, distinct functional somatic syndromes are 
studied more meticulously. Cairns and Hotopf for example, found 28 papers describing the 
clinical follow-up of patients after the diagnosis chronic fatigue syndrome (CFS).13 The full 
recovery rate in these patients was only 5% and only 40% of the patients improved. Lower 
fatigue severity at baseline, a sense of control over symptoms, and not attributing illness to a 
physical cause were associated with a good outcome. Their findings of the prognostic 
significance of the fatigue severity at baseline are in line with our findings.
The mismatch in the doctor-patient communication
An important task for GPs is listening to patients,14,15 as patients seek understanding for their 
symptoms16-19 and want to feel that the GP accepts the symptoms as real.20 To achieve this, 
consultations skills, including exploration and explanation, are needed. However, we found 
that exploration was only practiced to a limited extend by GPs when encountering patients with 
persistent MUS. This is in line with the findings of others. According to Stewart et al. GPs do not 
explore the reason for encounter and the worries of the patients in approximately half of the 
consultations.21 Furthermore, in about 20% of all consultations the patient has an biomedical or 
psychosocial agenda which is not addressed in the consultation.22 An important tool to explore 
patients' expectations and concerns is responding to patients' cues.23,24 Cues are non-explicit 
remarks that can enclose a special meaning and point towards ideas, worries or expectations. 
Discussing these cues enable better understanding of the reason for encounter, cognitions and 
emotions.25,26 However, Salmon et al found that during the initial presentation of MUS, GPs' 
engagement with explicit cues about emotional or social problems was limited.27 This is in line 
with our findings, as we found that GPs' exploration of patients' reason for encounter, beliefs 
and concerns is also limited in persistent MUS consultations. Not exploring patients' beliefs and 
expectations has several disadvantages. Firstly, patients might think that the GP is not listening 
carefully, does not want to understand the meaning of the symptoms or is not interested in the 
patient.28 Secondly, contrary to what is expected, these consultations will last significantly 
longer. For example, Levinson found that in a majority of the consultations (79%), GPs missed 
the opportunity to react to the cues given in the consultation resulting in a significant longer
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duration of these consultations.29 Thirdly, not building a shared understanding regarding the 
symptoms hampers effective explanation.20'30-32 This might explain why GPs provide reassurance 
without a clear explanation of the symptoms27; they simply lack information. For example, 
normalization of symptoms and telling patients that they don't have a disease without 
providing tangible mechanisms grounded in patients' concerns is not effective and results in 
more demand for health-care.32 Finally, patient's satisfaction, adherence and health are 
reduced.21,33'34 However, what we also have found in the video consultation study was that GPs 
gave patients with persistent MUS ample opportunity to tell their story and this is exactly what 
these patients want. In the interview study we found that patients want their GP to be mindfully 
present, to listen to their story and to give them room to tell their story. Churchill described the 
importance of taking time for the patients and demonstrating that there is space for their story.35 
Furthermore, giving patients time for their story is one of the important elements of working in a 
patient-centred way.36 However, we think that GPs' patient-centred working skills can further 
be improved by a more focused communication, including enhancing GPs' exploratory 
behaviour.
Prior research has indicated that doctor-patient communication is associated with patient 
health outcomes.37-39 Studies in cancer care revealed that words can be therapeutic because when 
patients feel understood and reassured resulting in positive psychosocial health outcomes.40,41 
Thomas showed the importance of being positive during consultations with patients with 
MUS.42 He studied patients receiving a positive consultation (firm diagnosis and confidence of a 
good prognosis) or a non-positive consultation (no firm assurance and unsure about the 
prognosis). Two weeks after the consultation, patients who received the positive consultation 
were significantly more satisfied. Furthermore, 64% of those patients got better, compared with 
39% of those who received a negative consultation. The role of patient- provider communication 
was also studied in patients with osteoarthritis of the knee receiving traditional Chinese 
acupuncture and sham acupuncture.43 Patient receiving a 'high expectations' communication 
style (acupuncturist conveyed positive expectations of improvement about his/her treatment) 
experienced statistically significant improvement in pain (effect size 0.25) and satisfaction 
(effect size 0.22) compared with patients receiving a 'neutral expectations' communication style 
(acupuncturist conveyed neutral expectations of improvement about his/her treatment). Cals 
et al. evaluated the effect of doctor-patient communication on antibiotic prescribing for lower 
respiratory tract infection and on patient recovery.44 They found that GPs who received a 
training in enhanced communication skills prescribed significantly fewer antibiotics than those 
not trained in these communication skills (27% vs 54%, P<0.01).
The three studies described above show that positive doctor-patient communication is essential 
for the effectiveness of treatments in health problems in primary care. One of the proposed
pathways through which doctor-patient communication can contribute to improved health is a 
shared understanding of illness.45 Although reaching a shared understanding in patients with 
persistent MUS is often difficult15 and treatment for these patients are not easily available, a 
positive doctor-patient communication is an important tool in the management of these 
patients.
The importance of the doctor-patient relationship
GPs in our study recognized the importance of establishing an ongoing and effective doctor- 
patient relationship with patients with persistent MUS. Furthermore, they took responsibility to 
build and maintain such a relationship. T aking this responsibility fits well in the values of family 
medicine and general practice.30'46 Important indicators of the quality of the doctor-patient 
relationship include mutual trust among GPs and patients, personal continuity, empathy, 
compassion and the patient's perception of feeling respected and being cared for.45'47
It is known from the literature that the quality of the doctor-patient relationship affects health 
outcomes by promoting patient's emotional well-being, enhancing continuity of care, patient 
satisfaction, and patient commitment to treatment plans.48-50 Furthermore, in psychotherapy 
outcome research therapist-client relationship factors have been estimated to contribute 30% of 
patient outcomes.51 Di Blasi et al. reviewed the empirical evidence of the therapeutic effect of the 
doctor-patient relationship in medicine.52 They identified 25 trials studying the effects of the 
patient-practitioner relationship on patients' health status. GPs who attempted to form a warm 
and friendly relationship with their patients were found to be more effective than practitioners 
who kept their consultations impersonal and formal.
Some studies have established the association between doctor-patient relationship and patient 
health outcomes in mental health. Van Os et al. examined the effect of depression treatment, 
empathy and support, and their interaction on patient outcomes for depression in primary.53 
They found that only the combination of depression treatment according to the guidelines and 
empathy and support resulted in an effective treatment of depression in primary care. Kaptchuk 
et al. evaluated the effect of the doctor-patient relationship in patients with irritable bowel 
syndrome (IBS).54 They found that augmented interaction (a warm, empathetic, and confident 
patient-practitioner relationship) was more effective than limited interaction (patients 
reporting adequate symptom relieve: respectively, 61% vs 53%). Smith et al. studied the effect of 
explicitly establishing a good patient-provider relationship in high-utilizing patients with MUS 
in primary care.55'56 They found an absolute 14% improvement (48% improved vs 34% improved) 
on the mental composite score of the SF-36 among those receiving the intervention, compared 
with those who did not. Furthermore, depression and disability scores, as well as satisfaction 
improved.
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The three studies described above as well as the review of Di Blasi et al.52 show that the doctor- 
patient relationship is an important and potent therapeutic component which should not be 
ignored. Furthermore, the role of the doctor-patient relationship should be explicitly addressed 
in the treatment of (persistent) MUS in primary care. However, the doctor-patient relationship 
should not be a primary goal of the consultation as, according to Chew-Graham, this may result 
in GPs feelings of powerlessness to resolve the symptoms and problems presented and collusion 
with patients' illness behaviour that maintain chronic incapacity.57 Therefore, the doctor-patient 
relationship should always be a means in stead of an arm to provide effective care.
Methodological considerations 
The quantitative methods
To identify patient characteristics, course and prognosis of patients with persistent MUS we 
performed (1) an observational study with a comparison control group using CMR longitudinal 
data (chapter 2) and (2) a systematic review of the literature regarding prognostic factors in 
patients presenting persistent MUS (chapter 3). Here we will describe the strengths and 
limitations of the research methods we used in these two chapters.
Strengths
The CMR registration project is, as far as we are aware, the only morbidity registration system 
with a structural possibility to classify patients with chronic functional somatic symptoms (i.e. 
persistent MUS). The validity of morbidity registration is enhanced by monthly meetings of all 
GPs involved to discuss classification problems, to monitor the application of diagnostic criteria 
and to discuss coding problems of hypothetical case histories.58 Longitudinal research in the 
field of MUS is mostly done by using questionnaires.59,60 However, questionnaires have been 
shown to produce unreliable results due to recall bias. For example, the Psychological Problems 
in General Health Care (PPGHC) study examined the stability of somatisation disorder and 
somatisation symptoms and concluded that somatisation disorder showed considerable 
instability during 12 months.61 In our review and our CMR registration study, MUS and 
persistent MUS was diagnosed by the GPs or investigators themselves in patients experiencing a 
certain threshold of relevance of symptoms as they seek medical care for them meaning that the 
diagnosis of (persistent) MUS was not related to the recall of 'lifetime' symptoms.62 
Our systematic review is the first which systematically searched for studies on prognostic 
factors in patients with persistent MUS. We used an extensive search strategy to identify 
relevant studies and we independently assessed the quality of included studies with a validated 
checklist. Furthermore, we searched all relevant databases, in- and excluded studies with two 
researchers independently and did not use language restrictions. Although the heterogeneity of
included studies was high, we were able to perform a best-evidence synthesis to summarize the 
value of the different prognostic indicators taking methodological quality into account.
Limitations
In the CMR registration there might be an interdoctor variation in the diagnosis chronic 
functional somatic symptoms as diagnosing these patients will always remain an interpretation 
of the symptoms in which GPs will use their knowledge of the context of the specific 
patients.21'58'63 One might argue that the higher frequency of GP visits, referrals and diagnostic 
test was to be expected in advance, as the diagnosis chronic functional somatic symptoms can 
only be made after repeated consultations for physical symptoms that remain medically 
unexplained after adequate examination.
There were some limitations regarding the quality of included studies of the review. Firstly, the 
numbers of participants enrolled in the cohorts is limited. Secondly, only a minority of the 
included studies presented sufficient data on the duration of symptoms at baseline. Thirdly, a 
detailed description of treatments during follow-up was absent although we assume that all 
patients received some kind of treatment during the follow-up.
The qualitative methods
Most chapters of this thesis used qualitative research methods to explore the care GPs deliver to 
patients with persistent MUS and to explore the care patients with persistent MUS expect. The 
qualitative research methods used in this thesis are: qualitative interviews (chapter 4), focus 
group discussions (chapter 5), consultation analysis (chapter 7), qualitative analysis of the 
literature (chapter 8 and 9) and nominal group technique (chapter 10). Here we will discuss the 
strengths and limitations of the research methods used in these different chapters.
Strengths
The qualitative methods used in the interview study, the focus group study, the two literature 
studies and nominal group technique has been recommended as the best method to explore and 
clarify opinions.64 For researching the doctor-patient communication during consultations, 
video-recording has been recommended as the best method.31 In all qualitative studies we used a 
cyclical and interactive way of collecting and analyzing data in order to progressively refine the 
focus and explore the data in depth.65 Furthermore, we transcribed the data verbatim, entered 
the full texts into Altas.ti, and coded and re-organized data by two researchers independently 
using the principles of constant comparative analysis.66 The constant comparative method 
constitute the core of qualitative analysis in qualitative research.67
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Our patient interview study is the first study on opinions and expectations of patients with 
documented, persistent MUS and reflects opinions of patients who have had recent and 
relatively frequent encounters with the healthcare system and their GP. Therefore, their 
opinions are built on a broad and recent experience with medical services. By using a purposive 
sampling strategy and a triangulation strategy of asking independent GPs to judge our results 
we were able to capture and verify the variety of opinions present in the population of GPs. As 
the focus group study examined GPs' perceptions and not actual behaviour, we performed a 
video consultation study. As neither the GP nor the patient was aware of the subject of study and 
as there is little evidence that video-recording influences the behaviour of either the GPs or 
patients, the Hawthorne effect (the effect that participants improve or modify their behaviour in 
response of the fact that they are being studied) in our video consultation study was limited. The 
qualitative analysis of the literature regarding explanatory models of MUS and expert opinions 
on the management of MUS gave a broad overview of this field. We used an extensive and 
systematic search strategy to identify relevant papers and we included and coded the full text 
papers by two independent researchers to minimize biases.
In this thesis we integrated more qualitative research techniques for data collection and 
analysis, also referred to as mixed method research. Therefore, we were able to benefit from 
combining the strengths of the different research methods resulting in a more holistic, valid and 
robust exploration and description of the difficulties arising when GPs encounter patients with 
persistent MUS.68"70 Furthermore, this helped us to gain more insight into the complex 
phenomenon of persistent MUS in primary care.
Limitations
Qualitative research methods are not suited to quantify a certain phenomenon or variable, or to 
generalize results from a small sample to a larger population. Therefore the results of our 
interview study, focus group study, video consultation study, two literature studies and 
nominal group technique should not be interpreted with a quantitative view. The methods 
allow the in-depth exploration of the lived experience or actual behaviour of individuals or a 
small group of people and put these into the context of the day-to-day reality. Generalization 
towards GPs or towards patients with persistent MUS in general is only possible after 
quantitative research in random samples of patients and/or GPs, based on hypotheses 
resulting from qualitative analyses.
Patient interviews about opinions on the doctor-patient relationship give only a snapshot in 
time, whereas this relationship is built over time and over many consultations. Patients' 
perspectives might have changed over time as a response to their experiences with the GP 
and/or the health care system. The same counts for the video consultation study, as each new
consultation carries over memories of previous ones which might have influenced the 
videotaped consultation. These longitudinal influences on the doctor-patient communication 
and relationship were not captured in these studies. Furthermore, although participation bias in 
our video consultations study was limited (response rate 89%), in our interview study this kind 
of bias might have influenced our findings (response rate 39%) as patients who are satisfied with 
their GP are possibly more inclined to participate in the interview study. In contrast to one-to- 
one interviews, during focus group discussions group dynamics might result in the articulation 
of group norms or consensus in stead of provoking individual contrasting opinions. By using a 
purposive sampling strategy and a skilled moderator during the focus group discussions, we 
tried to provoke and capture the full variety of GPs' opinions. In our two literature studies we 
did a qualitative analysis of the literature. Although such an analysis is not as objective as a 
meta-analysis, we were able to summarize the range of explanatory models and important 
elements in the interventions described in the scientific literature nowadays. This summary and 
overview might help to guide future intervention strategies for patients with persistent MUS. 
However, we are not able to draw conclusions on the degree of evidence and the effectiveness of 
the explanatory models and important elements in the interventions for patients with persistent 
MUS as we did not study the evidence regarding these models and elements.
Recommendations for clinical practice
The worries of GPs regarding the development of persistent MUS are mostly not justified as the 
majority of these patients generally have a favourable prognosis. Establishing the number of 
somatic symptoms and the seriousness of the condition during the first consultations might help 
GPs to value the risk of persistence and may guide GPs whether to offer only reassurance about 
the favourable prognosis or a more intensive approach. Furthermore, it seems important to 
communicate this favourable and positive prognosis with the patient during the MUS 
consultation.
To improve the outcomes for patients with persistent MUS, GPs have to focus on the 
consultation itself, the presented symptoms, and the words they use during these consultations. 
GPs have to improve their communication towards a more clear and focused communication 
style by (1) the exploration of patients' needs, beliefs, concerns and expectations, (2) the 
exploration of the reason for encounter, (3) active listening and noticing cues, (4) agenda setting 
and summarizing the information obtained during the consultation, (5) providing tangible, 
positively formulated explanations incorporating patients' beliefs and concerns. Furthermore, a 
positive and continuous doctor-patient relationship is necessary for a consultation to be 
effective. Therefore, GPs have to focus on (a) taking patients seriously, (b) showing empathy, (c)
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understanding the context of an individual patient with his or her illness and (d) mutual trust. 
Regularly scheduled appointments can serve as a tool for this.
Creating a safe therapeutic environment shaped by a clear and focused communication and a 
therapeutic doctor-patient relationship might be key to improve the health care delivered to 
patients with persistent MUS.
Recommendation for future research
Although this thesis makes an important contribution to a more patient-oriented way of 
studying the possibilities for improving the health care delivered to patients with persistent 
MUS, more research is needed to provide GPs with instructions and advices for the best 
individualized therapeutic approaches towards these patients. As our research agenda in MUS, 
defined by GPs from all over the world, indicated, more research is needed on (1) aetiology and 
course, (2) problems in the consultation, and (3) therapeutic options.
Regarding aetiology and course, there is need for more well-conducted prospective cohort 
studies with a reasonable number of patients (>200 patients), in which assessment of treatments 
during follow-up and inclusion of patients at a similar point in the course of there disease are 
important topics. These studies should incorporate the quality of the communication and the 
doctor-patient relationship, in order to reveal which nonspecific aspects of the clinical 
encounter affects help-seeking behaviour in these patients, and the outcome of the consultations 
with these patients.
Regarding the problems in the consultation, there is need for further examination of the efficacy 
of improving the exploration of patients' ideas, concerns and expectation and the structure of the 
persistent MUS consultation. Furthermore, our findings should be confirmed in a larger, 
prospective qualitative study that could track doctor-patient communication regarding MUS 
over time. Such studies should reveal whether patients wish and accept a more in-depth 
exploration and structure of the consultation.
Regarding therapeutic options for patients with persistent MUS, mixed method methodology 
may reveal effective methods of explaining the symptoms. Furthermore, this research should 
study the effects of the (improvement of the) quality of the GP-patient relationship on 
symptoms, impairment, disability and satisfaction in these patients.
Recommendations for medical education
Medical students and GP residents have to realize that they have powerful tools to effectively 
manage and treat patients with persistent MUS. These students and residents have to be 
convinced of this powerful tools, for example by presenting them the available evidence, about 
the importance of a positive consultation and communication style and the therapeutic effects of 
the doctor-patient relationship. Furthermore, we have to teach them about patients' preferences 
and experts opinions regarding the management of persistent MUS in primary care.
Given that ideas in doctors' minds play such an important role, it is imperative that something 
should be done about the way doctors are trained. In particular, we need to pay special attention 
to the side-effects of the monolithic position of the biomedical approach. We need to teach our 
students that the biomedical model is only one of many perspectives. We also need to focus on 
the fact that doctors usually view symptoms as expressions of disease and on the fact that 
doctors consider symptoms with a clear underlying pathology to be more real than symptoms 
that cannot be objectively measured.
Renewed attention for the consultation behaviour is desirable. This extra attention means 
paying attention to symptoms, expectations, ideas and feelings regarding presented symptoms 
in order to attain a good understanding of the symptoms, finding common ground and building 
mutual trust. Generic elements such as attentive listening, explaining symptoms to patients and 
ways to reassure patients needs further attention
Conclusion
The majority of patients with MUS have a favourable prognosis. Only a minority ends up in a 
chronic condition. Establishing the number, diversity and severity of the symptoms during the 
first consultations might help GPs to value the risk of persistence of the symptoms.
There seems to be a mismatch between what patients with persistent MUS want and what GPs 
deliver to them. Patients want a tangible and positive formulated explanation for their 
symptoms, whereas GPs face difficulties in doing so. Furthermore, patients with persistent 
MUS want GPs to pay attention to their ideas, concerns and expectations, whereas GPs actual 
behaviour during the encounters with these patients show the opposite (i.e. limited exploratory 
behaviour).
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Patients with persistent MUS and GPs agree on the importance of a good doctor-patient 
relationship. They both value a personal continuing GP-patient relationship built upon 
physician attitude, medical competence, availability and shared authority. However, at the 
same time GPs indicate that they often face difficulties in preserving the doctor-patient 
relationship during encounters with these patients. They try to balance between the 
maintenance of the relationship and the prevention of unintended consequences of their 
interventions.
Based on these findings we conclude that there seems to be room for improving the care and 
outcomes for patients with persistent MUS. For example by establishing a more clear and 
focused communication style in which patients' ideas, concerns and expectations are explored 
and taken into account. Active listening, noticing cues, agenda setting, summarizing the 
information obtained during the consultation, exploring the reason for encounter, and giving 
tangible and positively formulated explanations can help with that. Furthermore, a positive 
doctor-patient relationship in which patients are taken seriously, GPs show empathy and try to 
understanding the context of an individual patient, and both patients and GPs work on mutual 
trust, might contribute to improve the care and outcomes for these patients.
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This thesis explored (1) the care patients with persistent MUS expect when visiting the GP, (2) 
the care GPs deliver to patients with persistent MUS and (3) the way GPs experience the care 
they deliver to their patients with persistent MUS. Furthermore, we present starting points for 
intervention strategies for patients with persistent MUS in primary care in order to improve the 
care for these, often functionally impaired, patients.
Chapter 1. General introduction.
In this chapter the rationale, aims and outline of this thesis are described.
Medically unexplained symptoms (MUS) are common and most of these symptoms are 
transient. However, a minority of the patients will keep visiting the doctor because of MUS (i.e. 
persistent MUS). This minority represent a major problem in health care as they are responsible 
for high, often unnecessary, health care costs. Furthermore, these patients suffer from their 
symptoms and are functionally impaired.
We explored the knowledge regarding the problems arising when GPs meet patients with 
persistent MUS in daily practice. Furthermore, we indicated knowledge gaps regarding the care 
GPs deliver and the care patients expect when encountering with persistent MUS.
Patients with persistent MUS often feel the skepticism of their doctors and have the feeling that 
the GPs don't take them serious. They are often dissatisfied with the medical care they receive. 
Doctors experience patients with persistent MUS as difficult to manage. They tend to believe 
that (1) these patients fail to see the connection between physical symptoms and psychological 
distress, and that (2) there is incongruence between the presentation of MUS and the actual 
burden. Furthermore, they feel pressurized to offer somatic interventions. Consultations 
between GPs and patients with MUS seems to be less patient-centred. In these consultations 
patients with MUS did not pressurize for somatic interventions, but desired more emotional 
support.
Most research regarding the problematic interaction between GPs and patients with MUS did 
not specifically focus on patients with persistent MUS. During the chronic condition in which 
patients persistently present MUS to their GP, GPs have to find a way to manage these patients in 




Chapter 2. Chronic functional somatic symptoms: a single syndrome?
In this chapter we aimed to identify distinctive features in patients with persistent MUS by 
studying the Continuous Morbidity Registration database. This is the only morbidity 
registration system in the world with a structural possibility to classify patients with persistent 
MUS (CMR classifies persistent MUS as chronic functional somatic symptoms (CFSS)). We 
included 182 patients with persistent MUS and 182 matched controls from this registration 
system and collected data on comorbidity, referrals, diagnostic tests, hospital admissions, 
medication use and number of visits to the GP over a period of 10 years prior to the diagnosis. We 
found that during the 10 years prior to the diagnosis persistent MUS patients presented MUS in 
at least two body systems and used more somatic and psychotropic drugs compared to controls. 
Furthermore, they visited the GP twice as much and had more psychiatric morbidity, and were 
referred more often to mental health workers and somatic specialists. The number of patients 
undergoing diagnostic test was also higher. Hospital admission rates were equal. We concluded 
that patients with persistent MUS have a great diversity of unexplained symptoms, use more 
somatic and psychotropic drugs in the years before diagnosis and show high rates of referrals 
and psychiatric morbidity compared with controls.
Chapter 3. Medically unexplained symptoms, somatisation disorder and 
hypochondriasis: course and prognosis. A systematic review.
In chapter 3 we studied the course of MUS, somatisation disorder and hypochondriasis and 
related prognostic factors. We searched the relevant databases of the medical literature to select 
studies focusing on patients with MUS, somatisation and hypochondriasis and to assess 
prognostic factors. We performed a best-evidence synthesis for the interpretation of the results. 
We could include six studies on MUS, six studies on hypochondriasis and one study on abridged 
somatisation and found that approximately 50 to 75% of the patients with MUS improved, 
whereas 10-30% of patients with MUS deteriorate. In patients with hypochondriasis recovery 
rates varied between one third to 50%. In studies on MUS and hypochondriasis we found some 
evidence that the number of somatic symptoms and the seriousness of the condition at baseline 
influenced course and prognosis. Comorbid anxiety and depression did not seem to predict the 
course of MUS, abridged somatisation or hypochondriasis. We concluded that due to the limited 
number of studies and their high heterogeneity, there is a lack of empirical evidence to identify 
relevant prognostic factors in patients with persistent MUS. However, it seems that a more 
serious condition at baseline is associated with a worse outcome.
S
Chapter 4. The doctor-patient relationship from the perspective of patients with 
persistent medically unexplained symptoms. An interview study.
In Chapter 4 we studied the perspectives of patients with persistent MUS regarding their 
expectations of GPs' health care. By conducting qualitative semi-structured interviews with 17 
patients with persistent MUS we were able to reveal opinions of patients with a documented 
long history of presenting MUS. All patients stressed the importance of a personal continuing 
doctor-patient relationship. They indicate that such a relationship is built on physician attitude, 
medical competence, availability and shared authority. Patients want to be taken serious in a 
non-judgmental open communication style. They appreciate a thorough exploration and a 
comprehensible explanation of the symptoms. Furthermore, they want a competent. GP who is 
easily accessible and who engages them as partners in the consultation and decision making 
process. We conclude that patients with persistent MUS appreciate a patient-centred 
communication and orientation to a form of care in which personal continuity and continuity of 
the relationship are important elements.
The doctor
Chapter 5. Explanation and relations. How do general practitioners deal with 
patients with persistent medically unexplained symptoms: a focus group study.
This chapter explored GPs' perceptions about explaining MUS to patients with persistent MUS 
and about how relationships with these patient evolve over time in daily practice. We used a 
qualitative focus group approach in which twenty-two GPs within five focus groups were 
interviewed. GPs indicated that they recognise the importance of an adequate explanation of the 
diagnosis of MUS but often feel incapable of being able to explain it clearly to their patients. 
Therefore, they try to reassure patients in non-specific ways, for example by telling patients that 
there is no disease, by using metaphors and by normalizing the symptoms. When patients keep 
returning to the GP with MUS, GPs stress the importance of maintaining the doctor-patient 
relationship. GPs describe three different models to do this: mutual alliance characterized by 
ritual care (e.g. regular physical examination, regular doctor visits) with approval of the patient 
and the doctor, ambivalent alliance characterized by ritual care without approval of the doctor 
and non-alliance characterized by cutting of all reasons for encounter in which symptoms are 
not of somatic origin. We conclude that GPs experience difficulties in explaining the symptoms 
and that they meticulously balance between maintaining a good doctor-patient relationship and 




Chapter 6. 'Well doctor, it is all about how life is lived': cues as a tool in the medical 
consultation.
In this chapter we described a patient with unexplained palpitations during vacuuming. During 
one of the consultations she provided an important psychosocial cue which changed my 
perspective on her palpitations, resulting in a deeper understanding of her symptoms. We 
experienced that this non-explicit remark that enclosed a special meaning served as a tool to 
clarify the patient's agenda. This resulted in a mutual understanding about the symptoms, 
enhanced the therapeutic relationship and improved the illness outcome. We concluded that 
noticing cues in the medical consultation helps the doctor to understand the patient's real 
worries and gives a better understanding of the patient's perspective.
Chapter 7. How patients and family physicians communicate about persistent 
medically unexplained symptoms. A qualitative study of video-recorded 
consultations.
This chapter describes an exploratory, qualitative analysis of 20 videotaped consultations 
between GPs and patients with persistent MUS in order to study doctor-patient interaction 
styles and to study on which stages of the consultation patients and doctors focus within the 
available time. We found that patients presented many symptoms in a rather unstructured way. 
However, GPs hardly use structuring techniques such as agenda setting and summarizing. 
Patients with persistent MUS got much opportunity to tell their story, but the reasons for 
encounter, their beliefs and concerns were not discussed in a structured manner. Most of the 
time patients themselves had to initiated discussion of their ideas, concerns and expectations. 
However, GPs' extensive explanations of the origin of the symptoms often did not take patients' 
beliefs and concerns into account. We concluded that due to patients' multiple symptom 
presentation and the absence of GPs' structuring techniques, consultations of patients with 
persistent MUS in this study proceed rather unfocused. However, patients got ample 
opportunity to tell their story. Furthermore, patients with persistent MUS might benefit from 
structured consultations focused on the exploration of the reason for encounter.
Starting points for improving management
Chapter 8. Experts' opinions on the management of medically unexplained 
symptoms in primary care. A qualitative analysis of narrative reviews and scientific 
editorials.
This chapter reviewed important and effective elements in the treatment of patients with MUS S
in primary care according to experts in MUS research in order to explore effective and acceptable 
strategies to manage these functionally impaired patients. We performed a systematic search of 
narrative reviews and scientific editorials in the most important databases of the medical 
literature and triangulated our findings by conducting a focus group interview with MUS 
experts. We included 7 scientific editorials and 23 narrative reviews. According to MUS experts 
the most important elements in the treatment of MUS are: creating a safe therapeutic 
environment; generic interventions (such as motivational interviewing, giving tangible 
explanations, reassurance and regularly scheduled appointments); and specific interventions 
(such as cognitive approaches and pharmacotherapy). However, in contrast to most specific 
interventions, experts rarely describe the effects of generic interventions, doctor-patient 
communication and relationship quantitatively in their scientific editorials and narrative 
reviews. MUS experts indicate that a multi-component approach in which these three important 
elements are combined are most helpful for patients with MUS. We concluded that, in contrast to 
most specific interventions, opinions of MUS experts regarding generic interventions and 
creating a safe therapeutic relationship seem to be more based on theory and experience, than on 
quantitative research. Studies showing the effectiveness of these elements in the management of 
MUS in primary care are still scarce. Research as well as medical practice should focus more on 
these non-specific aspects of the medical consultation.
Chapter 9. Explanatory models of medically unexplained symptoms: a qualitative 
analysis of the literature.
This chapter provides an overview of explanatory models for MUS in order to provide GPs with 
explanatory models known from the scientific literature that may be useful in daily medical 
practice. Therefore we performed a systematic search of reviews in the relevant databases of the 
scientific literature and analyzed the data qualitatively according to the principles of constant 
comparative analysis to identify specific explanatory models. We distinguished nine specific 
explanatory models of MUS in the literature: somatosensory amplification, sensitization, 
sensitivity, immune system sensitization, endocrine dysregulation, signal filter model, illness 
behaviour model, autonomous nervous system dysfunction and abnormal proprioception. The 
nine different explanatory models focus on different domains, including: somatic causes, 
perception, illness behaviour and predisposition. We also found one meta-model, which 
incorporates these four domains: the cognitive behavioural therapy model. We concluded that 
although GPs often face difficulties when providing explanations to patients with MUS, there 




Chapter 10. Medically unexplained symptoms in family medicine: defining a 
research agenda. Proceedings from WONCA 2007.
In this chapter we detected knowledge gaps in MUS and established priorities in MUS research 
by bringing together experts of MUS research and discussing the state of the art in MUS research 
internationally. By using a nominal group technique, we generated research topics and themes, 
set priorities in MUS research and proposed a research agenda. Participants' (66 researchers and 
GPs from 29 nationalities) most important research topics were 'formulating a broadly accepted 
definition of MUS', 'finding a strategy to recognize MUS better and at an earlier stage', 'studying 
the value of self-management and empowerment in patients with MUS' and 'finding predictors 
to decide which strategy will best help the individual patient with MUS'. Priorities in research 
themes of MUS were: (i) therapeutic options for patients with MUS and (ii) problems in 
consultations with these patients. We concluded that more research on MUS in primary care is 
needed to improve the consultations with and management of these patients. Furthermore, 
internationally primary care conferences seemed to be excellent for exchanging ideas and 
formulating central issues of research.
Chapter 11. General discussion.
This final chapter considers the results described in this thesis together with some 
methodological issues, and ends with implications and recommendations for intervention 
strategies and suggestions for further research and general practice.
We conclude that (1) the majority of the patients with MUS have a favourable prognosis and that 
establishing the number, diversity and severity of the symptoms during the first consultation 
might help GPs to value the risk of persistence of the symptoms, (2) there seems to be a mismatch 
between what patients with persistent MUS want and what they receive from their GP, and (3) 
patients and GPs agree on the importance of a good doctor-patient relationship. Therefore, 
exploring and taking into account patients' ideas, concerns and expectations, together with 
building a positive doctor-patient relationship, might contribute to improve the care and 
outcomes for patients with persistent MUS.
The most important recommendations for clinical practice are that we have to focus on the 
consultation itself, the presented symptoms, and the words we use during these consultations. 
Furthermore, we have to focus on creating a safe therapeutic environment shaped by a clear and 
focused communication and a therapeutic doctor-patient relationship.
The most important recommendations for future research are that future MUS research has to 
take the doctor-patient communication and relationship into account in order to reveal which 
nonspecific aspects of the clinical encounter affects the outcome of these consultations.
Furthermore, effective methods of explaining symptoms to patients with persistent MUS have 
to be tested.
Medical students and GP residents have to be taught that a positive consultations and 
communication style and a good doctor-patient relationship are therapeutic in itself and 




Dit proefschrift beschrijft (1) de zorg die patiënten met persisterende somatisch onvoldoende 
verklaarde lichamelijke klachten (SOLK) verwachten van hun huisarts, (2) de zorg die 
huisartsen leveren aan patiënten met persisterende SOLK en (3) de ervaringen van huisartsen 
met de zorg voor patiënten met persisterende SOLK. Vervolgens presenteren we 
uitgangspunten voor de behandeling en begeleiding van deze patiënten in de 
huisartsenpraktijk met als doel de zorg te verbeteren voor deze patiënten die vaak erg beperkt 
zijn in hun functioneren.
Hoofdstuk 1. Algemene inleiding.
In dit hoofdstuk beschrijven we de achtergronden, doelen en opbouw van dit proefschrift.
SOLK komen veel voor en meestal zijn deze klachten van voorbijgaande aard. Echter, een 
minderheid van de patiënten blijft de huisarts bezoeken met SOLK omdat de klachten 
aanhouden (i.e. persisterende SOLK). Deze minderheid vormt een groot probleem voor de 
g ezon d h eid szorg  om dat ze v eran tw o o rd e lijk  is voor hoge, vaak  onnod ige, 
gezondheidszorgkosten. Bovendien hebben deze patiënten vaak veel last van hun klachten en 
ondervinden ze beperkingen in hun dagelijks leven ten gevolge van de klachten. Consulten met 
deze patiënten in de huisartspraktijk verlopen vaak niet zonder problemen.
We beschrijven de reeds bestaande kennis over de problemen die ontstaan wanneer huisartsen 
en patiënten met persisterende SOLK elkaar ontmoeten in de dagelijkse praktijk. Daarnaast 
geven we aan waar meer kennis nodig is over de zorg die huisartsen leveren en de zorg die 
patiënten verwachten op het moment dat ze het spreekuur bezoeken met persisterende SOLK.
Patiënten met persisterende SOLK voelen vaak de scepsis van de verschillende dokters en 
hebben vaak het gevoel dat de huisarts de klachten niet serieus neemt. Ze zijn vaak ontevreden 
over de medische zorg die ze krijgen. Dokters vinden patiënten met persisterende SOLK vaak 
moeilijk te behandelen. Ze hebben de neiging te denken dat (1) deze patiënten de link tussen 
lichamelijke klachten en psychosociale problemen niet zien, en dat (2) de klachtpresentatie en de 
daadwerkelijke ziektelast niet met elkaar in overeenstemming zijn. Daarnaast voelen 
huisartsen zich vaak onder druk gezet om somatische interventies aan te bieden. Consulten 
tussen huisartsen en patiënten met SOLK lijken weinig patiëntgericht. Bovendien blijkt dat 
patiënten met SOLK helemaal geen druk uitoefenen voor het krijgen van somatische 
interventies, maar dat ze vooral emotionele ondersteuning van hun huisarts willen.
Het meeste onderzoek naar de moeizame interactie tussen huisartsen en patiënten met SOLK is 
niet specifiek gericht op patiënten met persisterende SOLK. Wanneer de klachten chronisch
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worden en patiënten het spreekuur van de huisarts blijven bezoeken met SOLK, moet de 
huisarts een manier vinden om deze patiënten te behandelen en te begeleiden om zo de 
gezondheid van deze patiënten te verbeteren.
De patiënt
Hoofdstuk 2. Chronisch functionele klachten: één syndroom?
Het doel van dit hoofdstuk is om, vanuit de Continue Morbiditeit Registratie (CMR), 
onderscheidende kenmerken van patiënten met persisterende SOLK te identificeren. De CMR 
database is het enige registratie systeem in de wereld dat structureel patiënten met 
persisterende SOLK in de huisartspraktijk registreert. De CMR classificeert persisterende SOLK 
als chronisch nerveus-functionele klachten. We includeerden 182 patiënten met persisterende 
SOLK en 182 controlepatiënten vanuit de CMR database en we verzamelden data over een 
periode van 10 jaar voorafgaand aan de diagnose betreffende comorbiditeit, verwijzingen, 
diagnostische testen, ziekenhuisopnames, medicatiegebruik en het aantal bezoeken aan de 
huisarts. We vonden dat gedurende de 10 jaar voor de diagnose persisterende SOLK patiënten 
onverklaarde klachten presenteerden in minstens twee delen van het lichaam en dat deze 
patiënten meer somatische medicatie en meer psychofarmaca gebruikten dan de patiënten 
zonder persisterende SOLK. Bovendien bezochten patiënten met persisterende SOLK hun 
huisarts twee keer zo vaak, hadden ze meer psychiatrische comorbiditeit en werden ze vaker 
verwezen naar de geestelijke gezondheidszorg en somatisch medisch specialisten. Het aantal 
patiënten dat een diagnostische test onderging was ook hoger. Ziekenhuisopnames waren 
gelijk. We concluderen dat patiënten met persisterende SOLK een grote diversiteit aan 
onverklaarde klachten presenteren, meer somatische medicatie en psychofarmaca gebruiken in 
de jaren voor de diagnose, dat ze vaker verwezen worden en meer psychiatrische aandoeningen 
hebben in vergelijking met controlepatiënten.
Hoofdstuk 3. Somatische onvoldoende verklaarde lichamelijke klachten, 
somatisatiestoornis en hypochondrie: beloop en prognose. Een systematische 
review.
In hoofdstuk 3 beschrijven we het beloop van SOLK, somatisatiestoornis en hypochondrie en 
hun prognostische factoren. We doorzochten de medische literatuur en selecteerden 
onderzoeken gericht op SOLK, somatisatie en hypochondrie en hun prognostische factoren. We 
voerden een best-evidence synthese uit om de resultaten te interpreteren. We konden zes 
onderzoeken naar SOLK, zes onderzoeken naar hypochondrie en één onderzoek naar de 
verkorte vorm van somatisatiestoornis (i.e. abridged somatisation) includeren en vonden dat 
ongeveer 50 tot 70 % van de patiënten met SOLK verbeterden en 10 tot 30 % van de patiënten met
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SOLK verslechterden. Bij patiënten met hypochondrie vonden we herstelpercentages van 30 tot 
50%. In de onderzoeken naar SOLK en hypochondrie vonden we enig bewijs dat het aantal 
klachten en de ernst van de klachten op baseline het beloop en de prognose beïnvloeden. 
Comorbiditeit van angst of depressie lijkt het beloop van hypochondrie niet te beïnvloeden. 
Onderzoeken naar de invloed van angst of depressie op het beloop van SOLK laten 
tegenstrijdige resultaten zien. We concluderen dat door het beperkt aantal onderzoeken en de 
grote heterogeniteit van die onderzoeken het onvoldoende mogelijk is om relevante 
prognostische factoren bij patiënten met persisterende SOLK te identificeren. Wel lijkt de ernst 
van de klachten op baseline geassocieerd met een slechter beloop.
Hoofdstuk 4. De arts-patiënt relatie volgens patiënten met persisterende SOLK. Een 
interview studie.
In hoofdstuk 4 onderzoeken we de verwachtingen die patiënten met persisterende SOLK 
hebben van de huisartsenzorg. We namen bij 17 patiënten met persisterende SOLK een semi- 
gestructureerd interview af om de meningen en opvattingen van deze patiënten boven tafel te 
krijgen. Alle patiënten benadrukten het belang van een persoonlijke langdurige arts-patiënt 
relatie. Patiënten gaven aan dat een dergelijke relatie gebaseerd is op de attitude, de medische 
competentie, de beschikbaarheid van de dokter en het hebben van een gedeelde 
verantwoordelijkheid. Patiënten willen serieus genomen worden door een huisarts die een niet- 
veroordelende open manier van communiceren gebruikt. Ze waarderen een nauwgezette 
uitdieping van hun klachten en een begrijpelijke uitleg. Bovendien willen ze een competente 
huisarts die gemakkelijk toegankelijk is en die hen betrekt als partners in het consult en het 
besluitvormingsproces. We concluderen dat patiënten met persisterende SOLK een 
patiëntgerichte communicatie waarderen waarbij ze een persoonlijke langdurige arts-patiënt 
relatie erg belangrijk vinden.
De dokter
Hoofdstuk 5. Uitleg en relatie. Hoe gaan huisartsen om met patiënten met 
persisterende SOLK: een focusgroep onderzoek.
Dit hoofdstuk belicht de meningen en opvattingen van huisartsen over de uitleg van de klachten 
aan patiënten met persisterende SOLK en hoe de relatie met deze patiënten zich ontwikkeld in 
de loop van de tijd. We gebruikten een kwalitatieve focusgroep benadering waarin we 22 
huisartsen verdeeld over 5 focusgroepen interviewden. Huisartsen geven aan dat ze het belang 
van een goede uitleg van de persisterende SOLK onderkennen, maar dat ze vaak grote moeite 
hebben met het geven van een dergelijke uitleg. Daarom proberen ze patiënten gerust te stellen 
op een niet-specifieke manier, bijvoorbeeld door te zeggen dat er geen ziekte is, door metaforen S
te gebruiken en door de klachten te normaliseren. Wanneer patiënten terug blijven komen bij de 
huisarts met persisterende SOLK, is het volgens huisartsen belang om de arts-patiënt relatie 
goed in stand te houden. Ze beschrijven drie verschillende modellen om dit te doen: (1) 
onderlinge alliantie gekenmerkt door zorgrituelen (zoals regelmatig lichamelijk onderzoek, 
regelmatig contact met de huisarts) met goedkeuring van zowel de patiënt als de dokter; (2) 
ambivalente alliantie gekenmerkt door zorgrituelen zonder dat de dokter deze eigenlijk 
goedkeurt; (3) non-alliantie gekenmerkt door het afkappen van alle consulten waarin klachten 
worden gepresenteerd zonder duidelijk lichamelijke oorzaak. We concluderen dat huisartsen 
moeilijkheden ervaren bij het uitleggen van de klachten en dat ze nauwgezet balanceren tussen 
het in stand houden van de arts-patiënt relatie en het voorkomen van de negatieve 
consequenties van onnodige interventies.
Het consult
Hoofdstuk 6. 'Ach dokter, het leven wordt nu eenmaal zo geleefd': het gebruik van 
hints in het consult.
In dit hoofdstuk beschrijven we een patiënt met onverklaarde hartkloppingen tijdens het 
stofzuigen. Tijdens een van de consulten gaf ze een belangrijke psychosociale hint die mijn 
perspectief op haar hartkloppingen veranderde en resulteerde in een beter begrip van haar 
klachten. Ik ondervond dat deze niet expliciete maar toch bijzondere opmerking behulpzaam 
was voor het verder uitdiepen van het verhaal van de patiënt. Dit resulteerde in een gezamenlijk 
begrip van de klachten, versterkte de therapeutische relatie en bevorderde het ziektebeloop. We 
concluderen dat het oppikken van hints in het consult de dokter kan helpen om de mening, 
opvattingen, verwachtingen en angst en zo het perspectief van de patiënt beter te begrijpen.
Hoofdstuk 7. Hoe praten patiënten en huisartsen over persisterende SOLK? Een 
kwalitatief onderzoek van video consulten.
Dit hoofdstuk beschrijft een explorerende, kwalitatieve analyse van 20 consulten opgenomen 
op videotape tussen huisartsen en patiënten met persisterende SOLK. Hierin belichten we de 
arts-patiënt communicatie en onderzoeken we op welke onderdelen in het consult patiënten en 
dokters zich richten. Patiënten blijken meerdere klachten te presenteren kris-kras door het 
consult heen. Huisartsen gebruiken echter nauwelijks gesprekstechnieken, zoals het bepalen 
van de agenda en samenvatten, om deze consulten te structureren. Patiënten met persisterende 
SOLK krijgen ruim de mogelijkheid om hun verhaal te vertellen. De reden van komst, hun 
ideeën en angsten worden echter niet structureel besproken. Meestal initiëren patiënten zelf een 
discussie over hun eigen ideeën, angsten en verwachtingen. De uitgebreide uitleg die huisartsen 
geven over de persisterende SOLK houdt vaak geen rekening met deze ideeën en angsten. We
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concluderen dat doordat patiënten meerdere klachten presenteren en huisartsen deze consulten 
niet actief structureren, consulten met patiënten met persisterende SOLK weinig gericht zijn op 
het structureel uitdiepen van de klachten, ideeën, opvattingen en verwachtingen van patiënten. 
Wel krijgen patiënten ruim de mogelijkheid om hun verhaal te vertellen. Patiënten met 
persisterende SOLK hebben waarschijnlijk baat bij gestructureerde consulten gericht op het 
uitdiepen van de reden van komst.
Uitgangspunten voor het verbeteren van de behandeling en begeleiding
Hoofdstuk 8. Meningen van experts over de behandeling en begeleiding van 
patiënten met SOLK in de huisartspraktijk. Een kwalitatieve analyse van reviews 
en editorials.
In dit hoofdstuk gaan we op zoek naar belangrijke en effectieve elementen in de behandeling en 
begeleiding van patiënten met SOLK in de huisartspraktijk. Daarvoor inventariseerden we de 
meningen van wetenschappelijke experts op het gebied van SOLK. We voerden een 
sy stem atisch e zoek actie  u it naar rev iew s (ov erz ich tsartik e len ) en ed itoria ls  
(hoofdredactionelen) in de medische literatuur. We controleerden onze bevindingen aan de 
hand van een focus groep interview met wetenschappelijke experts in Nederland. We 
includeerden 7 editorials en 23 reviews. Volgens de wetenschappelijke experts zijn de meest 
belangrijke elementen in de behandeling en begeleiding van patiënten met SOLK: het creëren 
van een veilige therapeutische omgeving; generieke interventies (zoals motiverend 
interviewen, het geven van een duidelijke uitleg, geruststelling en regelmatige 
vervolgconsulten); en specifieke interventies (zoals cognitieve behandelingen en 
farmacotherapie). In tegenstelling tot de meeste specifieke interventies beschrijven 
wetenschappelijke experts bijna nooit de kwantitatieve effecten van de generieke interventies, 
de arts-patiënt communicatie en de arts-patiënt relatie. Wetenschappelijke experts geven aan 
dat een meervoudige benadering waarin deze drie belangrijke elementen worden 
gecombineerd het beste helpt bij patiënten met SOLK. We concluderen dat, in tegenstelling tot 
de meeste specifieke interventies, de meningen en opvattingen van wetenschappelijke experts 
over generieke interventies en het creëren van een veilige therapeutische omgeving meer 
gebaseerd lijken te zijn op theorie en persoonlijke ervaring, dan op kwantitatief onderzoek. 
Onderzoeken die de effectiviteit van deze elementen in de behandeling en begeleiding van 
SOLK onderzoeken zijn schaars. Onderzoek en de dagelijkse praktijk moet zich meer richten op 
deze non-specifieke aspecten van het consult.
S
Hoofdstuk 9. Verklaringsmodellen van SOLK: een kwalitatieve analyse van de 
literatuur.
Dit hoofdstuk geeft een overzicht van de verklaringsmodellen voor SOLK beschreven in de 
medisch wetenschappelijke literatuur. Kennis van deze verklaringsmodellen kan behulpzaam 
zijn voor de dagelijkse praktijk van huisartsen. We verrichtten een systematische zoekactie in de 
medische literatuur en analyseerden de data kwalitatief volgens de principes van de constant 
vergelijkende analyse. We konden negen specifieke verklaringsmodellen voor SOLK 
identificeren in de literatuur: somatosensorische amplificatie, sensitisatie, overgevoeligheid, 
gevoeligheid van het immuunsysteem, endocriene dysregulatie, signaal-filter theorie, 
ziektegedrag model, dysfunctie van het autonoom zenuwstelsel en abnormale proprioceptie. 
De negen verschillende verklaringsmodellen zijn gericht op verschillende domeinen, te weten: 
lichamelijke oorzaken, perceptie, ziektegedrag en aanleg. We vonden ook een overkoepelend 
model die de vier domeinen incorporeert: het cognitieve gedragsmodel. We concluderen dat er 
meerdere verklaringsmodellen in de medische literatuur te vinden zijn die eventueel gebruikt 
kunnen worden in de dagelijkse praktijk.
Hoofdstuk 10. SOLK in de huisartsgeneeskunde: het definiëren van een 
onderzoeksagenda. Uitkomsten van WONCA 2007.
In dit hoofdstuk gaan we op zoek naar ontbrekende kennis op het gebied van SOLK om 
vervolgens prioriteiten in het SOLK onderzoek aan te geven. Dit deden we door 
wetenschappelijk experts op het gebied van SOLK uit meerdere landen bijeen te brengen en de 
stand van zaken van het wetenschappelijk onderzoek naar SOLK te bespreken. We gebruikten 
een nominale groepstechniek om onderzoeksonderwerpen en thema's te genereren en 
prioriteiten voor het SOLK onderzoek aan te brengen. Hieruit werd een onderzoeksagenda 
opgebouwd. De deelnemers bestonden uit 66 wetenschappelijk onderzoekers en huisartsen uit
29 verschillende landen. Zij gaven aan dat 'het formuleren van een breed gedragen en 
geaccepteerde definitie van SOLK', 'het vinden van een manier om SOLK in een eerder stadium 
te herkennen', 'het bestuderen van de waarde van zelf-management en empowerment bij 
patiënten met SOLK' en 'het vinden van voorspellers om te bepalen welke behandeling het 
meest effectief is bij de individuele patiënt met SOLK' de belangrijkste onderzoeksonderwerpen 
zijn. Ze gaven de hoogste prioriteit aan de volgende onderzoeksthema's: (i) therapeutische 
opties voor patiënten met SOLK en (ii) problemen in het consult met deze patiënten. We 
concluderen dat er meer onderzoek naar SOLK in de huisartsgeneeskunde nodig is om de 
consulten met en de behandeling en begeleiding van deze patiënten te verbeteren. Bovendien 
zijn internationale huisartsgeneeskundige congressen een uitstekende mogelijkheid om ideeën 
uit te wisselen en onderzoeksthema's te bespreken.
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Hoofdstuk 11. Algemene discussie.
Dit laatste hoofdstuk plaatst de resultaten van dit proefschrift in z'n perspectief, bespreekt 
enkele methodologische kwesties, geeft implicaties en aanbevelingen voor de behandeling en 
begeleiding van patiënten met persisterende SOLK en geeft suggesties voor verder onderzoek 
en de dagelijkse praktijk.
We concluderen dat (1) de meerderheid van de patiënten met SOLK een goede prognose heeft en 
dat het vaststellen van het aantal, de diversiteit en de ernst van de klachten tijden het eerste 
consult huisartsen kan helpen om het risico van persisteren van klachten in te schatten, (2) er een 
mismatch is tussen wat patiënten met persisterende SOLK willen en wat ze daadwerkelijk 
krijgen van hun huisarts, en (3) patiënten en huisartsen het eens zijn over het belang van een 
goede arts-patiënt relatie. Het uitdiepen van de ideeën, angsten en verwachtingen van de 
patiënt tezamen met het opbouwen van een positieve arts-patiënt relatie dragen bij aan het 
verbeteren van de zorg en haar uitkomsten voor patiënten met persisterende SOLK.
De belangrijkste aanbevelingen voor de dagelijkse praktijk zijn dat we ons moeten richten op de 
consultvoering, de klachten die de patiënt presenteert en de woorden die we gebruiken in deze 
consulten. Daarnaast moeten we ons richten op het creëren van een veilige therapeutische 
omgeving voortkomend uit een heldere en gerichte communicatie en een therapeutische arts- 
patiënt relatie.
De belangrijkste aanbevelingen voor toekomstig onderzoek is dat onderzoek naar SOLK zich 
moet richten op de communicatie en relatie tussen arts en patiënt, om zodoende te achterhalen 
welke non-specifieke aspecten van het consult de uitkomsten van deze consulten beïnvloeden. 
Daarnaast is er behoefte aan onderzoek naar welke manieren effectief zijn om klachten uit te 
leggen aan patiënten met persisterende SOLK.
We moeten medisch studenten en huisartsen in opleiding leren dat een positief consult, 
positieve communicatie en een goede arts-patiënt relatie therapeutisch in zichzelf zijn en 
daarmee een erg krachtig en belangrijk instrument om patiënten met persisterende SOLK te 





In 2002 begon ik met dit project. In 2011 dan uiteindelijk de afronding. Sommigen van u zullen 
wel denken, had dat niet wat sneller gekund? Ach ja, vast wel, zou mijn antwoord zijn, maar er 
zijn ook zoveel andere leuke dingen: de huisartsopleiding, redactielidmaatschap bij Huisarts en 
Wetenschap, internationale congressen en samenwerkingsverbanden, meeschrijven aan 
nationale (multidisciplinaire) richtlijnen, een eigen praktijk starten en opbouwen en natuurlijk 
de persoonlijke patiëntenzorg. En veel belangrijker nog: trouwen met mijn jeugdliefde, een huis 
kopen, twee prachtige zoons krijgen en een leuk sociaal leven met familie en vrienden. Werk en 
privé in een continu samenspel, en dat maakt de afronding van dit proefschrift ook zo mooi en 
bijzonder.
Voor een succesvol samenspel is natuurlijk de inzet van meerdere personen nodig. Zij krijgen 
dan ook een welverdiende plek in mijn dankwoord. Zo'n dankwoord is altijd gevaarlijk omdat 
ik natuurlijk mensen zal vergeten te noemen. Daarom wil ik bij deze alle mensen bedanken die 
hun steentje hebben bijgedragen aan al het leuks dat ik in de afgelopen 10 jaar heb mogen doen.
Peter Lucassen. Peter, jij bent de geestelijk vader van dit project, maar bovenal een goede vriend. 
Je hebt het project bedacht en uitgeschreven. Onze eerste kennismaking was in 2002 toen ik me 
meldde bij de toenmalige afdeling Huisartsgeneeskunde (HAG) van het UMC St. Radboud. Ik 
wilde mijn huisartsopleiding graag combineren met een onderzoek, het liefst een klinische trial, 
over een duidelijk somatische aandoening. En jij kwam met een kwalitatief onderzoek naar 
onverklaarde lichamelijke klachten! Hoe vaag en pseudowetenschappelijk wil je het hebben, 
dacht ik toen nog. Toch besloot ik, hoewel jij dat niet verwacht had, toe te happen. Achteraf de 
beste keus die ik had kunnen maken. Samen hebben we de ontdekkingreis door kwalitatief 
onderzoek en onverklaarde klachten ondernomen. Het was prachtig! Mede door de frequente 
koffiediscussies werd mij steeds helderder waar het echt om gaat bij patiënten met onverklaarde 
klachten en daarmee in de huisartsgeneeskunde. De persoonlijke zorg die jij aan je patiënten 
geeft, geef je ook aan je promovendi. Je bent een groot voorbeeld voor mij.
Chris van W eel. Beste Chris, ik ben enorm trots dat je mijn promotor bent. Hoewel je veel in het 
buitenland was, heb je mijn vorderingen in onderzoeksland van dichtbij gadegeslagen. Je vaak 
subtiele commentaren op mijn stukken waren heerlijk om te verwerken. De stukken werden er 
zienderogen beter van. Altijd had je oog voor de kern van het huisartsenvak die door moest 
klinken in wat ik schreef. Ik heb er graag gebruik van gemaakt. Net als van je formidabele 
internationale netwerk. Daar kreeg ik pas echt goed zicht op tijdens de WONCA World en de 
NAPCRG annual meeting in 2004 in Orlando, Florida. De manier waarop je mij gevraagd en 
ongevraagd voorstelde aan en in contact bracht met al die internationaal bekende
huisartsonderzoekers heb ik als een groot voorrecht ervaren. Ik raad alle jonge 
huisartsonderzoekers op de afdeling aan nu het nog kan, gretig gebruik te maken van je 
naamsbekendheid en enorme internationale netwerk.
Eric van Rijswijk. Eric, ik ben erg blij dat je mijn tweede copromotor bent. In de tijd dat ik begon 
op de afdeling was jij bezig met de afronding van je eigen proefschrift. Ondertussen heb je een 
geheel eigen onderzoekslijn palliatieve zorg opgebouwd. De enorme snelheid waarmee je dat 
doet vind ik bewonderenswaardig. Het samen stukken schrijven, medisch studenten 
begeleiden en natuurlijk de gezellige congresbezoeken maakten mijn promotietraject tot een 
feest.
Lieke Hassink-Franke. Onderzoeksmaatje! We begonnen ongeveer gelijktijdig met ons traject 
en zaten jaren op dezelfde kamer. In Orlando sliepen we zelfs op dezelfde kamer (schuld van 
Twanny!). Wat is het heerlijk om met iemand met zoveel positieve energie en enthousiasme te 
mogen samenwerken. We hebben onze ganggenoten vaak gestoord met ons harde gelach. En 
dat zal de komende tijd nog wel zo blijven, want we zullen de komende jaren samen de NMP-kar 
gaan trekken. Lieke, ik ben ontzettend blij dat je mijn paranimf wilt zijn.
Evelyn van W eel -  Baum garten. Beste Evelyn, samen met Peter, Eric en Lieke hebben we op 
menig internationaal congres ons GGZ gedachtegoed gepresenteerd en verder uitgewerkt. 
Presentaties, workshops, forums en posters, niets was je te gek. Veelal zat jij deze bijeenkomsten 
op een interactieve en levendige manier voor. Je onderwijsachtergrond kwam daar geweldig bij 
van pas. Door jouw Mental Health netwerk ontstonden er internationale samenwerkings­
verbanden en hebben we de GGZ onderzoekslijn internationaal op de kaart kunnen zetten. De 
aanwezigheid van Chris Dowrick in mijn manuscriptcommissie heb ik daarmee vooral aan jou 
te danken.
M ark van der W el. Mark, ik weet niet of je verwacht had dat ik je zo prominent in mijn 
dankwoord zou noemen. Toch doe ik het. De laatste jaren zijn we, tot mijn grote plezier, steeds 
intensiever gaan samenwerken. Je scherpzinnigheid, doorvragen en immer kritische blik 
dwingen me vaak tot nadenken. Onze trip naar Japan (we konden niet eens languit liggen in de 
business class), de hot tub op Vancouver Island (gelukkig hadden we bier en rendiersnacks) en 
de dance events tijdens de NAPCRG (wij sprongen het hoogst) waren hoogtepunten naast het 
harde werken wat we daar deden. Ik hoop, en ga er van uit, dat we nog veel meer zullen gaan 
samenwerken in de toekomst.
Huub M eijerink. Amice, vriend van het eerste uur, paranimf. We ontmoetten elkaar in de 
collegezaal in Rotterdam, september 1995, en zijn daarna samen opgetrokken in het medische
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wereldje. Van studie naar co-schap, van basisarts tot specialist, van Rotterdam naar Nijmegen, 
van doctorandus naar doctor. Hoe moet dat nou nu jij naar Heerenveen vertrekt om daar als 
orthopeed te gaan werken? Graag een huis met aanlegsteiger en een boot, dan komen wij wel 
logeren!
De huisartsgeneeskunde leer je niet vanuit boeken, leer je niet vanuit onderzoek, maar leer je 
eigenlijk alleen maar door het dagelijks in praktijk te brengen:
Huisartsopleiding Nijmegen (VOHA). Ben Bottema bedankt voor het faciliteren van mijn 
gecombineerde onderzoeks- en opleidingstraject. Rudy en Marijke Kleerekooper-Corsten, 
bedankt dat ik mijn eerste huisartsopleidingsjaar bij jullie in Elst heb mogen doen. De gezellige 
diensten zonder huisartsenpost (!) en met macaroni (van Leonard) in m'n haar zal ik niet snel 
vergeten. Jaap Schreuder, mijn derdejaars opleider in Malden, bedankt dat je mij een kijkje in de 
keuken van het lokale, regionale en landelijke bestuur van de huisartsgeneeskunde hebt 
gegeven. Destijds in de huisartsopleiding een ondergeschoven kindje, maar voor mij, dankzij 
j ou, een enorme aanvulling op mijn opleiding.
Huisartspraktijk M esker-Niesten. Jeanne en Pierre, bij jullie kwam ik als net afgestudeerde 
huisarts om als waarnemer ervaring op te doen. Eigenlijk heb ik bij jullie een vervolgopleiding in 
de kernwaarden van de huisartsgeneeskunde gekregen. Elke woensdag aan het eind van de 
middag een patiëntenbespreking met veel discussies over onverklaarde klachten, 
contextgeneeskunde en persoonlijke patiëntenzorg. Door de vier jaar die ik bij en met jullie heb 
gewerkt ben ik een andere en ik denk veel betere huisarts geworden. Ik vind jullie een groot 
voorbeeld voor de nieuwe generatie huisartsen.
H u isartsp rak tijk  O osterhout. Collega huisartsen Charles en Erna, Han en Inge, 
doktersassistentes Marije, Karin, Audry, Hanneke en Laura, praktijkondersteuners Dyan, Ada 
en Miep en financieel medewerker Lydia, wat een geweldig team hebben wij toch in Oosterhout. 
Een heerlijke werksfeer waar iedereen zichzelf kan zijn en waar veel wordt gelachen. Het is voor 
mij een groot voorrecht om deel uit te maken van dat team. Wat ben ik blij dat ik in Oosterhout 
terecht ben gekomen. Annemarie Uijen, jij bent de enige vrouw (naast Marjolein) met wie ik een 
contract heb. Ik ben ontzettend blij dat we samen onze praktijk en patiëntenzorg vorm kunnen 
geven. Je energie en spontaniteit werken erg aanstekelijk. Wat ben ik blij dat jij in Oosterhout 
terecht bent gekomen.
Patiënten en huisartsen. Op deze plek wil ik alle patiënten en huisartsen hartelijk bedanken die 
hebben meegewerkt aan dit onderzoek door deel te nemen aan de focus groep discussies, diepte 
interviews en video consulten. Zonder hen was er geen onderzoek en dus geen proefschrift.
Mijn speciale dank gaat uit naar de CMR artsen die hun praktijken openstelden voor mijn 
onderzoek naar patiënten met 1359-3.
Hoewel je de huisartsgeneeskunde niet leert vanuit onderzoek, denk ik wel dat ik een betere 
huisarts ben geworden door mijn onderzoek:
Coauteurs. Eloy van de Lisdonk, Hans Bor, Machteld Borghuis, Floris van de Laar, Anne 
Speckens, Juke Nijenhuis, Karel van Spaendonck, Sandra van Dulmen, Mieke Heijmans, Janine 
van Ravenzwaaij en Rhona Eveleigh bedankt voor de meer dan prettige samenwerking bij het 
opzetten, analyseren en schrijven van onze artikelen.
Chris Dowrick. Dear Chris, we met for the first time in the reggae pub in Universal Studios in 
Orlando, Florida. I was familiar with your name from your research papers on MUS. Together 
with T ony Kendrick, Saskia Zandstra, Lieke Hassink-Franke and Peter Lucassen we danced the 
whole night and drunk lots of beer. After that event we met on almost all WON CA and N APCRG 
meetings. Our collaboration in the workshops, forums and papers was great. Your view on MUS 
and mental health was of great importance for my thesis. Thank you for participating in the 
assessment of my thesis. I hope we can work with you and your department even more closely in 
the near future.
Oud redactieleden H&W. Als jonge huisartsonderzoeker trad ik toe tot de redactie van Huisarts 
en Wetenschap, de leukste commissie in huisartsenland die er bestaat. Ik heb ontzettend veel 
van jullie geleerd: van het schrijven van stukken tot het netjes opstellen van herschrijfbrieven, 
van kritisch lezen tot het eten van kledderige broodjes. Joost Zaat, bedankt voor je kundige en 
kritische begeleiding tijdens deze periode. Jij hebt me leren schrijven. Ik vind het een grote eer 
dat je vandaag plaats neemt in mijn corona.
M arjolein Berger. Bij jou deed ik mijn eerste onderzoekservaring op tijdens mijn 
afstudeeronderzoek op de afdeling huisartsgeneeskunde in Rotterdam. Jij liet me zien hoe leuk 
en intrigerend, maar ook hoe ingewikkeld het doen van onderzoek is. Toen Peter met z'n idee 
over kwalitatief onderzoek bij onverklaarde klachten kwam, adviseerde jij mij om die uitdaging 
aan te gaan. Met Peter als begeleider zou het immers altijd goed komen, zo verzekerde jij mij. 
Marjolein, dat was het beste advies dat je me kon geven. Ik ben daarom ook ontzettend trots dat 
je als kersverse hoogleraar huisartsgeneeskunde zitting hebt in mijn corona.
Richtlijncom m issies. Henriette van der Horst, Ingrid Arnold en Nettie Blankenstein, ik heb 
zelden drie zo daadkrachtige dames gezien die het huisartsgeneeskundige gedachtegoed tot op 
het bot verdedigen en uitdragen. Ik heb genoten van de scherpe discussies tijdens de
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multidisciplinaire richtlijn vergaderingen en de NHG standaarden werkgroep over SOLK. 
Maar bovenal zijn jullie gewoon drie heel plezierige mensen om mee samen te werken.
Secretariaat ELG. Twanny Jeijsman, Caroline Roos en Tilly Pouwels, jullie zijn de ruggengraat 
van de onderzoeksafdeling ELG. Het secretariaat is altijd een heerlijke plek om even bij te 
kletsen, uit te blazen of praktische zaken te regelen. Ik ben altijd weer verbaasd over jullie 
enthousiasme en snelheid. Ontzettend bedankt voor alles.
Kamergenoten. Vorig jaar moest er plots verhuisd worden. Maakten Lieke en ik dan zoveel 
lawaai? Met twee psychiaters in opleiding, Hiske van Ravesteijn en Inge van Dijk, kreeg de 
kamer een extra dimensie. En de gezelligheid was gewaarborgd. Lea Peters, onze 
onderzoeksassistente, jij bent echt van alle markten thuis. In je vakantie bedacht je dat mijn 
proefschrift een QR-code moest hebben. Briljant idee! Daarnaast ben jij de continuïteit van zorg 
(hoe huisartsgeneeskundig is dat!) op onze kamer. Je attente houding en aandacht voor iedereen 
op de kamer en de gang is de smeerolie voor onze fijne samenwerking.
Persoonlijke patiëntenzorg als huisarts en drukke academische bezigheden als huisarts- 
onderzoeker zijn eigenlijk alleen maar mogelijk vanuit een stevig fundament van vrienden, 
buren, familie en thuisfront:
Vrienden. Het zijn er teveel om allemaal persoonlijk bij naam te noemen. Met een 
kam eradengroep uit Tubbergen (nog vanuit m ijn m iddelbare schooltijd ), een 
vriendinnengroep uit Enter (vanuit de middelbare schooltijd van Marjolein) en een 
vriendenkring uit Nijmegen (opgebouwd sinds we in Nijmegen zijn komen wonen) voel ik met 
schatrijk. Door alle kinderen die er de afgelopen jaren zijn geboren is ons aantal bijna 
verdubbeld. Ons huis wordt zo langzamerhand te klein voor het vieren van de verjaardagen. 
Bedankt voor alle gezelligheid!
In heb bijzonder wil ik op deze plaats Joost Perik bedanken. Gekscherend heb ik al eens 
geroepen dat ik je net zo goed in dienst kon nemen. Joost, jij hebt de hele lay-out en ontwerp van 
mijn proefschrift vorm gegeven. Deze fantastische vormgeving komt volledig op jouw conto. 
Onwijs bedankt!
Buren. Buren van de Vossenlaan, we zeggen zo vaak, beter een goede buur dan een verre vriend ! 
En zo is het ook echt. Wat is het toch heerlijk om in zo'n fijn buurtje te wonen. Even een praatje, 
even een kop koffie, even een voetbalwedstrijd (fijn te merken dat FC Twente ook in jullie hart 
een warm plekje heeft gekregen) en ondertussen de nodige biertjes en wijntjes. Ik geniet elke dag 
van jullie fijne betrokkenheid bij ons gezin.
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Familie. Coen mijn tweelingbroer (en natuurlijk Anne Marije), Frank mijn kleine broertje (en 
natuurlijk Martine), niemand van ons is in Tubbergen gebleven. We zijn alle drie een andere 
richting op gegaan. Amstelveen, Utrecht en Nijmegen. Chartaal geld, pensioenen en 
geneeskunde. En eigenlijk maakt dat onze band alleen maar sterker. Dank, dat jullie er altijd 
gewoon zijn.
Schoonzus Annemarie, ik ken je al vanaf je 10de jaar. Zo oud was je toen ik voor het eerst bij jullie 
over de vloer kwam. Inmiddels zijn er vele jaren verstreken, maar je bent nog steeds m'n kleine 
schoonzusje. Je altij d goede humeur en gezelligheid maken je frequente bezoekjes aan Nijmegen 
altijd erg speciaal.
Ben en Hermien Hofsté, jullie gastvrijheid in Almelo heb ik altijd als iets heel bijzonders ervaren. 
In mijn studententijd stond er vrijdagavond altijd een bord eten en gezelligheid op me te 
wachten. De ritjes naar Tubbergen en naar de trein waren jullie nooit teveel. Jullie oprechte 
interesse in wat ik daar toch allemaal op de universiteit aan het doen was, heeft me altijd veel 
goed gedaan.
Pa en ma, veel van wat ik heb bereikt heb ik aan jullie te danken. Jullie lieten me studeren, 
stimuleerden me om buiten Twente te kijken (achter Almelo wordt immers ook brood 
gebakken) en lieten me vrij in de keuzes die ik maakte. Resultaat is wel dat jullie nu een eind 
moeten rijden om de kleinkinderen te zien opgroeien. Mede door jullie steun en vertrouwen sta 
ik vanmiddag hier mijn proefschrift te verdedigen en heb ik me kunnen ontwikkelen tot degene 
die ik nu ben. Bedankt dat jullie steeds voor ons klaar staan!
H et thuisfront. Lieve Marjolein, wat begon met brommers kiek'n aan de Benninksweg in 
Reutum (bie Bais) duurt nog altijd voort. Ik ben blij dat ik bij alle belangrijke stappen en keuzes in 
ons leven kan terugvallen op jou. Door je evenwichtigheid, mensenkennis en altijd goede 
humeur kunnen we samen de hele wereld aan. Bedankt voor je ongelofelijke grote steun, 
vertrouwen en liefde. Op naar een geweldige toekomst sam en........
Lieve Jop en Guus, in jullie kleine leventjes zijn jullie vooral bezig met eten, spelen en slapen. 
Later als jullie groot zijn zal ik jullie alles vertellen over deze mooie dag. Jullie vrolijke lach en 
gebrabbel maakt mijn leven compleet.
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Chronic functional somatic symptoms: an international GP perspective.
Olde Hartman TC, Lucassen P, van Rijswijk E.
Workshop.
European Organization o f  National Colleges, Academies and Academic Associations o f General Practitioners/Family Physicians 
(Wonca Europe2006), Florence (Italy).
Medically Unexplained Symptoms in primary care: the state of the art.
Olde Hartman TC, Lucassen PLBJ, van Weel-Baumgarten E, Franke LJA.
Symposium.
European Organization o f  National Colleges, Academies and Academic Associations o f General Practitioners/Family Physicians 
(Wonca W orld2007), Singapore
Medically Unexplained Symptoms in primary care: where should we go.
Olde Hartman TC, Lucassen PLBJ, van Weel-Baumgarten E, Franke LJA.
Workshop.
European Organization o f  National Colleges, Academies and Academic Associations o f General Practitioners/Family Physicians 
(Wonca World 2007), Singapore
Medically unexplained symptoms, somatization and hypochondriasis: course and prognosis. A systematic review.
Olde Hartman TC, Borghuis M, van de Laar F, Lucassen PLBJ, Speckens AE, van Weel C. Poster presentation.
North American Primary Care Research Group (NAPCRG), annual meeting 2007, Vancouver (Canada)
[Mental health problems and the presentation of minor illnesses]. Kleine kwalen bij patiënten met een depressie of 
chronisch onverklaarde lichamelijke klachten.
Olde Hartman TC, van Rijswijk E, Franke LJA, Bor H, van Weel-Baumgarten EM, Lucassen PLBJ.
Oral presentation
Jubileumsymposium CMR NMP 'omzien en vooruitkijken', UMC St. Radboud 2007, Nijmegen (The Netherlands)
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Problematic communication with patients with medically unexplained symptoms.
Olde Hartman TC , van Rijswijk E, van Dulmen S, Lucassen P, Schellevis F, van Weel C. Poster presentation.
North American Primary Care Research Group (NAPCRG), annual meeting 2008, Puerto Rico (USA)
Medically unexplained symptoms (MUS) in family medicine: towards consensus on the management of MUS.
Olde Hartman TC, Dowrick C, van Weel-Baumgarten E, Lucassen P, van Ravesteijn H, Rask M, Rosendal M, Olesen F, 
Fortes S.
Workshop.
World Organization o f  National Colleges, Academies and Academic Associations o f  General Practitioners/Family Physicians (Wonca 
W orld2010), Cancun (Mexico)
Medically unexplained symptoms (MUS) in family medicine: the state of the art.
Olde Hartman TC, Dowrick C, van Weel-Baumgarten E, Lucassen P, van Ravesteijn H, Rask M, Rosendal M, Olesen F, 
Fortes S.
Symposium.
European Organization o f  National Colleges, Academies and Academic Associations o f General Practitioners/Family Physicians 
(Wonca World 2010), Cancun (Mexico)
Combining residency and research
[Scientific publishing for GP registrars]. Wetenschappelijk publiceren voor huisartsen-in-opleiding 
Olde Hartman TC, Zaat JOM.
Cursus (in cooperation with language institute Vrije Universiteit Amsterdam).
Nederlands Huisarts Genootschap 2005, Utrecht (The Netherlands)
AIOTHO's: bedreigde diersoort of succesverhaal. 
olde Hartman TC, Licht-Strunk E, Schellinghout J.
Workshop.
NHG wetenschapsdag2008, Rotterdam (TheNetherlands)
Combining FP residency and PhD programs, the start of future international initiatives.
olde Hartman TC, Miedema B, Kendrick T, Bell Brown J, Falloon K, Goodyear-Smith F, Gunn J, Dowrick C, Aroll B, Licht­
Strunk E, van Weel C.
Breakfast meeting.
North American Primary Care Research Group (NAPCRG), annual meeting 2008, Puerto Rico (USA)
Combining vocational and research training. 
olde Hartman T C .
Oral presentation.
LOVAH congres 2009, Utrecht (The Netherlands)
Combining vocational and research training in primary care. 
van der Wel M, olde H artman TC, Rosser W, van Weel C. W orksho p.
Workshop.
European Organization o f  National Colleges, Academies and Academic Associations o f General Practitioners/Family Physicians 
(Wonca Europe 2009), Basel (Switzerland)
Combining vocational and research training: Building research capacity and leadership in primary care.
olde H artman TC, van der Wel M, Falloon K, van Weel C, Kendrick T, Belle Brown J, Aroll B, Dowrick C, Miedema B, G unn J .
Forum.
North American Primary Care Research Group (NAPCRG), annual meeting 2009, Montreal (Canada)
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Research -  what is research and how do I get started?
Harris N, olde Hartman T C .
Workshop.
World Organization o f  National Colleges, Academies and Academic Associations o f  General Practitioners/Family Physicians (Wonca 
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